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This study explores the experiences of patients being considered for colorectal liver resection 
combined with the views of health professionals involved in this pathway with the sole intention of 
developing a supportive model of care for future patients. 
The treatment of colorectal liver metastases (CRLM) has continued to evolve with promising pace 
(Stintzig 2018, Adam & Kitano 2019). For many patients, multimodal treatment including surgery and 
systemic anti-cancer therapy have created a paradigm shift in how a diagnosis of secondary colorectal 
liver disease is viewed. With this in mind, there is a necessity to develop patient services to be 
responsive to the needs of those living longer with secondary cancer (Kmietowicz 2015), particularly 
as issues of survivorship begin to emerge (Haggstrom & Cheung 2019). More than 50% of patients with 
colorectal cancer will develop CRLM at some point in their disease trajectory (Chow & Chok 2019), 
making the prospect of radical treatments certainly attractive. Yet, only 20-30% people with CRLM will 
be eligible for surgery (Manfredi et al 2006, Valderrama-Treviño et al 2017) and as such, issues of 
uncertainty can punctuate the pathway to potential surgery and beyond. Observationally, working as 
a nurse specialist within the multidisciplinary colorectal cancer team, it is evident that the pathway to 
liver resection can be especially demanding for patients, as patients hold in tension the knowledge 
that their cancer has metastasised with the hope for containment or even cure. However, there is little 
evidence from the literature to support such observations or how the needs of these patients can best 
be met.  
In order to address unanswered questions regarding support, this study is primarily a 
phenomenological inquiry, staged around the examination of an existing pathway in Phase 1 of the 
study. In response to this phase, an interim period allowed for the development of a new support 
structure, led by the specialist nursing team, incorporating a systematic telephone model, 
development of a patient literature series and development of a patient buddy service. Phase 2 of the 
study allowed for evaluation of this service development.  Both phases include qualitative data from 
interviews with patients who had been considered for CRLM as well as focus group data from health 
professionals involved with the pathway.  
The study is influenced by hermeneutic phenomenology as developed by the twentieth century 
philosopher, Hans-Georg Gadamer (1960, 1996), in order to guide both method and meaning 
throughout the progress of the work detailed in the thesis. It draws on the tenets of Gadamer’s ‘fusion 
of horizons’ (1960) as a fitting vantage point incorporating different viewpoints and my own having 
insider-outsider knowledge as the researcher. It also latterly brings in the relevance of Frank’s illness 
narrative (1995). Three overarching themes were identified from Phase 1 which were embedded in 
the pathway and specific aspects were used to develop the support model; 
- a path of expectation; an enduring horizon 
- the companion of uncertainty; a unified horizon 
- a journey of personal understanding; an individual horizon 
 
Moreover, complete analysis from both sets of data uncovered a central strand in these unique and 
differing patient experiences which translated these experiences into stories of hope. Hope was the 
mechanism used throughout the pathway and expectation, uncertainty and understanding were 
components of that hope. This calls into question how we, as health professionals, view hope in 







The management of bowel cancer continues to develop with increasing options for treating 
cancer that has spread (metastasised) to the liver. The use of liver resection (surgical removal 
of part of the liver) can be used to treat and in some cases cure bowel cancer that has 
metastasised to the liver. The liver is the most common site for bowel cancer to spread to 
and approximately 30% of people, with such spread, will be eligible for surgical resection. 
Yet, the process of workup to this surgery can be challenging for patients and their families 
as the route to surgery is full of uncertainty. This study uses a research approach, named 
hermeneutic phenomenology, to understand more about the experiences of patients who 
are being considered for colorectal liver resection. The research also explores the views and 
experiences of health professionals. The researcher’s position with insider knowledge of the 
care also has a bearing on the study to help with interpretation of the findings. The overall 
goal of the research is to enhance and improve the services for, and experiences of, future 
patients.  
 
The study was conducted in 2 phases. Phase 1 involved the interviewing of 16 patients who 
had been considered for the liver resection described above, 12 of whom proceeded to liver 
resection, and 4 who did not. A focus group was also conducted with health care 
professionals involved in the management of patients with potentially operable liver 
metastases.  The findings from the interviews and focus group were reviewed during an 
interim period, allowing for a new support pathway to be established. This involved a 
telephone support service run by the specialist nursing team, the development of a leaflet 
series and the setting up of a patient ‘buddy’ service. Phase 2 of the study involved evaluating 
the new service by the interviewing of a further 16 patients and conducting a second health 
professional focus group. The overall analysis showed that these experiences could be seen 
as stories of hope involving expectation, uncertainty and understanding. Health professionals 
have a valuable role to play in facilitating patient hope amidst uncertainty and in providing a 












Through a patient’s eyes… 
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“So far down the track now” 
“We cannot understand without wanting to understand, that is, without 
wanting to let something be said...Understanding does not occur when 
we try to intercept what someone wants to say to us by claiming we 
already know it.”  (Gadamer 1964, p.101-102) 
1.1 Chapter overview: Using unease  
Most research is borne out of a sense of being ill at ease, a feeling that something is lacking 
or could be improved but so far the evidence remains insufficient to support that feeling. The 
catalyst for the work presented in this thesis is no different. It emanated from a feeling of 
being uneasy with the status quo around the support in the pathway for those being 
considered for surgical resection of colorectal liver metastases (CRLM).  More than 50% of 
patients with colorectal cancer will develop CRLM, (García-Alfonso et al 2015). Surgery 
remains the only treatment to remove disease and improve survival (Choong & Ammori 
2014, Chow & Chok 2019) although approximately only 20-30% people with CRLM will be 
eligible for surgery (Manfredi et al 2006, Valderrama-Treviño et al 2017).  Developments in 
diagnostic radiology, surgery, and oncology have helped to maximise the number of patients 
being offered surgical liver resection (Venook & Curley 2019). These developments have also 
given way to a more encouraging picture of the treatment of CRLM and this has helped to 
deepen the overall understanding of what it means to live with colorectal liver metastases.  
This study is primarily a phenomenological inquiry, staged around the examination of an 
existing pathway and a revised pathway of support. The study is influenced by hermeneutic 
phenomenology as developed by the twentieth century philosopher, Hans-Georg Gadamer 
(1900-2002), in order to guide both method and meaning throughout the progress of the 
work detailed in the thesis. 
While working within the colorectal multidisciplinary team, my and many of my colleagues’ 
observations, regarding the CRLM pathway led to a feeling of dissatisfaction with the current 
support situation. Yet, my initial concern was that my vantage point of the CRLM pathway 
was more than that of purely observer. The position was one of observer yet with insider 
knowledge of how the pathway functioned and the resulting effect that both awareness of 
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metastatic disease and the process of that pathway could throw into the lives of those 
experiencing it first-hand.  From this position as both observer and insider, it was evident 
that advances in medicine have created new possibilities for extending life while at the same 
time, creating new challenges in communicating what is right as well as what is possible. I 
could clearly identify with Atul Gawande and his sentiments expressed in ‘Being Mortal’, 
writing,   
“People live longer and better than at any other time in history. But 
scientific advances have turned the process of aging and dying into 
medical experiences, matters to be managed by health care 
professionals. And we in the medical world have proved alarmingly 
unprepared for it.” (Gawande, 2014a, p.6)  
An overall tension was apparent in situations borne out with patients holding onto the 
possibility of liver resection for CRLM and finally achieving that as a reality. These tensions 
were, from my perspective, exemplified at the outset in this pathway and throughout the 
process of being considered for liver resection. I wondered in all the virtue of advances, were 
we somehow implicitly asking patients to get on and live with a palpable sense of uncertainty, 
whilst being guilty of ‘leaving them to it’ and not fully realising how much through medical 
advances and our associated hospital systems we were asking of patients. Being immersed 
in the daily challenges of a varied practice, while ironically feeling like we were ‘doing our 
job’, could also blind us from any of real sense of what patients experienced.  
What was not clear was, if these feelings of unease were also the experience of the patients 
on the receiving side of being considered for surgery, surgery that had the potential to either 
remove metastatic disease in their liver or potentially extend their life. For this reason, I 
wanted to utilise that feeling of unease I experienced as a nurse specialist working within the 
colorectal multidisciplinary team with as a catalyst for further inquiry. This was married up 
with a desire not just to inquire, but also to improve or enhance the existing pathway.  What 
follows in this thesis is the experiential account of a total of thirty-two patients who were 
considered for CRLM, sixteen prior to introducing a revised support pathway and sixteen 
following revision of that pathway. It also includes accounts of multidisciplinary members of 
the colorectal cancer team who were involved with major treatment decisions in this 
pathway, captured in two focus groups. A grant with a pragmatic service improvement focus 
was secured to undertake this work. The primary aim of this study is to investigate how 
primarily patients and health care professionals experience the pathway to CRLM before 
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(Phase 1) and after a service improvement to that pathway (Phase 2). The service 
improvement is based upon the analysis of interviews and the focus group in Phase 1. A 
secondary aim is to assess whether additional support interventions can add benefit to the 
experience of being considered for CRLM surgery.   
 
1.2 Merging perspectives 
 
The last decade has given rise to the inclusion of patient viewpoints not only as a way of 
measuring performance quality and care outcomes but also as recognising the person as an 
individual at the centre of care (Raleigh et al 2015). Bate & Robert (2006) saw this inclusion 
of the patient viewpoint stemming from the turn of the millennium with a particular focus in 
service improvement incorporating the voice of the user. The white paper, ‘Creating a 
patient-led NHS: Delivering the NHS Improvement Plan’, (Department of Health, (DH), 2005) 
made direct reference to eliciting patient preferences and experiences and utilising patient 
involvement as a means to delivering the NHS Improvement Plan set out in 2004, (DH 2004). 
Yet, Bate & Robert (2006) recognised that much of this renewed focus on patient 
involvement had been around for a long time and “unfortunately what it gains in longevity, 
it seems to lack in vitality and urgency’” (p.307). What was often masking as experience was 
not really in-depth experience from the patient’s account of using a service or of living with 
an illness but more of a fleeting capture of involvement in a world of survey culture and 
stakeholder events.  
Moreover, this renewed inclusion and preoccupation with patient perspective, continued to 
gather momentum and evidenced itself further in a number of government reviews and 
policies recommending the need to review services by including measures of patient 
experience.  These have included, the Darzi review (DH 2007), the NHS Outcomes Framework 
(DH 2014a) and the NHS Mandate (DH 2014b). Sadly, it has also included the report on the 
service failure at mid Staffordshire NHS Foundation Trust, commonly known as the Francis 
Inquiry (Mid Staffordshire NHS Foundation Trust Public Inquiry 2013). In this case, national 
and worldwide lessons have been learned in the way services are provided when there is a 
failure to put the patient and relevant others at the centre of care received. Extending out 
from patient and user perspective in health services is also a recognition that patient 
experience has a vital role to play in guiding research design (Boote et al 2013, Baxter et al 
2016), such as that advocated through the role of the INVOLVE network, run by The National 
Institute of Health Research (NIHR) (NIHR 2017).  
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Bate & Robert (2006) strongly advocate experience-based design in health care which did 
more than focus on quality, effectiveness and safety. Having undertaken previous service 
development research, I had been attracted to this more holistic mindset, one in which as 
Bate & Robert promoted, the system was co-designed with the patient rather than 
redesigned around the patient. Bate & Robert distinguish between using experience rather 
than attitudes in research. The focus here ought to be on asking questions which elicit details 
of what the experience was like beyond the what was good and what was bad, which often 
only captures attitudes. Going beyond the surface of experience lends itself well to the 
process of phenomenological inquiry, where deeper elements of hidden meaning could also 
be discovered and attributed to processes at work in the CRLM pathway and how this might 
affect the lives of individuals. It is that knowledge of the experience that holds a sense of 
richness. It is not necessarily bound to any prior expertise and as such represents an unique 
angle.   
“Knowledge of the experience, held only by the patient, is unique and 
precious.” (Bate & Robert 2006, p.307)  
While recognition of the uniqueness of patient experience is rightly justified and is able to 
lend itself to many uses, my concern in obtaining patient experience alone is that the voice 
and insight of the health professional often seems disregarded and undervalued. Where 
there is appeal in patient co-design of services, what is debatable in the terms expressed by 
Bate & Roberts, is the idea that patients can input their perspectives and experiences on level 
terms with health professionals. My understanding is that is less to do with the weight and 
equality of experience offered by both but more to do about validating both experiences. 
What health professionals may lack in richness of personal experience they may make up for 
in observation and involvement of patient experiences over time, combined with an 
understanding of particular nuances of existing processes operating within given systems.  
 
For this reason, I was attracted to the concept as expressed in the Gadamerian metaphor 
named the ‘Fusion of Horizons’ conveyed in Hans-Georg Gadamer’s magnum opus, ‘Truth 
and Method’ which was written in his native language of German in 1960. It is important to 
note that I have not read the original due to my unfamiliarity with German, but that unless 
otherwise specified, I have used the 2013 English translation, revised by Weinsheimer & 
Marshall (Gadamer 2013). Through the concept of fused horizons, different interpretations 
of the experienced phenomenon are brought together through language to produce a shared 
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understanding of the experience of a given phenomenon (McManus Holroyd 2007), in this 
sense the CRLM pathway. The fusion of horizons could be a historical past position with a 
current horizon of the present or through merging different perspectives where there is a 
fusion of the familiar with the less familiar, a bridging in a gap of knowledge.   Using this 
concept had immense value to me in this work because as I saw it, there was a fusion of 
horizons, on a number of levels. The first was the fusion between participant and self as 
researcher in order to bring about meaning between the dialogue in interviews and the focus 
group. The opening quotation of this chapter, from an essay written by Gadamer in 
‘Aesthetics and Hermeneutics’ in 1964, highlights that we cannot understand if we assume 
that we know already. Language is the means through which these experiences are 
communicated and interpretation of this dialogue takes place through examination of 
language in the real time of interviews and in the transcripted text which reflects a concept 
central in Gadamer’s hermeneutic phenomenology (Kafle 2013). These experiences often 
span many months and in some cases years, consuming a significant part of that individual’s 
life cycle.  I could therefore appreciate that these experiences were stories told from the 
starting point and wrapped up with the time of diagnosis when patients viewed their sense 
of health to have changed.   
 
The second was the fusion of the experiences of the patients and health professionals, taking 
place in the standard pathway and the enhanced pathway. The third was the fusion required 
to utilise the findings from the standard pathway and work alongside colleagues to deliver a 
service change. The fourth but perhaps not exhaustive plane of fusion, was that as an insider 
with prior knowledge of the CRLM pathway, I had to be aware of my pre-existing a priori 
experience gained from working within the team while at the same time realising that I could 
not entirely separate or bracket that knowledge out as if I was a blank slate, as favoured by 
advocates of Husserlian phenomenology (Dowling 2007).   It was at this point that the insider-
outsider role of researcher merged. These different levels of fusion, each operated their own 
hermeneutical circle or circle of interpretation in order to work through the process of giving 
meaning to the text and shape for service improvement.  As the process of finding meaning 
is iterative in nature involving a cyclical nature of induction, this is also true of the changing 
picture of a more aggressive treatment approach in colorectal metastatic disease. It is worth 
acknowledging, that this study is set within a rapidly developing treatment picture for 
secondary disease, something of which represents a new kind of understanding of metastatic 
disease and a new way of viewing these stories in the context of survivorship. 
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1.3 Developing a new concept of metastatic disease  
The title of this chapter ‘So far down the track, now”, is taken from an interview conducted 
with a female participant who was interviewed in the first phase of patient interviews and 
was considered for liver surgery.  Sadly, her disease progressed and liver resection became 
no longer feasible yet her quotation speaks into the present. The word ‘now’ can be seen to 
be connected with Heidegger’s Daesin sense of being and “actuality in time” for this 
individual from his major work, ‘Being and Time’ in 1927 (Heidegger 2010, p.408). Here time 
takes on a personification element for this individual.  It echoes the sense of anticipation, 
restlessness and hopefulness with the process of being considered for liver surgery, hinting 
at the idea of hurdles to be overcome which might have led to the goal of surgery.  Time is 
hugely relevant and it is also pertinent to the idea that significant advances have been made 
in cancer treatment as a whole, which have given reason to hope.  
Cancer treatment as a whole has come a considerable way since Sidney Farber’s studies on 
the effects of folic acid and the resultant developments made in treating childhood acute 
lymphoblastic leukaemia in the late 1940s, which led to Sidney Farber being heralded as the 
father of modern day chemotherapy (Miller 2006).  The last six decades in particular have 
seen considerable change with a particular focus on multi-modality treatment and with the 
emergence of newer targeted therapies on the pharmaceutical market (Binefa et al 2014, 
García-Alfonso et al 2015, Aziz et al 2017). As such the developed world has seen a major 
paradigm shift in the way in which in which cancer is treated. Improvements in sanitation, 
introduction of vaccination of infectious diseases and the establishment of formalised health 
care have all helped to play a part. Whereas fifty years ago, the main cause of death was 
infection (McKie 2015), now heart disease and cancer are major killers (Vineis & Wild 2013) 
with 1 in 4 expected to die of cancer and 1 in 2 who will develop cancer in a lifetime (Cancer 
Research UK 2017).  Yet in common cancers, such as breast, colorectal and prostate, huge 
advances have given way to greater survival benefit. This is now an emerging picture for the 
management of metastatic disease, particularly in breast cancer and now gaining ground in 
colorectal.  
The management of metastatic colorectal cancer is rapidly evolving.   Over the last decade 
advancements in tumour staging, surgical technique and systemic chemotherapy (Pozzo et 
al 2008, Abdalla 2011, Haddad et al 2011) have pushed the boundaries of what was 
previously deemed palliative, to that of potentially curable disease.  With no treatment a 
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median survival of 6-9 months would be expected but combined hepatic resection and 
chemotherapy has pushed a 5-year survival reported between 37-58% (Van Cutsem et al 
2010, Morris et al 2010). Notably the majority of ground has been gained in CRLM resection 
but advances have also been seen in colorectal lung metastases resection and in the use of 
sequential resection for colorectal liver and lung metastases combined (Rajakannu 2015). In 
addition the use of targeted therapies in combination with pelvic clearance surgery has also 
seen a more aggressive approach in the management of colorectal peritoneal disease ( März 
& Piso 2015). Overall this has led to a more promising picture in the management of 
colorectal metastases and has set the management within the context of the survivorship 
agenda and living with the presence of metastatic disease.  While this is exciting, it is clearly 
not the uplifting treatment picture that is evident to us in practice which may be complicated 
further by disease staging or existing co-morbidities.   
As disease management becomes more complex, so too does communicating the treatment 
pathway.  On the one hand, life expectancy is longer which is giving way to a much fitter 
population in their seventh decade but how long at what resultant physical and economic 
cost can aggressive management of metastatic disease realistically take place?  This brings 
into focus questions over the difficulty of practising realistic medicine as advocated by the 
Chief Medical Officer, Dr Catherine Calderwood, as valuable as that intent might be (The 
Scottish Government, 2016).  This is simply because medical advances do not apply or bring 
benefit to all which brings us back to the often hidden and stark sentiments expressed by 
Gawande (2014b) that life is both unique and mortal. Attributing meaning to such major 
times in life when mortality may be more keenly felt, such as the potential to undergo liver 
resection for colorectal metastases, becomes more pertinent to understand. 
1.4 Finding method, finding meaning 
 
As outlined in this chapter, the methodology adopted in this thesis is a hermeneutical 
phenomenological inquiry predominantly around the patient’s experience of being 
considered for a CRLM resection with reference to the health professional’s experience of 
that pathway. The study is conducted in two phases. Phase 1 involves evaluation of an 
existing or standard pathway by way of 16 patient interviews and one health professional 
focus group. An interim phase allows for revision of that pathway based upon the findings in 
Phase 1. Phase 2 allows for further evaluation of the revised or enhanced pathway. In this 
way, an evaluation of experience takes place following an intervention.  Therefore two sets 
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of findings will be presented. Collectively the findings may also give further depth of meaning 
to the experience of being considered for CRLM resection. The form of this thesis reflects the 
linear pragmatic progression of the study and also reflects the form of the stories being 
revealed, each starting with a clear beginning (diagnosis), a middle section (period of 
reflection over events) and an ending (outcome of treatment decision).   
Chapter one has set out the introduction to the study, providing a backdrop as to the 
rationale and catalyst for the study. Chapter two provides a treatment overview of CRLM in 
order to provide the medical context to the advances made in this area. Chapter three details 
the relevant patient literature in this area and parallel areas of literature. In chapter four, the 
concept of hope is explored as relevant to the CRLM pathway which is punctuated with 
uncertainty. Chapter five presents the chosen research design and methodology for this 
study. Particular attention is given to show the appropriate use of hermeneutic 
phenomenological inquiry, which is heavily influenced by the work of Gadamer in 1960. In 
chapter six, the findings of Phase 1 are presented. The framework for analysis of findings 
detailed in chapter six and chapter eight have been guided by Smith et al (2009) in their 
approach known as Interpretative Phenomenological Analysis (IPA).  These guiding principles 
have been used intuitively in an iterative fashion, creating a hermeneutic circle of 
interpretation to arrive at meaning which has then prompted a review of the existing 
pathway.  Chapter seven details the interim period of service revision based on the findings 
in chapter six. Chapter eight returns to present the findings of the enhanced CRLM pathway 
in Phase 2.  Finally, chapter nine brings together the findings in the discussion to show that 
these patient experiences are indeed stories on a continuum of hope.  
1.5 Chapter summary 
This introductory chapter has set the scene for the work contained in this thesis by reflecting 
upon the impetus for the research study, the changing treatment context of colorectal liver 
metastases and arguably the need to conceptualise colorectal metastatic disease differently 
than has been commonly viewed when the option of colorectal liver resection is feasible. It 
has also referred to the research methodology of hermeneutic phenomenology and analysis 
method of Interpretative Phenomenological Analysis (IPA) as fitting to this research. The 
importance of merging patient perspectives with health professionals and  that of the 
researcher has been set out as an important element in this work, in order to embed patient 




The Nature and Management of Resectable Colorectal Liver 
Metastases 
“We look for medicine to be an orderly field of knowledge and 
procedure. But it is not. It is an imperfect science, an enterprise of 
constantly changing knowledge, uncertain information, fallible 
individuals, and at the same time lives on the line…The gap between 
what we know and what we aim for persists. And this gap complicates 
everything we do.” (Gawande, 2007, p.7) 
 
2.1 Chapter overview  
The treatment picture for colorectal liver metastases (CRLM) has seen dramatic change over 
the last three decades (Rees et al 2014, Kassahun 2015, Adam & Kitano 2019) and continues 
to evolve with rapid pace. No longer does a diagnosis of liver metastases from a colorectal 
cancer primary, necessarily mean treatment with palliative intent. Indeed, with careful 
patient selection, five-year survival rates from liver resection reported between 40-60% are 
encouraging in patients with liver limited disease (Abbas et al 2011, Twenzg & Aloia 2013, 
Dhir & Sassoon 2016). As such, the notion of survivorship is beginning to emerge for this 
patient population (Rees et al 2014).  Yet, as one might expect in such an evolving area of 
treatment, there remain unresolved issues and controversies in the optimal management of 
resectable liver metastases. This is partly reflected by a lack of randomised controlled trials 
in this field and consequently, finding a unity of consensus among practitioners can be 
difficult (Brudvik et al 2016). A key consideration to this is that approximately 60%-70% of 
patients develop recurrent disease either in the liver or elsewhere and approximately one-
third of these patients will die within 2 years of surgery (Jones et al 2012). The heterogenous 
outcome is of course reflected in patient health and biological characteristics of the tumour 
so this in turn makes patient selection all the more important. This chapter will set the scene 
for the context of the study by setting out the current management of resectable CRLM and 
outlining the main controversies in this area. In so doing, it will act as a precursor to the 
review of analytical and theoretical literature pertinent to the study as discussed in Chapter 
3 and Chapter 4. This chapter will reflect upon the changing context of treatment for this 
patient group before considering the biomedical context and current treatment of resectable 
CRLM.  Techniques to improve CRLM resection will also be discussed along with 
developments in surgery and associated outcome implications. While many of the challenges 
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of CRLM treatment will be blended throughout the different sections, the chapter will 
conclude with a summary of the main controversies in this field which are important to hold 
in balance as the patients’ experiences of the pathway unfold in the remainder of the thesis.  
 
2.2 The changing context of colorectal liver metastases treatment  
The idea of rendering metastatic disease operable is hugely exciting, both in terms of 
treatment advances but more importantly for those living with the consequences of such 
disease. Liver metastasectomy, the removal of metastatic disease by surgery, has been 
recognised since the beginning of the 1980s as the only potentially curative treatment 
(Capussotti 2011). No other medical intervention concerning CRC liver metastases has 
yielded the five-year survival rates that have been reported with   promising results from 
early series of up to 58% with surgical liver resection (Abdalla et al 2006, Van Cutsem et al 
2010). This is hugely significant since the five-year survival rates for primary bowel cancer, 
staged at Dukes C with lymph node involvement are within a reach of being comparable, 
lying at just over 60% (Cancer Research UK Statistics 2019a).   Improvements in the treatment 
of colorectal liver metastases are also set against the context of treatment change for 
primary bowel cancer and primary cancer in general as outlined in Chapter 1. Cancer 
Research UK Statistics (2019b) indicate that the five-year survival rates for bowel cancer in 
general have doubled over the last 40 years. This is partly attributed to improved detection 
of earlier disease and advances in surgical technique and cytotoxic therapies (Taylor et al 
2010). Where liver metastases are concerned, surgical resection is heralded as the gold 
standard, offering the only optimism for potential cure. This compares favourably with no 
treatment for colorectal cancer metastases, where original retrospective studies have shown 
a 2-8% five-year survival rate with a median 6 months survival (Wood et al 1976, Wagner et 
al 1984) when CRLM are not treated by any treatment modality. It is more difficult to obtain 
current comparative survival rates today where no active treatment is utilised, given the 
ethical considerations involved in withholding active treatment options available.   Even the 
advancements made in palliative care, since the late 70s and early 80s have had a direct 
impact on patient survival with metastatic disease (Gawande 2014b).  
 
A number of factors have helped to bring about more specific improvements in survival 
associated with liver surgery. One of the main challenges of operating on the liver has been 
its highly vascular nature, which often accounted for surgically related death or post-
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operative complications (Aragon & Solomon 2012). The first liver resection was recorded by 
Langenbuch in 1886 (Ravikumar et al 1990) and resulted in the patient dying shortly after 
surgery. Blood loss continued to impede survival until methods to address vascular damage 
were found.  Now, surgical advances in blood sparing techniques and precision liver 
dissection techniques along with improvements in pre-operative imaging and anaesthetic 
advances (Chowdhury 2010) have made more liver resections eminently possible with vastly 
reduced complications and associated mortality. As such, mortality rates have fallen and are 
now below 1-2% (Capusotti 2015). Also contributing greatly to the attempt to render the liver 
operable for surgery, has been the role of chemotherapy.  Writing in the preface to the 
surgical textbook Capusotti (2015, p.ix) writes that  
“the history and evolution of surgery for colorectal liver metastases 
cannot ignore chemotherapy” (Capusotti 2015, p.ix). 
This highlights the interdependency of different medical disciplines in tackling disease and 
breeds a new understanding of the need for multidisciplinary working. Advances in the 
treatment efficacy of chemotherapeutic agents and newer agents such as the use of 
monocolonal antibiodies e.g. cetuximab also set the context of rapidly evolving treatments 
which have been responsible for improving outcomes in CRLM resection (Choong & Ammori 
2014).  This will be looked at in more detail in.  
 
In addition, the role of colorectal cancer follow-up with Carcinoembryonic Antigen (CEA) 
blood monitoring and combined CT imaging have also played a role in detecting early 
metastatic disease (Steele et al 2007). Although the consensus remains out on the optimum 
timeframe for colorectal follow-up or in some cases the value (Jorgenson et al 2015, Makhoul 
et al 2015), it is likely that without it, the number of cases of liver metastases (and indeed 
lung metastases and peritoneal metastases) might not be referred at timely intervals to 
intervening surgical teams for assessment in the detection of first known metastatic disease.  
 
2.3 Colorectal metastases: the biomedical context  
Before looking at the current management of CRLM it is worth pausing to consider the 
biomedical context of colorectal liver metastases in relation to its primary presentation. 
 
2.3.1 Epidemiology of colorectal liver metastases 
Recent figures suggest that colorectal cancer is the third most common type of cancer, 
recorded separately for men and women in the United Kingdom (UK) with approximately 
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42,000 people diagnosed every year (Cancer Research UK, Statistics 2019b). It is the second 
most common cause of cancer death contributing to over 16,000 UK deaths per year, as 
reported by Cancer Research UK, Statistics (2019b). The liver is the most common site for 
colorectal cancer to spread, second only to lymph node metastases (Simmonds et al 2006). 
Approximately 20-25% of patients present with liver metastases at the time of their primary 
diagnosis (Morris et al 2010) and a further 40-50% develop a metachronous liver metastasis 
following bowel surgery (Stangl et al 2010). With this in mind, approximately 20-25% of 
patients with CRLM are thought to be candidates for surgical resection (Manfredi et al 2006). 
Liver metastases are commonly categorised into two groups according to time of 
presentation; synchronous and metachronous. Synchronous liver metastases are those that 
are deemed evident within a year of the primary tumour and metachronous metastases 
present after this period, normally after primary surgical treatment has been completed 
(Mohammed & Bala 2009).  Overall the risk of recurrence is deemed greatest in the first two 
years following surgery (Metcalfe et al 2004), and therefore the majority of surveillance 
programmes have been targeted to detect recurrent liver metastases during this time.    
 
2.3.2 Pathophysiology of the liver 
The liver is the largest solid organ in the body and is located on the right-hand side of the 
body lying underneath the right rib cage, as seen in Figure 2.1 of the digestive system. It 
consists of 2 lobes, the larger right lobe and the smaller left lobe.  
 
Figure 2.1: The Digestive system.  





Anatomically, the liver has been divided into sections (see Figure 2.2, overleaf). These 
sections are labelled as 8 distinct segments; segment 1 is the caudate lobe, segments 2 
through 4 form the anatomic left lobe and segments 5–8 form the anatomic right lobe. The 
segment divisions are based on the direction of the hepatic veins in relation to the intra 
hepatic distribution of blood through the portal vein. The liver carries out numerous 
functions which can be categorised into metabolic, storage and secretary functions, having a 
key role in blood filtration by the absorption of nutrients, production of quick release glucose 
and fighting infection (Watson 2011). It is unique in that it has two separate sources of blood 
supply; the hepatic artery which provides oxygenated blood and the hepatic portal vein 
which carries blood from the intestines and spleen back to the liver to extract nutrients 
(Bijlani & Manjunatha 2011). It is the shared blood supply of the colon and liver, from the 
portal vein, which provides an easy transport route for bowel cancer cells to spread and lodge 
in the liver.  It is thought that the mechanism of spread occurs in a stepwise fashion from the 
portal vein to the liver before spreading to the systemic circulation (Simmonds et al 2006). 
Therefore, the attraction of treating the liver is clear; if the liver can be effectively treated, 
the progression of disease spread can be halted, with the outcome of extending life or 
perhaps, eradication of disease.  
 
 
Figure 2.2: Anatomical sections of the liver and liver drainage.  





2.4 Key factors in the pathway to colorectal liver resection 
A number of factors are integral to obtaining liver resection. These are outlined in the 
following section.  
 
2.4.1 Multidisciplinary management  
Managing the treatment of patients with CRLM is now recommended practice within the 
context of a multidisciplinary team meeting (MDM) (Scottish Intercollegiate Guidelines 
Network, (SIGN) 2011, National Institute for Health and Care Excellence (NICE) 2020). The 
Colorectal MDT initially refers patients to the Hepatobiliary (HPB) MDT for review although 
referral can go between both MDTs throughout a patient’s management of liver metastases 
in order that appropriate expertise is involved in decision making and planning treatment.  
The MDTs involve input which integrates surgery and oncology with the support of diagnostic 
imaging, pathology and specialist nursing input. This is of benefit in considering technical 
issues of resectability, the role of perioperative chemotherapy in tumour downstaging and in 
limiting recurrence, tumour features, patient fitness and patient preference.  With treatment 
pathways often taking many months before liver resection takes place, the nurse specialist 
has an important role to play as a patient’s point of contact and advocate in a pathway which 
has much uncertainty.  
 
Patients with liver metastases are far from a homogenous group but broadly can be 
categorised into three main groups; those diagnosed with a synchronous liver metastases up 
to a year from the primary diagnosis, those diagnosed with a metachronous liver metastases 
on follow-up having had primary bowel surgery and those diagnosed with a further liver 
metastases having already had liver resection. Appropriate treatment will be dependent 
upon presentation. A multidisciplinary environment allows for optimal strategic 
management of these patients, many of whom require complex decision making (Dhir & 
Sasson 2016, Nathan & Wong 2016).  Where liver metastases occur on presentation with the 
primary tumour, decisions require to be made as to whether to carry out a synchronous or 
staged resection and in what order. In addition, patients may have other metastatic disease 
present which can contribute to the complexity of management. Patients developing a liver 
secondary during follow-up can already have undergone significant treatment. Close 
multidisciplinary working in order to maintain timely decision making for this group of 
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patients is crucial and recognises that no one speciality should have dominance in the 
treatment decision making over another.  
 
2.4.2 Defining resectable disease 
Defining resectable disease has proved challenging and is something which has evolved over 
time. Almost 30 years ago, resectability was defined as less than four metastases, the 
absence of extrahepatic disease and a resection margin of at least 1cm (Ekberg et al 1986). 
Liver resections were not recommended unless inclusion criteria were met but over the 
years, as technological advances have occurred, the criteria have been liberalised. Choong & 
Ammori (2014) point out that early resectability criteria were based on treatments in the 
1980s where poorer imaging and less effective chemotherapy were employed.  Currently, 
resectability is based on the remnant liver rather than on specific inclusion criteria. It is 
essential to have a sufficient remnant liver volume of more than 20% of the total estimated 
liver volume, to maintain adequate vascular inflow and outflow and biliary drainage (Pawlik 
2007).  The overall aim is to remove both macroscopic and microscopic evidence of cancer. 
A clinical risk score devised by Fong et al (1999) remains one of the most commonly used 
prognostic scoring methods in this area as referred to in Box 2.1. It is also worth noting that 
many predictors are not related to the presence of symptoms so it is important that follow-
up should contain regular imaging and CEA tumour marker testing.  
 Box 2.1: Predictors of poor outcome, CRLM resection 
 Source: adapted from Fong et al (1999) and Nordlinger et al (1996).  
 
It is likely that as surgical techniques and more effective chemotherapeutic agents are 
developed that the definition of resectability will continue to expand. Contraindications to 
liver surgery are more likely to revolve around the future liver remnant, patient co-morbidity 
and poor functional status (Choong & Ammori 2014). Keeping apace with evolving issues of 
resectability requires ongoing team communication in order to ensure that appropriate 
Predictors of poor outcomes following CRLM resection  
- Positive surgical resection margin  
- Extrahepatic disease  
- Node positive colorectal cancer 
- Disease free interval from primary tumour less than 1 year 
- Multiple liver metastases  
- CEA more than 200ng/ml following surgery 
- More than 1 metastatic deposit 
- Greater than 5cm diameter of any one lesion 
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referrals are made to the hepatobiliary team.  In turn, keeping abreast of changing 
information may also create a significant strain on patients and their families waiting for new 
communication about their treatment pathway.  
 
2.4.3 Imaging in the management of colorectal liver metastases 
A diagnosis of CRLM is made by appropriate imaging such as computerised tomography scan 
(CT), magnetic resonance imaging (MRI), positron emission tomography-computed 
tomography (PET-CT) or ultrasound. Histological confirmation is not recommended as there 
is some evidence that a liver biopsy can result in poorer outcome after liver resection due to 
possible disease tracking and spread via biopsy needle (Garden et al 2006). Initial staging by 
way of a CT scan of chest, abdomen and pelvis may suggest presence of liver metastases. An 
MRI will provide further detail on anatomical positioning of liver metastases.   
 
A PET-CT will rule out or confirm presence of additional sites of secondary spread, by 
detecting radiation from a radiotracer called fluorodeoxyglucose (FDG) which is similar to 
naturally occurring glucose in the body (NHS UK 2018, https://www.nhs.uk/conditions/pet-
scan/).  Analysing build-up of this glucose solution determines how well certain organs are 
performing and how likely secondary spread is to those organs that highlight as having more 
glucose uptake. Just over a decade ago, all patients had to travel to Basingstoke from 
Scotland for a PET facility. At the time of writing, there are now four major centres with 
patient PET facilities in Scotland, but image reporting and cost of running is both costly.  
Interestingly, a randomised controlled trial reported by Moulton et al (2014) has questioned 
the value in PET-CT in addition to CT alone. The trial, which randomised patients to either 
PET-CT or CT alone prior to hepatic resection for CRLM did not result in frequent changes in 
decision making across the groups of patients which may suggest that CT alone can 
determine decision making in this setting with a cost reduction in imaging. It is worth noting 
that additional secondary sites of metastatic disease detected through imaging will not 
necessarily exclude a patient from CRLM as these sites may be considered amenable to 
further resection, e.g. lung. Cases with extra-hepatic metastases need to be considered on 
an individual basis (Choong & Ammori 2014) and increasingly demonstrate the advancement 
in surgical resection of metastases located at different sites.  
 
A particular challenge in the area of imaging is the issue of disappearing liver metastases 
following pre-operative chemotherapy. Disappearing liver metastases refers to the complete 
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response or disappearance of liver metastases following preoperative chemotherapy and can 
occur in up to a quarter of patients who undergo chemotherapy in either a neoadjuvant 
setting for resectable liver metastases or as a conversion therapy for unresectable 
metastases  (Kassahun 2015, Dhir & Sasson 2016). Kassahun points out that although the 
beneficial effect of liver resection on survival is clear, the extent to which liver disesase is 
resectable when not easily seen on imaging, has not yet been established. This can make it 
particularly challenging for surgeons to resect. It may also prove a particularly challenging 
aspect to communicate to patients, with the potential for accompanying emotional burden, 
adding in an additional level of uncertainty amid the process of waiting.  
 
2.5 Treatment of resectable colorectal liver metastases  
As outlined in section 2.4.1., the overall treatment of CRLM requires a multidisciplinary 
approach. Yet, the overall treatment of CRLM is not an exact science, and this can best be 
understood through stage at disease presentation and whether liver metastases present with 
a synchronous bowel primary or as a metachronous finding during a period of follow-up.  In 
addition, this can highlight some of the uncertainties surrounding treatment.  
 
2.5.1 Order of treatment in synchronous presentation of CRLM  
The order of resecting synchronous CRLM remains controversial and is well debated in the 
literature (Choong & Ammori 2014, Collins & Chua 2017). There is little definitive evidence 
to support whether resection of the bowel primary should occur prior to liver metastases 
resection or whether both primary and liver metastases can be resected simultaneously. 
Retrospective reviews of caseloads have shown simultaneous resection to be safe and should 
be considered where the location of the tumour is amenable to a simultaneous resection and 
where joint expertise from a bowel and hepatobiliary surgeon can be co-ordinated (Martin 
et al 2003, Chu et al 2004). Certainly, clinical presentation may guide the decision to operate 
on the primary tumour first if a patient presents with obstruction, bleeding or perforation 
(Mohammed & Bala 2009). Where simultaneous resection cannot be performed, 
multidisciplinary clinical judgement is important to consider cases on an individual basis with 








2.5.2 The role of systemic anti-cancer therapy (SACT) 
The term systemic anti-cancer therapy or SACT, has come to denote the move away from 
chemotherapy solely being utilised as a systemic cancer therapy and encapsulates the use of 
other systemic and newer targeted therapies or biologic therapies, such as monoclonal 
antibodies and immunotherapies. Newer forms of systemic treatment may complement 
conventional chemotherapy or in some cancer treatment regimens may replace them.  In 
CRLM management both chemotherapy and more recently, monoclonal antibodies are 
utilised.  
 
The purpose of chemotherapy in the context of CRLM resection is either to improve long 
term survival following liver resection or to facilitate liver resection in those patients who are 
considered to have borderline resectable disease or non-resectable CRLM. The greatest 
evidence for using chemotherapy in combination with surgery stems from the European 
Organisation for Research and Treatment of Cancer, (EORTC), randomised trial using FOLFOX 
(5FU/ leucovorin/oxaliplatin) chemotherapy perioperatively with surgery against surgery 
alone (Nordlinger et al 2008). The results showed a 7-8% improvement in 3-year progression-
free survival in those patients who received perioperative chemotherapy, to approximately 
35%, compared to resection alone at 28% (Nordlinger et al 2008). As such chemotherapy is 
used more often prior to liver surgery rather than following liver resection in order to reduce 
likelihood of recurrence (Ismaili 2011, Wang & Li 2012).  A standard regime of neoadjuvant 
FOLFOX or CAPOX (capecitabine and oxaliplatin) may last for 6 cycles (approximately 3-4 
months) (Brandi et al 2016). For the individual with liver metastases, length of SACT 
treatment has a likely additional psychological burden when the desire is to achieve liver 
resection, and certain scenarios can significantly extend the pathway. For example, for some 
patients presenting with a synchronous liver metastases and rectal primary, where the liver 
may be considered as borderline for resection, the length of time to liver resection may take 
12-18 months. In such cases, overall treatment may invovle down-staging primary radiation 
with chemotherapy followed by primary surgery and use of chemotherapy plus or minus a 
targeted therapy, in order to attempt to convert liver disease resectable.  
 
Chemotherapy may be considered following liver surgery depending on pathology or 
particularly if a patient did not receive chemotherapy perioperatively (Wang & Li 2012).  
There is also increasing evidence to say that where patients have borderline resectability, a 
combination of oxaliplatin (or irinotecan) and 5-FU/leucvovorin chemotherapy can be used 
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as a downstaging agent to convert unresectable disease to resectable (Wang & Li 2012). In 
some cases perioperative chemotherapy is best avoided if a patient has had recent 
chemotherapy (usually within 2 years) or has evidence of a fatty liver (Ismaili 2013). In such 
cases there is greater likelihood of causing damage to the liver and creating post-op surgical 
complications. Chemotherapy in general is associated with injury to liver parenchyma with 
oxaliplatin and irinotecan both responsible for causing steatosis and steatohepatitis (Passot 
et al 2016). Steatosis can increase blood loss after hepatectomy and steatohepatitis can 
impair liver regeneration.  Careful pre-assessment of the liver can help to determine impact 
of chemotherapy when used pre-operatively and leaving at least 5 weeks between 
chemotherapy and liver resection can reduce liver injury (Passot et al 2016).  
 
Recently the use of monoclonal antibodies, such as cetuximab have provided further benefit 
in helping convert unresectable disease to resectable (Cooper & Curley 2013). Cetuximab is 
a targeted therapy that targets and binds to the epidermal growth factor receptors (EGFR) 
on cells. Cetuximab works by binding to EGFR on cancer cells which in turn blocks epidermal 
growth factor, to prevent cancer cell division and further regrowth (see Figure 2.3).  In this 
way it both blocks the signal for cell division and triggers an immune response from the 
individual. Common side effects are an acne like rash, which is commonly evident 2 weeks 
after starting treatment, skin fissures, nail changes and gastrointestinal effects such as 
nausea (Macmillan Cancer Support 2018, Petreilli et al 2018).   
 
Cetuximab is deemed suitable for those with bowel cancer who express a wild-type KRAS 
gene which is the non-mutated gene (Ismaili 2011). RAS mutations occur in approximately 
45% colorectal cancers (Cercek et al 2017). The clinical implication of this is that patients with 
metastatic colorectal cancer who are being considered for cetuximab should be tested for 
the presence of a KRAS mutation prior to therapy.  It is also deemed more effective for left 
sided tumours than right sided, although the mechanism for this is not clear (Goldberg et al 
2018).  
 
The most convincing evidence for improved response rates in first line metastatic colorectal 
cancer with cetuximab and chemotherapy comes from the CRYSTAL study (van Cutsem et al 
2011) and the COIN trial (Maughan et al 2011). The CRYSTAL study found prolonged overall 
and progression free survival with KRAS wild type tumours receiving cetuximab in 




did not show any benefit to either overall or progression free survival, it did show increased 
response to cetuximab in combination with capecitabine/oxaliplatin (CAPOX) or 
5FU/leucovorin/irinotecan (FOLFIRI) (Maughan et al 2011). Again of note, both treatment 
regimens have a specific side effect profile, with more commonly experienced side effects of 
CAPOX including skin redness (palmar plantar syndrome), peripheral neuropathy and 
gastrointestinal effects such as nausea, sore mouth and diarrhoea (Macmillan Cancer 
Support 2018b). FOLFIRI’s common side effect profile also includes gastrointestinal effects of 
nausea, diarrhoea and sore mouth and will cause hair loss (Macmillan Cancer Support 2018c). 
Understanding the side effect profile helps to understand the overall context of what patients 
are likely to encounter through the active process of being considered for CRLM resection in 
order to address quality of life issues during treatment.  
    
         
 
Figure 2.3: Mechanism of cetuximab  
Source: Lilly (2019), https://www.erbitux.com/understand-erbitux/mcrc.html 
 
Cetuximab is available for restricted use within the United Kingdom and has had varied 
adoption across the U.K. to the current recommendation. The recommendation for widened 
use was made first in Scotland in 2015. As of January 2015, The Scottish Medicines 
Consortium (SMC) accepted cetuximab under the following restriction, 
 “For use in patients with RAS wild-type metastatic colorectal cancer, in 
combination with irinotecan or oxaliplatin-based chemotherapy, in 
patients who have not previously received chemotherapy for their 
metastatic disease (first-line treatment).” (SMC 2018, para.1). 
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This was a widening of the previous restriction, implemented in 2010, whereby it was 
indicated for use in liver only metastases that were considered non-resectable but that may 
be amenable to potentially curative surgery following chemotherapy and cetuximab (SMC 
2014).  The new EPOC trial aimed to determine if the addition of monoclonal antibody 
therapy was of value in the neoadjuvant setting by randomising standard based 
chemotherapy (FOLOX or FOLFIRI) plus or minus cetuximab (Primrose et al 2014). After all, 
having already established the role of chemotherapy in the perioperative setting for CRLM, 
it seemed logical to proceed to the next step and ask whether outcomes could further be 
improved by combining biologic and cytotoxic agents (Nordlinger et al 2015). 
Surprisingly, an early review of the study at the end of 2012 showed a significant reduction 
in survival in the arm having chemotherapy and cetuximab which led to the trial being closed 
early for safety. Progression free survival was 13.6 mths vs 6.2 on the cetuximab arm and and 
likewise overall survival was 29.1 months vs 22.7 mths.  Primrose and colleagues concluded 
that cetuximab could not be recommended for use in the neoadjuvant setting, suggesting 
that cetuximab may cause some molecular interaction that required further examination.  
The results were highly contentious, going against previous studies that had shown 
improvement in survival with cetuximab.  The trial was criticised from a number of angles 
including taking RAS mutant expressing individuals into the study sample, poor study 
powering and difficulty modulating surgical variance across the U.K centres (Nordlinger et al 
2014). The results have been considered with caution, only prompting the need for further 
studies with the use of biologics and chemotherapy. Due to the concerns over study design 
and interpretation, the new EPOC study alone has not changed the recommendation that 
cetuximab can be used in first line treatment of metastatic colon cancer alongside 
conventional chemotherapy including oxaliplatin or irinotecan agents. Cetuximab’s 
incorporation into the management of metastatic colon cancer has contributed significantly 
to the treatment landscape of CRLM.  
2.6 Techniques to improve success of liver resection 
A number of techniques have helped to improve the success of liver resection and thereby 
leave a sufficient functioning liver remnant. These key techniques are mentioned as part of 






2.6.1 Portal vein embolisation  
Treatment advances have also led to novel approaches which can improve the resectability 
and outcomes of colorectal liver resection. Portal vein embolisation (PVE) uses the 
regenerative properties of the liver by redirecting portal blood supply to segments of the 
future liver remnant, which causes liver hypertrophy (Mohammed & Bala 2009). It is only 
indicated when the future liver remnant is considered too small to maintain function. Use of 
PVE has been associated with a reduced postoperative morbidity and an increase in the 
number of patients eligible for curative resection (May & Madoff 2012).  
 
2.6.2 Ablative techniques  
Ablative techniques such as Radiofrequency Ablation (RFA) or microwave ablation are also 
used to increase resectability by way of using heat energy to destroy cancer cells 
(Mohammed & Bala 2009). RFA is more commonly used and can be used more than once 
where indicated. A radiologist uses an electrode probe to apply an electrical current to a 
tumour. The current heats the cancer cells to a high temperature resulting in ablation and 
cell death. This can be done prior to liver resection in combination with the surgery to 
improve surgical outcome. Generally those lesions which measure 3cm or less and those 
which do not lie adjacent to major vascular structures are more amenable to RFA (Choong & 
Ammori 2014). Cryotherapy, involving the delivery of subzero temperatures to the liver via 
probes during surgery is used infrequently due to lack of evidence of therapeutic benefit 
(Macedo & Makarawo 2014). While some ablative techniques can be used as an adjunct to 
surgery, wide variation in outcome has been reported with insufficient evidence that ablative 
techniques could be used as a ‘stand alone’ treatment for liver metastases. As such the 
American Society of Clinical Oncology (ASCO) had recommended that international centres 
do not use ablation to treat liver metastases alone but continue to recommend liver resection 
as the gold standard of treatment (Wong et al 2010).  
 
2.6.3 Two staged liver resections  
A further way to increase resectability is by carrying out two staged liver resections. One such 
method of a staged liver resection that is increasingly considered is a technique called ALPPS 
(Associating Liver Partition and Portal vein Ligation for Staged hepatectomy) (Donati et al 
2013).  This technique utilises the regenerative abilities of the liver by allowing regrowth of 
the future liver remnant in between two liver operations. A staged hepatectomy is 
23 
 
particularly used in patients with extensive bilobar disease where the first liver operation 
plus or minus ablation would not yield a sufficient liver remnant (Choong & Ammori 2014). 
The least affected lobe of liver is generally operated on first to allow regeneration and further 
resection with the aim of clearing remaining disease in the second operation. Furthermore, 
in some cases, where recurrence occurs again in the liver, it is possible to continue to a re-
resection 2 or 3 times with curative intent (Cooper & Curly 2013). All cases are to be 
considered individually, carefully evaluating risk and benefit to a patient alongside their 
preferences for treatment approach (Nathan & Wong 2016). 
 
2.7 Surgical considerations in CRLM  
A number of aspects are of worth considering which are relevant to the current picture of 
colorectal liver resection. These are referred to in turn.  
 
2.7.1 Surgical developments  
The inherent characteristic of liver regeneration makes the liver amenable to surgery. 
However, the main problem has been the highly vascular nature of the liver so techniques 
which help to minimise blood loss are favoured. The traditional ‘clamp crushing’ technique 
to dissect hepatic parenchyma was compared with three newer innovations (the ultrasonic 
aspirating dissector, the Hydrojet and the dissecting sealer using radiofrequency ablation in 
a randomised controlled trial (Lesurtel et al 2005) and later in a Cochrane review (Gurusamy 
et al 2009). Little difference was demonstrated across the techniques but the traditional 
clamp crushing technique which is significantly cheaper was associated with faster tissue 
transection at surgery and lower transfusion requirements, therefore newer transection 
techniques have not been advocated in standard practice.  
 
There are no randomised trials in the use of laparoscopic surgery in CRLM, yet the review of 
retrospective series (Simillis et al 2007) has found laparoscopic hepatectomy to reduce blood 
loss and duration of hospital stay with oncological clearance similar to that for open 
hepatectomy.  In 2008, Buell et al (2009) deemed laparoscopic colorectal liver resection to 
be safe and effective for properly trained surgeons. Patients with limited tumour burden (2 
or fewer metastases)and those with small tumours in the left lateral segments of the liver 
have been reported as more suitable to laparoscopic surgery whereas those patients with 
tumours involving the inferior vena cava, portal veins or patients with multifocal or bilobar 
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metastases are best served with open surgery (Xie et al 2016). As with primary colorectal 
surgery, patient selection for laparoscopic surgery is crucial for safety and outcome.  
 
2.7.2 Outcome and recurrence following surgery  
 
In the absence of randomised controlled trials comparing colorectal liver surgery with other 
treatment options, it is difficult to ascertain the benefits of CRLM. Nevertheless, 5-year 
survival rates range between 40-60% and one fifth of patients may achieve survival of 10 
years or more (Nathan & Wong 2016). Complications of liver surgery can include infections, 
biliary and vascular complications and liver failure but the incidence is low and liver resection 
is also deemed safe for patients over 70 years with appropriate selection (Di Benedetto et al 
2011).  Approximately two-thirds of patients later develop a recurrent tumour, and half of 
them have a recurrent tumour in the liver (de Liguori-Carino 2008).  In addition, a R1 
resection (positive margin), while generally depicting worse disease behaviour, is not show 
to be related to overall survival when compared with R0 resections (Pencovich et al 2019).   
Several prognostic scores exist to predict a patient’s risk of recurrence and chances of long-
term survival on the basis of preoperatively measured parameters. The three most 
commonly used scoring systems in hepatic surgery are those of Nordlinger, Fong, and 
Iwatsuki (Kolev et al 2014). Essentially a low score equates to a lower risk of recurrence and 
overall survival. As yet, there are no preoperatively prognostic tools which can accurately 
identify patients who will not benefit from surgical treatment. Of relevance to add is that a 
number of patients already having had colorectal surgery will have residual effects of 
multimodal therapy for a colorectal primary. There is a growing body of evidence for the late 
term effects of multimodal therapy in the pelvis, particularly those located lower in the bowel 
in the rectum and sigmoid (Knowles et al 2013, van Heinsbergen 2018). This is of worth 
considering when one understands the long and complex journey many will have gone 
through before being considered for colorectal liver resection.  
2.7.3 Main controversies in colorectal liver resection 
Kassahun (2015) has collated the main unresolved areas in the management of colorectal 
cancer liver metastases existing around four central controversies; (1) the simultaneous 
approach for synchronous liver resection, (2) the use of pre-operative chemotherapy, (3) 
resection extent for disappearing liver metastases and (4) the sequencing of liver resection. 
The arguments for and against were summarised in a table in this paper and have been 
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included Table 2.1 overleaf.  The table provides a comprehensive overview of the arguments 
in the four main unresolved issues which have been highlighted in this chapter. Given the 
lack of evidence by way of randomised trials, it is perhaps understandable how the 
arguments differ. With differing of opinion at times among clinicians as to the rationale 
behind decisions, the importance of decision making through multidisciplinary team meeting 
comes into play so that decisions are made on an individual patient basis, according to 
staging, tumour and fitness for treatment. However, with the complexity conveyed in some 
of these arguments, it is worth stressing that this complexity is the same backdrop to which 
treatment decisions are shared with and conveyed to patients. With this knowledge in mind, 
informing some of this complexity may prove challenging.  
 
2.8 Implications for future patient outcomes  
A recent study by Rees et al (2014) using the quantitative quality of life tools with 232 
patients diagnosed between 2004-2007 have shown excellent quality of life, high levels of 
function and few symptoms at 1 year following CRLM resection. While no studies currently 
give patient reported outcomes longer than 1 year, it may be reasonable to assume that 
patients remaining disease free could expect a favourable quality of life similar to that 
reported by long term survivors of breast cancer (Hsu et al 2013). Survival from treatable 
metastatic colorectal cancer is not, as yet, akin to that of metastatic breast cancer, where 
survivors can live in excess of a decade.  However, the treatment advances made in this area 
are extending the boundaries of what was commonly expected for a diagnosis of CRLM and 
creating a new category of metastatic disease. This has an impact on how patients experience 
their treatment pathway, follow-up and ongoing survivorship needs. 
 
It is not surprising that where improved outcomes are concerned, much of the literature has 
focused on treatment efficacy and technique. There is a deficit of research which explores 
patients’ needs or experience of having undergone consideration for hepatic resection. Not 
all patients considered for liver resection will proceed to surgery and therefore the pathway 
can be punctuated with additional uncertainty. Patients can experience the tension of 
knowing that their cancer has spread whilst maintaining the hope for containment or even 





Treatment strategy Arguments in support of Arguments against  
The simultaneous 
approach 
No increase of morbidity and/or 
mortality in carefully selected 
patients  
 
Removal of all cancer in a single 
procedure; reduces disease 
dissemination  
 
Similar PFS and OS compared to 
those with staged resection 
Considerable increase of 
morbidity and or/mortality 
 
May result in unnecessary 
liver resection in rapidly 
progressing disease 
 
Higher recurrence. Negative 
impact on long term outcome 





Increases R0 resection rates 
 
Assesses responsiveness to specific 
chemotherapy thus identifying and 
selecting patients with favourable 
tumour biology. Improves PFS.  
Delays liver resection. May 
result in a unresectable state 
in non-responders 
 
May lead to liver parenchyma 
damage and increased 
postoperative morbidity  
 
No impact on PFS and OS 
Extensive resection for 
DLM  
Response on imaging does not 
necessarily signify clinical or 
pathological response (in up to 83% 
evidence of residual disease); so 
resect all initial sites if possible, 
despite disappearance on imaging 
As durable clinical response is 
as high as 62%, resect only 
residual macroscopic disease 
leaving the disappeared 
lesions in situ, continue 
systemic chemotherapy alone 
The liver-first approach It is the liver metastasis rather than 
the primary tumour that gives rise 
to systemic metastatic disease, so it 
should be addressed first 
 
It avoids the risk for progression of 
CRLM while the patient is treated 
for the primary tumour, especially if 
complications are encountered; 
thereby improving median survival 
and 3-year survival  
 
Option to give systemic 
chemotherapy as a first step early in 
the treatment course that may lead 
to an effective response in the 
primary tumour and avoids 
resection 
 
No, it is the primary tumour 
that produces systemic effects 
promoting angiogenesis in the 
liver, thus favouring the 
spread of metastatic disease 
 
Despite apparently similar 
treatment protocols in those 
few studies, the variations in 
survival rates of the liver-first 
approach are wide; so its 
comparison with the bowel-
first approach or the 
combined strategy is 
problematic 
Table 2.1: Summarised key controversies surrounding the management of colorectal 
cancer liver metastases. (Adapted from Kassahun, 2015). 
Terminology key; CRLM, colorectal liver metastases; DLM, disappearing (no longer visible on imaging) 
liver metastases; HR, hepatic resection, PFS, progression free survival; OS, overall survival; Pre-HR 




Observationally as health professionals looking on, it can be seen that the pathway holds 
much anxiety for patients and families. Often the treatment teams involved are located at 
different hospital sites and this may add further complexity for some patients when seeking 
to convey information at timely intervals. Additionally, this study takes place in the context 
of the busy clinical practice involved with the treatment management of both primary and 
secondary bowel cancer (see Appendix I). As treatment pathways become more 
individualised and perhaps more complex, the need for a point of contact across the pathway 
is realised.  Nurse specialists can work with patients to convey information across the 
pathway at relevant time points, manage expectations of timescales, tailor specific 
information needs, manage physical and side effects of systemic therapy and the liver 
resection and can help with goal setting, an important element of hope (Snyder 2000). 
However, with little evidence from the literature to reflect this or how the needs of such 
patients can best be met, it is difficult to rely on purely observational data.  
 
2.9 Chapter summary   
Advances in imaging, surgical technique and systemic therapies have led to exciting 
developments in the management of operable metastatic colorectal cancer with encouraging 
five-year survival rates (Rees et al 2014). Patients undergoing CRLM resection represent an 
increasing patient population where surgery can be utilised in managing secondary cancer. 
Consequently, this new picture of treatment requires a reconsideration of what we have 
conventionally understood by metastatic disease as discussed in Chapter 1 (1.3), ‘Growing a 
new concept of metastatic disease’.   While multimodal therapy has given cause to expand 
our understanding of metastatic disease in colorectal liver metastases, the combination of 
surgery and systemic anti-cancer therapy can make for a prolonged pathway of treatment 
and can have additional burden of recovery and residual side effects.  Although it is 
recognised that the pathway to liver resection is often complex and emotionally demanding, 
little is known of the reality of being considered for colorectal liver metastases resection from 
the patient’s perspective. The next chapter will consider the impact of liver resection on the 
patient by drawing on associated and comparable literature. Further research with this group 
of patients has value in seeking to improve the experience of the surgical pathway to liver 






A change of lens: from technical possibilities to patient perspective 
“We see the world through the lens of all our experiences; that is a 
fundamental part of the human condition” (Madeleine M Kunin, 2009, 
para.5). 
3.1 Chapter overview 
 
In 1962, scientific philosopher, Thomas Kuhn published perhaps one of the most influential 
philosophical texts of the twentieth century, ‘The Structure of Scientific Revolutions, in which 
he challenged traditional thinking on how humankind orders scientific progress and 
therefore understands the world.  Kuhn’s version of how science develops departs 
dramatically from positivist theories of a continual building upon of unshakeable knowledge 
to instead seeing scientific progress develop from changing intellectual circumstances and 
possibilities (Kuhn 2012). In this way progress reflects change that encompasses 
discontinuities in understanding and alternates between ‘normal’ steady progress and 
‘revolutionary’ phases where communities of specialists enter periods of turmoil, uncertainty 
and angst in their thinking (Naughton, 2012). The result of this is a change in the old paradigm 
of thinking to a new one which becomes accepted and the previous paradigm becomes 
deficient, representing a paradigm shift, a phase which is also familiar to us in modern day 
parlance. Kuhn understood that theoretical commitments between two scientists can 
influence how theories and knowledge are viewed.   
Interestingly, Kuhn’s argument was based upon the psychology of vision whereby the use of 
special goggles, can invert the world as upside down on the retina. Continual use of such 
googles will allow for compensation and resultant movement but when the goggles are 
removed, the view of the world initially seems displaced. Kuhn embraced the idea that how 
we view things alters over the course of our lives and as a result of exposure to experiences. 
This idea is also echoed in the opening quotation for this chapter by former American 
diplomat, Madeline Kunin, albeit from a socio-political viewpoint.  In a similar way, our 
concept of how we view and what we expect from medicine has changed. The last 50 years, 
in particular, have borne witness to incredible changes in the treatment of diseases such as 
tuberculosis and in improving survival in many of the common cancers (McKie 2015).  With 
such progress, we could be forgiven for thinking that developments in medicine will continue 
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at this pace. It is certainly encouraging to see how advances are beginning to challenge the 
idea that a diagnosis of cancer does not unequivocally equal a death sentence as 
conventionally viewed (Diamond 1999). Some treatment possibilities have given shape to a 
reality and pave the way to change a collective perspective about cancer across society and 
indeed our perspective of a diagnosis of metastatic cancer, most notably breast cancer 
(Sledge 2016).   
This chapter will turn to look at a different perspective; that of the patient. Yet,  qualitative 
studies dirctly related to colorectal liver metastase are limited.  The few that have been 
published, will be discussed in more detail before drawing in other qualitative research that 
has a bearing on CRLM, including a number of phenomenological studies relating to surgery 
for primary colorectal cancer. The content will then perhaps take a more surprising turn to 
look at literature in the area of liver transplant, which arguably may provide a parallel 
experience to CRLM. This was an area which came as an exciting and plausible consideration 
when reviewing the literature.  
 
3.2 Identification of literature 
 
Undoubtedly, Chapter 2 has highlighted that there is often a lack of consensus about the 
management of colorectal liver metastases. As in any area of healthcare, developments are 
always confined by what is technically possible and also, correctly, ethically plausible. While 
much of accepted practice in the treatment of CRLM has not been adopted by conducting 
randomised controlled trials, advances contributing to surgical technique, imaging and 
systemic anti-cancer treatments have pushed some of the boundaries in CRLM which in turn 
has broadened our understanding of what we once thought possible in the treatment of 
metastatic disease.  The developments are perhaps somewhat of a parallel to the traditional 
route of science as described by Kuhn (2012).  In this environment, there is considerable 
capacity for asking new questions and trying new methods of treatment in an attempt for 
progress in the overall management of colorectal liver metastases. As indicated by Kuhn, 
many revolutions of theory may be required in a bid to move understanding along. The 
medical literature in colorectal liver metastases (CRLM) has naturally centred around 
principles of delivery, efficacy and safety, sharing the technical viewpoint from the clinician’s 
perspective. However, what of the view from a different lens; what of the patient’s 




To this end, literature searches and an alert notification system (2000 onwards) were 
established using the databases, CINAHL, EMBASE, MEDLINE, the COCHRANE LIBRARY and 
DISCOVER ED (University of Edinburgh database).  Combinations of the words, ‘experience’, 
‘qualitative’, ‘phenomenology’ ‘liver metastases’, liver secondary’, ‘liver resection’, 
‘pathway’ and ‘journey’ were used.  Reading was not limited to these searches but acted as 
a springboard to other areas of reading.  Whereas management of uncertainty is well 
documented in the literature, as evidenced in chapter 2, there is a deficit of qualitative 
research in this area for those having, or being considered, for surgical resection of colorectal 
liver metastases.   This was very much the position at the conception of this study and 
remains the case.  
 
Where there is a limited literature base, it is often challenging firstly, to identify a suitably 
comparable area of literature and, secondly, to know where to discontinue the search 
appropriately. I was aware of the qualitative literature on living and dying with colorectal 
cancer but it was clear from the outset that resection of colorectal liver metastases with 
favourable five year survival rates,  did not sit well within a palliative context as referenced 
in Chapter  1 and Chapter 2. My clinical experience also bore witness to this, thus preventing 
me from aligning liver resection to end of life literature. On reflection, I note there may be 
some relevance to the literature on the fear of recurrence but this was not included in the 
literature search at the outset as many participants already came to the study with 
recurrence as a starting point. As such, this research did not have the scope to look 
specifically at the issues around recurrence but rather the focus was on the process of being 
considered for CRLM and the pathway itself. Figure 3.1, overleaf, outlines the literature 
search. The Critical Appraisal Skills Programme (CASP) criteria (https://casp-uk.net/wp-
content/uploads/2018/01/CASP-Qualitative-Checklist-2018.pdf) provided a useful tool in 
appraising the research literature. The ten questions on the qualitative checklist allowed 
study rigour, credibility and trustworthiness to be constructively appraised for inclusion.  
 
The key literature in this Chapter and in Chapter 4 drew firstly on phenomenological studies, 
directly related to the use of surgery in colorectal liver metastases, before incorporating 
phenomenological colorectal cancer or other related qualitative cancer  literature. It is 




















                                                                                                                                                                                                                                            









Figure 3.1: PRISMA flow diagram showing strategy for literature inclusion 
drawn relevance from them. The parallel literature that I saw best fitting to the CRLM 
pathway experience did not necessarily sit best with colorectal cancer per se or other related 
cancer experiences but on review of the literature, I was drawn to phenomenological 
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Hepatobiliary team from observations within their practice, reaffirmed the relevance of 
drawing upon this literature for the comparison it drew with liver related surgery, waiting 
and uncertainty over a significant time period. The extension of the literature into hope  in 
the following chapter arose from the links with uncertainty and waiting for this population 
and the focus that maintaining hope amidst a complex surgical pathway had for patients with 
colorectal liver metastases. 
At the outset, the study always had a service development outcome in mind, with the 
mainstay of study funding reflecting this intention. Relevant patient experience literature to 
support the study application was limited. It was only later with the study commencing, that 
the first and, as yet, only phenomenological account of patients having undergone liver 
resection was published in 2009 by American authors McCahill & Hamel-Bisssell in the 
Journal of Supportive Palliative Care.  This work was not known about when selecting study 
design and methodology so had no influence on this current study. Yet, as this is the only 
published study, it remains the main reference point of directly relevant literature and will 
be discussed in section 3.2. Further review of literature yielded two other studies as relevant 
to patient experience in surgery for liver metastases. While neither may be perhaps seen as 
a best fit, their place in section 3.2 is justified as they directly relate to the use of major 
surgical intervention for CRLM.  An overview of the main three studies are included in Table 
3.1. The second study is a Norwegian study by Vidnes et al (2013) and interestingly reports 
on the more experimental use of liver transplant surgery for treating CRLM. It has been 
included as it reports on the use of radical surgery for CRLM and there may be some useful 
considerations. A quantitative quality of life search was also undertaken as part of this study 
and referred to in section 3.2.  The third study was undertaken as a doctorate in Health 
Psychology by Whale (2016) and reported on the findings of qualitative interviews conducted 
with a selection of patients who had been part of a previous study cohort assessing the use 
of the European Organisation for Research and Treatment of Cancer Core Quality of Life 
(EORTC QLQ-C30) and colorectal cancer liver metastasis specific module (EORTC QLQ-
LMC21).  
Outside of these studies included in Section 3.2. and in the absence of directly comparable 
studies, one of the challenges has been how far to widen the net in order to draw on other 
studies which may have relevance to the CRLM study group. The next obvious search 
extension to look for qualitative literature is the use of surgery in other areas of colorectal 
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metastatic surgery, such as lung resection or peritoneal resection which have been referred 
to in Chapter 2. Searches yielded nothing for this and likewise there was no published 
qualitative work in the use of surgery for metastases in other cancer types.  The absence of 
qualitative work in metastatic cancer surgery then becomes a feature in itself and additional 
sources of reference require to be drawn on for consideration.  
3.3 Colorectal liver metastases surgery from the patient’s perspective  
Patients with liver metastases are far from a homogenous group but broadly can be 
categorised into three main groups; those diagnosed with a synchronous liver metastases at 
the same time of their bowel primary, those diagnosed on follow-up having had primary 
bowel surgery and those diagnosed with a further liver metastases having already had liver 
resection. Where liver metastases have been diagnosed at the same time as the primary 
tumour, patient assessment is necessary in order to ascertain if both tumours can be 
resected under a synchronous resection or a staged resection. If a staged resection of primary 
bowel tumour and liver metastases is to be carried out, the order of tumour resection will 
need to be assessed in order to maximise the feasibility of removing both tumours and to 
maximise the overall patient outcome in both survival and reduction of tumour (Kassahun 
2015, Wang et al 2016). Patients developing a liver secondary during follow-up may already 
have undergone significant treatment. In addition, patients may have evidence of other 
metastatic disease, e.g. lung metastases, either diagnosed at the outset of original bowel 
primary or during follow-up. This can add to the complexity of management as discussed in 
chapter 2. Close multidisciplinary working in order to maintain timely decision making for 
this group of patients is crucial (SIGN 2011, NICE 2020).  
The ‘typical’ pathway for cancer treatment is often likened to somewhat of a rollercoaster 
journey (Fawcett 2011) with emotional and physical setbacks accounting for some of the 
journey lows and the success of treatment or resolution of symptoms equating to feelings of 
relief experienced on the peaks or highs of the journey. This may be exemplified in the 
pathway to hepatic resection for colorectal liver metastases, where patients may be 
overwhelmed with the knowledge that their cancer has spread beyond that of the primary 
bowel site while at the same time holding the additional burden of whether or not they are 
eligible for surgical resection (Chiappa et al 2009). Where liver metastases are resectable, a 
typical pathway to liver resection, where neo-adjuvant cytotoxic therapy is not advocated, 
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can take approximately 2-3 months and where neo-adjuvant cytotoxic therapy is advocated 
can take approximately 6 months (local data). In more complex cases, where liver metastases 
are deemed to have borderline liver resectability and present alongside a bowel primary also 
requiring resection, the length of wait before a decision is made regarding a liver resection 
can exceed a year. This may be especially the case for those with a rectal tumour requiring 
downstaging radiation and surgery to treat the rectal primary (local data). With these 
scenarios in mind, it must be recognised that there can be a significant wait for patients living 
with the hope of a liver resection but also with the fear that the disease may grow and rule 
out the possibility of liver surgery.   
 
Perhaps it is not surprising that there is a deficit of publications which survey patients’ needs 
or experience, since colorectal liver resection has grown from a base in palliative surgery.  As 
such there is much emphasis on improved survival, and so that may be why much of the 
hepatic resection literature focuses on treatment efficacy and surgical outcome. It can be 
argued that only when a procedure has gathered momentum as standard practice (and often 
in the absence of randomised controlled trials), does the perspective and experience of the 
participant come into the fore. Reed et al (2009) report that there has been difficulty 
recruiting patients with metastatic disease to studies because of the nature of their disease. 
However, one could expect that recruitment to studies for metastatic disease will improve 
as standard treatment options continue to improve survival.  For those who develop liver 
metastases growth of disease bulk is slow when compared with metastatic disease in other 
cancer types, (e.g. lung, pancreatic) and it is therefore conceivable that patients who are 
actively treated for CRLM are in a position to be invited to take part in phenomenological 
studies in order to open up their experience, which in turn may be used by health 
professionals to make improvements to care. It is likely that as treatment options for 
metastatic cancer types improve, so too will patient recruitment for qualitative studies.  
 
3.3.1 Patient experience of colorectal liver metastases resection  
As set out above, there is only one American study by McCahill & Hamel-Bissell (2009) which 
report the experiences of patients who had undergone resection for colorectal liver 
metastases, primarily around the area of treatment decision making. Published in 2009, in a 
non-mainstream oncology journal, with only an impact factor of 1.199, the study serves as 
something of a marker in time evidencing the cusp of cultural treatment changes in 
metastatic colorectal cancer.  This can be seen as the study was conducted between 2005 
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and 2006 but includes participants who have had surgery and or ablation for CRLM between 
2003 and 2006, at a time when surgery was becoming more conventionally used in the 
management of CRLM. Study characteristics can be viewed in Table 3.1 below.  
 
The study reflects a change in optimism at a time when boundaries of colorectal cancer 
management were being extended from that of purely palliative management to using 
surgery to treat liver metastases more aggressively with the aim of control and the potential 
for cure.  This study is clear in its aim in seeking to identify common themes in patient 
experience of surgical treatment for liver metastases. By so doing patient factors important 
to surgical decision making could be identified. The rationale behind this was that clinicians 
should better understand the patient experience and hence identify potential barriers to the 
treatment experience or avoid patient misunderstanding. As a phenomenological qualitative 
study which is now over a decade old, it was conducted retrospectively with 12 patients by 
means of a single semi-structured interview in patients’ homes over a period of just over 12 
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The participants had a mean age of 63, which is within the expected norm for those with 
bowel cancer. The age range of 43-75 years also reflects that these patients were not in 
senior decades where surgical fitness of additional co-morbidities generally makes it more 
difficult to proceed with surgical resection. Ten participants had colon cancer and two rectal 
cancer, with seven men and five women being interviewed. None of these patients reported 
any symptoms which again is typical with this patient group and typifies the reality of a well 
patient group with metastatic liver only colorectal disease.   Patients initially were reported 
to have had liver only metastases and had undergone liver resection, ablation or both over a 
three and a half year period (January 2003 – June 2006).  The lengthy retrospective period 
did mean that for some patients, an interview was being conducted 2 years after the 
treatment which could pose a long period to recall information. This was likely to reflect the 
small patient caseload in the early to mid first decade of 2000 and the often lengthy 
treatment period for some patients. 
The study did acknowledge that including only patients who had a successful outcome from 
treatment for interview may bias results towards a positive experience. In order to avoid this, 
the researchers included three patients who developed further recurrence which was then 
not amenable to further surgery. This would be an important consideration in sample 
inclusion for any future study. However, on further examination of the surgical liver 
procedure only one of these patients had undergone a hepatic wedge resection. One patient 
had undergone radio frequency ablation (RFA) as discussed in chapter 2 and the other had 
undergone an exploratory laparotomy only.  The laparotomy would not fall within the 
original suggested criteria for the study, i.e. liver resection, ablation or both and perhaps this 
patient should have been excluded from the study.  
This presents one of the main difficulties with the study in that it does not include patients 
experiencing homogenous treatments. The patient sample included two patients who were 
treated with radiofrequency ablation (RFA) as their first treatment before liver resection and 
a further two who had RFA alone. Considering it is recognised that RFA is not as effective as 
surgical resection (Wong et al 2010), it is unclear as to the purpose of their inclusion as the 
rationale and explanation for treatment would be different from that of surgical resection.  
As discussed in chapter 2, RFA alone is often performed percutaneously in a radiology 
department and is therefore less likely to be seen primarily as a surgical treatment. It may be 
that the RFA reported in this study was performed in surgical conditions with a general 
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anaesthetic rather than percutaneous but it is not clear. This may simply reflect changes in 
practice as treatment develops. 
Much of the focus of the study was on the expectation from the surgical consultation rather 
than across the pathway as a whole and sought to identify common themes in “order to 
identify factors of importance in treatment decision making” (McCahill & Hamel-Bissell 2009, 
p.65). Focusing on the surgical consultation, it can appear that the decision to proceed to 
surgery was to be carefully weighed up in terms of a treatment preference. The reality may 
be for those with metastatic disease that there is less of an option in making a decision as 
the realisation of what it means to decline treatment is evident. Certainly, all the patients 
viewed the surgery as holding no guarantees for disease cure but yet was seen, at the very 
least, as an opportunity to extend their lives.  The authors acknowledge that they did not 
include any patients who were offered surgical treatment but declined. It is not clear if such 
participants were available during the recruitment time as declining treatment is itself an 
important and valid decision to support patients through.   The participants saw the overall 
decision for liver surgery to involve several steps rather than being seen as one definite point 
or event. This is interesting as health care professionals can often pinpoint when a decision 
has been made to go ahead with surgery, but the patients in this study are experiencing a 
continuum of events which take them closer to the actual surgery and recovery phase. This 
continuum involves, initiating the idea to go ahead with a surgical option, undergoing 
surgery, recovery period and living with the consequences of surgery. These events are a 
continuum, wrapped up in the very context of waiting.  
Using Colaizzi’s procedural steps in the data analysis, McCahill & Hamel-Bissell (2009) 
revealed six main themes that had reflected on the patient experience; communication with 
their health care provider, support, personal attitude, care uncertainty, coping strategies and 
hospital care concerns. The communication style of their health care provider (surgeon, 
oncologist or nurses) helped to set the tone of their treatment experience. Examples of 
positive communication included, thorough explanations, honest appraisal of risks and 
appropriate non-verbal communication which helped to give patients trust and confidence. 
Negative communication styles were experienced when patients felt rushed or a treatment 
option appeared to be forced upon them rather than including the patient’s opinion. In the 
same way it was recognised that support from others was key in undergoing treatment and 
positive and negative factors also applied. All patients noted that support from primarily 
38 
 
family and secondly social networks outside the health care environment, gave them hope 
and encouragement to continue with treatment. Outside support could also be negative at 
times when family members became overzealous to influence treatment decisions.  External 
support networks while acknowledged by health professionals as being important in 
preventing isolation (Macmillan Cancer Support 2013) are largely invisible to the clinical 
teams. The daily impact of the process of an individual being considered for CRLM must have 
its strain on family members and it is essential that those caring for the individuals also have 
access to appropriate support. 
With regard to the patient’s own attitude, all patients noted that having a positive outlook 
and resolve to have liver surgery would help to contribute to a positive outcome. This did not 
mean that they were responsible for the outcome but that through this life changing 
diagnosis they were free to concentrate on the important things in life such as family and 
previously meaningful situations in life were now challenged. The tension of having 
treatment to extend their life but with no absolute certainty was noted in, arguably, the key 
theme of cure uncertainty. All patients were under no illusion that the cancer could return 
and as a result the concept of waiting returned as a feature in the recovery period and was 
especially heightened during waiting for results of follow-up scans. Coping strategies helped 
patients to adapt to the life changing diagnosis such as taking a day at a time, living in the 
moment and facing emotions rather than hiding them. In the theme hospital care concerns, 
negative concerns included lack of communication among inpatient staff which left a 
negative impression on their hospital stay where help received was noted to leave a positive 
impression. It was not clear whether this inpatient stay related to their surgical experience 
or also chemotherapy experience. Lastly internet information, was seen as more of a support 
for family members than for patients. Six patients noted the lack of information on surgical 
resection of liver metastases and what was there was very negative about the process which 
often led them to avoid the internet. Overall the study showed that patients showed a high 
level of satisfaction with treatment despite three of the group sustaining recurrence.  
McCahil & Hamel- Bissell (2009) conclude that further work, especially on a larger scale, was 
required to validate these findings. 
 
3.3.2 Patient experience of liver transplantation for colorectal liver metastases  
 
Considering that there are no further published qualitative studies on colorectal liver 
resection, the net needed to be cast further afield to capture associated surgical literature. 
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The following study characteristics can be viewed in Table 3.2 below. The Norwegian 
qualitative study by Vidnes et al (2013) reports the patient experience of surgical treatment 

















































































































































Table 3.2:  Related patient experience for colorectal liver metastases (liver transplant) 
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Liver transplantation is the accepted treatment for chronic and acute liver diseases and its 
use as treatment for colorectal liver metastases has been limited due to 1 and 5 year survival 
rates of 61% and 18% respectively (Hoti & Adam 2008). It has been more successfully used 
in cholangiocarcinoma (Rea et al 2005) and hepatocellular carcinoma (Onaca et al 2007) and 
with improvements in reported quality of life in general liver transplanted patients (Adam & 
Hoti 2009). The availability of liver donors is very limited in the UK so the approach of liver 
transplantation alone makes this study interesting. The study was a mixed methods study, to 
evaluate the use of liver transplantation in cure or prolonging life with 25 patients with 
colorectal cancer and liver only metastases. The first study (Vidnes et al 2013) focused on 9 
of the 25 patients to conduct semi-structured interviews at least 6 months following liver 
transplant. The second study reported by Andersen et al (2012) with the same patient group, 
used the validated EORTC quality of life questionnaires a year after treatment was complete 
to ascertain recovery and function following surgery. Interviews were conducted over a one 
and half year period between 2007-2008 with patients who had received liver transplant 
between November 2006 and March 2008. The patient group were slightly younger than 
those in McCahill & Hamel-Bissell’s study (2009) with an age range of 50-63 and a median 
age of 56 years.  
Three main themes emerged from the interview data; a renewed gift of life, living between 
hope and despair and back to normal life. These themes resonate with those identified in 
McCahill & Hamel-Bissell’s study (2009) where patients were both grateful and realistic about 
the opportunity for liver resection to prolong their life, rather than necessarily provide a cure 
and seeking to find a new normal in life following surgery. Despite both studies using surgery 
to treat CRLM the Norwegian paper does not refer to the American study. All nine patients 
also reported equal or better global health scores compared to baseline scores and reported 
good functional scores during follow-up points at 3, 6 and 12 months following liver 
transplant (Andersen et al 2012) showing it to be effective in this initial year period. A further 
period of follow-up would be necessary to further evaluate the value of liver transplant in 
CRLM considering that with the use of cytotoxic medication alone, disease progression often 
exceeds 18 months (Choong & Ammori 2014). Both liver resection and the more 
experimental liver transplant  represent aggressive surgical intervention in the management 
of liver metastases. Notably, although Andersen et al’s study (2012) refers to the use of 
transplant, their quality of life (QoL) results echo previous liver resection studies showing 
overall good quality of life following liver resection using patient reported QoL measures 
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(Martin et al 2007, Wiering et al 2010, Rees et al 2012). Utilising aggressive surgery becomes 
more acceptable in the context of quality of life. 
While it is not the remit of this chapter to discuss the use of quantitative QoL tools, it is 
important to note QoL tools are a significant in assessing patient related outcome and will be 
referred to more fully in Chapter 5 when considering relevant study methodology. Broadly 
speaking, the tools are a multidimensional construction with objective and subjective 
dimensions rated on a continuum of severity. 
They are often used to provide a longitudinal view of patient recovery, symptoms and short-
term impact of treatment. Such measures are useful in providing information on the 
suitability of different treatment approaches and can inform decision making. However, 
there is much debate on QoL tools, how QoL can be defined and measured. The EORTC QLQ-
C30 and LMC questionnaires were primarily developed to measure short-term QoL and major 
on physical symptoms. In considering study design some thought was given to the use of 
these questionnaires for this study. However, this was ruled out and the reasons for doing so 
are detailed in Chapter 5, Methodology. It became necessary to understand the reasons for 
using these tools and whether they would add anything to understanding an experience that 
was not dominated by physical symptoms. I wanted to understand the patient experience of 
being considered for liver resection up to the point when a decision was made rather than 
focusing on how the disease and treatment would affect physical health during the period of 
consideration for CRLM resection. Another important aspect to consider is that the impact 
of physical changes and the psychological change during this process of being considered for 
liver resection may not necessarily be linked to the severity of the disease. It is not always 
the severity of the condition that is an indicator as to how someone manages but may be 
how an individual perceives and adjusts to their situation that determines overall impact, as 
identified by one study concerning depression, anxiety and pain (Brown et al 2010).  
 
3.3.3 Patient experience of long-term survivorship from colorectal liver resection 
 
The final qualitative study of interest is Whale’s (2016) doctorate study in Health Psychology.  
The aim of the study was to investigate the impact of CRLM resection on patient longer term 
quality of life and survivorship experience. Whale was conscious of the limitations of 
quantitative quality of life measures in assessing longer term quality of life. Study 
characteristics can be viewed in Table 3.3 overleaf. 
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Fifteen patients were recruited from a previously recruited cohort of 241 patients who were 
recruited between April 2004 and May 2007 as a means of assessing longer term quality of 
life up to 5 years following standard resection of metastases from colorectal cancer from two 
UK sites in Bristol and Basingstoke. 
Table 3.3: Related qualitative literature within quality of life study, colorectal liver 
resection (Whale 2016) 
Whale had been involved in some of the recruitment to the larger EORTC study at the 
University of Bristol (Rees et al 2014) which was a longitudinal prospective cohort 
investigating patient reported outcomes. Patients completed the EORTC QLQ-C30 and LCM 
questionnaires at four weeks prior to surgery, followed by 3, 6 and 12 months after surgery 
and a final long-term questionnaire at 5 years following resection. It was during Whale’s 
involvement in quantitative quality of life data collection that she became curious as to 
whether the questions were capturing the full patient experience.  Whale (2016) felt that she 
needed to understand the experiences of long-term cancer survivors and questioned if QoL 
would accurately provide a detailed picture of long term survivor experiences, particularly if 
there was uncertainty over how objective a measurement QoL could be and whether it was 
better designed for capturing short term physical change.  QoL can change over time and it 
therefore seemed short-sighted that the same QoL measure and domains could be used at 
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term needs. Whale believed that survivorship and post-cancer identity would become a more 
pertinent focus for long-term cancer survivors.  
In comparison, Whale (2016) opted for qualitative enquiry with the CRLM resection group 
believing that this would provide greater insight into a neglected area of investigation. Her 
aims were to explore the long-term quality of life and survivorship experiences in patients 
having had CRLM resection using qualitative interviews and in so doing to explore the 
relevance of EORTC QLQ-C30 and LMC questionnaires.  
Whale’s (2016) study revealed 3 themes which provided insight into the meaning of 
survivorship at least five years following CRLM; 1) ‘Cancer and me; establishing a relationship 
with cancer’, 2) ‘Living with cancer’ and 3) ‘Aligning the long-term impacts; the person I’ve 
become’.  Although participants did mention some on-going physical affects, the focus of the 
interviews centred on coming to terms with their cancer and how they had coped with their 
experiences and adapted to their new post-cancer self. Coping strategies were utilised which 
helped to foster a positive attitude such as reframing their focus in life and gaining positive 
outlooks from religious and spiritual beliefs. Living with cancer, acknowledging and adapting 
to the person they had become as a result of their cancer experience was necessarily an on-
going experience.  
 
Whale concluded that the EORTC QLQ-C30 and LMC measures did not address the issues of 
survivorship nor postcancer identity change, which is only apparent over time and not 
captured within the questions present on either questionnaire. With the use of qualitative 
interviews, Whale could see that individuals who experienced CRLM, used various coping 
strategies to deal with their experience. Some of these strategies were linked to changes in 
self and their identity as a result of the cancer diagnosis and treatment experience, or a new 
post-self. For others their experience was wrapped with a sense of meaning. This included a 
shift in priorities, renewed affirmation of life, greater importance on social relationships, 
increased empathy for others and changes in interpersonal relationships. Whale (2016) 
argued that the changes in identity and viewpoints as part of a new cancer self were a form 
of post-traumatic growth, as a result of undergoing a traumatic experience such as cancer 
(Zoellner & Maercker 2006). Post- traumatic growth is a direct contrast to the concept of 
post-traumatic stress disorder where an individual had no benefit from experienced trauma 
only pain and anxiety (Hadit 2006). The period that Whale (2016) refers to, was not a natural 
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process of personal development but could be better understood as the process of putting 
back together the pieces of self that were shattered as a result of the trauma and finding 
meaning from that experience (Thornton & Perez 2006). Experiencing a trauma can change 
the internal schema of an individual’s world view, the way the see the world, self and others 
(Weisman & Worden 1977). This idea of a new lens from which to see the world after cancer 
is well supported in the literature and also was a sentiment picked up from McCahill & Hamel-
Bisell’s (2009) phenomenological study.  
3.4 Colorectal liver metastases; a comparable experience  
A number of qualitative studies directly related to the experience of undergoing colorectal 
primary surgery have used phenomenological method and, as such, may have some bearing 
on patients being considered for liver metastases surgery.  
3.4.1 Perspectives from phenomenology accounts in colorectal primary surgery  
Moene et al (2006) conducted interviews with 28 patients in order to study how they 
experienced their existential situation one week before colorectal surgery. Analysis was 
influenced by van Manen’s four fundamental lifeworld themes (van Manen 1997). Van 
Manen sees research efforts into human science as explorations into the structures of the 
human lifeworld. He devised four fundamental lifeworld themes (or existentials) to guide the 
reflection and analysis of human experience. These themes are the existential of lived space 
(spatiality), lived body (corporeality), lived time (temporality) and lived relation 
(relationality). Half of the patients in the study sample included patients having surgery for 
benign colorectal disease, so it is perhaps no surprise that differences were found in how 
patients with benign disease viewed their existential situation. The two main differences 
were found in the areas of spatiality and temporality. Patients with benign disease 
experienced a sense of increased spatiality, primarily feeling that restrictions in life and social 
interactions would be lifted as a result of the surgery whereas patients with malignant 
disease felt that their world was becoming increasingly narrow, that life was going through a 
new phase and that this may mean the end of life was at hand. Similarly, patients with 
malignant disease, experienced temporality or the sense of time differently feeling especially 
anxious leading up to the surgery whereas those with benign disease were more able to use 
the time before surgery to gather energy, relax and prepare. With regard to experiencing 
corporeality, both those with benign and malignant disease, felt that they were entrusting 
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their bodies to be cared for and had confidence in the competence of the staff whom they 
had met. A further aim of Moene et al’s (2006) study was to explore the value of the 
encounter between the preoperative nurse and patient and this was examined under van 
Manen’s theme of experiencing relationality. Although Moene et al (2006) acknowledge that 
relatives played a vital support role, patients also valued the staff they met before the 
operation. Key aspects of these interactions were noted as providing security and continuity 
which were important in establishing a relationship. However, the role of the preoperative 
nurse did not feature in the interview statements and Moene et al (2006) concluded that 
nurses could do more to address existential concerns. This is particularly pertinent when 
considering that many of the concerns patients have in life limiting illness are by nature 
concerns that touch on the very meaning and value of life. 
Perhaps it is too easy to overlook such concerns in the clinical ‘doing’ of practice whereas an 
individual’s attention may be focused around how clinical aspects will impact upon their life. 
Often the individual focus may centre around existential questions on ‘being’ rather than the 
‘doing’. The study is of interest to the experience of those being considered for CRLM, as it 
confirms that those with malignant colorectal primary disease have apparent existential 
concerns which health care professionals may not be detecting or missing the opportunity to 
address. It may also be postulated that existential concerns may be heightened in patients 
with metastatic colorectal liver disease who are being considered for CRLM where knowledge 
that potential surgery may significantly increase life while concerns may grow about 
maintaining eligibility for surgery. At the time of writing, this study is over a decade old and 
while the contribution of the preoperative nurse is referenced, since then the input of 
specialist team nurses or nurse specialists have also been acknowledged in the management 
of cancer (Leary et al 2008, National Cancer Action Team 2010, Royal College of Nursing 2010,  
Department of Health 2011, Macmillan 2015, Henry 2015, and Vidall et al 2015). The fact 
that the role of the nurse was seen as invisible in Moene et al’s study has application for 
nurse specialists who are well placed across the care trajectory in helping to manage a period 
of uncertainty for those being considered for CRLM. That is not to say, that existential 
concerns should not be addressed across the wider team, as indicated in this study by the 
peri-operative nurse when concerns about getting through the operation are especially 
foremost and surgical risk is considered. 
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Worster & Holmes have published two papers relating to the same study in 2008 and 2009 
with 20 participants (10 male and 10 female) who underwent abdominal surgery for a 
colorectal cancer primary. Interestingly, the initial purpose of the study was to discuss the 
post discharge experience as the main focus of the study but the study took an unexpected 
turn when they discovered that the participants chose to talk about the their pre-operative 
experiences, relating much back to diagnosis and their emotions in preparation for surgery. 
Participants were approached and interviewed four weeks following hospital discharge and 
data were analysed using Giorgi’s (1985) analytical method. Six key themes were identified 
as the following: I couldn’t believe it, being alone, informational needs, protecting family, 
unexpected consequences of investigations and loss of control. The key themes they felt 
could be a common feature of any cancer type and not necessarily colorectal cancer but had 
particular bearing on the need to address such issues in the workup to surgery. The fact that 
there was a desire to return to reflect on how things began which had led them to the need 
for surgery suggested the beneficial or therapeutic aspect of these interviews, something of 
which a few participants had openly commented to the research interviewer at the time of 
the interview. The role of the Clinical Nurse Specialist was acknowledged during these 
interviews in helping to manage some of the concerns raised from the themes and to 
navigate the way to surgery. A key message of the study was the need for patients to be the 
guide of the level of information they required in order to help gain a sense of control over 
an uncertain process and time in their lives.   
Worster & Holmes continued to write up their intended study when they published the post-
op experiences of the same group of patients in 2009. Again, using Giorgi’s (1985) data 
analysis method, eight themes emerged. These were listed as the following; ‘thank goodness 
that is over’, ‘needing information’, ‘loss of dignity’, ‘personal appearance’, ‘loss of control 
and mobility’, ‘inability to eat and drink’, ‘lack of sleep’ and ‘discharge’. These themes are not 
surprisingly linked to physical aspects of recovery as would be expected for four weeks after 
surgery. There is however, no mention of whether any surgery was conducted 
laparoscopically as this may have had a bearing on that initial recovery or patient’s 
perception of adjustment in that immediate post-operative period. It did however 
acknowledge that the impact of Enhanced Recovery After Surgery (ERAS) may have a bearing 
on recovery in the future. Here it can be seen that the context of recovery and advances in 
nutrition, exercise and surgical technique can all feed into the patient’s post-operative 
recovery experience.  
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A further phenomenological study by Khatri et al (2012) reported on the experience of twelve 
patients in Sydney, Australia three to six months after undergoing gastrointestinal surgery of 
curative intent.  In addition to eight patients with colorectal cancer, it also included 
oesophageal and pancreatic patients and reported on the experience of six carers, known to 
participants. The study was robustly conducted with all three nurse consultants who 
conducted patient interviews having undergone interview training and research based 
interview methodology. As such the study is well presented and is rich in data. All interviews 
were conducted via telephone due to the practical constraints in covering a wide rural area. 
The lack of face to face contact, did not seem to hinder the depth of data but there can be 
constraints to not being directly present with the interviewee such as not being able to 
consider non-verbal communication which is a rich source of context for the whole of the 
interview process (Kings & Horrocks 2010).     
Overall the findings showed that these patients encountered a sense of altered time and 
temporality which was in line with the Heideggarian philosophy used to underpin the study. 
Four key themes summed up the aspect of the temporal experience of undergoing 
gastrointestinal surgery, ‘a recall of intricate details’, ‘waiting’, ‘a changing pace of time’ and 
‘being towards death’. Despite being interviewed three to six months following surgery, the 
first theme, a recall of intricate details is a striking finding.  
3.4.2 Relevance of findings  
 In clinical experience, patients often recall and relay intricate details during history taking. 
Often these details are conveyed in a setting where time is limited perhaps during a clinic 
consultation, and often the history taker is keen to get beyond these details to what is of 
clinical significance to them. In such cases the recall of intricate details is often something to 
be skimmed over and are often lost and superseded by more relevant details as the history 
taker sieves for information. What is important from Khatri et al’s (2012) study is that it gives 
an understanding of why patients search to recall specific details of their lives. Firstly, it 
provides a context as to what was going on in their lives and hence what was important to 
them at the time. Secondly, when faced with the temporality of life, an awareness of time 
and the need to pin events to a date often become important. This echoes Heideggar’s view 
of time in that we can only understand the phenomenon of time in relation to death, an 
event which is outside of our life but yet marks the end of life (Alweiss 2002).  
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The second theme of ‘waiting’ was a dominant experience in this patient group. The 
relevance of waiting is borne out of uncertainty as to what lies ahead following surgery, 
perhaps by way of complications and as Khatri et al (2012) suggest this waiting is exacerbated 
by a patient’s awareness of mortality when faced with cancer surgery. Indeed, cancer 
treatment may be seen as a continuous cycle of waiting and is influenced by a perception of 
cancer as a growing entity that remains a threat until it removed. During this wait, Khatri et 
al (2012) found that it is natural for there to be a heightened anticipation of outcomes at 
various stages along the way and that this is relieved only by appointments. Irritability is a 
common feature and reports from carers and participants suggest it is to be expected.  A 
health professional who is able to help prepare and manage expectation throughout the 
different stages of treatment pathway may help to level out some of this anxiety through the 
process of waiting.   
The third theme, ‘a changing pace of time’ was also identified. Participants in Khatri et al’s 
(2012) study spoke about a slowing down of certain aspects of life and a speeding up of other 
areas. To many it was as if there was a holding pattern forced on life. The final theme of 
‘being towards death’, conveyed that despite all surgery was of curative intent, yet life was 
very much threatened. This feeling followed afterwards when results were given and despite 
being given good news, patients felt it was hard to let go of the awareness of mortality and 
difficult to have a longer-term perspective on life.  
While the study acknowledges the limitation of different types of gastrointestinal cancer and 
admits that the purpose was not to make a direct comparison, the findings combined with 
the Moene et al’s (2006) and Worster & Holmes (2008) (2009) studies, have relevance for 
the subset of patients being considered for CRLM.  
 
3.5 Consideration of colorectal liver metastases resection; a parallel patient experience? 
In the absence of additional experiential research among patients with potentially resectable 
liver metastases, it is necessary to consider other literature related to the treatment of life 
limiting conditions where the possibility of further surgery can cure, extend life or control 
quality of life if the illness were not treated. One obvious area to turn to is the resection of 
other solitary lesions in colorectal cancer such as lung metastases or that of potentially 
curative peritoneal disease resection. However, while surgery in both these areas is 
increasing, as outlined in chapter 2, no qualitative studies have yet been published.   Neither 
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have there been qualitative studies undertaken with those who have had liver resection due 
to secondary disease in other tumour groups such as breast cancer where liver resection is 
occasionally used. This makes drawing parallels with phenomenological studies in the use of 
liver resection in other primary cancers unfeasible.  
With such a sparse literature base to work from, a wider literature net requires to be cast in 
life limiting conditions where similarities in the pathway to surgery or nature of disease may 
exist. From the primary qualitative research study by McCahill & Hamel-Bissell (2009) there 
were both external factors and individual factors which helpfully contributed to the patient 
experience of the pathway to CRLM resection.  To summarise from the previous section, 
external factors were those of the communication style of health care professionals, external 
support, the uncertain nature of the pathway itself and experience during hospital stay. 
Those individual factors noted were personal attitude and coping strategies. One area where 
there may be similar themes identified is within the speciality of liver transplantation. It could 
be argued that the process of ‘being considered’ for CRLM resection and for a liver transplant 
is a similar concept in the face of a life threatening illness and this will be explored in this 
section.   
3.5.1 Liver transplant  
A liver transplant involves the surgical transplant and acceptance of a liver from a deceased 
donor. A strong, qualitative research base has developed in liver transplant mainly from the 
mid 1990s, since it gained acceptance as a successful and optimal treatment for end stage 
liver disease with 1 year and 5 year survival rates of 87% and 73% respectively (Adam et al 
2012, Alqahtani 2012). The widespread adoption of cyclosporine based immunosuppression 
as routine post-operative procedure and the standardisation of the transplant procedure 
during the late 1980s greatly contributed to now survival picture (Adam et al 2012).   
ESLD(End stage liver disease) results from advanced liver damage, more commonly seen 
through hepatitis C, alcoholism and cholestatic liver disease, such as primary biliary cirrhosis 
(Bjørk & Nåden 2006). Cirrhosis of the liver is a common feature where normal liver 
architecture is converted into abnormal nodules which contributes to portal hypertension 
and other complications such as gastrointestinal bleeding (Brown et al 2006). The primary 
reason for liver transplant of ESLD include commonly experienced symptoms of fatigue, 
muscle weakness, itching, nausea, weight loss, jaundice and fluid retention (Wainwright 
1997, Brown et al 2006, Findlay et al 2011). Encephalopathy can also occur with memory loss, 
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confusion and eventual coma (Findlay et al 2011). Like CRLM resection, the possibility of liver 
transplant has arisen as a consequence of innovation in surgical technique, however the 
scarcity of organ donation limits its availability to those in need. In view of the shortage of 
cadaveric livers, attempts have been made at prioritising patient need based on statistical 
formulas that predict who is most likely to die. The Model for End-Stage Liver Disease (MELD) 
is a commonly used scale with a higher score representing a  higher priority for 
transplantation (Brown et al 2006). Introducing such methods have not been without their 
difficulties and patients themselves have often reported being at the mercy of the MELD. 
Larson & Curtis’s (2006) perspectives on an ESLD case study, with the sub-title of ‘Too Well 
for Transplant, Too Sick for Life’ aptly captures this feeling, with patients themselves feeling 
symptomatically in need of a transplant but their MELD score suggesting otherwise.  
Due to the shortage of cadaveric livers, living-donor liver transplantation (LDLT) has been 
developed to address the shortfall, with the first adult transplant taking place in 1994 
(Hashikura et al 1994). However, living-donor liver transplant is also not without risk for the 
donor (Watanabe & Inoue 2009).  
3.5.2 Liver transplant: a comparable goal? 
The goals of liver transplantation are not dissimilar to the goals of liver resection;  firstly to 
prolong survival and secondly to improve overall quality of life for patients (Alqahtani 2012). 
The only point to note is that during the wait for liver transplant, patients’ quality of life is 
generally affected to the degree where life is restricted in a physical means, whereas patients 
who are being considered for liver resection are usually asymptomatic as the intention is to 
use liver resection at an early phase of liver metastases development. This is a marked 
difference between the potential liver resection group and liver transplant and may have 
considerable impact on the emotional and physical state of the individual. Should the CRLM 
disease remain, only then would quality of life issues would become a feature.  In both liver 
resection and liver transplant, surgery should be considered for appropriately selected 
patients for whom it would extend life expectancy beyond the prediction of the natural 
history of their disease. In both ESLD and CRLM without surgical treatment, there is no hope 
of cure and death is inevitable.  Therefore, it is reasonable to consider qualitative transplant 
literature for this reason. In addition, both disease processes involve multidisciplinary input, 
with the transplant team having a well established nursing role in patient counselling and 
support (Levenson & Olbrisch 1987, Brown et al 2006).  
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Liver transplant has a richer base in qualitative studies stemming from the late 80s. One early 
study by Levenson & Olbrisch (1987) studies the relationship of the transplant team with 
patients during the wait. Interestingly, patients found that silences during the wait often felt 
like an avoidance of contact by the team and made the wait more difficult. This does raise 
the question of the importance of confronting such silences during difficult waiting periods 
of treatment by means of regular contact. 
Much of the early focus on qualitative studies has been on aspects of pre and post treatment 
often involving quantitative quality of life measures as the physical change in health took 
place. Wainwright (1995) used grounded theory method to analyse data from in depth 
interviews covering patients adjustment post liver resection. His findings from the patient’s 
perspective viewed liver transplant as one of transformation, covering a five stage trajectory 
of ‘receiving the transplant’, ‘improving in hospital’, ‘improving at home’, ‘feeling well again’ 
and ‘reciprocating’.  Jones & Egan (2000) also looked at the patient experience of life pre-
transplant, during and after transplant and identified themes of quality of life, and factors of 
concern relating to finance, social support and psychological coping. One aspect which is 
apparent although not always labelled as such in the qualitative studies is the feature of 
waiting. This is common, both to the colorectal liver metastases resection pathway and the 
pathway to liver transplant in end stage liver disease. In Brown’s et al study (2006), eight 
themes emerged which were seen as important elements of the wait for liver transplant (see 
Table 3.4 along with the themes from the Norwegian study by Bjørk & Nåden (2008).  
Waiting themes identified in consideration of liver transplant for ESLD 
Brown et al (2006), USA Bjørk & Nåden (2009), Norway 
1) Transformation of self 1) Uncertainty 
2) Doctors, teams and trust 2) Mental wear and tear due to reduced energy 
3) Elation to despair 3) Existential brooding about the meaning of 
life 
4) Loss 4) Feelings of being mentally strong 
5) Questioning the process  
6) Searching  
7) Coping  
8) Paradox of Time  
Table 3.4: Main qualitative studies investigating waiting in liver transplant for ESLD 
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3.6 An identifiable feature of waiting 
There are two studies where the feature of waiting has been purposely investigated in liver 
transplant, an American study by Brown et al (2006) and a Norwegian study by Bjørk & Nåden 
(2008). Brown et al’s (2006) study is clear in its intention to investigate wait, which the 
authors state arose from a feeling of being “ill at ease” (p.119) with the status quo of the 
ESLD process. As psychiatrists they were involved to assess and verify that patients waiting 
for transplant, due to alcoholic and drug causality, had been abstinent for six months. 
Observationally in practice, Brown and colleagues could see a repetitive feature of strain on 
patients in the process of waiting. They write, 
“Out of the silences and repetitions of their time on the waiting list, an 
occasional voice was heard. It was at times an articulate plea for 
recognition of the uniqueness of their experience.” (Brown et al 2006 
p.132) 
This prompted one of the authors to “wonder about much more that was left unsaid and 
unexplored” p.132). Certainly, this feeling is echoed in the reason for the study detailed in 
this thesis.  The impetus for study was through having a feeling of being ill at ease that the 
process of being considered was having a significant effect on those patients waiting for 
surgical resection.  While it has been exciting to see the developments in the management 
of metastatic colorectal cancer, observationally, it can be seen that pathways of treatment 
have become more complex than the traditional elements of surgery plus or minus 
chemotherapy used in the palliative management of CRLM. In addition, the reality is, that the 
nature of such complex treatment pathways are often managed by different teams within 
their own discipline and departments, albeit acting as one commonly named team with 
shared decision making taking place through the multidisciplinary team meetings. An added 
element for consideration is that the teams sharing responsibility are often located on 
different hospital site locations which may prove more difficult both for patients and 
professionals in terms of pragmatics of management and communication.  It is not 
unreasonable to suggest that as treatment pathways become more complex, a more complex 
care experience is created? In such situations, patients can move ‘out of view’ of their central 
team who have referred on for expert input. If communication and support is not culturally 
similar across different hospital sites, this may create a feeling of invisibility for the patient. 
Perhaps, by the very nature of surgical developments for metastatic CRLM, health 
professionals inadvertently invite patients to consider treatment where nothing of the 
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impact of that treatment is really as yet known.  Indeed, Brown et al (2006) stated that the 
concern to investigate the liver transplant experience was “initiated by a sense of complicity 
in their suffering”.   The question then arises as to whether health professionals, have 
imposed a system upon patients that increases the burden of waiting?  As Brown et al (2006) 
write, 
“What happens in the waiting process might contribute to the 
comorbidity of illness and poorer quality of life” (Brown et al 2006 
p.120). 
If this is the case, then how we navigate patients through that wait is of consequence, 
particularly if it has an impact on their health. Three key concepts of waiting from the 
domains of patient experience literature in CRLM, colorectal primary surgery and liver 
transplant that are worth picking up on are isolation, uncertainty and survivorship.  
3.6.1 Isolation 
The Cambridge dictionary describes the noun ‘isolation’ as both  
“the condition of being alone, especially when this makes you feel 
unhappy” and “the fact that something is separate and not connected to 
other things” (The Cambridge Dictionary, online, 2018). 
This definition is thought provoking in the area of CRLM as indeed with reference to any 
cancer type, there will be some patients who have access to good family and social networks 
to draw support from and others who have little in the way of social interaction. What is 
interesting is that perhaps this definition does not touch on the idea that people can still be 
surrounded by others but have the feeling of being isolated. Indeed, perhaps being with 
others may even exacerbate feelings of isolation, with patients feeling separated from a 
commonality with those close to them even though they value their support. Macmillan 
published a report, (Macmillan Cancer Support 2013) revealing the difficulties that social 
isolation can have on people facing cancer treatment, although this mainly focuses on those 
who have little support.  Macmillan’s often heard line of ‘no one should face cancer alone’, 
rightly acknowledges that support from others is an essential part of helping to cope with a 
cancer diagnosis, yet patients can have good support but the feeling of being separate and 
not connected to other things, as the second noun definition by the Cambridge dictionary, 




This feeling of being alone, is also encountered at diagnosis. A qualitative study by Taylor 
(2001) using phenomenological methodology in 8 patients, only 4 weeks after diagnosis with 
a colorectal primary, discovered a striking and poignant theme of patients ‘feeling on their 
own’. It is likely that none of these patients were metastatic from the outset as Taylor speaks 
about them going on to have primary treatment. In interviewing these patients, she found 
that there was a tremendous sense of wanting to protect others from what they were going 
through. Some of this may have stemmed from embarrassment that was specifically related 
to the nature of bowel disease but meant that close family and friends were often kept away 
from patients’ true feelings. The researcher reports that an interesting benefit of this study 
was that some patients used the transcript which they were given from the interview and 
showed it to their relevant others as a means of expressing how they felt. What is not clear 
from the study was how other relevant others felt on reading the transcript or if there was 
any additional support offered to them. No doubt for some this may have been a useful 
exercise to encourage discussion but for others this may have a more negative impact 
warranting additional support.   
  
With an increasing group of metastatic patients living with and concurrently undergoing 
multimodal therapy as part of ongoing treatment, there are likely to be issues of isolation to 
be addressed. This will potentially have an impact on family and social relationships, working 
patterns and finance related decisions. This may also be the case for those having treatment 
for metastatic colorectal cancer.  
 
3.6.2  Uncertainty     
Uncertainty related to cancer treatment is a major theme in the literature.  Uncertainty is 
something from which we cannot escape in life. It is something which we are familiar with 
on a daily basis where we cannot predict what the day will hold and yet also at the same time 
uncertainty may be predicted at different stages of the life cycle, e.g. finding a job after a 
period of study or loss of job or readjusting to life after a bereavement. The concept of living 
with uncertainty is well documented in health literature, particularly where health concerns 
have a significant impact on life. A century ago, infections such as tuberculosis, influenza and 
pneumonia posed a serious threat to the health of the nation. The presence of death by way 
of infection, was commonly part of everyday life and for many cast an uncertain shadow over 
living.  The last century has, however, seen major advances in science and technology which 
have led to phenomenal breakthroughs in infection control so that while as a society we have 
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largely fought infection, that effort has now turned to fight diseases such as heart disease 
and cancer.  McKie writes,  
‘Cancer, so feared today, was not a pressing concern a century ago’ 
(McKie 2015, para.2). 
Indeed, quoting John Williams, then Head of Science Strategy Evaluation and Impact of the 
Wellcome Trust, McKie goes on to say,  
“If you don’t die of an infectious disease, you will still die of something 
else. It’s one of the certainties in life. So those who survived tuberculosis 
and flu eventually succumbed to something else – and very often that 
was cancer or cardiovascular disease, including stroke and heart attack.” 
(Williams in McKie 2015, para.8). 
Death, as John Williams states, is one of the certainties of life. It is a risk with a certain 
outcome. The commonly quoted idiom, “Nothing is certain but death and taxes” which 
appeared in an identifiable format in a letter to Jean-Baptiste Leroy from Benjamin Franklin 
in 1789, (Pirie 2019) is a commonly understood phrase. It resonates to those understanding 
the transience of life. When considering the area of CRLM resection, the transience and 
fragility of life is starkly put into focus and is set against risk. The risk of not getting through 
to surgical resection makes mortality certain. At the same time, the operation is not without 
risk itself.  It is important to ascertain if there are other areas where such uncertainty could 
exist in light of a similar risk.  
Simpson & Whyte’s (2005) qualitative study of 8 patients having completed treatment for 
bowel cancer found that all eight respondents highlighted the feeling of uncertainty over 
cancer recurrence.  One respondent reported, ‘It came once, it can come again’. This builds 
upon previous work in this area among patients having had potentially curative surgery 
(Galloway & Graydon 1996, Knowles et al 1999), although it could be argued that in the 
hepatic resection pathway, there is yet another level of uncertainty as for some patients they 
are waiting to see if their liver can be rendered operable by downstaging treatment.  
 
Doyle (2008), in her literature review using Rodgers evolutionary method (Rodgers 2000) to 
identify key themes, found that uncertainty and living with cancer were inextricably linked. 
Even those with a good prognosis were reported to suffer from anxiety over the concern of 
cancer recurrence and could feel powerless as to how they could ease themselves from the 
oppressive anxiety itself.  Interestingly, a longitudinal study by Mullens et al (2004) over 14 
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years, with 81 cancer survivors, found that those who had low level risk perceptions of a 
colorectal cancer recurrence were more likely (not statistically) to adopt protective health 
behaviours to improve their lifestyle and well-being. It is difficult to know if modifying 
behaviour is a pattern that is associated within the context of metastatic disease. Certainly, 
as the number of cancer survivors living with metastatic disease increase, there may be 
lifestyle changes made to improve their general health. This fits in with issues of both self-
management and survivorship.  
 
While uncertainty can exist around the ontological questions of being, it can also exist around 
immediate informational needs. Beaver et al’s (2010) well designed, exploratory study of the 
follow-up needs of 27 colorectal cancer patients, found that informational needs on 
completion of treatment were often unmet, as were psychosocial needs of dealing with 
cancer treatment.  In fact those who had convential follow-up, were less happy with how 
their needs had been met than those attending a nurse-led model of follow-up. Kidd (2011), 
in critiquing this study, suggests that the results might have given reference to how 
demographic and disease specific issues may have shaped patients perceived needs at the 
time. Indeed, when looking at the postoperative experiences of twenty colorectal cancer 
patients, Worster & Holmes (2009) found that many of the patients’ information concerns 
focused around physical needs due to the recency of their surgery. These needs might be 
very different at other points in their cancer journey.  When considering those patients on 
the pathway to liver resection, issues pertaining to uncertainty and informational need might 
be very different yet again. Hansen et al’s (2012) literature synthesis of patient uncertainty 
included literature related to oncology patients and suggested that interventions such as 
organising hospital trajectory, providing support through relationships and providing 
accurate communication could all be beneficial to manage uncertainty. Such measures could 
help patients live in the everyday while not letting distant treatment goals engulf living. 
Interestingly, from Brown et al’s (2006) experiential accounts of liver transplant, the patients 
awaiting transplant often felt the goal of the liver transplant became the overwhelming 
focus, whereas living in the present ought to have been the tangible thing to focus on. As one 
liver transplant patient, poignantly expresses,   
“The future is always the goal and the present is held up and forgotten” 




 3.6.3 Survivorship  
The previous two themes identified sit closely related to survivorship. Doyle (2008) writes 
that there is much emerging in this field but work is now long overdue due to an increase in 
cancer survivors. In seeking to define a cancer survivor, Doyle poses an interesting question, 
‘When does someone become a cancer survivor?’ Is cancer survivorship purely related to 
prognosis?  Interestingly, in metastatic colorectal cancer with liver metastases, a survival rate 
following hepatic resection can be as high as 50%.  Van Cutsem et al (2010) point out that 
this is a recurrence risk comparable to having adjuvant treatment following bowel surgery. 
When this is taken into account we begin to see cancer survivorship in different terms, akin 
to that of a chronic illness which requires ongoing management (Aziz & Rowland 2003, The 
Scottish Government 2008). This has significant impact on issues of recovery and follow-up.  
 
3.6 Chapter summary  
This chapter has set out the main phenomenological studies directly relating to the 
qualitative experience of being considered for colorectal liver metastases resection. It began 
by looking at three main studies (McCahill & Hamel Bissell 2009, Vidnes et al 2013 and Whale 
2016) which were directly related to the use of surgery in colorectal liver metastases. In the 
absence of further directly comparable literature, the literature search was widened to look 
at other phenomenological studies also concerned with surgery for a colorectal primary. It 
then drew upon phenomenological accounts of waiting for a liver transplant as a surprising 
comparable experience. The concept of a liver transplant has a generally accepted 
understanding as a significant ordeal, which if the goal of liver transplant is not met, means 
a significantly shorter life. When the emotional impact of CRLM is considered as comparable 
to a liver transplant, the psychological impact of being considered for a liver resection is not 
to be underestimated. Both processes consist of the certainty of the feature of waiting and 
for both the process could often be viewed as an active wait, with periods of treatment and 
follow-up to assess treatment. From the literature identified in this chapter, three aspects of 
waiting were selected as having particular bearing upon being considered for CRLM 
resection. These were identified as isolation, uncertainty and survivorship. It was these 
aspects of waiting when viewed in the context of the treatment development of CRLM that 
has led me to the concept of hope, a concept that holds the process of waiting together with 
evident uncertainty. For this reason, the concept and value of hope will be discussed in the 




A dissection of hope in cancer; origin, form and function 
“Hope is the thing with feathers, 
That perches in the soul 
And sings the tune without the words 
And never stops at all” 
 (Emily Dickinson 1891, in Dickinson 2016, p.94.) 
4.1 Chapter overview  
The media have been quick to communicate treatment advances in cancer to the general 
public in what seems like an explosion of media coverage in the past decade, in particular. 
News broadcasting, newspapers, magazines and social media are quick to pick up on success 
stories of cancer treatment or the potential breakthrough of a new treatment and what 
implications that might have for individuals with a particular cancer. Charities too have ridden 
on the crest of success, and strap lines such as ‘We will beat cancer sooner’ as used by a well 
known cancer charity, suggest an urgency to finally eradicate this disease and the pain it 
causes to those in society.  Looking back to the picture of cancer as evidenced in the 1950s 
and the huge advances made since, for example, in acute lymphoblastic childhood leukaemia 
(Pui & Evans (2013) it is understandable how we have cause to hope.  There appears to be a 
growing global sense of hope in the progress evidenced in the overall trend of survival rates 
for example as seen in breast, bowel and prostate cancers. In many cases we can see that 
this gives rise to an individual sense of increasing hope in treatment when presented with a 
cancer diagnosis. As health professionals, we commonly hear individuals and their families 
speak of a time when an older relative had cancer and very little could be done, often to 
finish the conversation with the phrase ‘that was then and this is now’, expressing the idea 
‘that things [treatment] will have moved on’.  Yet, we know that for many, the reality of living 
with cancer and a lack of treatment options are very real. Although there has been 
recognisable progress, the tangibility of hope is more nuanced when we get down to the 
individual level than we could be led to believe by media coverage alone.  
The literature reviewed in chapter three has led to a necessary pause and reflection on the 
concept of hope together with the role which hope plays for individuals with cancer and how 
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this might have a bearing on those patients being considered for CRLM resection.  This 
chapter will provide an analysis on the concept of hope before looking at the role of hope in 
those with cancer. It will include a reflection on the origins of hope, tracing it back to how it 
has been viewed in history with often an unfavourable stance before looking at two key 
theories of hope, Snyder (2000) and Herth (1990). It will conclude with the implications of 
hope in nursing and how hope may be fostered in situations where uncertainty is high, which 
may have bearing on those being considered for liver resection. It is the philosophical 
interrogation of hope that aids understanding and interpretation of the data and in turn, 
lends a practicality to how health professionals might utilise hope amidst uncertainty. 
4.2 The meaning and origins of hope 
Hope is a multifaceted, abstract concept and while it may differ in relation to an individual’s 
circumstance it is also a concept which is individually realised by its presence or its absence. 
Nweze et al (2013, px) in their analysis of the concept of hope, suggest that hope is appealing 
to us because of the focus it gives “to the various ways in which human beings survive in life, 
despite the many traumatic events that lead to the disruptions of life that occur”.  Few of us 
could fail to identify with either the traumatic life events or the ensuing disruption 
encountered as a result and so it is of little surprise that the entity of hope is something which 
has captured the fascination and speculation of theologians, philosophers, playwrights and 
songwriters across many centuries, in a bid to understand why we continue to hope when 
events happen that are not in our plan or sphere of control. Indeed, Hans-Georg Gadamer 
wrote with this sentiment very much in consideration in his major philosophical work Truth 
and Method’ (1960), that of interpreting events in life, even though we may not be 
consciously interpreting as a response to those events. In the prelude to the second edition, 
he writes, 
"My real concern was and is philosophic: not what we do or what we 
ought to do, but what happens to us over and above our wanting and 
doing". (Gadamer 2013, p.xxvi) 
With such general appeal and potential value, there is also little surprise to find that the 
application of hope has also been discussed extensively across different disciplines in 
literature (Cutcliffe & Herth 2012).  The recognition of the importance of hope to nursing 
practice has grown since the early 1990s with the contribution of Herth’s work in how hope 
is fostered in the terminally ill (Herth 1990) and there is now an understanding that hope is 
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a basic value in nursing, being firmly rooted within nursing philosophy (Hammer et al 2009).  
However, it is noted that different interpretations and conceptions of hope exist within 
different disciplines (Hammer et al 2009, Nweze et al 2013) and for this reason, defining it 
with some certainty has proved difficult.  
The word hope can be used against a continuum of situations with varying intensity of 
emotion, from the more mundane to the more poignant and serious situations in life. As both 
a noun and a verb it is a strong, active word and provides flexibility in the English language, 
ready to be applied with varying situation and sentiment. As a noun hope is defined as “a 
feeling of expectation and a desire for a particular thing to happen” and as a verb, “want[ing] 
something to happen or be the case”, (Oxford University Press, 2018 para.1)..    The converse 
of hope is to be hopeless. Cutliffe & Herth (2002) acknowledge that the words ‘despair’ and 
‘desperation’ also stem from the same Latin root as hopeless, which suggests a position on 
the further end of the spectrum of being without hope.   A second, although less typical 
definition of hope is “a feeling of trust”, (Oxford University Press, 2018, para.2) whereby the 
inference lies in trust in a relationship. This definition is not often alluded to in the hope 
literature but the relevance is worth noting in support of  the idea that trust frequently goes 
hand in hand with an expectation that a relational being or a belief in a higher power can 
bring about change in a situation.   
As a phenomenon, hope presents some unique challenges for theories of mind and theories 
of value. It is an attitude with a cognitive component, i.e. the idea that it is responsive to facts 
about how likely future events will happen but it also has a conative component, i.e., it 
reflects and draws upon our desires of what we want to occur. The interesting conundrum is 
that not all that we desire to happen is necessarily the result of a correct interpretation of 
events which raises the question could hope be reduced to the sum of our beliefs?  The 
concept of optimism has often been taken as synonymous with hope yet hope can be used 
to desire an outcome which is very unlikely and does not expect to happen, such as the cure 
of a terminal illness. Optimism does not seem to have a place such a situation as the 
probability makes the optimism obsolete. The role of optimism will be discussed later in this 
chapter within the section on hope theory.  Many philosophers feel that to understand hope 
properly is to see it as independent of an assessment of probability (Bloeser & Stahl 2017).  
This also raises the question that if hope still occurs despite evaluating the facts of probability 
which might render it useless, can it be misleading, distorting and unhelpful?   
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We can see that hope can be used within a continuum of situations from the mundane to the 
poignant and differs widely according to personal experience. Francis Bacon is reported to 
have said that ‘hope is a good breakfast but it is a bad supper’ (Bacon cited in Spedding et al 
1859, p.168) while the following quotation from Benjamin Franklin hints at the futility of 
hoping alone without purpose, 
‘He that lives upon hope will die fasting’ (Franklin 1848 p.2) 
These thoughts prompt the question, is hope useful or is it merely an illusion? This also has 
bearing on how useful hope is when faced with extreme situations of health such as 
metastatic liver disease as discussed in this thesis. At this point it is worth pausing to look at 
different concepts of hope through history in order to give some context to these questions.  
By examining the origins of hope, we can see how historic thinking has helped to shape our 
current understanding of some important elements of hope, which are relevant to difficult 
periods of life such as life threatening illness.    
4.2.1 Hope as viewed in ancient times 
Early accounts of hope in Greek mythology, have often had negative connotations as 
something to be wary off which could mislead actions. An account by Thucydides suggests 
that those who hope seem to have a poor understanding of their situation and fail to come 
up with their own plans for success (Schlosser 2012). This account was often directly seen in 
the context of war, The Peloponnesian War in this case. In Hesiod’s tale of Pandora after all 
of life’s miseries had escaped from Pandora’s jar, hope was the one thing that remained 
(Verdenius 1985), although there are differing interpretations of this. The more commonly 
understood interpretation is that hope was left in the box as a distinctly positive force for 
comfort amidst widespread evil. While Verdenius suggests that it may have been left in the 
box to keep hope away from man as hope has an undesirable consequence often resulting in 
lack of productivity through idleness (Bloeser & Stahl 2017).  The use of Pandora’s box is a 
good example of how the concept of hope is different to each of us and how cultural 
interpretation plays a bearing on individual meaning. Plato too reports hope as a negative 
influence in Timaeus when he recounts that divine beings have given a number of attributes 
along with a ‘gullible hope’ (Plato, Timaeus as translated Waterfield, 2008 p.69b). However, 
in the Philebus he gives a more favourable view of hope suggesting that expectation of future 
pleasures are called hopes (Forte 2016).  
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Likewise, Aristotle recounts a more positive view of hope when he discusses the virtue of 
courage (Bloeser & Stahl 2017). In his discussion it would seem there is a contrast between 
hope and courage yet there is also a link between hope and courage by exercising an inner 
confidence. Aristotle speaking on confidence writes,  
“The coward, then, is a despairing sort of person; for he fears everything. 
The brave man, on the other hand, has the opposite disposition; for 
confidence is the mark of a hopeful disposition”. (Aristotle, The 
Nicomachean Ethics, 2009 p.51).  
This is interesting because not every hopeful person could be viewed or may necessarily see 
themselves as courageous but Aristotle by virtue sees every courageous person to be 
hopeful. In this way the action of being hopeful creates confidence. Although not discussed, 
perhaps the confidence that others exert in a situation may affect the individual’s action of 
hoping. This in turn may lead to a position of trust which may also help individual’s hope in 
others to see them through a difficult situation, despite the overall outcome.  
 
In ancient Greece, the concept of hope was less well viewed by Stoic philosophers. Perhaps 
this was not surprising, as the practice of Stoicism was developed by Zeno Citium around 3rd 
century B.C (Bloeser & Stahl 2017) and focused on development self-control and fortitude as 
a way of overcoming emotions which could be seen as destructive or unhelpful. Its basis has 
an important inference on hope as its intention is to transform emotions rather than deny 
their existence altogether through the practice of asceticism, that is, abstaining from 
pleasures of the world. This in turn should create clear judgement and ultimately the goal of 
freedom from suffering. It can be seen how by ‘turning off’ the mechanism of hope that this 
may lead to unnecessary suffering if the mind is not allowed to follow in a meaningless or 
futile hope.  Seneca, in particular, revealed a negative view of hope through Stoic philosophy 
in that he believed hope to be caught up with fear. He said, 
“Widely different though they are, the two of them march in unison like 
a prisoner and the escort he is handcuffed to. Fear keeps pace with 
hope” (Seneca, 1969 as cited in Rorty 2003).  
Seneca, almost simplistically, felt that if we avoided hope we could avoid fear and this would 
lead us to concentrate on the present and thus achieve a state of inner calm with our current 
situation and environment. In this way, hope had little purpose in contributing to the view of 
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one’s future. This is in direct contrast to the theological hope as outlined in the following 
section.  
4.2.2 A Christian view of hope  
The Christian view of hope has been focused on. This is not to say that in other major 
religions, hope is not evident but Christianity provides such a rich literary source of hope and 
has been the context of our cultural heritage in the UK. In addition, Christianity has either 
underpinned many of the major Western philosophers theories or has been referred to in 
order to reject Christianity as an alternative way of thinking. Theologically, the Christian 
perspective is wrapped up in hope. Cutcliffe & Herth (2002) state that, 
“If hope is considered in terms of the Christian faith then it can be 
argued that hope has existed almost as long as man has existed.” 
(p.833) 
The Christian faith is one of reconciliation between man and God, a rescue story and 
therefore one of hope. Hope is mentioned 129 times in the Bible and is connected with not 
just the present life but the securing of life after death which was made possible through the 
death and then resurrection of Jesus. In this way faith and hope are intrinsically linked and 
as portrayed by the theological philosopher, William Lynch (1965) seeing hope as a product 
of faith (Capps 2016). An example of this is seen in the book of Hebrews, Chapter 11, verse 
1, “Now faith is confidence in what we hope for and assurance about what we do not see”, 
revealing that hope appears to be a product of faith (Hebrews 11:1, NIV, 2018). This faith is 
expectant and confident and suggests something more than a short-lived hope but rather a 
certainty. Hope in this perspective is not restricted to life on earth but goes beyond death 
and provides meaning to that death and future existence beyond death.  
Augustine and Aquinas see hope as one of the central virtues of a Christian belief (Bloeser & 
Stahl 2017).  They do not see that the hope has formed the belief as if by some way of comfort 
but that the hope has is attributed to a rational faith and will therefore drive actions.  In 
Romans 8, Paul states that believers have a certain hope and alludes to the idea that hope 
can often be the product of suffering, (Romans 8, NIV 2018). At this point, Paul is referring to 
the suffering that Christ went through but individually we can see that hope really comes into 
play in situations where individuals are struggling or suffering. Augustine distinguished hope 
from faith in that hope is therefore forward looking, anticipating a time when suffering will 
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be alleviated in a situation or ultimately will end in death which will herald the afterlife. Faith 
is what this hope is based on (Bloeser & Stahl 2017). Indeed, it is the redemption view 
through Christ that has driven the basis of Christian political reform, whereby punishment is 
not solely linked with proportionality of the crime but also towards restoration of the 
individual criminal, purely because hope is present (Kempshall 2003). Aquinas also examines 
everyday ordinary hope, seeing it as a passion which drives forward actions in his account in 
Summa theologiae (Lamb 2016) while at the same time being based upon a rational faith. In 
this way, hope can seen intrinsically connected to faith and love, stemming from rationality 
of knowledge, passion of belief and facilitating action.  
4.2.3 Seventeenth and eighteenth century view of hope 
During this period the majority of philosophers saw hope as a passion operating from within 
which could motivate either a rational or irrational action. This is true of Descartes, who in 
Passions of the Soul, (1649) saw hope as a weaker form of confidence where one would tend 
to think of an event as likely but not a certainty (Bloeser & Stahl 2017). It is this element of 
uncertainty that introduces anxiety and in this way hope and anxiety can often accompany 
one another. Thomas Hobbes saw hope as a cognitive process which meant that because it 
is bound up with our thinking, this can also play a part in deliberation (Bobier 2017).  Spinoza 
failed to see hope as a rational process, seeing it as fundamentally irrational false belief and 
went so far to argue in Ethics (Spinoza 1677) that it was one of the causes of superstition 
(Bloeser & Stahl 2017). Hope, he argued was always caught up with fear rather than just 
anxiety and was why we should try to free ourselves from the desire for hope. Hume also 
views hope as a passion which comes about when the mind weighs up probable events that 
have absolute certainty and absolute impossibility. In the weighing up of events the mind can 
entertain contrary viewpoints of hope or fear which give rise to joy or sorrow.   These feelings 
can persist and can affect the perception of the actual outcome.  
Immanuel Kant makes a connection between hope, reason and judgement in his works, 
Critique of Pure Reason and Critique of the Power of Judgement where he grapples with 
fundamental questions of what can be known and what may be hoped for and what should 
be done (Beylevard & Ziche 2015). Kant’s view of hope connects with moral action and 
decision making which is rational but is also connected with his belief in God. The hope of an 
immortal life goes beyond all that is seen in the suffering of this life and, to Kant, reason 
makes immortality necessary. Yet critics of Kant believe that hope is an attitude that can be 
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independent from faith and that hope provides a reason for belief, themes that have been 
echoed before in the previous section (Bloeser & Stahl 2017).  
4.2.4 A post-Kantian and Existential view of hope 
Kant’s contribution to metaphysics, epistemology, ethics and aesthetics led him to be one of 
the most influential philosophers in Western philosophy. His significance was such that the 
period following after was referenced as post-Kantian. There appear to be two distinct views 
of hope in post-Kantian philosophy. Kierkegaard and Marcel view hope as a means to 
overcome the limits of ordinary experience and Schopenhauer, Nietzsche and Camus see 
hope as an expression of a misguided relationship to the world therefore querying its value. 
(Bloeser & Stahl 2017). Kierkegaard seems to distinguish between heavenly or eternal hope 
with an earthly or temporal hope, appearing to equate an eternal view of hope within a 
Christian tradition (Fremstedal 2012). Cutcliffe and Herth (2002), I believe mistakenly, look 
to Kierkegaard’s definition of faith to suggest that Kierkegaard does not see that eternal 
salvation could be secured. However, Kierkegaard’s acknowledgement that faith is the 
antithesis of reason, does not mean, in itself, that an eternal hope does not exist. An earthly 
hope is framed by an understanding according to its probability, whereas an eternal hope 
exceeds understanding, representing a nuanced difference from Kant’s reasoned view of 
eternal hope.  
In contrast Schopenhauer, understands that it is natural for humans to want to hope but 
believed it is something we should do less of as too much hope may make it impossible to 
grasp things are relevant to consider in an assessment of a situation (Bloeser & Stahl 2017). 
Hope can lead to disappointment when the outcome is not realised but it can even cause 
disappointment when it is realised in that it may not have created as much satisfaction than 
was previously anticipated. Colloquially speaking, this ‘grass is greener’ notion is well 
recognised. Nietzche is similarly critical of his view of hope. When interpreting Pandora’s 
myth, in Human, All Too Human (1878) he calls hope as the worst of all evils because it 
prolongs the torments of man (Averill & Sandararajan 2015). For Nietsche, reasonable hope 
is a trust in an individual’s capacity to bring about a desired outcome. However, while this 
may work in certain areas of life, how individual effort will bring about a desired outcome in 
circumstances beyond our control, such as life threatening illness, is less clear.  Albert Camus 
is equally clear about his mistrust of hope, particularly hope in an afterlife esteeming the 
viewpoint that we do not need hope to cope with the hardships of life and death (Moeller 
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1958). Death should be seen as an absurdity but that that should not take us away from the 
enjoyment of the here and now. Interestingly, despite Camus’s negative view of hope, he still 
states that it is almost impossible to live without hope even if one wishes to rid themselves 
of it (Bloeser & Stahl 2017). Is hope therefore something so internal and deep rooted as 
suggested by the opening lines of Emily Dickinson’s poem at the start of this chapter, that it 
is etched in our very makeup?  What is apparent is that in all of these accounts of hope from 
ancient times to existentialism, there is a constant ebb and flow of negative aspects of hope 
and positive components that have helped shape our thinking today in everyday life from the 
less pressing situations to the more pertinent.   Having looked at the origins of hope, the next 
section will briefly look at two main theories of hope theory, before looking at the role of 
hope in nursing.  
4.3 Key modern theories of hope 
It is important to note that while there are a number of hope theories, there are two modern 
theories that have gained significance in understanding how hope is utilised in life and are of 
direct relevance to this study, the first from the field of psychology and the second borne 
within nursing science. The first is Snyder’s hope theory (Snyder 2000) which argues that 
hope should be viewed as a cognitive skill rather than purely a reactive emotion whereby an 
individual shows ability to motivate towards a specific goal. The second is Herth’s theory of 
hope which deals more specifically with an individual’s future goals as they relate to coping 
with illness (Herth 2000). Both have a distinctively different feel and focus from the 
philosophy previously discussed, but both see hope as a positive and often goal related force. 
Both have relevance to considering how hope can be part of the fabric of caring for those 
patients who are potentially eligible for liver resection. 
4.3.1 Snyder’s hope theory  
Charles Snyder, an American psychologist has been hugely influential in shaping a collective 
understanding of hope and in contributing to theory development. Snyder admits that the 
concept of hope and how it lends itself to be utilised throughout the life cycle, has been a 
concept that has fascinated him endlessly, much even to the bemusement of his wider family 
circle (Snyder 2000). His evolution of hope theory stemmed back from the mid 1980s when 
he was researching how people make excuses when they perform badly or make mistakes 
(Snyder, Higgins & Stucky 2005). Through this research Snyder found that the converse side 
of excuse making was a motive about achieving goals. This led Snyder to think about hope as 
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a mechanism for achieving goals and from there he went onto publishing his first article on 
hope (Snyder 1989).  In developing his  theory, Snyder had reviewed motivational literature 
of the 1960s and 1970s which looked at an individual’s desire to set goals and was struck by 
the idea of hope as a motivational factor in goal setting from work such as Cantril, Farber, 
Frank and Stotland (Snyder 2000). While he identified with this work, Snyder felt there was 
something missing from the explanation of hope as a motivational factor. Much discussion 
about hope had seen hope spring from a feeling, something which can be understood from 
the previous sections on the history of hope. Snyder believed that the missing element was 
to place thinking at the heart of understanding hope rather than feelings or emotions. 
Someway towards defining hope, Snyder concluded, 
“Hope as I was coming to define it, was primarily a way of thinking, with 
feelings playing an important, albeit contributory role” (Snyder 2002, 
p.249). 
Perhaps in this way, hope when viewed as a cognitive process, is not seen as an emotional 
reaction purely for the purposes of just being optimistic or hopeful but is actually a state of 
mind which can be used to drive forward intentions.  Again, this can be linked back to 
historical concepts of hope as viewed theologically, whereby hope was a reasonable hope, 
considered and rationalised by the mind. It is this element of hope that can be both intriguing 
and attractive. The rational nature of attaching thought as the driving element of hope means 
that it less disposed to use emotion purely as a driving mechanism which could more easily 
lead to unrealistic expectations of hope. Within the context of patients being considered for 
liver resection for CRLM, particularly where the nature of that pathway can rapidly change 
(as referred to in Chapter Three), then the need to view hope as reasoned is one that can be 
argued to have value both to the clinician and the patient.  
With the basis of human actions being goal related, Snyder postulated that we use routes or 
pathways to plan these goals and then attach a motivational force to carry them out. 
Research on hope and goal direction eventually led to a definition of hope in 1991 by Snyder 
and his colleagues as, 
“Hope is a positive motivational state that is based on an interactively 
derived sense of successful (a) agency (goal-directed energy) and (b) 
pathways (planning to meet goals)” (Snyder, Irving & Anderson 1991, 
p.287).  
Snyder (2000) also defined hope as, 
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 “the sum of perceived capabilities to produce routes to desired goals, 
along with the perceived motivation to use those routes” (Snyder 2002).   
 
In either definition three clear elements of hope are identified, goals, pathways and agency.  
Hopeful thinking combines both pathways and agency thought. Snyder describes goals as the 
anchors of hope theory as they provide direction, categorising goals into positive goal 
outcomes and negative goal outcomes and also maintenance and enhancement goals. 
Maintenance goals refer to goal directed thoughts that are concerned with the everyday 
goals of living whereas enhancement goals are those thought processes which involve 
bettering of a situation that has some degree of profoundness or weight to an individual’s 
life. What is interesting is that Snyder had changed his views on how much certainty needed 
to be attached to hope goals. He initially thought that hope was only hope if it had some 
perceived uncertainty, i.e. that having hope was not applicable if the probability of an event 
was extremely high or extremely low. However, Snyder reported that further research had 
shown that high-hope individuals had often injected some uncertainty into a goal situation 
that had seemed certain and conversely, had also altered their thought processes about 
seeming likely to fail situations in order to achieve what seemed like the impossible. These 
elements introduce that it is not just the event that is of question, but how an individual 
views their situation that can alter their sense of hope. This has immense relevance when 
dealing with individuals in clinical situations and is a reminder to withhold assumptions about 
goal attainment in health as they will be heavily influenced by an individual’s personal trait 
and also their experience in that situation which may bear upon how they utilise hope. It can 
mean that one person might hear the same message as another person in a similar situation 
but react differently. It can also mean that two family members can hear the same 
information and interpret it differently due to their construct of hope.  
The pathway component refers to the routes taken to achieve the goals and also the 
individual’s perceived ability to produce these routes. It is the tendency of the human brain 
to work out goal pursuits from Point A to Point B. Put simply, hope involves the will to get 
there and different ways to get there (Kaufman 2011).  Snyder again reports a difference in 
high-hope individuals, in that beyond the main route, high-hope individuals should be more 
apt at producing alternative routes to achieve the same goal. They also possess the flexibility 
to adapt their route, particularly when faced with impeding factors. The agency factor is the 
motivational agent available to bring about the goals. Synder describes this as the energy 
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required to start the route to bring about the goal. He reveals that it takes on a special 
significance when people encounter blockages, as the motivation can help channel energy 
towards the next best alternative route. A fourth component of Synder’s hope theory, 
inferred to by its lack of absence in the definition are barriers. Barriers or obstacles block 
achieving goals by either making the individual give up or reinvent new pathways in order to 
attain the goal. Certainly, Snyder (2002) found that positive emotions can more easily 
overcome barriers, and work by Diener (1984) found that goal blockages are more often 
related to negative emotions. However, this may not always be the case as there may be 
times when having positive emotions may not lead to goal attainment. For example, one 
might feel positively about getting to a liver resection but the nature of liver disease after 
chemotherapy might make the liver inoperable. Positive emotions may in this case become 
a barrier to adjustment to the new state of disease. Certainly, Synder’s work utilises hope as 
a mechanism in current psychotherapy whereby a therapist will help an individual to identify 
and work on barriers which may impede success in achieving goal attainment.  Clients are 
enabled to set realistic and specific goals while being mindful of the ability required to 
achieve goals along with identifying the most appropriate pathways to achieve set goals.  
Whilst high hope individuals have been found to correlate with some beneficial constructs, 
such as academic achievement (Snyder et al 2002) and lower levels of depression (Snyder 
2004), the popular adage ‘think positive’, may also have a few problems. The belief in the 
power of positive thinking is so common place that one might think that it could eliminate 
negativity and change the course of illness. Yet, what we see in life, is something very 
different. Research on weight loss led by Oettingen (Oettingen & Wadden 1991) found that 
women who were asked to employ positive thinking to visualise successful weight loss 
actually lost less weight than their counterparts who also had negative pessimistic 
expectations of weight loss to consider. They found that expectation and fantasy thinking 
produced different results which at first seemed counter intuitive. This was later replicated 
by Kappes et al 2011 when they conducted a similar exercise with college students. In this 
Oettingen concluded that, 
 “dreaming about the future calms you down, measurably 
reducing systolic blood pressure, but it also can drain you of the energy 
you need to take action in pursuit of your goals” (Oettingen 2015).  
What Oettingen proposes instead is something called ‘mental contrasting’ which is an 
approach to positive thinking but taking the realism and pragmatism usually present in 
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negative thinking. Oettingen breaks mental contrasting into four steps that are easily 
remembered and applicable to challenging situations. They fit into an acronym know as 
WOOP and enable the individual to mentally confront the situation by visualising their 
desired result but together naming the realistic obstacles in way of the desired outcome. The 
first step is WISH where time is taken to identify a wish regarding the situation that is realistic 
and challenging. When compared to Snyder’s work, this would be known as what we 
commonly call goals. The second step is to identify the OUTCOME, where the best possible 
consequences of this wish would come true and visualising the feeling that would create. The 
third step is to identify the OBSTACLE or obstacles standing in the way of the wish. The idea 
here is that they are given appropriate time and not shied away from with a cursory mention 
but envisioned with the same degree of thought and energy as the positive outcomes have 
been given.  In this way it the pragmatism comes in and the mind begins to acknowledge the 
complete reality of the situation. The fourth step is the PLAN which is about stating a way for 
success to be achieved which is specific and realistic. This is akin to Synder’s pathway in his 
hope theory model. While some of this may sound quite simplistic, studies have shown that 
there is a distinct difference in positive thinking without taking in the approach used in 
mental contrasting. People using mental contrasting were found to exercise more (Stadler et 
al 2009), have a higher nutritional intake, (Stadler et al 2010), cultivate healthier relationships 
(Houssais et al 2013) and even recover from chronic back pain quicker than compared to 
positive thinkers alone (Christiansen et al 2010). This may be because they factored in the 
risk of not doing a certain behaviour.  It would seem that there are different types of positive 
thinking; fantasising which may do more harm than good and mental contrasting which takes 
in aspects of negative thinking that may be more effective in helping wishes or goals become 
actualised. Criticisms of this form of positive thinking may be that it only tackles one kind of 
goal, such as a goal that requires commitment like weight loss or working for a qualification. 
What of those situations, where the result is not solely up to the individual such as goals in 
health as clearly depicted in the pathway to CRLM?  Kaye Herth’s work on hope in health care 
situations is especially relevant to consider.  
4.3.2 Herth’s contribution to hope theory in health 
Whereas Synder’s theory focuses on utilising hope as a mechanism to overcome lack of 
motivation, another major theory as developed by Kaye Herth relates to how an individual 
constructs goals amid illness.  Much of Herth’s lifetime research has focused on hope in 
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individuals with a chronic or terminal illness and the impact on their families and significant 
others as well as research on homeless families and children.  Herth’s doctorate work in 1982  
with cancer patients became the spark to examine hope and contribute towards 
development of hope theory and a tool for measuring hope, named the Herth Hope Index 
(1994). Herth became particularly interested in how hope was maintained when events were 
not entirely constrained by ones own motivational force. This has parallels with the idea 
expressed by Gadamer in Truth and Method (Gadamer 2013) at the opening section of this 
chapter whereby his interest lay with what happens when life is above our control.  In such 
situations, Herth recognises that maintaining realistic goals is more difficult as the individual 
is less likely to have direct control, for example as is often evident in health. Hearth sees hope 
as a  
“motivational and cognitive attribute that is theoretically necessary to 
initiate and sustain action toward goal attainment” (Herth 2000).  
Much of Herth’s work aligns itself with Marcel’s existential viewpoint that human beings have 
an endless possibility of improving their own being or that there is something inherent in 
them that that causes hope. This allows them to adjust goals from mastering and defeating 
an illness, which may not necessarily resolve, to being concerned with how to deal personally 
with the illness itself. Herth (2000) provides the example of someone with a chronic illness 
deciding not to use alcohol as a way of easing the pain of illness but instead choosing to 
surround themselves with friends and family. There is a strong cognitive element where 
decision making is closely influenced by individual hope, but not of a general hope for health 
resolution or cure but for specific hopes along the way while living with illness.  Decision 
making becomes influenced by personal hope but also hope fuels decision making and a 
cyclical process, can become apparent.  Whilst the nature of the goals in Herth’s model differ 
with those in Synder’s model, they both view hope as a way to maintain personal motivation. 
Adopting a combination of these models can perhaps avoid some of the pitfalls as described 
by Oettingen (2015) regarding optimism.  
4.4 Examining the role of hope in nursing 
There is now a growing body of literature which would suggest that nurses can utilise and 
help apply the concept of hope in a therapeutic approach with individuals and their families 
facing periods of ill-health. Masera (2010) points out that the meaning and significance of 
hope for individuals will depend upon an individual’s life circumstances and how their 
72 
 
personal philosophical stance shapes that hope. Perhaps for this reason, Masera (2010) 
alludes to the challenge that bringing hope into difficult health situations may have for 
nurses.     
“Instilling hope is a major task for nurses in situations of distress, 
discomfort, inadequacy and dependency” (Masera 2010, p.69).  
Any nursing environment will immediately reveal many threats to hope. Masera (2010) 
identifies these as pain, uncontrolled symptoms, spiritual distress, fatigue, anxiety, social 
isolation and loneliness. Masera also identifies that external threats of perceptions of 
hopelessness from health professionals and family can also attack personal hope. This is 
important to consider as this sense of hopelessness from others may well be communicated 
strongly through language and by non-verbal communication but may have a powerful 
eroding effect of personal hope. Masera (2010) also senses that this may well be the context 
of modern medicine where there is much focus on cure but not care. In so doing, Masera 
(2010) revisits Jean Watson’s theory of human caring, originally developed in 1979 but with 
subsequent revisions, as somewhat of an antidote to what could be a very imbalanced view 
of care if it was only attached to cure. Among ten constructs of caring in nursing, hope is 
listed as one of them. The context to the development of this theory during the late 
seventies/earlier eighties was that care did not get lost while changes in healthcare delivery 
systems were intensifying nursing responsibilities and workloads.  As developments in 
medicine continue apace it is always worth pausing to ensure that hope as part of the wider 
context of care does not get suppressed even in those situations where cure is no longer 
evident.  
Cutcliffe & Herth (2012) offer a logical sequence of steps for examining the nature, origin and 
background of hope in nursing literature as set out in Table 4.1. overleaf. Much of this relates 
to the account in section 4.1 but it is worth briefly revisiting this from their viewpoint. They 
begin by examining the theological and philosophical origins and background of hope as 
listed in steps 1 and 2 and cover Chinese, East Indian, Ancient Greek, Christian and Existential 
perspectives. Their brief overview concludes that there is no direct reference to hope from a 
Chinese or East Indian perspective and that from an Ancient Grecian perspective, 





Logical sequence of steps for examining the nature, origin and background of hope 
Step 1:  What is the origin of hope and does the theological literature allude to 
this origin? 
 
Step 2: What is the philosophical background of hope? 
 
Step 3:  When and in what manner did hope begin to be considered within 
healthcare literature? 
 
Step 4:  What definitions of hope are there in the theoretical and empirical 
healthcare literature? 
 
Step 5: What are the key themes of hope that are evident in these definitions? 
 
Step 6:  Do these definitions and their inter-relations provide an indication of the 
elements of hope and hoping that appear to be implicit in the literature? 
 
Table 4.1: Cutcliffe & Herth’s (2012) sequence for examining hope 
Cutliffe & Herth (2012) feel there is merit in examining the existential perspective also as it 
shares some commonalities of the Christian perspective but from a counter position.  Both  
Nietzsche and Sartre advocated that as man becomes more aware of his existence over time 
he can almost become more aware of the absurdity of his existence and the sense of despair 
that accompanies those sentiments (Thompson 2008). This position tends to suggest that life 
itself carries no meaning and indeed if faith in God cannot be proven then hope may be 
unreasonable. However, as already seen, there may not be any visible evidence for the hope 
that people have, especially when it may not correlate to a physical state of health.  To 
counter the existential perspective, Marcel (1948) sees that if we can function in a finite 
world and influence our existence then at some micro level we are able to make a difference 
in our community and assert change (Greenaway 2018). This leads to a more positive view 
of the world and reinstates meaning, which for some existential philosophers is more closely 
aligned with the Christian perspective. Therefore, a hope for future outcomes that do not yet 
exist share more parallel links with possessing faith and are often linked to human and 
spiritual existence, even if individuals may not possess a faith belief as such (Cutcliffe & Herth 
2002). Drawing on the work of Hinds (1984) in defining hope and Raleigh (1992) with 
identifying sources of hope in chronic illness, they write, 
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“To the person who has hope and who experiences a sense of 
hopefulness, it is the most logical, sensible thing. If hope provides one 
with a sense that one has a future, and also enables one to cope with 
events in the present, then (if one wishes to preserve one’s existence) it 
is a logical state of being.” (Cutcliffe & Herth 2002, p.835).  
4.4.1 Hope in nursing literature 
Much of the literature in nursing stems from observations or studies with cancer patients. 
An early study by DuFault & Martoocchio (1985) collected qualitative data among 35 elderly 
patients with cancer and then 47 terminally ill patients. While the methods of data collection 
and analysis are not made transparent, their early study was a good starting point from which 
to look at hope in cancer. They revealed two spheres of hope, a generalised hope which was 
broad in outlook and a particularised hope which was related to a specific outcome. They 
also described six dimensions of hope which could belong to either sphere of hope; affective, 
cognitive, behavioural, affiliative, temporal and contextual. This work perhaps looked more 
at the structural components of hope and is more theoretical in nature than helping to reveal 
concepts that are readily translated into practice.  
Using grounded theory, Owen (1989) induced a conceptual model of hope from his study in 
which he collated clinical nurse specialists’ perceptions of hope in their patients. While it is 
unusual to look at perceptions of hope as viewed through the eyes of someone else, the 
study does give a worthwhile angle because of the positioning and intensity of contact of the 
nurse specialist across a spectrum of a patient’s illness journey.  Six themes were elicited 
from the study and are outlined in Table 4.2. overleaf. They help to give a workable list of 
attributes of what hope looks like in practice.  
Certainly, it may not be necessary or possible for an individual to possess all of these aspects 
at one time but the themes identified are concepts which resonate with the overwhelming 
sentiment, that hope is positive. Hammer et al (2009) state that despite the lack of consensus 
as to the attributes of hope, that hope has a positive role in human life and is both universal 
and specific. It is universal in that it is a general belief in the future and a defence against 
possible despair but it is also specific and directed to an event or object. Perhaps this idea of 
a defence against despair is an element worth noting and one with which Morse and 
Doberneck’s (1995) study resonates with the third of their seven universal components of 




The six themes in Owen’s (1989) conceptual model of hope 
Goal setting:  Hopeful patients engaged in setting (and revising) attainable goals. It 
may be worth noting that the goals of these patients noticeably 






Hopeful patients were described as having several hopeful personally 
characteristics (e.g. courage, optimism and a positive attitude) 
Future 
redefinition: 
Hopeful patients were described as those who saw or perceived the 
future, and this future was not quantified in time 
 
Meaning in life: Hopeful patients were those who equated hope with a meaningful life 
Peace: Hopeful patients were described as being at peace or comfortable with 
their situation 
 
Energy:   Hopeful patients were described as being those who possessed and 
gave out energy. Additionally, Owen reported that the hopeful patient 
needed energy to remain hopeful, hope required energy and gave 
energy 
 
Table 4.2: Owen’s (1989) conceptual model of hope 
Seven abstract and universal components of hope 
 A realistic initial assessment of the predicament or threat 
The envisioning of alternatives and the setting of goals 
A bracing for negative outcomes 
A realistic assessment of personal resources and of external conditions and resources 
 
The socialisation of mutually supportive relationships 
The continuous evaluation for signs that reinforce the selected goals 
A determination to endure  
 
Table 4.3. Morse and Doberneck’s (1995) seven abstract and universal components of hope 
These attributes also bring into play the community aspect of hope when Morse and 
Doberneck refer to seeking external help through mutually supportive relationships in 
component five and in taking stock of what personal resources they have to equip them 
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during this period in number four. This combined with personal review of signs that their 
goals are being met, has introduced a more reflective and supportive view of hope. In 
addition to a positive focus, Morse and Doberneck’s (1995) work also introduces the idea 
that factoring in negative outcomes are all part of hope in that they suggest it is healthy to 
be prepared for a negative outcome, one that was different to what was hoped for in 
component three.  Haarse and et (2002) also identify with a potentially negative sentiment 
in their attributes of hope, that of uncertainty. One of the perplexing features about hope, is 
the element of uncertainty. It is of course that only while there is uncertainty, can there be 
hope. Haarse et al (2002) define hope as 
“an energised mental state involving feelings of uncertainty or 
uneasiness which is characterised by a cognitive action oriented 
expectation that a positive future goal or result is possible” (Haarse et al 
2002). 
Despite uncertainty, hope is known as a positive state and this quote suggests that it is one 
that is required to be realistic in expectation as it can be utilised to achieve goals that are 
potentially possible.  
Yet hope is fluid, adaptive and responsive and so as a result goals have to be reset and the 
future redefined as Owen (1989) has suggested in his conceptual model of hope in Table 2. 
A common theme in the nursing hope literature is that there is a changing hope trajectory 
across an illness period. Herth (2018) recognises this illness trajectory and it is easily 
identifiable in chronic illness and terminal illness. Colquhoun & Hill (2011) note in cancer 
literature, that the nature of hope changes from that of diagnosis to treatment and should 
cancer progress, hope will change through a palliative phase. Sanders et al (2012) define the 
hope trajectory in cancer as  
“the state of desiring an identified possible event or future outcome, 
which then becomes the hope object. The hope trajectory is the 
changing pattern the hope object takes as the cancer progresses” 
(Sanders et al 2012, p.241). 
This may be especially seen when the object of hope is no longer cure and the hope object 
needs to change to a realistic hope.  Setting realistic goals has become an important aspect 
of personalised care in the palliative care setting (Colquhoun & Hill 2011). Sanders et al (2012) 
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drawing upon Nurgat et al’s (2005) work involving patients’ motivations to take part in clinical 
trials, write that most individuals manage to make transitions within their disease, using a 
realistic hope. Evidence would suggest that there are many patients who remain hopeful 
right up to the end of life despite a terminal diagnosis or illness period (McIntyre & Chaplin 
2007) and manage successfully to readjust their goals.  This may point back to the 
characteristic of the universality of hope, i.e. that there is something inside of us as humans 
to causes us to hope. There are, however, some patients who cannot revise their hope object 
and persist in an unrealistic hope trajectory. In this instance the hope object becomes 
maladaptive and can create potential communication difficulties, not just for the patient but 
also for their families and healthcare team. An interesting paper by Pergert & Lutzen (2012) 
suggest that in such cases where patients wish to hold onto an unrealistic hope that a 
tempering of the truth may occur by the healthcare team in order to protect the patient’s 
view of hope. This may be especially tempting when the disease progression is rapid and the 
patient may not be showing readiness to understand the reality of their disease since the 
diagnosis period has merged with progression. Doing so may actually cause further emotional 
difficulties for the patient as time goes on into the patient’s illness.  Pergert & Lutzen (2012) 
argue that, 
“To suggest that hope is versus truth or that hope needs to be balanced 
with honesty/truthfulness may distort you to believe that truth and hope 
are irreconcilable dichotomies. On the contrary, truth telling has been 
found to support hope.” (Pergert & Lutzen, 2012, p.24) 
Some factors may act as threats to hope and may well cause an individual to have an 
unrealistic hope.  Miller (2007) outlines the following factors, one’s life philosophy and the 
meaning that one attaches to events, a sense of optimism and any personal or spiritual 
beliefs. Colquhoun & Hill (2011) also identify not feeling valued as a person, having a sense 
of abandonment or isolation and very importantly poor symptom control. There may also be 
other factors which greatly influence hope as specific to a cancer situation, such as personal 
experience of family cancer in the past. 
4.4.2. Role of the nurse in fostering hope  
Nweze et al (2013) report that there is increasing evidence to show that nurses have a role 
in facilitating hope. Randall & Downie (2006) are quick to point out that while nurses can 
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have a role in fostering hope, the hope belongs to the patient, and they are the origins of 
their hope. It is not our hope. 
“Whilst we ought to encourage people to hope for outcomes which are 
probable, and to help them adjust away from hopes for the extremely 
unlikely, at the same time we ought not to seek to control their hopes” 
Randall & Downie (2006, p210.) 
Nweze et al (2013) suggest that nurses may be well placed to offer hope due to their constant 
interaction with patients in similar situations so that they have an understating of what can 
be achieved. This also feeds into the importance of trust in the nursing relationship, making 
it easier for the patient to set goals to be realised. Establishing and building upon trust from 
the outset of the patient nurse relationship is important and is likely to require highly 
developed communication and clinical judgement. The beginning of that relationship is often 
emotionally challenged set within the context of a diagnosis. This is evidenced in research by 
Cao et al (2017) who researched communication with doctors giving a diagnosis of cancer 
and how that affected trust and hope in patients. A number of factors can affect how the 
initial diagnosis consultation can be perceived and recalled by the patient. Clinical 
presentation and the absence of symptoms may make it particularly difficult to absorb and 
recognise that the information discussed pertains to them. Working within this sector, 
episodes can be recalled where diagnosis information is not well received by the recipient 
due to emotions of anger and distress. How unfavourable bad news may be, how it is 
communicated has shown to influence patients’ treatment decisions, adjustment, well-being 
and in some cases survival (Ptacek et al 1996, Fallowfield & Jenkins 2004, Sastre et al 2011). 
This should not perhaps be surprising, when we consider the central issue of trust at stake 
when making significant health and treatment decisions.  
Indeed, this very aspect, touches on the centrality of caring for individuals rather than 
treating the disease. Cao et al (2017) recognised how adverse communication could be hard 
to turn around but the study contained little in the way of what constituted effective 
disclosure which opened up aspects of hope and was closely linked to trust. Cao et al’s study 
(2017) is based in China and they acknowledge that although Asian medical systems are now 
under the same pressures as Western countries, in delivering a wider range of treatments 
amid time constraints while meeting targeted goals, they realise that Asia in general is still 
facing a disclosure dilemma, something which Western countries have for the most part 
resolved. They state that Asian doctors are trying to move away from restricted patient 
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disclosure due to cultural, often family led protective mechanisms at work and become more 
like Western countries who have shed any of these approaches; consulting the family first 
before the patient, providing no disclosure, ambiguous disclosure or false disclosure (Kakai 
2002).  
Cao et al’s (2017) quantitative study utilised a specifically devised and tested questionnaire 
in addition to the validated Herth hope instrument and Wake Forest physician trust scale to 
assess 192 patients at a major university teaching hospital, the majority having had a 
diagnosis of lung cancer or breast cancer. Perceived emotional support from doctors was 
positively (but not significantly) associated with levels of trust and significantly associated 
with hope in doctors. The one striking feature of this study was that on the questionnaire, 
the word ‘disease’ was used instead of ‘cancer’. One might argue that although, all patients 
were eligible as they knew they had cancer, this might also influence how patients responded 
to the hope scale. The decision may have been based on the author’s reference to Farber et 
al’s (2002) study, which found that after clear disclosure of cancer to a patient, patients did 
not want the word reiterated at every stage. The study has implications in that throughout a 
period of elongated treatment and decision making, such as in CRLM, emotional support 
would appear to be key. Often in this setting, it is the nurse specialist who in addition to the 
medical professionals, are able to provide this support, often based over a longer continuum 
of a patient professional relationship. This relationship may also be key in addressing 
situations where hope related to treatment is not achievable due to disease progression, 
technical feasibility or patient health. 
 The idea that disclosure of honest information or prognosis is harmful and suppresses hope 
can no longer be viewed as helpful. This is evident in practice and can led to lack of 
preparation for the next stage of disease or even death. This is supported by an American 
surgical literature review by Winner et al (2017) who concluded that enhanced preoperative 
surgical discussion could maintain hope even if the topic is a bad prognosis or eventual death. 
From the literature reviewed, hope was often seen as optimism in relation to prognosis. This 
corresponds with the section relating to Snyder’s hope theory (section 4.2.1) where some of 
the difficulties of optimism were discussed. This has the tendency to create a singular hope 
whereas honest, patient-driven discussions could still allow for hope in other areas such as 
cancer recurrence, preferences of care and also future planning. Winner et al (2017) 
identified four main themes whereby patient-surgeon communication could fail: 1) a lack of 
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clarity perpetuating prognostic misperception, 2) prognostic discussions proving emotionally 
challenging, 3) patient’s suspension of belief and 4) information largely thought to be 
antithetical. The overall key, Winner and colleagues feel, is that both surgeon and patient 
need the opportunity to articulate their goals and expected roles in the decision making 
process. In response to these communication failings evidenced in surgical literature, Winner 
et al (2017) suggest practical considerations to facilitate hope which are not just focused 
around prognosis. They suggest that clinicians need to know what kind of communicators 
they are, to examine failings such as relying on euphemisms, rushing over uncomfortable 
areas or failing to evoke feedback on information received. They also suggest that surgeons 
should not assume they know what patients want to hear, appreciating that a patient may 
not rationalise information or decisions about surgery in the same way. Other suggestions 
include, emphasising the choice of treatments and the range of therapeutic goals, which are 
not just surgical removal of the cancer, prescribing ‘homework’ for patients, whereby they 
allow time for discussion at home with significant others about choices and preferences, 
finding time for further discussion if needed or enabling others to have these discussions. 
Importantly, they also suggest that clinicians should not be afraid of realism or discussing 
non-curative goals.  
Moving away from hope seen as solely as cure can also allow for focus on other important 
issues such as, achievement of life events, relief of pain, maintaining independence resolving 
outstanding issues and even preparing for death. Allowing for this draws upon Snyder’s 
achievement orientated view of hope, with the use of pathways to allow for achievable goal 
setting. Although Winner et al’s (2017) paper focused on the surgeon’s role primarily in 
leading these consultations, there is much for the nurse specialist here, being well placed 
between surgical and oncology teams to facilitate discussions in a less time restricted 
manner. This contact may open up the concept of hope into other areas thereby moving it 
away from purely a cure or surgically driven hope. This paper has considerable relevance 
considered in the context of surgical resection of liver metastases, where the ultimate goal 
of that pathway is to achieve surgery albeit that may not always be achievable. Focusing on 
additional hopes throughout that pathway are particularly relevant and require a specific set 
of communication skills, which the nurse specialist is well placed to bring to the cancer team.  
Other authors have identified a number of strategies for maintaining hope, in addition to 
ensuring physical needs are met, which require advanced communication skills as indicated 
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by Winner et al (2017).  Colquhoun & Hill (2011) highlight a number of key strategies or 
interventions which nurses can use to sustain hope as shown in Box 4.1.  
Box 4.1: Key strategies for sustaining hope, Colquhoun & Hill (2011) 
A further aspect to consider which is not noted here is signposting patients to others to help 
meet queries or concerns. If nurses are to facilitate hope in others then Morse & Doberneck 
(1995) suggests that they should have a high degree of self awareness and an understanding 
of what they look to for hope themselves. As much of this work may be emotionally 
demanding for the nurse, nurses may benefit from adequate support mechanisms for 
themselves in the workplace.  
4.5 Hope in colorectal cancer literature  
In the absence of any papers directly concerned with hope in those with potentially 
resectable liver metastases, it is worth looking at literature referring to hope in colorectal 
cancer. One study has direct relevance, seeing hope as a critical factor rather than a vague 
by-product of care. Beckman et al (2013) brought this to bear when they interviewed ten 
patients with advanced colorectal cancer in order to explore by thematic analysis what the 
content of hope was in these patients. Their four themes revealed that (1) hope was 
essential, (2) involved a change in perspective, (3) had a specific content and (4) required 
communication. Themes 1, 2 and 4 while rich in data themselves are more self explanatory. 
The third theme is of particular interest because it unpacks three sub-themes in the content 
Key strategies for sustaining hope 
● Maintaining the pa ent’s physical comfort 
● Supporting meaningful relationships with family and the healthcare team 
● Ensuring that the pa ent and family feel valued as individuals  
● Encouraging the pa ent to iden fy and achieve important aims 
● Enabling the pa ent and family to retain choice and control 
● Promo ng reflec on on life and crea ng meaning and legacy 
● Providing opportuni es for spiritual quest, expression and growth 
● Using light-heartedness and humour appropriately  
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of hope. These are the desire for normalcy, future plans and a continued hope for cure. At 
first glance these are themes that one would understand to sit comfortably within the 
context of potentially curable disease. Yet, Beckman et al (2013) were quick to point out that 
they had included patients with advanced disease who both had potentially curable and 
incurable disease as they wanted to examine the role of hope independent of hoping for a 
cure.  
Indeed, this sentiment is picked up by Weeks et al (2012) whose study of patients 
understanding of the rationale for chemotherapy in advanced cancer, had found that despite 
often being told that disease was not treatable, adults still hoped for a cure. This also 
corresponds with the idea that hope is embedded within and is hard to suppress, as the 
reference to Emily Dickinson’s literature at the beginning of Chapter 3 suggests. Arthur 
Frank’s (2014) personal revelations when his mother was dying powerfully convey this 
sentiment. He recalls his father focusing on the normalcy of that life that they used to know, 
still expressing that his wife could get back to this life if only she could get her strength up. 
Such responses are regularly evident in the clinical setting. Very often, the expression of 
normalcy, future plans and continued hope for cure may co-exist. This does not mean that 
the patient is in denial, an aspect which will be discussed further in Chapter 9.  
4.6 Chapter summary 
To summarise, hope can be adopted in all stages of the cancer trajectory. As Saeteren et al 
(2011) write a cancer diagnosis is  
“an existential upheaval which takes the patients through demanding 
phases filled with contradictory emotions and uncertainty” (Saeteren et 
al 2011, p.811.) 
Hope gives direction, purpose and meaning and helps to secure achievable goals yet when 
those goals are no longer possible, hope reacts flexibly to readjust goals.  Continued advances 
in treatment are pushing the boundaries of what was commonly expected in the 
management of colorectal cancer liver metastases. To comprehend that liver metastases 
might be rendered operable and completely resected provides another interesting avenue 






From Musings to Method 
“What man needs is not just the persistent posing of ultimate questions, 
but the sense of what is feasible, what is possible, what is correct, here 
and now. The philosopher, of all people, must, I think, be aware of the 
tension between what he claims to achieve and the reality in which he 
finds himself.” (Gadamer 2013, p.xxxv).  
5.1 Chapter overview 
This chapter will focus on the chosen research methodology and method adopted for this 
study. In so doing, it will set out the chosen processes behind the study and the tools used in 
conducting the study to answer the study questions. The chapter itself tells something of the 
story of my journey as a researcher, as it details the initial thinking about the study area, 
conceptualisation of appropriate research design and determining practical considerations 
in order to provide functional procedure. The chapter also explains the relevance of choosing 
a theoretical framework suitable to this qualitative study as a hermeneutic 
phenomenological approach and introduces the key figures instrumental in the 
phenomenological movement before introducing Gadamer whose philosophy has more 
particularly influenced this study. My position to this study and setting is also examined, 
having that of an insider-outsider position as both researcher and practitioner within this 
environment. Adopting a reflexive approach has been critical to the study and one, in which 
I believe, sits alongside Gadamerian phenomenology in that it also provides another ‘fusion 
of horizons’. Finally, issues of rigour and adoption of analysis are discussed.  
5.2 Research journey 
Before deciding to undertake this study, I remember others who had encouraged me to 
commit to my intended research subject for the journey it would present. Initially my 
thoughts were not necessarily on the journey that I would encounter as a researcher but on 
hearing and giving voice to the experiences of those on the colorectal resection pathway. My 
hope was that by so doing, that these experiences could be utilised to improve that pathway 
to create a tangible benefit to patients being considered for liver resection. Nonetheless, on 
the surface, ‘the journey’ sounded intriguing and hinted at being rewarding.  The reality is 
that journeys are made up of many ups and downs on the way, a sentiment that is echoed in 
MacKenzie & Ling’s (2009), wittily entitled paper ‘The research journey: A Lonely Planet 
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Approach’. As with all journeys, it is only towards the end of that journey, that one gains 
perspective from where they have been and how far they had travelled, both personally and 
pragmatically. At the outset of the research journey, I grappled with how best to design the 
study and what methodology might be more appropriate. Funding provided, through a local  
NHS Foundation Grant, had an associated ethos of service improvement. This gave the 
research a pragmatic focus and early thoughts regarding methodology learned towards 
action research which could be easily understood against the context of the cyclical nature 
of evaluating a service, reviewing and then evaluating that service after changes were 
implemented. Action research generally follows a cyclical process of, plan act observe reflect 
replan (McDermott & McNiff 2016) and because of this has had general appeal in studies 
relating to social and political transformation (McNiff 2013). A guiding basis for action 
research as a methodology is the improvement of a situation and as Winter & Munn-Giddings 
(2001) suggest this carries an ethical value and “practical responsibility for others wellbeing” 
(p.220).  While such values are worthy in themselves to conduct research, I still felt there 
could be something impersonal about utilising action research as a methodology. My 
intentions were firstly to understand and then to let the experiences of those being 
considered for liver resection drive forward a change. Although perhaps a subtle difference, 
my concern with action research alone, was that too much emphasis would be placed on the 
service alone rather than the people who encountered that service.  
Further considerations were given as to whether a more longitudinal focus might work and 
lend itself to a mixed methods research, so that the use of quantitative data could lend an 
insight into quality of life experience at different timepoints in the wait for liver resection. 
This was rejected as the literature and also observation suggested that the majority of people 
waiting for CRLM encounter few symptoms as discussed in Chapter 3. Finally, I also 
considered using focus groups throughout this study for patients as well as health 
professionals but again dismissed this as I was interested in not only a collective story but 
also the uniqueness of each person’s story and I felt that that was harder to capture where 
patients were grouped together in focus groups.  
Whilst ideas can be captured and reshaped in research, time gives no such luxury.  The reality 
in research is that the clock is ticking from the moment funding commences. Time helpfully 
places boundaries around ideas but allows for focus of the original ideas of research design. 
In my case, this is what occurred and I was able to reflect on my original ideas to proceed 
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quickly to ethics application when the study funding commenced.  My main concern was that 
the voice, the language, the very nature of ‘being’ considered for liver resection was heard 
and for this reason I decided upon hermeneutic phenomenological inquiry. The rationale and 
background for choosing this is discussed in section 5.4 and 5.5.  
5.3 Ethical approval  
The conduct of any research study relies heavily on guiding ethical principles. The most 
common way of defining ethics is based around norms of conduct that distinguish between 
acceptable and unacceptable behaviour (Resnik 2015). There is a pragmatic distinction 
between formal codes of conduct agreed by governing research bodies and the ability of the 
researcher to conduct themselves according to that guidance throughout the research study. 
Section 5.9.2 addresses how I sought to adopt ethical safeguards in the practice of this 
research study.   
Formal ethical approval was sought and granted  in December 2012 from the local Research 
and Ethics Committee (REC) and from local NHS and ACCORD Research and Development (R 
& D) Offices through the online Integrated Research Application System (IRAS) 
(https://www.myresearchproject.org.uk). This importantly, also allowed approval to access 
the study sample within three hospitals within a major teaching network. Working within the 
colorectal team, gaining physical access to participants was perhaps easier than coming in as 
an outside researcher but formal approval, while not only necessary, also ensured 
accountability despite being known as a member of that team. I endeavoured to conduct 
myself as researcher in the same professional manner that I adopted in everyday practice as 
a member of the colorectal team.  Funding primarily provided by a local Health Foundation 
Fund and latterly by an oncology endowment fund allowed me to step out of normal practice 
and concentrate on the study for 3 years and 3 months. Ethical approval gave me the guiding 
principles to ensure that there was no harm to participants, informed consent was 
maintained, privacy was withheld and no deception with regard to participants or data took 
place as, outlined in early ethical principles by Diener & Crandall (1978). Strict adherence to 
the research inclusion/exclusion criteria was maintained for patient protection and study 
validity (Holloway & Wheeler 2002). Close multidisciplinary team working was in place to 
ensure that all patients were suitable to approach. The tone that I wished to set throughout 
the study was one of permissive inquiry, whereby it was clear to participants that they were 
consenting for use of their personal treatment stories to be heard and analysed and that I in 
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turn had to take care to honour the personal nature of their stories through careful 
interpretation, which in turn had the power to drive forward a change in service for future 
patients.  
5.4 Research Design 
The choice of study methodology discloses something about the researcher’s view of reality 
and their commitment to guide the study alongside theoretical frameworks pertaining to that 
reality. A qualitative research paradigm has been chosen to answer the research questions 
in this study. This was deemed suitable following a review of the two research strategies 
which underpin medical and nursing research; quantitative and qualitative.  
A quantitative paradigm focuses on the cause and effect relationship between variables and 
is concerned with measurement whereas qualitative research is predominantly focused on 
words and meaning (Weaver & Olsen 2006, Bryman 2016a). A quantitative research strategy 
is deductive seeking to test theory whereas qualitative research is inductive by nature 
seeking to generate theory (Malterud 2001, Bryman 2016a).   Qualitative research has a 
particular strength in eliciting the commonly untold aspects of everyday or more complex 
human experiences (Bryman 2016a, Polit & Beck 2010, Tilley 2011). Unlike quantitative 
research, it can capture the depth of human emotion for a given situation or context. 
The value and constraints of each can be understood when looking at each paradigm’s own 
epistemological, ontological and methodological position which in turn frames how a study 
will be conducted (Cibangu 2010).   Quantitative research adopts a positivist epistemological 
position which presumes that phenomena can be measured according to the practices of a 
natural science model whereas the epistemological position of qualitative research is 
interpretivism which emphasises the way in which individuals interpret their social world 
(Bryman 2016a). The ontological orientation for quantitative research arises from a view that 
social reality is objective. This is compared with a view of reality that is named constructionist 
in qualitative research, which supports the idea that reality is constructed or made sense of 
by an individual (Barab et al 2007).   
A key methodology of interpretivism as displayed by qualitative research is phenomenology. 
Phenomenology as a research method is well suited for exploring people’s life experiences 
(Parahoo 2014).  Indeed Parahoo (2014) believes that phenomenology is well placed to 
explore patients’ experiences of illness. As Simpson & Whyte (2006) outline, phenomenology 
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is linked to the ontological question ‘What is being’, which again is conducive to an 
exploratory study on patient experiences during illness.  
Commonly, and inaccurately, methodology and method are frequently used interchangeably 
in qualitative research (Cram 2013). This has often led to confusion and a lack of clarity over 
which one is being referred to. For the purpose of clarity, the research method can be 
described as the tools, techniques or processes that are used to conduct the research 
whereas the research methodology is the study of that method or as Cram (2013) refers to 
“the principles that guide our research practices” (Cram 2013, para. 3). Any chosen research 
method should be conducive to the area to be studied and that method should be heavily 
influenced and shaped by underpinning methodology. Each should support and reflect the 
other and sit comfortably together.  
5.4.1 Incorporating the insider-outsider (emic-etic) position into methodology 
Importantly, time to undertake the research while not practising in my usual clinical role,  
allowed me a degree of distance from everyday clinical commitments. It also allowed me to 
adopt a sole researcher role with the added benefit of insider knowledge, without having any 
existing contact with the research participants. It may also have allowed the participants to 
speak about their experiences more freely, knowing that I had not been directly involved in 
their care. It is maintained that this position as researcher with insider knowledge was 
integral to both the design and analysis of the study.  It gave a unique position and framework 
of understanding, having both practical implications, as mentioned above, and theoretical 
implications. 
 
In ethnographic research, reference is often made to the ‘etic’ and ‘emic’ position. These 
terms were coined by the linguist, Kenneth Pike in 1954. Pike argued that linguistic tools, 
offering a certain position, could be adapted in order to understand social behaviours (Beals 
et al 2019). Emic is the view from within the social group and etic is that of the observer, i.e. 
outwith the social group to be studied (Lapan et al 2012, Zeegers & Barron 2015, Silverman 
2017). I steered away from using these terms, directly seeing them to have greater value to 
ethnographic research. However, I could clearly see the emic-etic considerations in relation 
to how I positioned myself as researcher.  Instead, I favoured the terms insider-outsider to 
reveal that I saw myself as an instrument of the research (Zeegers & Barron 2015), 
synonymous with having a bearing upon the method and resultant analysis. I was not an 
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insider in the sense that I had shared the same  experience as the participants but that I had 
a pre-existing knowledge of the participants’ world. Adopting the outsider position as solely 
researcher for this time and not that of my usual clinical role, allowed me to enter into the 
world of participant with no knowledge as to the specifics of their individual story. The aspect 
of insider-outsider lent a balance on the continuum of objectivity as a researcher, blending 
both positions. Perhaps conversely, the insider knowledge may have improved objectivity 
rather than hindered it, allowing interpretation  of the participants’ words to be weighed 
against a more complete understanding of the multi-factorial agents at work in the pathway 
to CRLM. This positioning also reflected the chosen methodology drawn from Gadamer’s 
fusion of horizons as explained in section 5.5.3, whereby pre-existing knowledge is absorbed 
into and reflected on as part of the interpretative process.  
 
5.5 Theoretical Framework 
This section details the background to the chosen research method by providing a brief 
historical reference to the conception of hermeneutic phenomenology and its key attributes 
which make it relevant to the study drawing upon the influence of Gadamer and more 
recently van Manen.  
5.5.1 Key figures in phenomenology  
A key founder of phenomenology was Edmund Husserl (1859-1938) who developed his 
thinking on understanding conscious experience following his dissatisfaction with the natural 
science model adopted in positivism which he saw as inflexible to individual experiences 
(McConnell-Henry et al 2009). This was later applied to the social sciences by Alfred Schutz 
(1899-1959) who advocated the researcher to block out or ‘bracket’ their own 
preconceptions in order to gain a pure as form as possible of the participants’ experience 
(Bryman 2016a). In contrast to this, Hermeneutical Phenomenology seeks to acknowledge 
the researcher’s involvement in the making of and presentation of the data and in 
acknowledging any pre-existing judgements about the patient group (Taylor 2001). As the 
researcher has worked with the proposed patient group and intends to facilitate much of the 
study in face-to-face interviews, a hermeneutical phenomenology will be the preferred 
methodology for the patient experience work.  
Each research paradigm has its own benefit when addressing different questions. By general 
comparison, in simple terms, quantitative research tends to focus on a cause and effect 
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relationship between two variables and is concerned with measurements, whereas 
qualitative research is predominantly concerned with words and meaning (Bryman 2016b).  
By nature, a quantitative research strategy is deductive, seeking to test theory, whereas 
qualitative research is inductive and seeks to generate theory (Malterud 2001, Bryman 
2016a).   The value and constraints of each can be understood when looking at each 
paradigm’s own, epistemological and ontological position, which in turn frames how a study 
will be conducted (Cibangu 2010).   Quantitative research adopts a positivist epistemological 
position which presumes that phenomenon can be measured according to the practices of a 
natural science model, whereas the epistemological position of qualitative research is 
interpretivism, which emphasises the way in which individuals interpret their social world 
(Bryman 2016a). The ontological orientation for quantitative research arises from a view that 
social reality is objective. This is compared with a view of reality that is named constructionist 
in qualitative research, which supports the idea that reality is constructed or made sense of 
by an individual (Barab et al 2007).  In this way, Bryman (2016a p.26) states that 
interpretivism uses a “different logic of research procedure, one that reflects the 
distinctiveness of humans against the natural order”.  In this study, it is certainly the 
distinctiveness of both the human experience in conjunction with understanding advances in 
surgery that lends itself to a method of qualitative enquiry in order to capture those unique 
aspects of human understanding and associated meaning.  Typically, sample selection, data 
collection and data analysis tend to differ depending on which research paradigm is selected.  
Bryman (2016b) points out in his critique of each method, that qualitative research can be 
more subjective, less generalisable and harder to replicate mainly due to smaller sample sizes 
and the disparity between participant response, whereas quantitative methods produce 
more valid, generalisable results due to larger sample sizes and more controlled variables. 
However, it is worth noting that it is harder to attach personal meaning to quantitative 
research or answer questions of a moral or ethical nature (Malterud 2001).   Considering the 
above it can be seen that a qualitative research paradigm is best placed to explore the patient 
experiences of those being considered for surgical resection of liver metastases.   
5.5.2 Hermeneutic phenomenology 
The use of qualitative research in health and social science arose from a growing 
disenchantment with the limits of quantitative research in the 1980’s (Osborne 1994). During 
this time, there was a pulling away from empirical methods as used in positivism and a search 
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for methodologies that would be responsive to the realm of human knowledge.  Laverty 
(2003) refers to some popular methodologies as phenomenology, hermeneutic 
phenomenology, ethnography and grounded theory that grew out of an appeal against 
positivism. This next section will focus on phenomenology and hermeneutic phenomenology 
in order to show why this study will adopt a hermeneutic phenomenological inquiry based 
on the work of Gadamer. It will begin by setting the historical context and relevance of the 
distinctiveness of phenomenology and hermeneutic phenomenology, in which the 
background of Gadamer’s work is set.  
A key methodology of interpretivism is phenomenology. Phenomenology has its roots in 20th 
Century Eastern philosophy (Starks & Trinidad 2007).  As indicated above, Edmund Husserl 
(1859-1938) is often referred to as the father of phenomenology (van Manen 1997).  A 
mathematician by profession, Husserl developed his thinking on understanding conscious 
experience following his dissatisfaction with the natural science model adopted in positivism 
which he saw as inflexible to individual experiences (McConnell-Henry et al 2009). Husserl 
criticised psychology in its methodology as humans were living subjects and did not have 
automatic, controlled reactions. He felt that important variables were omitted in psychology 
that only served to create artificial situations. This denotes somewhat of a drawing away 
from Cartesian dualism as proposed by Descartes who saw a division between the state of 
mind and the state of body (Laverty 2003). Phenomenology is essentially the study of lived 
human experience in the world (van Manen 1997) and as such is well suited to exploring 
people’s life experiences (Parahoo 2006). Starks and Trinidad (2007) write that analysts of 
phenomenology look to capture what are the meanings and common features of human 
experience. Indeed Parahoo (2006) believes that phenomenology is well placed to explore 
patients’ experiences of illness. As Simpson & Whyte (2006) outline, phenomenology is linked 
to the ontological question ‘What is being?’. This sits well with this study which focuses on 
patient experiences during consideration of surgical resection of liver metastases, a crucial 
period where there is tension between the hope of life that the surgery might offer against 
the reality that may present itself if surgery is not possible. A Finnish study by Saeteren, et al 
(2011) certainly described a co-tension between the possibility of life or death among 15 
patients with advanced cancer, as ‘latching onto life’, even though there was no more 
treatment that could be offered. It’s therefore important to explore meaning in a situation, 




A key feature of Husserlian phenomenology is the concept of ‘reduction’ or ‘bracketing’. 
Husserl believed that one’s own judgements about the phenomena to be studied required 
to be suspended in order to accurately see the phenomena more clearly. Giorgi (2007) writes 
that Heidegger was eager to find a method that led to gaining secure knowledge and 
incorporating reduction allowed him to do this, where careful emphasis was placed on 
description. Perhaps it is not surprising that with Husserl’s background in mathematics and 
logistics he placed so much emphasis on description. The method of bracketing was later 
applied to the social sciences by Alfred Schutz (1899-1959) who advocated the researcher to 
block out their own preconceptions in order to gain as pure as form as possible of the 
participants’ experience (Bryman 2016a). In Laverty’s paper (2003) she asks the question how 
does one actually go about this process? Laverty draws on descriptions by Klein & Westcott 
and Polkinghorne that essentially use careful description of the phenomena studied to 
reduce personal presuppositions. However, the reality may be that not even the researcher 
can escape their own social constructions.  
This leads onto a consideration of the place of hermeneutical phenomenology in qualitative 
research. Hermeneutics is the theory of interpretation (Smith et al 2009). Schleiermacher, 
considered as one of the early fathers of hermeneutics, defined hermeneutics as “the art of 
understanding the discourse of another person correctly” (Schleiermacher as cited in Bowie 
1998, p.xx).  Hermeneutical phenomenology can best be attributed to the German 
philosopher Martin Heidegger (1889-1976). Heidegger moved from theology into philosophy 
and taught at Freiberg University, eventually taking over Husserl’s professorship (Laverty 
2003). However, as time went on, Heidegger disassociated himself with Husserlian thinking 
which had focused on studying phenomena through careful description involving reduction 
and he began to develop phenomenology from an ontological position (Giorgi 2007). 
Heidegger became concerned with the question of being and to some extent this may not be 
surprising, given his roots in theology.  Heidegger referred to the German word ‘dasein’, 
meaning being or existence, and set out the importance of this concept in his work ‘Being 
and Time’ (1962) where he pursues the question of being. In contrast to Husserl, Heidegger 
believed that the state of consciousness is inseparable from the history of our lived 
experience (Polkinghorne 1983) and gave voice to the concept that pre-understanding of the 
world is not something that we can set aside. While Heidegger understood the stance that 
Husserl took on concept reduction, he did not embrace it and pulled further away from a 
Cartesian dualism than Husserl ever did. Heidegger believed that all interactions on a human 
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scale require interpretation and we do this by relying on our backgrounds, or what Heidegger 
names ‘historicality’ (Lawn 2006).  As understanding was essentially wrapped up in being, 
much priority was therefore given to interpretation rather than purely description. Rather 
than seek to set aside our pre-understandings of phenomenon to be studied, Heidegger 
sought to become as aware of them as possible and account for them. Taylor (2001) writes 
that in this way, hermeneutical phenomenology can acknowledge the researcher’s 
involvement in the making of and presentation of the data and in acknowledging any pre-
existing judgements about the patient group to be researched.  
As a philosopher, immersed frequently in written texts, Heidegger had devised what he 
named a ‘hermeneutic circle’ in order to understand and attribute meaning in a text. 
Individual parts of text or the whole text could not be understood without reference to other 
parts of the text and in this way the search for meaning became circular (Polkinghorne 1983). 
In the same way that Heidegger’s concept of the hermeneutic circle (1962) expressed the 
process of retrieving meaning from a text with reference to its cultural and historical context, 
hermeneutic phenomenology could be used to find meaning among lived experiences 
(Annells 1996). Much of this experience is hidden or often the taken for granted and requires 
to be exposed. Therefore, Heidegger believed that accessing texts could bring to the fore 
meaning and make the implicit more explicit. Laverty (2003) includes written, verbal, visual 
arts or music as examples of texts. The study of texts has been especially relevant to this 
study as recordings of interviews and a focus group have yielded transcripts which can be 
analysed for not only the obvious but for the hidden as well, for example cultural, 
environmental constraints.  
5.5.3 Introducing Gadamer  
Hans-Georg Gadamer (1900-2002) is, arguably, responsible for the extension of hermeneutic 
phenomenological thinking. Gadamer was taught under both Husserl at Freiburg and 
Heidegger at Freiburg and Marburg University (Laverty 2003). While Heidegger focused on 
the question of being, Gadamer extended this to ask, how was understanding possible? In 
this way his work has a practical extension of Heidegger’s in application to research (Laverty 
2003). He was particularly concerned with understanding when life occurs “over and above 
our wanting and doing” (Gadamer 2013, p.xxvi).Undoubtedly when placed in the context of 
a diagnosis of metastatic cancer, these words sound a poignancy for those experiencing life 
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in the midst of a diagnosis that occurs ‘over and above... wanting and doing’.Gadamer agrees 
with Heidegger in the importance of language as the key to understanding, stating that, 
“Language is the universal medium in which understanding occurs. Understanding comes 
through interpreting”. (Gadamer 2013, p.407)      
 
  and 
“Understanding is always more than merely re-creating someone else’s 
meaning. Questioning opens up possibilities of meaning and thus what is 
meaningful passes into one’s own thinking on the subject…” (Gadamer 
2013, p.388). 
 
In this way further reference is made to the hermeneutic circle, whereby language is to be 
understood as part of the whole. There is a constant movement which runs back and forth 
until all of the text is understood (Polkinghorne 1983). Flowing on from this is the idea that 
we cannot bracket off our consciousness when we approach text or others experience but 
we come to interpret it in what Gadamer calls a ‘fusion of horizons’ (Gadamer 2013).  He 
describes this horizon as a vision which includes everything seen from a vantage point. The 
ability to question oneself as well as interpret the data is a constant process which gives new 
horizons (Laverty 2003) or as Gadamer suggests the fusion of the text’s horizon with that of 
the interpreter.  To some extent Gadamer acknowledges that a level of prejudice (i.e. 
foreknowledge of the phenomenon to be studied) is vital in achieving meaning (Annells 1996, 
Laverty 2003). Gadamer was not without his critics, with notably Habermas criticising 
Gadamer’s reliance on tradition without apparent question and Derrida taking the view that 
Gadamer’s understanding of the person meant the individual was to be seen as correct in 
their understanding (Lawn 2006).   Many of these differences were reconciled through 
discussion but Gadamer’s hermeneutics are particularly suited to this study. Indeed, in the 
consideration of resection of liver metastases I, myself as researcher had a fore-knowledge 
of the clinical system and pathway and therefore  an awareness of some of the ‘traditions’ 
that it may hold. I had also conducted the interviews and been present at the focus group 
and as such has had exposure to the process of interpretation that starts at data collection. 
Rather than abandon this level of foreknowledge, hermeneutical phenomenology as 
proposed by Gadamer, would suggest that this level of knowledge is essential in the overall 
interpretation and search for shared meaning. Further to that, a starting point of belief what 
the patient shared was essential to consider change. As this study has a focus on service 
development and improvement, Gadamer’s hermeneutic philosophy will become heavily 
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relied upon in order to utilise the data and make changes to the pathway in the context of a 
known hospital environment.   
5.5.4 Contribution of van Manen to hermeneutic philosophy 
At this point it is necessary to refer to the impact of the Canadian phenomenologist Max van 
Manen (1942 – present) on hermeneutic philosophy. Van Manen’s work stemmed from his 
dissatisfaction with pedagogical approaches to education in the Netherlands which 
contrasted to a more systems analysis approach of North American education. Van Manen’s 
work has gained contemporary popularity not only among educationalists but also among 
nurses and health care practitioners (Dowling 2007, Earle 2010).  Indeed, Van Manen’s 
publication of Phenomenology of practice: Meaning-Giving Methods in Phenomenological 
Research and Writing (2014) draws on the meaning and practice of phenomenology in 
professional contexts of healthcare and psychology as well as pedagogy and education. His 
development of four fundamental existentials, (or lifeworld themes) named, Spatiality, 
Corporeality, Temporality and Relationality, (van Manen 1997) have been widely used in 
providing guidance for researchers approaching phenomenological writing (Dowling 2007).  
While of this has an attraction, there were several reasons why I wanted to inform the study 
by Gadamerian philosophy rather than van Manen’s. Firstly, I was attracted to Gadamer’s 
teaching on phenomenology as being a product of the early father’s of phenomenological 
debate and secondly, he was the first to acknowledge the fusion of horizons. This was 
concept was particularly important to me as I not only wanted to reflect my place as 
researcher in coming to an interpretation with the participants but I also wanted to reflect 2 
further fusion of horizons, that of my role as insider-outsider researcher and the fusion of 
the input of the health professionals with the participants.  
5.6 Research aims 
The following points set out the aims of this phenomenological inquiry concerned with 
patient experience of the pathway to CRLM resection; 
●To inves gate how pa ents experience the pathway to liver resec on 
●To examine how health care professionals view the pathway to liver resec on for pa ents 
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●To use the experiences of both pa ents and health care professionals to plan and 
implement a service improvement to the pathway with the addition of supportive nursing 
intervention.  
●To explore whether addi onal nursing interven ons during this pathway improve the 
experiences of patients being considered for surgical resection of liver metastases following 
service change. 
5.7 Research Method 
In order to investigate these aims, this phenomenological inquiry has been designed in two 
phases. Phase 1 involved patient interviews (semi-structured) with a patient sample group in 
order to assess the experiences of patients who had been considered for CRLM resection. 
This phase also included a focus group with a group of health care professionals involved in 
the pathway to liver resection to assess their experience, personal challenges and 
perceptions of the current pathway. 
An interim period was built into the study to evaluate the findings from the patient interviews 
and the health care professional focus group. The researcher and nursing team, together 
with the support of the study steering group utilised these findings to consider what support 
changes could occur in the pathway and what additional nursing interventions could be 
offered to support patients through this demanding pathway. The model of nursing 
intervention was dependent and reflected the findings from Phase 1. The second phase also 
involved interviewing a further patient sample group who were considered for liver resection 
following implementation of the service change. A further focus group with the health care 
professionals was also conducted to ascertain change.  
Figure 5.1 overleaf, shows the study schedule. I set out to maintain the sequence of events 
as and timing as indicated in the study schedule to honour requirements of the study funding. 
During this time, I also met the requirements of six-monthly study progress reports to the 
local Health Foundation and ensured feedback of progress to the study steering group. I was 


























Figure 5.1: Timeline of study events 
 
5.7.1 Samples and setting 
Patients who were considered for liver resection during the time period of 2011-2012 were 
recruited to the study using a purposeful maximum variation method. A purposeful sample 
method is the most common sampling method used in phenomenological methodology in 
qualitative research (Simpson & Whyte 2006). It is well matched to the proposed study as it 
is assumed that people who have experience of the hepatic resection pathway are best 
placed to improve the knowledge in this area. A random sampling method would therefore 
serve no purpose in this study. In qualitative research, smaller samples are acceptable as they 
enable in-depth study of an experience and thus allow for a richness of data about an 
individual experience (Bryman 2016b, Worster & Holmes 2009). The study was also 
conducted within a restricted timeframe so a smaller sample number allows the researcher 
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As qualitative research is ‘data dense’, smaller sample sizes can be considered when 
compared to those required for quantitative studies where attention may be given to 
calculating prevalence of a phenomenon or statistical trends. A previous qualitative study in 
this area, conducted in America, (McCahill & Hamel- Bissell 2009) had twelve patients and 
smaller sample sizes of eight to twelve participants are deemed adequate for interview work 
of an exploratory nature (Bryman 2016b). Sample size was achieved when the point of 
theoretical saturation was reached, that is, when there was confidence that recurrent 
themes are expressed and no new thematic data was emerging.  
Currently there are no prospective database systems in place to readily identify patients who 
have been considered for resection of liver metastases from a colorectal cancer primary. 
However, based on in house figures from the hepatobiliary unit in 2012 there were over thirty 
patients who had a liver resection and a further eight patients who were considered for a 
liver resection but did not proceed, for a number of reasons, although some of these also 
included patients who developed additional metastatic presentation, e.g. lung.  Further 
discussion with members of the multidisciplinary colorectal cancer team suggested that 
patient recruitment should be relatively easily secured. 
According to the maximum variation principle, often adopted in purposeful sampling, the 
intention of the study was to recruit patients with a range of experiences, e.g. those who had 
synchronous liver metastases and metachronous liver metastases, those who have had clear 
operability and borderline operability. This will therefore include patients who have been 
successful in proceeding to a liver operation and those who have not, for a number of reasons 
(e.g. disease recurrence, failure to respond to chemotherapy, co-morbid complications). 
Including patients who did not have liver resection is seen as a measure of improving validity, 
as it may be that there was a tendency for those achieving liver resection to reflect back on 
the pathway more favourably considering their more favourable outcome. The diverse 
inclusion among the study sample allowed for the patient population to be reflected across 
its breadth of population. This, importantly added credibility to the study sample and 
research as a whole.   It is important to stress that the focus is on the pathway as a whole 
rather than on the outcome of being considered for surgical resection of CRLM.  The study 
inclusion/exclusion criteria for patents are listed in Table 5.1.  
An important consideration when agreeing eligibility criteria was a firm agreement to those 
with liver only metastases. As noted in Chapter Three, it is not only with liver metastases 
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where advancements in metastatic treatment have been seen. Initial discussions with 
clinicians involved in the treatment of those with CRLM expressed such concerns and that it 
would be good to include those who had for example liver and lung metastases. 
Inclusion criteria Exclusion criteria 
- All patients with liver only metastases of 
colorectal origin being considered for 
surgical resection of liver metastases. 
- Patients treated within the boundaries of 
NHS Lothian. 
- Patients who are able to provide informed 
consent to allow for participation in the 
study. 
- All patients over age 18. 
- Patients with other known metastases 
originating from a bowel primary, e.g. lung, 
peritoneal metastases. 
- Patients with known cognitive impairment 
which would make it difficult to elicit their 
experience through an interview method. 
- Patients with known significant mental 
health diagnosis which would make it 
difficult to elicit their experience through an 
interview method. 
Table 5.1:  Study eligibility  
Notably this would have increased the potential for patient recruitment. However, although 
these thoughts were acknowledged it was decided to focus on those with liver only 
metastases as the introduction of the surgical management of a non-liver metastases can 
make for a more complex and very different pathway. In addition, as outlined in Chapter 
three, liver only metastases are more frequently occurring and historically the case for 
surgical treatment is more developed. These sentiments were also echoed by the steering 
group.  
The study was confined to those in NHS Lothian. Patient interviews took place on the 
premises of either two local teaching hospitals or in the patient’s own home. Locations within 
the two teaching hospitals were used for the health professional focus groups in both Phases.   
 5.7.2 Phase 1 
Nineteen patients were eligible from information provided from an in-house hepatobiliary 
database of patients considered for liver resection in 2011 and 2012. A good response to 
invitation by letter was received, with 16 patient interviews taking place between March-
June 2013. Three patients declined, two expressing that they would rather ‘move on’ from 
this period and one as he was taking the opportunity to travel for an extended period out 
with the interview period. Twelve of the sixteen patients who consented, had undergone 
liver resection and four became ineligible for resection. For two of these patients this was 
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due to disease progression and for the remainder two due to associated co-morbidities. 
Table. 5.2 overleaf displays the characteristics of the study sample for Phase 1.  
The focus group was conducted in May 2013 at a local Maggie’s Centre, and was attended by 
four health professionals. Two could not attend due to emergency liver transplant but one 
(Consultant Hepatobiliary surgeon) was later interviewed by the focus group facilitator on a 
separate occasion. This demonstrates the reality of conducting research within a reactive 
clinical setting. Table 5.3 overleaf displays the make-up of the Phase 1 focus group. 
5.7.3 Interim period 
An eight month interim period (July 2013  – February 2014) allowed for data analysis from 
Phase 1 and implementation of a new model of support for patients undergoing CRLM. This 
time also allowed for consideration of suitable approaches in response to the findings and 
development and implementation of one model of support for patients. This interim period 
is detailed in Chapter 7 and focuses on the background and rationale for the development of 
a systematic nurse-led telephone support model, development of a patient information 
series regarding colorectal liver resection and a formation of a patient buddy support service.  
Following the interim period, it then became possible to begin patient recruitment to 
evaluate the experience of future patients who were being considered for CRLM and to 
ascertain the value of the implementation of the support model.  Using purposive sampling, 
potential participants were identified prospectively from the colorectal multi-disciplinary 
meeting from January 2014 – December 2016. The majority of interviews were conducted by 
December 2015 but due to the often elongated nature of the pathway, it took until December 
2016 to recruit patients who did not proceed to liver resection. This is an important 
consideration because the previous patients in Phase 1 had been recruited retrospectively. 
In this phase, patients were required to be identified prospectively but could not be 
approached until after liver resection was completed or a definite decision not to proceed to 
liver resection had been confirmed with the patient and documented. Interviews continued 






















subsequent 2 liver resections 
Yes x3  
Chris* Male 53 Synchronous  Primary bowel surgery 
chemo liver resection 
Yes 
Andrew* Male 66 Synchronous Primary bowel surgery 
chemoliver resection 
Yes 
Craig Male 55 Synchronous Primary bowel surgery 
chemoliver resection 
Yes 
Alex Male 70 Metachronous 
(during follow-
up) 




Paul Male 70 Synchronous Primary bowel surgery + 
defunctioning stoma 
No 








Amy Female 65 Synchronous Synchronous primary and liver 
resectionchemo 
Yes 
Laura Female 76 Synchronous Primary bowel surgery 
chemoliver resection 
Yes 
Steven Male 72 Synchronous Short course 
radiotherapyPrimary surgery 
No 
Richard Male 77 Synchronous Primary bowel surgery 
chemoliver resection 
Yes 
Tom Male 57 Synchronous Primary surgerychemo No 
Jennifer* Female 74 Synchronous Synchronous primary and liver 
resection 
Yes 
Robert Male 63 Synchronous Primary bowel surgery 
chemoliver resection 
Yes 
Lynn Female 62 Synchronous Primary bowel surgery 
chemoliver resection 
Yes 
Julia Female 60 Synchronous Primary surgerychemo No 
Table 5.2: Study Characteristics of Phase 1 participant sample  







Table 5.3: Health professional make-up of Phase 1 focus group 
Health professionals present at focus group Phase 1 




Colorectal nurse specialist 
Researcher (myself) as observer 
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5.7.4 Phase 2  
Once again, a good response to invitation by letter was received with thirteen patient 
interviews taking place between July 2014 - June 2015. Five out of the 18 patients 
approached, declined, expressing in a similar way to those in Phase 1, that they would rather 
‘move on’ from this period and concentrate on their recovery and follow-up. During this 
period, July 2014 – June 2015 there were just under fifty patients eligible for liver resection 
but it took longer to follow through and find patients who became ineligible for liver 
resection. For Phase 2 of the study,  twelve participants had undergone liver resection and 
four became ineligible for resection. All four of these patients could not proceed due to 
disease progression where it was apparent that interim imaging had upstaged their initial 
potentially resectable disease. Table. 5.4 overleaf displays the characteristics of the study 
sample for Phase 2.  
The focus group was conducted in May 2014 at a large teaching hospital for the convenience 
of those representing the hepatobiliary service. It was attended by six health professionals. 
Table 5.5 displays the make-up of the Phase 2 focus group. 
5.8 Practical considerations 
A number of practical considerations were important to the recruitment process and ensure 
patient throughout the process. These are outlined in turn.  
5.8.1 Access to participants 
Appropriateness of potential patients for the study was checked with a respective consultant 
before an invitation letter and information letter from a consultant of the direct care team 
was sent (see Appendix II – V for examples of patient study documentation). Patients were 
invited to respond by telephoning the research office or returning a response slip in a 
stamped addressed envelope. The researcher and an independent study adviser were 
introduced in this documentation. Participants were made aware that, should they 
participate, their GP would be informed (see Appendix VI). Potential participants in the health 
professional group were known to the researcher and members of the multidisciplinary team 
were invited by letter from the researcher with an attached information letter (see Appendix 
VII – VIII for examples of health professional documentation). Documentation was adjusted 














Lisa Female 49 Synchronous Primary bowel resection 
chemoliver resection 
Yes 









Archie Male 77 Synchronous Primary bowel resectionliver 
resection 
Yes 





















Judith Female 72 Metachronous 
 
Primary bowel resectionliver 
resection 
Yes 
Carol Female 73 Metachronous  Primary bowel resectionliver 
resection 
Yes 
Mark Male 51 Synchronous Defunctioning 
stomadownstaging radiation 
to rectal primaryprimary 




Diane Female 73 Synchronous Synchronous bowel resection 
with liver resection 
Yes 
Kenneth Male 60 Synchronous Bowel resectionchemo No 
Daniel Male 52 Synchronous Bowel resectionchemo No 
Ann Female 67 Synchronous Bowel resectionchemo + 
cetuximab 
No 





Table 5.4 :Study Characteristics of Phase 2 participant sample 




Health professionals present at focus group Phase 2 




Colorectal nurse specialist 1 
Colorectal nurse specialist 2 
Hepatobiliary surgeon 
Researcher (myself) as observer 
Table 5.5: Health professional make-up of Phase 2 focus group 
5.8.2 Timing and presentation 
Checking a patient’s eligibility with a respective consultant ensures that recruitment to 
patient interviews are well managed. This may reduce patient distress particularly in cases 
where patients are still receiving chemotherapy following liver resection or receiving ongoing 
treatment for complications encountered as part of overall treatment.  Potential participants 
for the patient interviews were given at least one week to consider the invitation letter 
before the researcher made a follow-up phone call to answer any queries and ascertain 
interest. In the majority of cases this follow-up phone call was not required. The researcher 
ensured that they were clearly introduced, taking the time to check receipt of invitation letter 
and that the potential patient had the time to talk. Caution was exercised to ensure that no 
coercive language was adopted during the call.  For those wishing to proceed , an agreed 
date, a time and location of the patient’s choice was made.   
Potential health care professionals were given one week to respond to the invitation letter. 
A lack of response was followed up by an email to ascertain willingness and availability. Once 
participants were confirmed, care was taken to set a convenient date, time and location for 
the focus group. Patients were invited to participate in one interview lasting approximately 
one hour and similarly the health care time commitment was approximately one hour. A 
different set of patients and health care professionals were then asked to repeat interviews 
and a focus group respectively after a planned intervention in the interim period.   
5.8.3 Development of interview/focus group schedule  
Themes for the interview and focus group were developed according to literature outlined 
earlier and on discussion with colleagues in multidisciplinary team. An example interview 
schedule can be viewed in Appendix IX for those patients participating in semi-structured 
104 
 
interviews. Questions were adapted at the time of the interview according to (a) patient’s 
disease presentation and (b) response given. This ensured that the interview was participant 
led. An independent facilitator adapted the themes and questions used for the patient 
interviews to the health professional focus group in order to develop a discussion schedule.  
5.8.4 Data collection procedure 
In both Phase 1 and Phase 2, semi-structured interviews were used with patients and one 
focus group with Health Care Professionals. Both interviews and the focus group were audio-
recorded for transcription and analysis. Patient interviews lasted for approximately one hour 
and included a number of open questions. Prompts were used to aid the participant in 
discussion and check understanding but care was taken to avoid leading questions or 
influencing participants’ responses.  
Health care professionals involved in the colorectal cancer pathway were invited to take part 
in a focus group lasting one hour. An independent facilitator was used to facilitate group 
discussion. This was of value as the researcher was considered to be too closely connected 
to the health professional participants and allowed for some distance. Open ended questions 
were adopted and prompts were used to check understanding and elicit further discussion. 
Questions with the same themes used for patient interviews were used with the focus group, 
but were angled towards their role as health care professionals. Written consent was 
obtained before commencing participant interviews and the focus group.  
5.8.5 Rigour, credibility and trustworthiness 
There is an ethical responsibility to conduct rigourous research and all research should be 
underpinned by principles of rigour, credibility and trustworthiness. These principles apply 
to quantitative research but the means by which they are achieved in qualitative research 
will differ according to their ontological base (Leung 2015). Rigour should be evident 
throughout a study from design to data collection, analysis and dissemination. Maintaining 
rigour is a way of preventing harm to participants and to ensure the credibility and 
trustworthiness of findings for further application. Criteria for determining trustworthiness 
were introduced by Guba & Lincoln in the 1980s opting to replace commonly used 
terminology for achieving rigour, such as reliability, validity and generalisability with 
dependency, credibility and transferability (Morse 2015). In this study, rigour was ensured 
through my integrity as a researcher and the use of reflexive practice  (Avis 2002) as more 
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fully expanded in section 5.10.4. Regular discussion with supervisors on particular aspects of 
study design, ethical considerations, sample population, analysis and dissemination of results 
were key to maintaining both rigour and credibility.  
 
Credibility was ensured by several means.  My sustained period of involvement in the study 
helped to confirm that I had a good knowledge of the area, alongside my inside knowledge 
of the existing area. Peer debriefing with members of the steering group, immediate team 
members and member checking of transcripts also helped to limit bias and reduce omissions 
(Lapan et al 2012). This is further detailed in Sections,  7.2.1, 7.2.2. and 9.10.    Keeping a 
researcher journal to document my understanding of the research journey was also useful to 
self check my own thoughts guiding the analysis. Finally, using the fusion of horizons as 
outlined at the outset in Chapter 1, Section 1.2, reflected a blending of viewpoints, (patients, 
health professionals and my own as insider-outsider reseacher). This can be considered akin 
to triangulation, a method used to enhance the trustworthiness of qualitative research, by 
utilising different sources of data on the same topic to compare and contrast differences and 
similarities (Schensul 2012).  This adds a strength to the methodology in that the topic of 
CRLM under scrutiny is supported by the gathering of information from different groups. This 
in turn supports and validates each source, increasing data trustworthiness. 
 
5.9 Chosen qualitative method: the medium of interview 
It would appear that interviews play a crucial part in our society in understanding the world 
we live in. Interviews appear to be everywhere. They are never far from the ‘flick of a remote’ 
or remnants overheard in a more casual social setting.  The idea of the ‘interview society’, a 
term coined by David Silverman (2017) is one with which we can readily identify, yet the 
apparent infiltration of the interview could give rise to the idea that conducting an interview 
requires nothing more than everyday conversational skill (Holstein & Gubruim 2004, Rubin 
& Rubin 2005, Atkinson & Silverman 2007).  When placed in the context of research, the 
interview is seen as an art or craft, something requiring a unique skill set and an 
understanding of the process and associated investment and risk to both the researcher and 
participant (Kvale & Brinkman 2009, Roulston 2011). Loftland and Loftland (1995) argue that 
when undertaking research interviewing, the researcher should expect to come into contact 
with some raw human emotion. This may especially be the case when conducting interviews 
involving a sensitive or emotive issue as is the case in this study subject. The medium of 
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interview became an important way to ‘be with’ the participant in sharing their horizon of 
interpretation, and in understanding heard language as vital to that understanding and 
future interpretation. This became important in reflecting a key component of Gadamerian 
thinking of interpretation. For this reason, the next sections, outline some considerations in 
undertaking interviews.  
 
5.9.1 The context of the research interview:  an emotionally sensitive nature 
While the advances in the treatment of liver metastases are hugely exciting, (as detailed in 
Chapter 2), observations in the care setting would suggest that the pathway to liver resection 
is extremely demanding for patients, with the pathway taking several months for surgical 
workup depending on tumour presentation, pre-operative imaging and possible requirement 
for chemotherapy.   The day to day reality, is that discussions are inevitably of an emotionally 
sensitive nature. Defining what constitutes an emotionally sensitive issue among participants 
is not straightforward. There appears almost to be a taken for granted understanding of what 
is meant by emotional sensitivity when reading research literature. While this may be more 
obvious from situations presented in papers such as Gadd’s (2004) work in violence in 
intimate relationships or Goodrum & Key’s (2007) studies in bereavement from murder and 
abortion, defining a subject as emotionally sensitive may not necessarily mean that it is 
perceived as such by a participant.  The Oxford English Dictionary defines emotion as ‘a 
strong feeling deriving from one’s circumstances, mood or relationship with others’ (Oxford 
University Press, 2018, para.1). In this study, I was keen not to assume that the interviewees 
would necessarily encounter the interviews as emotionally sensitive but equally I wanted to 
be attuned to the possibility that the interviews held that potential of confronting the 
participants with raw emotion. This may be especially the case when participants reflect back 
on events either pertinent to their treatment, or to events at that time, or to current events 
coinciding with the time of recalling the information.  
 
Before discussing the skills required during the interview process, this section will address 
issues considered as essential pre-requisites to facilitate the interview process. These pre-
requisites are important for any type of research interviewing, but in the context of 
interviewing participants where emotionally sensitive issues could become apparent, robust 
preparation and adequate thought must prove beneficial to both the researcher and 
potential participants. This is a sentiment echoed by many researchers (Mason 2002, 
Hubbard et al 2001, King & Horrocks 2010). The overall process of preparation can set the 
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tone for the actual interview by providing safeguards to both the researcher and participant 
in reducing the risk of potential harm and enabling a more critical process of researcher 
inquiry which may in turn facilitate the generation of richer interview data.  
 
 5.9.2 Establishing the interview approach and schedule 
When studying a particular participant group the researcher needs to identify the most 
appropriate research design and methodology pertinent to the group and associated 
research question (Rubin & Rubin 2005, Bryman 2016b).    Bearing this context in mind, the 
use of the research interview is a useful qualitative tool, ideally placed to elicit knowledge 
and understanding in an area where little is known (Mason 2002, Rubin & Rubin 2005).  A 
qualitative research design using phenomenological method was used in this study as it is 
suited to explore the subjective world of human experience rather than quantitative research 
(King & Horrocks 2010). Utilising a quantitative approach and tools would only fail to yield 
meaningful data and would not reflect an ontological position which considers people’s 
knowledge and experiences are meaningful properties in the social world (Mason 2002). 
Before approaching their participant group, the researcher should consider the issues faced 
by the potential participants. This may arise from relevant literature or a priori knowledge 
from previous contact with the participants or perhaps from related research. This 
consideration may then form the basis of an interview schedule which may be used to guide 
the interview or act as an aide memoire to the researcher. How structured or unstructured 
the interview should be is something the researcher will need to decide upon as suited to the 
participant group and data.  In their paper, Corbin & Morse (2003) helpfully outline, three 
different modes of interviewing in a table (structured, semi-structured and close-ended 
questioning) along with their associated control over the interview from the researcher and 
participant’s perspective.  Corbin & Morse (2003) suggest, that when dealing with sensitive 
issues, the use of the unstructured interview can give more control to the participant and 
this can allow the interview to be set at the pace of the participant therefore putting them 
more at ease. However, Corbin & Morse are quick to point out that this unstructured 
approach has its own risk.  It clearly shifts the power dynamic and conversation to the 
participant, which carries the risk that the researcher may not get the data relating to certain 




A semi-structured interview was used with the focus on a collaborative or facilitative 
interviewer-participant relationship. This helps to balance the perceived power dynamic 
between researcher and participant. Sinding & Aronson (2003) report that unequal power 
dynamics can often be evident particularly where care has failed in healthcare.  In interviews 
that have already been conducted by the researcher in Phase 1 of the study, the researcher 
found that the majority of participants led the conversation as they relaxed into the 
environment and the researcher did not have to diligently adhere to the schedule as if in 
some robotic style of questioning. However, familiarisation with the interview schedule did 
mean that in rare times when the conversation ‘dried’ then the researcher always had a 
direction in which to guide further exploration. On reflection, a structured interview schedule 
would have been too inflexible and may have hidden some of the emotional aspect that 
needed to be uncovered.    
 
5.10 Adopting ethical safeguards 
Hubbard et al (2001) are quick to point out that ethical issues are certain to be present when 
researchers look at emotionally sensitive topics. Traditionally Fontana & Frey (2005) have 
reported that ethical considerations revolve around three key concerns; informed consent, 
right to privacy and protection from harm. Knowing or having access to the participant pool 
is central in achieving consent (Schulman-Green et al, 2009). Care should be taken to avoid 
participant pressure and to allow adequate time to weigh up involvement.  In the case of the 
liver metastases study, the ethics committee did acknowledge that participants were likely 
to experience emotional vulnerability and they requested that the participant invitation 
letter was sent from a named oncologist in order that the study was directly connected to 
their direct health care team (see Appendix II - IV). This allowed additional support in the 
case of emotional challenges arising as a result of their care that had been triggered by the 
interviews. Oncology based psychological support was also built into the study support 
structure should patients wish to take this up. Both these measures allowed clear boundaries 
between the researcher and interviewer.   
 
5.10.1 Consent 
For those participants in the patient group, informed consent was sought by signature to 
ensure agreement. The informed consent document was sent out in the original information 
pack and some participants chose to return it signed to the research office while for others, 
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consent was taken prior to the research interview. The interviews took place within 1-3 
weeks of ascertaining that the participant was happy to proceed. The consent document was 
taken to the interview if it had been signed earlier and discussed again as a further way of 
checking that the participant was happy to proceed.  It was always co-signed by myself as 
researcher before the interview began. This allowed for time to ascertain understanding of 
the participant's involvement before the interview commenced. Consenting to only one 
interview prior the interview began, made it unlikely that a participant would not proceed. 
Informed consent was also taken by the researcher prior to the focus group for those in the 
health professional group. Participants in this group also received a written information sheet 
about the study beforehand.  
 
5.10.2 Data storage and confidentiality 
Local ‘in-house’ hospital databases and medical records were reviewed to screen identifiable 
personal information of patients. Electronic transfer of data from patient databases was 
encrypted for transfer and stored only on a hospital secure drive. Information from the 
databases was extracted by hospital staff who already had authorised access as part of their 
routine workload. Medical records were reviewed by myself in the capacity of both 
researcher and, as part of the existing clinical care team. Personal contact details of 
participants and consent records were treated sensitively and kept in a locked drawer of a 
filing cabinet along with any identifiable patient files and audio files. All publication of direct 
quotations will be anonymised and no data has been published or presented that would 
allow individuals to be identified. Coded transcripts were stored on a NHS computer with 
existing safety access controls in place. No identifiable data was shared with the transcriber.    
As a member of the direct healthcare team, the researcher adheres to the Data Protection 
Act and NHS Code of Confidentiality and has ensured that the study was conducted in 
adherence to these policies. 
An independent risk assessment was also performed by the local Clinical Trials Monitor and 
by the local Quality Assurance Group with the outcome that no regular monitoring of patient 
safety was required throughout the study and that no audit required to take place before, 





5.10.3 Minimising the possibility of harm 
Even though the nature of the interviews were likely to be emotionally sensitive, it was 
anticipated that no prolonged emotional harm would occur to the participants.  Although 
everything possible was in place to minimise distress, it was recognised that a patient 
interview may trigger emotional upset when discussing issues relating to a diagnosis of 
metastatic cancer and potential treatment. If patients were to become distressed during the 
interview, care was taken to stop the interview.  It was written into the ethics of the study 
that if a patient was too distressed and wished to withdraw from the study, they were given 
reassurance that they could do so and this would not affect their care. 
As a nurse specialist, the researcher is experienced in managing distress and signposting to 
other services should the need have arisen. Additional support for the patient could be 
sought with the patient's approval e.g. their General practitioner (GP). A study letter was sent 
to the respective GP of each participant to inform them that their patient had taken part in 
the study (see Appendix VI).  The Clinical Psychology department within the hospital were 
also in agreement to take patient referrals with a patient's approval, should this have been 
deemed appropriate. They were also able to offer advice to the researcher if required. 
Having had direct experience of the pathway, patients are often keen to share their 
experience as a way of voicing and making sense of that experience. It may help that they 
can do this with a researcher, who as a nurse specialist is familiar within the field. In addition, 
the feeling of being listened to will ensure that they feel they can contribute to change and 
any possible improvement to the care of future patients. 
There were minimal risks to the researcher. When a home interview was conducted at the 
patient's request, the researcher left details with a colleague of the location. The researcher 
also had regular supervision from the Clinical Psychology service within the local hospital, 
should any distressing issues from the patient interviews require to be discussed. 
Mason (2002) suggests that when doing qualitative interviewing, there should be moral 
research practice at every stage. 
“This means attempting not only to carry out our data generation and 
analysis morally, but also to plan our research and frame our questions 




In this way, it goes beyond the actual interview and into how data is heard, analysed and 
presented. Of course, Mason (2002) is quick to point out that despite such good intentions, 
research can throw up some competing interests which might also compete the ethical 
stance of the researcher. In such cases, the researcher should keep ensuring that they ask 
themselves the difficult questions and strive hard to know how to answer them. This analytic 
approach helps to maintain researcher accountability throughout the study. Indeed, within 
the last decade, more attention has been given to the emotional challenges of the researcher 
when dealing with sensitive issues (Hubbard et al 2001, Holstein and Gubrium, 2004) and not 
just the participant.  This has led to the consideration of necessary support measures being 
embedded in the ethical submission process (Kings & Horrocks 2010) and notes a move away 
from the traditional viewpoint that it is only the participant who can encounter harm.  
 
5.10.4 Fostering a reflexive approach 
Hubbard et al (2001) refer to a challenge that often presents itself when undertaking 
qualitative research. This challenge often seems like a paradox, 
“The challenge therefore is how we can construct meaning and develop 
understanding and knowledge in an academic environment that, on the 
whole, trains researchers to be objective and ‘extract out’ emotion.” 
(Hubbard et al 2001, p.136).  
They argue that we are taught to extract out emotion in an attempt to become more 
objective rather than bear witness to its influence.  Avis (2002) grapples with the idea of 
putting ‘self’ into research in a useful and, indeed, amusing self-analytical chapter, entitled, 
‘Making Space for Subjectivities in Interviews’. After much grappling about how to present 
self, position self, and be self, she concludes, 
“The practice of reflexivity is one that attempts explicitly to link the idea 
of self to the process of knowledge construction” (Avis, 2002, p.205).  
 
The process of being reflexive is inextricably linked to all stages of the research process, 
writing in the researcher rather than writing out. The idea that knowledge is constructed 
because of the presence of an active rather than neutral researcher leads Holstein & Gubrium 
(2004 p. 157) to suggest that “all interviews are unavoidably active meaning-making 





5.11 Skills required for the interview process 
Where possible, excerpts from the interview transcription were used to reflect upon the 
researcher’s own interview practice with particpants.  In transcripts ‘I’ will represent the 
interviewer and ‘P’ the participant. The words interviewer and researcher will be used 
interchangeably. I felt that this was important, not only as a way of showing a reflexive 
approach used, but also as a way of showing transparency in the interview medium.  
 
5.11.1 Entering the shoes of the other 
It was the researcher’s intention to delve into the world of the participant. Having the time 
allocated during an interview provides something of a luxury and privilege. Entering into the 
shoes of the participant takes time and does not happen instantly (Schulman-Green et al 
2009, Dickson-Swift et al 2007). It is a gradual process and from the outset the researcher 
can aid this by ensuring that the participant is comfortable. Much of this may be done off-
tape in the initial encounter with the interviewer taking a hospitality role but ensuring the 
comfort of the participant throughout is something which the interviewer will continue to be 
aware of.  
 
For some researchers, nothing of the world of the other will be known while others will have 
some level of existing knowledge about the subject or participant group. Either way, it is 
important that the researcher sets aside any assumptions or value judgements which they 
have consciously or unconsciously formulated.  For the liver metastases study, the researcher 
was familiar with the care setting and treatment pathway involved for participants and it was 
important that open questions were used to enter into their experiences rather than focus 
on what the researcher perceived problem areas or emotions were. The use of a broad 
question at the beginning of the interview was used to open up the interview to the 
participant. The interview transcript reads as follows (after introductions and a brief 
description of the research, off-tape): 
I: “If possible, can you take me back to the start and tell me how you 
were when you were diagnosed, how well you were and what symptoms 
you had at the time?” 
 
This question allowed both the researcher and interviewer get off the starting block and 
provide some safe context in which to set the rest of the interview. On reflection, the 
question appears to be split into three parts although all parts are essentially seeking the 
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same thing, that is an entry into what it was like to be diagnosed which could then be opened 
further. Schulman-Green et al (2009) in their practical paper suggest ten techniques for 
interviewing the seriously ill at end of life. They offer technique number 6, ‘start with safe 
ground and peel back the layers’ in sequence to technique number 4 ‘develop a sense of the 
participant’. The ten techniques are of use if they are taken as suggestive rather than 
prescriptive for they could not be applied in some magical sequence in every interview. 
Drawing on work by McHale-Wiegand et al (2008) they show that layering less sensitive 
questions towards more sensitive questions and then less sensitive questions at the 
interview closure is a way of minimising participant burden but also of the researcher peeling 
back the layers of the participant’s story and the associated meaning.  
5.11.2 Encouraging a sense of safety and trust 
Choosing an environment to help respect privacy is an initial way of encouraging safety (Kvale 
& Brinkman 2009).  Where an interview takes place in the participant’s home, it may be 
helpful to ask if they wish another member of the family to be present as a way of ensuring 
safety or as a way of checking the participant’s consent to that other member who may 
assume they can be present.  
A further way to establish trust is through the presentation of the researcher and the 
introductions they make (Hubbard et al 2001, King & Horrocks 2010). As the researcher is a 
member of the direct health care team, it was important that awareness was given to any 
power dynamic that could make the respondent feel like there was a correct answer or want 
to gloss over any difficulties in their care in order to please the researcher. The participant 
may make judgements about the researcher’s position which in turn may put barriers up to 
data being shared in a more collaborative way (Kvale 2006).  In the liver metastases study, 
the researcher opened by briefly reminding the participant of the purpose of the interview 
and how the data would be used. The researcher stressed  
I: “that there are no right or wrong answers, that all views or experiences are 
important no matter whether these have been positive or negative. The aim 
is that insights are gained from your experience and as a result improvements 
can be made to the service.” 
Putting the participant at ease from the outset is crucial in establishing trust (Rubin & Rubin 
2005, Schulman-Green et al 2009). Asking for consent to audio-record and explain that notes 
may be taken are all ways to recognise the personal nature of what will be shared. Conveying 
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interest will show the participant that what they share will be valued. Rapport is widely 
acknowledged as important in facilitating the researcher-participant relationship (Dickson-
Swift 2007, Kvale & Brinkman 2009, Bondi 2013.  From the outset it could be as something 
as simple as making a comment to put them at ease if they have been late due to trying to 
find a parking space or picking up on a conversational cue in their initial introductions. This 
rapport is something that is built on throughout the whole interview process. Bondi (2013) 
in her revealed interview excerpts with Katherine found that the first 15 minutes of the 
interview was a ‘checking out’ time by Katherine to establish trust and after that rapport was 
generated. A similar experience was found by myself as researcher in this study. This was not 
wasted time, but part of putting the interviewee at ease. Gadd (2004) acknowledges that 
developing rapport is not always easy to do, especially when the interviewee has known to 
cause harm, or as Hubbard et al 2001, suggest when we find ourselves not warming to a 
participant.   
Often in the back of the mind of the researcher is ‘am I obtaining relevant data?’ When data 
are not forthcoming, it may be because rapport has been affected. In Dickson-Swift et al’s 
(2007) study, participants talked about an uneasiness over the use of self-disclosure in order 
to build rapport. Each researcher needs to decide the level of self-disclosure they are 
comfortable with without compromising their position as the researcher. For example, in a 
study with cancer patients, it may not be appropriate to disclose a personal family experience 
of cancer or indeed perhaps further, a researcher’s own cancer experience. Doing so may 
take the focus away from the participant and cause them to assume the researcher knows 
what they are talking about. Equally there may be a time for revealing something of the self 
and world of the researcher at the discretion of the researcher. In one case, I, as researcher, 
used an example from another participant to gain entry into a new subject but did not reveal 
any details of the other participant. This statement appealed to the identity of an emerging 
group of participants ‘out there’ which could then be further probed.  
I: “Another participant in the study was saying (and to what extent you will 
agree with this, I’m not sure), but she was mentioning how the media can be 
sometimes quite unhelpful?” 
In this way the virtual rapport of another participant was used to move a subject on and yet 
continue to build on the existing rapport between researcher and current participant. 
Interestingly Rubin & Rubin (2005) suggest that a reciprocal dialogue in interviewing does 
not always have to be equal in order for the participant to disclose their experiences.  
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When talking freely in an interview a participant may find themselves sharing something they 
later regretted or did not realise they would elicit at the outset of the interview (Kvale 1996). 
Towards the end of the interview, the researcher can address this by asking the participant 
if they are comfortable with what they have shared and if they would like to view a transcript 
or summary of the interview once completed.  In this way they can have the opportunity to 
reflect on what they have shared and correct anything they did not want to share. This will 
ensure that the level of trust continues well after the interview into analysis and 
dissemination of findings. Goodrum & Keys (2007) speak about lack of acknowledgment and 
how an overly professional approach can be unhelpful especially in dealing with very 
emotional issues. Probing through the pain can still be done if done with recognition of 
sensitivities. A continual awareness of patient posture and non-verbal cues will help with this.  
Should it become apparent that the distress is too great to carry on, it can be agreed to stop 
the audio recording for a time or to move on to a further subject. After the interview has 
finished it may be necessary to signpost for additional help. Procedures determined for 
ethical review should help with this but the researcher will need to consider from the outset 
what their contact with the participant should be after the interview has taken place 
(Schulman-Green et al 2009).  
5.11.3 Facilitating flow 
The ability to listen during interviewing would seem an obvious quality to possess as a 
researcher but the process of listening actively to the verbal and non-verbal is a recognised 
skill (Kings & Horrocks 2010).   Anyone who has practised interviewing will be aware of the 
difficulty involved in hearing what the participant has said and being able to respond to it. It 
is all too easy to be considering further questions to keep the flow of conversation going or 
thinking over what has been said in relation to the wider research questions (Mason 2002). 
Attending a research training course will help to develop these skills (Roulston et al 2003) as 
will undertaking some pilot interviews with similar participants to test out the interview 
schedule (Bryman 2016c). 
Throughout the interview the interviewer will draw on a range of strategies to facilitate flow 
and elicit data.  In the liver metastases study, showing interest through verbal utterances 
such as “uh, hah”, “right”, “um hum” were used across the interview to display attentiveness. 
Roulston et al (2003) in their interviews with 12 students undertaking research training found 
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that verbal utterances featured more than the students had been aware of during the 
interview and demonstrated engaging emotion on the researcher’s part.  
5.11.4 Summarising 
One commonly used strategy was summarising phrases that Mrs X had said in order to check 
understanding. 
P: “When I was told about spread” 
I: “Secondaries?” 
P: “Yes, I really went in not expecting, …I know you learn to modify your 
expectations but I really didn’t expect that, that day, so...I thought this 
would be the end of it” 
In this the interviewer clarified what was said to ensure the participant understood they each 
had the same understanding of ‘spread’ so that further questions could be asked.   
Further in the interview, summarising is used to go deeper into a specific issue of patient 
control. 
I: “And it sounds like, what’s very important is that sense of control because 
you’ve worked with Dr B and he’s worked with what you want as well.” 
 
This gave Mrs X further affirmation to talk about meaning of control to her in decision 
making.  
5.11.5 Redirecting 
Part of the rationale of using a collaborative approach in semi-structured interviewing is that 
there are some specific data that the researcher is aiming to obtain. Corbin and Morse (2003) 
speak of the purpose of interviewing and Mason (2002) about using the structure of 
interviews to access ‘situated knowledge’. In this study, the interviewer wanted to move back 
to a point about diagnosis and redirected the participant back. 
I: “And just to take you back a bit to the time when you were in clinic to see 
Mr P” 
 
Again, this was used further in the interview. 
 
I: “Prior to that when you had initially seen Mr P, how sure were you of a 




Both of these examples led the participant back to reveal deeper insights on diagnosis that 
might have been glossed over.  
5.11.6 Incorporating the use of gentle humour 
The use of gentle humour can be used to aid interview progression. On one occasion in the 
liver metastases study the interviewer’s phone clattered to the floor and fell apart at a point 
where the participant was getting emotional when she was talking about the worry a head 
CT had caused her in thinking the cancer had progressed further than she thought. At this 
point the researcher said “Don’t panic” which was followed by laughter from both and 
transcribed to show this. On reflection, reading the transcript without the context, it looks 
like the researcher is saying not to panic about the worry, but in actual fact is really saying 
everything is under control with the phone and gives reassurance that the participant can 
continue. Unexpected occurrences will happen during the interview but if dealt with in a 
reassuring manner, the story of the participant will not be lost.  
Humour is often exhibited by participants. Occasionally patients paused to share a funny 
story about an incident that had happened and that lightened the intensity of the nature of 
the interview. One participant in Phase 1, a previous submarine engineer, had explained that 
he was not claustrophobic of the MRI scanner despite being in it numerous times added,  
P: “ Well, when you crawl down a 21" tube, hundreds of feet 
underwater, just to check it’s all right,  claustrophobia doesn’t come into 
it!”  
On another occasion, a participant in Phase 2 had explained how the consultant had visited 
her bedside post surgery. She remembers feeling very weak but trying to make light of it 
when the consultant joked that he didn’t know what had happened to her, remarking that 
‘she looked like she had been hit by a train’. Even at day 1 post surgery, she was able to reply, 
P: “Well, you were driving it!”  
She remembers the lightness that the incident had brought and on reflection had recognised 
that such a remark might not have had the same effect with another individual but she knew 
that her consultant had the connection with her to do so. Such occasions provide not only an 
insight into a participant’s personality which usually correlate with their spoken words and 
interpretation of events but it also provides a good opportunity to build rapport during the 
interview process which can open up deeper levels of questioning. The use of humour was 
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noted as intrinsic to hope by Coloqhoun & Hill (2012) and also through Herth’s work (Herth 
2018). 
5.11.7 Repetition of participant’s words 
A simple use of repetition of a few words can act as a probe to see if the participant wishes 
to add anything further.  In this case of the study in question, the dialogue flows as follows: 
P: “I felt that I had actually gone back to the beginning and back” 
 
I: “Back to the beginning” 
 
P: “I thought I had actually gone really backwards, worse than I had ever 
felt, even at the very start of it and you know, I know that’s not anybody’s in 
particular, anybody’s fault and I know they were all, they all were very sorry 
that I was in that situation if you like, but it’s, yeah it’s pretty devastating”. 
 
At this time the researcher felt it was right to echo back the sentiment offered by the 
participant which then allowed Mrs X to give a fuller explanation of her meaning. Mrs X 
paused before elaborating.  Knowing how long to leave a pause is a skill which the researcher 
learns to manage to allow the participant to be forthcoming.  
5.11.8 Protecting self as researcher 
Interviewing can also reveal difficult emotions for the researcher. For participants and 
researcher both, emotional unease or upset may occur during the interview and can persist 
after the interview. The researcher may be exposed to feelings unexpected to them and may 
feel that they cannot show much of this during the interview for fear of affecting rapport 
therefore hindering data. Dickson-Swift et al’s (2007) paper focuses on concern for 
researcher during interviewing. After interviewing 30 researchers from the field of public 
health, issues included managing their own emotions and difficulty leaving the field. They 
suggest that these issues are related to the process of qualitative research and not 
quantitative and they are compounded when dealing with sensitive issues. Certainly, the 
researcher needs to have external support in order to talk through any difficulty arising (King 
& Horrocks 2010). Regular supervision and colleague support will help with this.  In the liver 
met study, myself as the researcher had access to debriefing offered through the psychology 
unit. This was deemed necessary as part of the ethical submission. I did come across a 
disturbing account from one participant of something that had happened during his life. 
Throughout the interview I was aware I had to prevent my focus from oscillating between 
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what had occurred through the fault of the participant and the interview structure. At times, 
it felt the interview opportunity became more like a confessional as he reminisced over his 
life against the backdrop of his illness experience. It was also a reminder that the participant 
in the interview is no less like a protagonist in any story. Our empathy does not always follow 
the protagonist. In the context of care, this is also true and can present challenges for how 
we deal with certain patient experiences. While I did not need to speak to anyone after this 
interview experience, it allowed me to reflect on not only aspects of my own character that 
found this story so difficult but also made me more aware of using skills that would help to 
protect myself emotionally, should a similar situation occur.  
Once again, the data generated from interviews is not neutral. If employing a transcriber it 
may be worth alerting them to interviews or excerpts that may sound emotionally difficult 
when heard. This was found to be the case in the liver metastases study as the transcriber 
expressed it helpful to be forewarned about anything of an emotionally sensitive nature as 
she tended to get involved in the lives of the participants. This would concur with Kleinman 
& Copp’s (1993) sentiment that we feel the participants are ‘living inside our heads” (p.8). 
We want our data to be meaningful and have impact on dissemination yet often we neglect 
that we or others involved in the process of transcribing or analysing can become affected 
too. Shared data is never neutral. Perhaps an awareness that aspects of the research can 
affect anyone in the analysis process, such as transcribers is required too.  
5.12 Analytical approach 
Having found a fitting methodology in hermeneutic phenomenology based on Gadamerian 
philosophy, applicable to the study subject and context of experience of liver metastases 
pending surgical resection, it was equally necessary to adopt an appropriate analytic 
approach. The process of analysing qualitative data has often been described as something 
of a mystical process (Thorne 2000) or as Scheillerup (2008) refers to, while referencing the 
work of previous scholars, the ‘black box’ of qualitative research practice (p.164). Yet, with 
greater emphasis being placed on the value of reflexivity in research practice (Watt 2007), 
more attention is being drawn to prising open that black and making sense of how exactly 
findings are achieved. While I have been influenced by the work of Gadamer for reasons 
discussed in section rather than the work of more modern contributors to phenomenology, 
such as van Manen, I wanted to choose an analytical  method that gave a suggested structure 
to analysis while at the same time shed light into how the data was analysed. For this reason, 
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I adopted a more modern analysis method in Interpretative Phenomenological Approach 
(IPA) and the sections 5.12.1 -5.12.3 will discuss the relevance of this method to the study, 
and how the approach helped to find meaning to the individual interviews and the focus 
group. The elements of analysis have been adopted as a relevant guiding factor for the data 
concerned in this study.  
5.12.1 Interpretative Phenomenological Approach (IPA) 
Interpretative Phenomenological Approach (IPA) has been developed and introduced by 
psychologist Jonathan Smith in his seminal article in 1996, as a new way of analysing 
experience, but also complement traditional methods in quantitative and qualitative 
psychology (Smith 1996).  Popular qualitative methods up until this point had included 
grounded theory, conversation analysis and narrative psychology (Cassidy et al 2011). IPA 
has over time been developed by Smith, Larkin and Flowers (2009) to become a methodology 
in its own right, rather purely a tool for analysing data.  IPA is an approach “committed to the 
examination of how people make sense of their major life experiences” (Smith, Larkin & 
Flowers 2009, p.1) which seeks to pull four elements together, a detailed examination of 
participants’ “lifeworlds”, their experience of a particular phenomenon, how they have made 
sense of these experiences and the meaning they attached to them (Smith 1996).  While IPA 
began its life in the field of psychology, it has gained notoriety in other disciplines. IPA has 
been recommended for use in healthcare because of its “practical orientation (Payne, Dean 
& Smith 2006). The intention from the outset of conducting this study was that it would have 
a practical use in influencing a service. Having outlined the shape of the study earlier in this 
chapter, IPA analysis appealed to me as having a transferability from the discipline of 
psychology to direct relevance to a nursing study that was intentionally practical in design. 
Cassidy et al (2011) note the attractiveness in using IPA in the clinical setting where there is 
a particular cross-disciplinary interest. With relevance to this study involving participants 
with colorectal liver metastases, multi-disciplinary input is key, a concept that has been 
directly referred to in Chapter 2. IPA lends itself to understanding from the perspectives of 
the participants but also those involved in the given study context. This analytic approach 
was again deemed suitable because of several elements of interpretation required. Firstly, 
the data gained from the participants, secondly that from the health professionals involved 
in the liver metastases pathway and thirdly the level of interpretation from myself as 
researcher but with relevant insider knowledge. All of these elements, I felt were critical to 
building up from the descriptive to the interpretative and were vital to producing a more 
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nuanced and empathic service provision on review of the initial data. It draws upon three 
main strands of understanding having a base in hermeneutics, phenomenology and 
ideography with the result that the uniqueness of individual experience are valued. 
 
5.12.2 The notion of experience 
At this stage is it worth pausing to consider the concept of experience being analysed.  
Experience is somewhat of a complex concept, our lives being made up of a range of 
experiences. Phenomenology researchers and Smith et al (2009,) in particular would argue 
that IPA researchers, are particularly interested when the everyday experience take on a 
particular significance. For some degree, we do this everyday for ourselves. Taylor’s  (1985) 
work notes that humans are ‘self-interpreting animals’ who are active in interpreting events, 
objects and people in their lives. Evaluating those experiences helps us to make decisions. 
Smith et al (2009) speak of a hierarchy of experience which can be found in one experience.  
As we attribute meaning, that experience deepens and can become more significant, having 
now become an experience. Smith et al (2009) cite Dilthey to demonstrate how the smallest 
unit of experience grows into something more meaningful.   
“Whatever presents itself as a unit in the flow of time because it has a 
unitary meaning, is the smallest unit which can be called an experience. 
Any more comprehensive unit which is made up of parts of a life, linked 
by a common meaning, is also called an experience, even when the parts 
are separated by interrupting events.” (Dilthey, as cited by Smith et al 
2009, p.210).  
 
It is this comprehensive unit of experience that I was particularly interested in for those who 
were considered for liver resection. On observation of the pathway to potential liver 
resection, there is a comprehensive unit of experience centered around whether or not an 
individual will make it to resection. For me, this was the identified common meaning, but it 
was unknown what other meanings individuals themselves attached to this period of time. 
As was outlined in Chapter 2, this period of time could span over many months so Dilthey’s 
recognition of parts of an overall experience being separated by interrupting events seemed 
fitting to place in the context of the analysis. Unravelling the patient experiences recounted 
in the interviews could lead to a spiraling out effect of the experiences hidden from the 
everyday vantage point as health professional and help to reshape some of the service for 
future patients. Incorporating the data from the health professional focus group could also 
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lead to a layering up approach which would provide valuable combined insight. IPA 
recognises that the data shared by participants is dependent on what participants share with 
the researcher so that in turn the researcher needs to interpret participants accounts in order 
to understand their experience. In this way a double hermeneutic occurs where the 
researcher is actively employed in sense making of what the participant is also making sense 
of from within their framework of understanding. 
 
5.12.3 Finding shape  
Producing meaning is an iterative and complex task, despite what would be considered in 
quantitative terms, a relatively small sample group. The interesting and perhaps surprising 
fact is that IPA, as with other qualitative analysis does not provide a one fit single method for 
working with data. Smith et al (2009) realise that for the novice qualitative researcher this 
non prescriptive means can be a daunting realization, however it is exactly the lack of a 
prescription that allows one to analyse the data with integrity.  
 
5.12.4 MAXQDA  
Qualitative research can generate a huge amount of data which requires management not 
only for working with but also as a means of producing an audit trail to assist with issues of 
reliability.  In order to assist with organising the data from a pragmatic approach, a qualitative 
computer programme was utilised. Having undertaken practical instruction on NVivo and 
entered a couple of interviews onto this programme, I shortly after became aware of the 
qualitative software named MAXQDA (MAXQDA 2020). I found the format of MAXQDA more 
intuitive to work with than NVivo which I had been aware of through reading and a more 
formal introduction to on a number of taught qualitative courses. I purchased MAXQDA plus, 
an extended version of MAXQDA. This allowed me to store audio files, transcripts and field 
notes and other relevant notes in the one place. Of practical importance, the data could also 
be analysed in a four-screen window, enabling ease to apply codes and memos. The benefit 
of MAXQDA was that it included a MAXDictio mode enabling searches on particular words 
whereby vocabulary and word frequency analyses could be conducted to help support or 
create particular codes or themes themselves.  
 
5.12.5 Returning to Gadamer  
As outlined earlier, Gadamer placed emphasis on the value of language as a key to 
understanding human experience. Through the common feature of language, a way to enter 
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into the world of another is made accessible. Gadamer placed important emphasis on 
language presented in written text which could then be interpreted, although hermeneutics 
has now developed beyond purely written language.  
“Gadamer frames reading and writing not as mastery of language or 
literacy skills, but as engagement with ‘what is at stake’. (McCormack 
2014, p.58) 
For Gadamer, we are beings immersed in language. It is our everyday medium and a rich 
source of understanding. Gadamer argues that it is through language the world is opened up 
for us. The language contained within the data is under examination and IPA is deemed as a 
suitable analysis method to examine the research questions at stake. This links well with 
Gadamerian philosophy as an important element of both is the moving between the part and 
the whole. That is each part of the sentence will have meaning as well as the whole.  
 
Looking at the transcript text can be done in the context of the whole transcript, i.e. what is 
being said in the whole interview. Each interview can also be viewed as part of what is being 
said overall and likewise each section or each sentence as part of the individual interview. 
This is reflective in the layering up approach of data through the use of IPA. Analysis also 
brings alive the Gadamerian dialogue between our own pre-understandings and newly 
emerging understandings from the participant’s world where the two collide. The medium 
for this is analysis. This is going on all the time, through dialogue with the participant during 
the interview, through rereading the text and field notes, and through the more systematic 
process of analysis, in this case IPA. This fusion of horizons (Gadamer 2013) aptly fits with the 
merging of participant interviews, health professional views and the interpretation of the 
researcher in this study. 
 
5.13 The process of analysis 
Thorne (2000) describes data analysis as a process that essentially transforms raw data into 
new knowledge.  It does indeed sound a magical effortless process but the resounding 
question as a researcher and particularly a novice qualitative researcher is ‘how?...how does 
that process work?’.   Thorne is clear that analysis is something that the researcher must 
engage in throughout all phases of their research. It is active and engaging and she would 





bit that commonly gets labelled as data analysis. Ziebland & McPherson (2006) echo this 
sentiment. When researching the researcher’s mind is often full of questions at different 
time-points. Without realising it, analysis is a continual process all the way from deciding on 
a research question, recruiting participants, handling raw data and reporting on the findings. 
For this reason, I tried to transfer as much of my thinking into MAXQDA as well as the 
interview transcripts in order that as much as the context of the research was close at hand 
and visible to me. The documents transferred to MAXQDA were:- 
- Research proposal containing background to study and research questions 
- Interview schedule 
- Typed field notes of hand written field notes from four interviews 
- Summary of interviews 
- Transcript of interviews 
- Audio files of interviews 
This meant that all the documents could be stored in their ‘electronic filing cabinet’, aptly 
referred as by Fielding & Lee (2002) for easy access and cross reference.  There is much 
written about good data management or a ‘tidy filing cabinet’ and the benefit of this 
particularly evident when dealing with a large dataset (McLellan et al 2003, Franzosi et al 
2013). The transcriber was experienced in transcribing in health research and to ensure that 
the transcript was reliable, I listened to the audio recording while reading the transcript. 
Wainwright and Russell (2010) stress the importance of this when the researcher and 
transcriber are different. This way any additional punctuation could be added and some of 
the ‘unheard’ communication could be annotated onto the transcript at particular points. In 
this way I was able to be taken back to the time of the interview and also to aid with the 
familiarisation of data. During this familiarisation process, I reread the transcripts and then I 
reread sections in their context, working to annotate on a ‘golden paper copy’ and also make 
further notes on additional paper. Having done this, and now beginning to get a grasp of 
what was contained in each interview, I was then in a position to reduce the data in a precis 
of each transcript. This very much echoed the summary written after the time of interviewing 
and recorded in the memo. At this point in analysis I had reached a descriptive phase where 
I could adequately explain what the key features of each interview was but only by coding in 
order to generate themes, could I begin to deepen the analysis (Ryan & Bernard 2003, 
Richards 2015). Although their publication is written with NVivo in mind, Welsh (2002) 
provides some helpful advice, commenting,  
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“It is important that researchers recognise the value of both manual and 
electronic tools in qualitative data analysis and management and do not 
reify one over the other but instead remain open to, and make use of, 
the advantages of each” (Welsh, 2002, para. 12). 
Smith et al (2009) helpfully point out six steps to analyse data, detailed in Table 5.6 
overleaf. 
 
5.13.1 Coding for emergent themes 
In the CAQDAS software, MAXQDA this is done through selecting sections of text/words and 
placing them at nodes. These act as a gathering point for specific areas of interest (Bryman 
2016d). Development of the codes was for me a dual process between paper and working 
with the documents in MAXQDA. This use of paper and screen allowed me to look at the data 
differently.  Working within the area of research, it was tempting to assume that I had a clear 
sense of what the codes were but I resisted the temptation immediately to use a priori coding 
in order see what was striking about the data and as an attempt to let the data speak. I found 
the section entitled ‘What to look for when you are coding’ in the online article by Taylor & 
Gibbss (2005) especially useful to bear in mind when attributing data at codes. 
 
Following this I coded according to my four main research questions and then topics from my 
interview schedule.  What is especially helpful about working with MAXQDA is the ability to 
have imported internal documents alongside research data to work closely with them.  
Finally, I coded according to words that ‘sprung out’ at me after having familiarised myself 
with the data, such as ‘secondary’, ‘choice’, ‘hope’, ‘futile’. Putting all this together I ended 
up with 35 codes. In order to make sense of these codes further, I began aggregating them 
under parent codes and could then see which codes were redundant. This process left me 
with 15 codes as displayed in Table 5.7 overleaf. Each of these contained at least 2 sub codes.  
Deciding which code to attribute a text to is up to the judgement of the researcher.  For 
example, placing a perceived attitude of a medical team member, could fall either into code 
03 or code 07. I found that noting a description of the code in the properties box was helpful. 
In addition, importing a codebook into MAXQDA would also prove useful and could allow for 







Step  Name Characteristics of step 
1 Reading and re-reading Entering the participants’ world. 
Making the participant the focus of the analysis. 
2 Initial noting Produce detailed set of notes and comments on 
data. 
Descriptive comments, Exploratory comments, 
Linguistic comments, Conceptual comments. 
Deconstruction. 
Produce overview summary of initial notes. 
3 Developing emergent themes Turning data and notes into themes. 
Themes reflect participant data and 
researcher’s interpretation – a synergistic 
process of description and interpretation. 
4 Searching for connections 
across emergent themes 
Map how themes fit together. Use methods 
such as Abstraction, Subsumption, Polarization, 
Contextualisation, Numeration and Function if 
helpful.  
Result will be themes and super-ordinate 
themes from one participant.  
5 Moving to the next case Repeating the process. 
Maintaining initial distance from previous case.  
6 Looking for patterns across 
cases 
Examine connections across cases. 
Reconfigure/relabel/ discard themes. 
Developing levels of interpretation. 
 Table 5.6: IPA suggested steps for analysis (adapted from Smith, et al, 2009) 
 
Workable master codes 
Workable codes      
01 diagnosis     
02 recovery from primary surgery 
03 relationship with medical team 
04 Relationship with specialist nursing team 
05 Side effects of treatment/chemo 
06 imaging 
07 changing nature of scans 
08 communication 
09 managing other conditions with secondary cancer 
10 managing life with secondary cancer 
11 Information 
12 social/family relationships 
13 external support 
14 use of language with strength of feeling 
15 tensions in pathway 




5.13.2 Advantages and disadvantages of using CAQDAS 
One of the features of MAXQDA of which I was particularly interested in, was its ability to 
demonstrate transparency in how findings were achieved. It is harder to do this with a pen 
and post-it notes, although one might argue that in order to achieve true transparency, the 
researcher might need to give their software up for perusal in conjunction with their findings. 
Nonetheless, working with CADQAS software allows the researcher to keep track of their own 
thinking and the linkages made with data. This is surely an attractive feature and should 
contribute with representative reporting of findings and aid issues of reliability and validity 
(Kelle & Laurie 1995, Gibbs & Managabeira 2002, Franzosi et al 2013).   In addition, Robertson 
(2008) advocates using CADQAS software to map the overall process of the researcher’s 
journey to recall thought progression and improve transparency.  If a strength of MAXQDA 
has been its efficiency to code, so too is it a weakness (Welsh 2002, Bryman 2016d). I did find 
that I could easily code more than I required and even have enough data for two different 
research studies, something commonly known as the ‘coding trap’ (Richards 2015, p.118). 
Working with the research questions and interview schedule helped with this as too did 
checking the coding stripes tool. Using personal judgement and knowing when to stop are 
skills the researcher must exercise (Richards 2015). 
 
Other less favourable aspects of computer assisted programmes are a feeling of being slightly 
removed from the data (Bryman 2016d) as computer management can attribute a clinical 
feel. This may be the case especially when using CAQDAS for interactions in focus groups as 
reported by Catterall and Maclaran in 1997 (Bryman 2016d).  Attention to data organisation 
will help to hear the individual voices within the focus group. In addition, electronic software, 
can be prone to computer glitches, crashing and loosing of data, making back-up of work 
essential.  While CADQAS software it extremely beneficial, it cannot replace the thinking 
ability of the researcher as Goble et al (2012) conclude, 
“Analysis will always be bound by the researcher’s abilities; while 
computer programs may enhance those abilities, they will never replace 
them.” (Goble et al 2012, para. 4. 
As analysis develops, the researcher looks for patterns/themes in the codes (Bryman 2016b). 
These themes are essentially recurring patterns of meaning that are likely to identify an area 
of concern to the participant (Todres & Holloway 2010). After an initial list of themes were 
created, they were clustered into connected areas. These were then divided into main 
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themes, super-ordinate and sub-ordinate themes. The themes from both the patient 
interviews and health professional focus group were then used to drive forward a service 
change and plan targeted nursing intervention in the interim phase as follows in Chapter 6.  
5.14 Chapter Summary 
This chapter has discussed the chosen methodology of hermeneutic phenomenology as 
influenced by Gadamerian philosophy as appropriate to the study context of the experiences 
of those undergoing liver resection for a colorectal metastases. Consideration has been given 
to the skill set required for conducting interviews of an emotionally sensitive nature, and the 
reflexivity required as a researcher during and after the interviews have been conducted.  An 
overview of the practical and ethical considerations have been examined and the suitability 
of Smith et al’s (2009) Interpretative Phenomenological Analysis also has been established. 
This methodological chapter sets the framework from which to view the results of Phase 1 in 


















Seeing different horizons - findings from Phase 1 
“The real being of language is that into which we are taken up when we 
hear it — what is said”. (Gadamer, (1966) as translated by Linge, 2008 
p.65) 
6.1 Chapter overview 
This chapter will present the findings of the sixteen interviews and the focus group from 
Phase 1 of the study.  It is the result of the immersive and labour-intensive process of analysis 
as outlined in Chapter 5. It aims to take the reader back to the interviews, as if they were 
there, back to the events, language and phenomena described.  To this effect, this chapter 
has a different feel on reading. As a health professional with an insider vista, so much of 
health care is reactive and fast paced.  Decisions are frequently made on assessment of large 
amounts of assimilated information, either in response to a patient’s condition or in response 
to current evidence and protocols. The day to day environment affords little time to 
understand the experiences of those we care for or those we work alongside. Both the 
interviews and focus group from each phase have provided an opportunity to gain insight 
into the experience of a known group of individuals. The interviews lend the occasion of being 
able to actively hear the experience of being considered for surgical CRLM resection, while 
the focus group allows the experiences of a group of health professionals to be aired in 
relation to this pathway. In contrast to the often, frantic daily nature of health care the 
interviews and focus group have offered the opportunity to ‘slow things down’ and reflect 
on the nature of experience. As a researcher with insider awareness of the CRLM pathway, it 
is recognised that assumptions need to be set aside as to what that experience might be, as 
eloquently expressed by Gadamer in the opening quotation of this thesis.  
With insider knowledge of any given health care pathway, it may be tempting for health 
professionals to pre-empt or claim knowledge of what issues may arise for patients but we 
are not the patient and our experiences are not theirs.  The findings presented are that 
attempt at giving a voice to those experiences without second guessing them in order to 
understand the CRLM pathway more fully, while at the same time acknowledging the role of 
interpretation that a researcher with insider knowledge has in the overall process.  
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As Smith et al (2009) suggest, there are different ways of structuring the findings of 
phenomenological writing when Interpretive Phenomenological Analysis (IPA) is used. One 
could see that the linear process of beginning, middle and end might fall neatly into disease, 
treatment, outcome or that the disease trajectory may be relevant as treatment decisions 
progress or different stages in the pathway might be appropriate. Other options may have 
been to look separately at the data from those who were able to proceed to liver resection 
and those who were not or to concentrate on the interviews and then to deal with the health 
professional data as a distinct group. While all of these options might have their place, three 
things shaped how this section was written. The first, was that I wanted the writing to reflect 
the whole of the pathway experience rather than be guilty of dividing the pathway up into 
how I might tend to view it as a health professional. This was important in the context that it 
was possible for the liver resection to take anything from three months to beyond a year 
when a staged bowel and liver resection was indicated. The second, was that the analysis 
itself dictated how the data was to be presented and indeed supported my view that the 
whole of the pathway experience should be represented. The third was that in line with the 
appropriate methodology chosen, the findings ought to represent a fusion of horizons of 
different viewpoints which was why it was important to include both the views of those 
individuals who had not proceeded to liver resection and the perspectives of health 
professionals involved in the pathway.  With this in mind, the analysis yielded three master 
themes which were linked to three horizons of understanding; 
- a path of expectation: an enduring horizon   
- the companion of uncertainty: a unified horizon 
- a journey of personal understanding: an individual horizon 
 
The table overleaf details the overall themes, stemming from the three horizons.  
 
From the master themes follow a number of superordinate themes and sub-ordinate themes. 
Sub-ordinate themes could sit independently as themes in their own right but flow from the 
superordinate themes. The themes are described and exemplified with extracts from 
participants and blended with analytic comments. In this way a narrative account follows 
which has been fused with the personal experience of the participant and the interpretative 
input of myself as researcher. When the term Phase 1 is used, this relates to Pathway A prior 
to the initial study findings. The discussion in Chapter 9 will pick up more fully on these 
concepts together with the findings chapter 8 from Phase 2. Pseudonyms (first name only) 
have been adopted within this chapter to protect the anonymity of participants.  The use of 
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pseudonyms reflects the use of phenomenological methodology in giving a more personal 
quality to the experiences presented. 
Master theme Super-ordinate themes Sub-ordinate themes 
1. A path of 
expectation: an 
enduring horizon   
 
1.1 Travelling with the backdrop of 






1.2 Hoping for chances: desiring 
life, desiring time 
 
1.1.1 Transitioning the diagnosis: 
from the well to the not so well 
1.1.2 Confronting a doubly 
shocking diagnosis  
1.1.3 Questioning in the context of 
‘me’ 
 
1.2.1   Looking forward to 
possibilities in medicine 
1.2.2. Acknowledging: There is no 
choice 
1.2.3 Treating with curative intent 
means an active wait 
 
2. The companion of 
uncertainty: a unified 
horizon 
 
2.1 Health professionals: guardians 




2.2 Reliable information: a remedy 
for uncertainty  
 
 
2.1.1 Oncology: a place of safe 
keeping 
2.1.2 Nurse specialists: a welcome 
companion  
 
2.2.1 Struggles of communication 
give way to fear 
2.2.2 Language has a memory  
2.2.3 Uncertainty: a forever friend 






3.1 Unintended journeys 
 
 
3.2 Arriving  
 
3.1.1 Understanding looks forward 
3.1.2 Gratitude gives back 
 
3.2.1 What matters most 
3.2.2 Keeping hope alive 
 
Table 6.1: Master and corresponding themes from Phase 1 analysis 
 
Understanding of data comes from understanding part and the whole. This happens on two 
levels. The use of IPA as a methodological framework allows dual aspects of interpretation 
by participant and by researcher. Through the process of data analysis, it can be seen that 
the patient is both participant and interpreter and the researcher is viewed as both observer 
and interpreter. Analysis is an attempt to understand what it is like to stand in the shoes of 
the participant. As Pietkiewicz and Smith (2014) outline, analysis is both descriptive because 
it is concerned with how things appear and interpretative because it recognises that there is 
no such thing as an uninterpreted phenomenon. While the participant might share what they 
know of their experience, Gadamer holds that the we (or in this case the researcher) will 
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interpret this experience with any foreknowledge or background to that situation or indeed 
any prejudices they may hold (Gadamer 2013). This is an important reality to be aware of 
during interpretation, particularly with the pre-knowledge that I had of both colorectal 
cancer and the liver metastases resection pathway. For me, looking at interpretative meaning 
through horizons was significant as it signified pulling all viewpoints including my own, 
together to arrive at a more complete sense of meaning. As Gadamer states, 
‘The concept of horizon suggests itself because it expresses the superior 
breadth of vision that the person who is trying to understand must 
have. To acquire a horizon means that one learns to look beyond what is 
close at hand – not in order to look away from it but to see it better.’ 
(Gadamer in Nixon, 2017, p.30) 
While any one patient account could give a rich narrative insight into the experience of being 
considered for a colorectal liver resection, it was the pulling together of these horizons of 
experience together with the horizon of those used to stepping back and seeing the whole 
pathway, i.e. the health professionals that would give I felt, as Gadamer expresses, that 
‘superior breadth of vision’. In addition, as a health professional familiar with the service, I 
had to ‘learn to look beyond what is close at hand’ with the intent of an improved line of 
vision and understanding.  
6.2 A path of expectation; an enduring horizon 
“Human life goes on this way in very diverse expectancy, expecting very 
different things according to different times and occasions and in 
different frames of mind, all life is again one nightwatch of expectancy”. 
Kierkegaard 1844, p.206  
Life is a rhythm of expectancy. The above quotation taken from Kierkegaard’s discourse 
entitled ‘Patience in Expectancy’ Kierkegaard (1844), highlights the rolling, seasonal nature 
of expectancy in life, stating prior to this reflection, that expectancy “will not cease as long 
as time separates and divides mortal life” (p.205). Perhaps due to our expectant nature as 
humans, we are always looking forward, always capable of planning our lives and what might 
come, but it is harder to do this when life takes different directions that we had not planned. 
There may be less resistance to expectancy when life is going well but Gadamer’s 
philosophical interest had been with understanding what happened when life events did not 
work out as expected and how we navigated life in such circumstances. Working within the 
colorectal cancer team and encountering patients who are being considered for liver 
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resection, is a clear example where life has not gone as planned. There is no doubt that this 
could certainly be said of any cancer diagnosis, but my interest lay in uncovering the 
experiences of this particular group with metastatic disease where the tension sat between 
the possibility of liver resection in the hope of extending life or possible cure and the 
knowledge that without resection, the diagnosis was certainly terminal.  These tensions only 
occur because of technological surgical advances often combined with developments in 
systemic anti-cancer therapies which have given rise to new opportunities in treating 
colorectal liver metastases. With this in mind, it is easy to perceive the weighty significance 
that an associated liver resection can have for an individual and their families and friends.  
An overarching theme of the experiences of the CRLM pathway has been one of anticipation 
and expectancy. As a noun, a definition of ‘expectancy’ is, 
 “The state of thinking or hoping that something, especially something 
good, will happen.” (Oxford University Press, 2018, online, paragraph 2)  
The English Oxford Living Dictionaries focuses on current word usage and practical usage 
which holds a subtle helpful element here. Many other definitions primarily connect 
expectancy with something good but this definition conveys the idea that the something 
good may not always follow through but that ultimately there will be a turn of events when 
something will happen. It is this idea that is seen in the liver resection pathway.  The 
‘something’ is when the possibility of being considered for liver resection over a period of 
time is either achieved or not achieved by way of resection. This was epitomised for me by 
two individuals by the following phrases that were spoken during their interviews.  
“I knew up front what my hopes and expectations were. I didn’t worry or 
panic once I knew that this was the road I was on you know, there’s no 
alternative, you know.” (Chris)  
and 
“I was on this track, happily following it if you like. There was no reason 
to go beyond that.” (Julia) 
Chris proceeded to liver resection and at the time of writing remains well, almost 5 years 
after his liver resection, while Julia, sadly, was not able to proceed to liver resection, having 
had further imaging which upstaged her liver disease after chemotherapy rendering her liver 
to be inoperable. She died approximately a year after her interview. The expectancy and 
hope that something could be done whilst not always knowing what that something was or 
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if it was possible is expressed through language and a tangible raw but reflective emotion 
throughout these interviews.  
As such this whole period from diagnosis of liver metastases to determining the possibility of 
resection becomes a journey filled with expectancy. The following sections will reveal the 
super-ordinate and sub-ordinate themes that sit within this first main theme to be presented, 
‘a path of expectation.’ 
The interviews began by asking the participants to tell the researcher something of the 
background to their diagnosis of both the bowel primary and the secondary spread to the 
liver. As highlighted in chapter 5, the format of the interviews used an aide memoir to allow 
for some semi-structuring of the interviews if needed. The reality was that very few 
participants required semi structured questions asked during the interview because they told 
their story of their experience of being considered for liver surgery with the natural flow of a 
story set with a beginning, middle and ending which was often neatly married up with a 
timeline of a diagnosis, treatment and outcome of treatment. Of the twelve who proceeded 
to liver surgery, ten were diagnosed with a synchronous liver secondary occurring at the 
same time as their primary bowel cancer. Of the four participants where liver surgery was 
considered but not possible, three were diagnosed with a liver secondary at the same time 
as the bowel primary. This means that only three of the participants had liver metastases 
detected during a period of follow-up under follow-up surveillance. However, what was 
evident from the interviews was that the spread to the liver was often wrapped up and 
inextricable from the original bowel primary. As a researcher, the interest and focus was on 
the secondary spread to the liver with an acknowledgment that this had come from the 
bowel whereas, as a patient, were it not for the fact that there had been a bowel cancer in 
the first instance, there would then be no liver secondary. As such the conversation around 
the getting to the liver diagnosis often batted back and forth in relation to their primary 
tumour diagnosis or diagnosis of synchronous liver metastases. Two sub themes which sat 
within a path of expectation: an enduring horizon were travelling with the backdrop of 
diagnosis and hoping for chances; desiring life, desiring time.  
6.2.1 Travelling with the backdrop of diagnosis   
While the general notion of going on and forward with a treatment plan was apparent there 
was an awareness that travel forward was done against a backdrop of the original diagnosis. 
The original diagnosis was either the primary tumour or when secondary spread to the liver 
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was discussed as part of that original diagnosis. For the three individuals who had a liver 
metastases diagnosed during follow-up, their initial thoughts went back to diagnosis of the 
primary tumour as revealed through the following quotations; 
“I remember getting a vibe from the endoscopy nurse. She said 
something like ‘not to worry that things would move quickly when I was 
in system’… I remember thinking ‘that doesn’t sound good if things need 
to move quickly.” (Helen)  
and 
“I had felt well so it was a shock when it [the diagnosis] came.” (Scott) 
These quotations transport the reader back to the time where the realisation that a primary 
bowel cancer had been detected. It was only later after primary bowel surgery and during 
follow-up that a liver metastases was detected. The realisation that something is wrong often 
unfolds to the individual before confirmation, as evidenced by Helen while Scott reveals the 
commonly felt emotion of shock with a cancer diagnosis. This shock was intensified 
particularly when Scott had no symptoms. Very often as highlighted by Helen, the idea that 
we want to reassure individuals can actually accentuate that feeling that something is wrong. 
This was also expressed by another participant who recalls going to their GP due to frequency 
of bowel function and later diagnosed with synchronous bowel and liver cancer.  
“When I think back, my GP was very diplomatic and I thought she must 
have thought this sounds like bowel cancer but we will not worry him 
and we’ll say, ‘oh it could be a thousand and one things’.” (Chris) 
This wandering back and forth in discussion throughout the interview was something that I 
remember during the interview being quite concerned about as if perhaps the interviewee 
hadn’t grasped that the discussion wasn’t predominantly about their diagnosis. This is a good 
example of seeing the actual interview as one part of the overall hermeneutic process in 
interpretative phenomenology as it is only when the analysis occurs that my fears were 
relieved. There were three common sub themes that ran through this theme of looking back 
to the context of diagnosis.  These were intermingled with thoughts about being prepared 
for liver resection. Clark (2008) writes that both doctor and patient come into a consultation 
with a different horizon. As is often evidenced in the clinical setting, it may be difficult to 
move a patient onto a new horizon of thinking because they are still caught up in the 
adjustment to the diagnosis. Annis (2018), herself identifying as a breast cancer survivor 
remembers the day of the diagnosis, when  
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“cancer came in like a wrecking ball to shatter my life into little pieces” 
(Annis 2018, paragraph 4).  
Certainly, while the focus group acknowledged the impact of diagnosis, there was more time 
taken up with the diagnosis in the patient interviews as it represented a significant time point 
where life as they knew it changed.  
6.2.1.1 Transitioning the diagnosis; from the well to the not so well 
During the interviews, there was recognition regarding a point where events in participants’ 
lives changed to alert them that there had been a change in their health. This was a precursor 
to the actual diagnosis of bowel cancer before acknowledgement of liver involvement. For 
the majority there were small signs that echoed their own suspicions regarding their health 
during the process of diagnosis and associated tests.  Looking back in the knowledge that this 
was bowel cancer, this process was part of the rationalisation that something in their health 
was not right. Apart from those who had presented as an emergency, all the participants 
reported feeling well. One participant explained, how on completing the bowel kit given to 
him by his GP, the speed at which the results were relayed back had confirmed his suspicions 
that something was wrong.  
“You know there is something wrong when a motor cycle outrider 
appears at your door and makes you sign for it.” (Robert)  
He went onto explain that after colonoscopy he knew that he knew something was amiss as 
he was one of the last patients in the day bed suite waiting to speak to a doctor.  
“Everyone else was gone and I was held back and they’ve taken blood 
samples from you so you know that there is something seriously wrong.” 
(Robert)  
For the majority this transition was a gradual process where signs along the pathway to 
diagnosis gave way to more concrete feelings that something was going to change in their 
health. An important part of the transition process was the acknowledgement of symptoms. 
The symptoms alerted individuals to the fact that something was not as well with their health 
as it should be. Nine out of the sixteen patients did present with symptoms to their GP, 
although these symptoms were not always initially attributed to bowel cancer as the 
following participants recall.   The interesting thing was that patients did often realise they 
reported symptoms of bowel cancer with three citing food poisoning, irritable bowel 
syndrome or piles as the reason for their change in bowel habit.  
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Conversely other patients, despite reporting symptoms, felt that either previous tests or 
being well had inoculated them to some degree of the possibility of concern.  
“It took me by surprise because my GP had said ‘there was nothing to 
worry about, it will not be anything sinister because we’ve already had 
that clear colonoscopy’.” (Amy) 
Interestingly two patients reported that they did not have any symptoms to alert them 
immediately prior to diagnosis. Both patients had their original bowel primary detected 
through the National Bowel Screening Programme. However, it later emerged during the 
interview that they both had experienced symptoms, one of weight loss and the other of 
bleeding.  
“I don’t know what happened in the past before my operation. I was 
14.5 stone but I went down to 13. My wife used to make my tea and I 
could hardly eat it and I was quite happy with a sandwich. Something 
must have been inside me that was making me lose my appetite and 
when I got told this, this could have always been to do with it.” (Craig) 
and 
“I had nae problems with my bowels or that…but a year ago before it, I 
passed some blood but they thought it was just piles and that and they 
gave us a steroid.” (Alex) 
On reflection, the manifestation of symptoms, helped individuals to move from the ‘well’ to 
the ‘not so well’.  Symptoms particularly were seen as an invasion into the normality of life. 
One partner echoed her husband’s sentiments when she described the abruptness of the 
transition from life as they had enjoyed it, to a different reality. 
“It was all so sudden…from my point of view it was quite traumatic and 
it was quite a shock because we were ticking along very nicely up until 
that point and then suddenly bang, you know, so that shock took a little 
while to recover from.” (Wife of Andrew)  
This was particularly the case when individuals were admitted as an emergency as Andrew 
had been following acute abdominal pain. Due to this there was little time to process the 
speed of transition to becoming unwell. This was a different picture for another participant 
when the diagnosis took place following primary bowel surgery, although the feeling of not 
being ‘well’ after surgery raised some suspicion, 
“I came back for follow-up every three months, but looking back I never 
actually felt well in myself after the surgery. I couldn’t quite pin point it. 
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My mother had bowel cancer but it had spread to the liver at diagnosis. 
It was different to me.” (Helen) 
There is the realisation through all of these that individuals realised that they were moving 
through a transition stage in their health but it was the diagnosis of liver metastases that 
gave individuals the greatest alarm. Perhaps this was because the majority of this sample 
group had synchronous liver metastases diagnosed at the same time as the bowel primary. 
It may also be because of the weight of significance of what metastases meant as conveyed 
in the next section.  
6.2.1.2 Confronting a doubly shocking diagnosis  
Two participants spoke about how difficult it was to have been diagnosed with liver 
metastases in a follow-up period after the bowel primary had been dealt with.  
“The news of the liver was horrific.  I said before how my mother had 
bowel cancer diagnosed and later in lymphatic system. She had a liver 
resection. From beginning to end she lived for six months. After the liver 
resection, she went downhill very fast, that was why it was so horrific, 
from that perspective, what going to happen to me?” (Helen)  
and 
“It was a bigger shock than even the bowel, because the bowel was cut 
out, you thought that was it, all dealt with so it was a bit of a shock 
when it was in the liver.” (Alex) 
For those with synchronous metastases, the following quotations highlight how difficult it 
was to comprehend the double diagnosis of both bowel and liver.  
“It was Ms x (surgeon) who told me that there was a liver tumour as 
well. It was quite shocking…I just sat there totally shocked, it was not 
what I was expecting.” (Amy) 
“It was slightly like getting hit with a shovel I suppose. It wasn’t just 
about the liver but just the shock in general and it being confirmed that 
you have got cancer.” (Richard) 
 “The biggest shock was the second, the liver one…that was a shatter 
because when he [oncologist] said, I was sort of freaking out in the sense 
that it is spreading and he assured me no.” (Lauren)  
“I got the bad news from him, [surgeon] that it had already spread with 
secondaries in the liver...I thought what on earth is going on here, I couldn’t 




There were those who spoke of secondary spread to the liver and the instant association they 
made with death as they struggled to make sense of what this meant for them or their 
families. The significance of secondary spread was understood to have had a gravity more so 
than had there been a primary diagnosis alone.  
 “You think its spread to other parts of my body, this is what they are telling me, 
this is a death sentence, that’s what your mind does.” (Robert)  
“A secondary in your liver and I said what does that mean? To me secondaries 
oh doom, doom, doom.” (Lynn).  
“You're going to die ay?  Well that was what you were saying, that was the 
thing you thought, am I going to be on a time limit here?” (Wife of Craig) 
For these participants at this time, it was harder to see a plan or way ahead. Conversely, there 
were others who reported feeling a more controlled response to the news of the liver 
metastases.   
 “Because I was told the spots on the liver were small, I didn’t worry at 
the time” (Paul, no op) 
 “I was on my own when I was told... I knew I was strong enough and I 
didn’t want anyone else to be hurt if that makes sense. At a phone call 
from my consultant after this time, my partner was saying what’s the 
prognosis?. Well it was 1:5, more on the bottom end of the spectrum so 
it’s no looking too good but I thought, ok, I can live with that.” (Tom, no 
op) 
 “After going through what I'd just been through, I thought oh well, looks 
like I've got to go through another op and after having all the ops I've 
had on my neck, and stuff like that, it's, I'm not being blasé about it, but 
it just, I just thought well if it's got to be done, it's got to be done.” 
(Andrew) 
“Och, it was upsetting, but I just had to accept it and just hopefully 
everything is going to be alright and that.” (Craig)  
The more philosophical approach to the reality of liver metastases, may have been partly due 
to individual personality and previous life experiences which may have shaped any reaction 
to such news. An interesting paper over a decade ago, reports how older adult cancer 
survivors were able to draw from previous life experiences and bring something positive to 
their cancer diagnosis (Towsley et al 2007). Difficulties may become apparent when coping 
styles that have either not been used effectively or are not adequate are brought to the new 
situation such as a cancer diagnosis. The nurse specialist is well placed to help patients 
140 
 
recognise and utilise individual coping styles to help manage uncertainty in the adjustment 
process.  
6.2.1.3 Questioning in the context of ‘me’ 
Patients revealed their thoughts of how they had come to have bowel cancer by either the 
context of family history or lifestyle choices. This also affected how they perceived their 
outlook on treatment. Of those interviewed, seven reported a family history of cancer which 
they saw as either important for how they viewed their current situation or how others in 
their family perceived it. Four of these seven, had a first degree relative who had bowel 
cancer. This could act as something that individuals had to ‘fight’ against as the first 
participant so vividly describes;  
“I said before how my mother had bowel cancer with lymphatic and liver 
metastases. She had a bowel resection and from beginning to end she 
lived for six months. She went down hill very fast. That was why it was so 
horrific. From that perspective, what was going to happen to me? When 
I had to tell my brother, I knew he thought the same as me, the same 
scenario.  My mother, couldn’t accept it but my attitude was different.” 
(Helen) 
In this way, there was an extra burden that the patient also carried, knowing that her brother 
also had this experience and feeling some of the pressure from that relationship. Later in the 
interview she went on to describe how because of her brother’s ongoing concern, she had to 
pull away from him to some degree as she felt the negativity that came out through concern 
was not helpful to her. Similarly, one patient had a similar ‘battle’ when his sister shared a 
friend’s take on his situation.   
“Unfortunately, I had lost a sister to leukaemia. I think some doctor 
friend of a sister said ‘oh that’s not good’, he’s got secondary cancer’ 
and they weren’t aware of the cure, so my sister was thinking I was on 
the terminal list but I didn’t believe that from day one anyway.” (Chris) 
In both cases, both these individuals managed to find the psychological strength to pull away 
from these thoughts at diagnosis and frame their situation more positively or as Chris 
indicated, refuse to give in to the idea that he was on the terminal list in the first place. This 
all pointed to the fact that they hoped for something else, which is linked with the findings 
in Section 6.2.2. Conversely, one patient admitted that as his sister had been through cancer 
and that she became a point of guidance and support,  
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“My sister had a similar op to me for bowel cancer. It was easy just to 
phone her up and say ‘look sis, I’ve got bowel cancer and she said don’t 
worry about it.” (Andrew) 
Two patients also shared their belief that stress in life had either caused led to their cancer 
or had certainly led them to not become aware of changes that were happening in their 
bodies which might alert them to seek help.  
“My husband was diagnosed as terminally ill and it was a very stressful 
time. I was his main carer and I was working full time. After his death, 
when I was about to go back to work, I suddenly realised physically that I 
wouldn’t be able to make it from the car park to the office and I realised 
that this was not mental but physical. I think in hindsight I had focused 
so much on the last year that we had together that I did not see I was 
becoming unwell.” (Scott) 
and 
“Looking back, I had been under a lot of stress at work. I’d ran the 
business for 27 years and I really do wish that I hadn’t put the company 
into liquidation. I was so involved and had carried on with the business, 
perhaps not seeing the signs.  It was very stressful and I’m a great 
believer that stress has to come out somewhere. I know there are no 
proven links with stress and cancer but things might be a lot different if I 
had of taken care of myself.” (Chris) 
Finally, Steven twice throughout the interview came back to discuss arthritis tablets that he 
believed he had been left on too long by his GP, believing there to be a link between this and 
development of his bowel cancer. What was of interest was that all of these examples look 
back to a time to explain how they arrived at where they were when interviewed. They do 
not look back to go forward, nor does it hinder their going forward but they all carry with 
them a backdrop of their diagnosis that provides the context as to how they got to be 
considered for liver resection. The diagnosis period holds vastly different meanings for 
individuals and health professionals but becomes a starting point for understanding potential 
treatment. Clark (2008) when considering Gadamer’s fusion of horizons, writes, 
“Understanding’ is the fusion of our past and present horizon” (Clark 
2008, p.3) 
In this way the past, present and future co-exist. We cannot have one without the others. 
The very fact that the present could not be formed without the past is why the diagnosis 
period comes and out of focus during the interviews. It is important to acknowledge in that 
it may also set the context for issues that arise in the rest of treatment.  
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6.2.2 Hoping for chances: desiring life, desiring time 
 
While the diagnosis formed an anchor point and provided contextual meaning as to why 
individuals found themselves being considered for liver resection, there was no sense in that 
individuals were ‘stuck’ at the diagnosis and could not move forward from this point. Rather 
there was a desire to know what might be done and a desire to live, knowing fully that the 
alternative to doing nothing, would almost certainly hasten symptoms, decline in health and 
eventual death.  Apart from the two patients who presented as emergencies, all patients 
were ‘well’. As seen in 6.2.1, the shock of a reality that does not correspond with what one 
perceives about their health can be hard to comprehend but may also spur individuals on 
further to find solutions before their health declines. Patients voiced security in knowing that 
there was a plan early on, even if they did not know what that plan was.  
 
The focus group was keen to hear the views of patients who had been through improvements 
to the pathway as they recognised that the perspective of the patient experience was missing 
from their discussion.  
“I think it will be interesting to hear the patients’ side of things as well, 
with the feedback and see where they perceive the gaps are” (Oncologist 
no.1) 
 
Clinicians operated from a position, knowing that what they perceived to be issues in the 
pathway may be different from those encountering it first- hand.  
 
6.2.2.1 Looking forward to possibilities in medicine 
 
There was recognition that until the standard treatment of liver resection was discussed by 
their health care team, that the majority of patients had not been familiar with this approach 
for secondary liver cancer. Only 2 patients had known indirectly through a friend of a similar 
situation where surgery was used as the optimum treatment for liver metastases, with others 
having stated similar sentiments as expressed by the following patient, 
 “I have never heard of this, I don’t know anyone who has had this 
[colorectal liver resection] before.” (Alex) 
Yet when ‘up against it’ with health, there is an anticipation borne in hope that in a country 
with an immense natural pride in the National Health Service, that something can be done. 
Combined with this is the knowledge that it is after all secondary cancer and therein lies a 
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tension about what can be done against the reality that cancer is a big force responsible for 
many deaths and has not been defeated. This may account for the growing picture that we 
see of many patients seeking alternative treatments elsewhere, many going to Europe or 
South America to pay for treatments have not been incorporated into the NHS cancer care 
due to lack of evidence (Gorski 2018). There is also a tension within individuals about the 
outcome of liver surgery, fluctuating between that of hesitant and hopeful of its success as 
Chris depicts in the following two quotations, 
“I don’t think there have been too many cases of people with secondary 
in the liver having had this operation and getting through.” (Chris) 
and 
“I thought if this had been five or ten years before, it would be on the 
terminal list and so it’s very important to get that across.” (Chris) 
Craig also echoed how much treatment overall for secondary bowel cancer had moved on,  
“25 or 30 years ago they would never have had a cure for me like, no, 
definitely not.” (Craig) 
This gentleman’s view was wrapped up in personal experience of family with bowel cancer 
when he could recount two cancer related deaths in the family.  
Yet once presented with the possibility of surgery, the participants were clear in their 
understanding that getting to the surgery was the treatment that would prolong life. 
Therefore, achieving liver resection became the outcome or goal.  
 “The solution of surgery was a big, big issue for me. If it was just chemo, 
that would be a different perspective, but I felt that I had a chance with 
the surgery. I felt safe in the knowledge that surgery was what I had to 
try to get to.” (Helen) 
and 
 “In my head surgery equalled potentially getting rid of this, the best way 
to get rid of it, fully accepting that it could be back. I wasn’t naïve 
enough to think that will be that but I thought if I can get to surgery that 
is my best option.” (Julia, no op)  
It was understood that historically surgery in this area was not used in this setting. This would 
have rendered a similar situation instantly palliative. Therefore, for these patients getting 
‘onto’ the liver resection pathway became of sole importance. It was the only option for 
curative treatment. The oncologists at the focus group, confirmed that there were only a 
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small number who had a second and third liver resection once recurrence was detected 
following liver resection. The overall benefit of removing disease in those who recurred was 
not known.  
““We don’t know the answer to this…but for the patients that have 
surgery that aren’t cured, has that still been a useful intervention in 
improving survival and improving quality of life by reducing the bulk of 
cancer?” (Oncologist no.1) 
The issue of quality of life could only be addressed through asking patients as to the perceived 
benefit of surgery despite potential or definite recurrence. 
6.2.2.2 Acknowledging: ‘There is no choice’ 
 
Having had the knowledge about what was potentially possible in liver resection, all 
participants  wished to be considered for liver surgery. Having included participants who did 
not proceed to liver resection, it was important to ensure that the outcome did not colour 
what they thought of their experience in being considered. It was clear that participants did 
not feel that they had a choice. There was no alternative presented but equally participants 
did not refuse to be considered which could have been viewed equally as a choice. There was 
a sense of following it on to as far as they could go until the decision was made which in itself 
showed how much they wanted to live.  
“I didn’t have to make a decision, I didn’t make a decision on that, there 
was no decision.” (Amy) 
“I said go for it, one way or the other, I’m no gonna back out of it ken, I 
just went for it and that was that.” (Craig) 
“Once I knew the road I was on, you know, there’s no alternative, you 
know…it was do this and hopefully survive, or don’t do this and you will 
be dead in three years’ time.” (Chris)  
An interesting point raised in the discussion was the use of risk data in helping patients look 
at the role of surgery, in the same way that data risk packages were used to help patients see 
the benefit of adjuvant therapies in the primary setting.  
 “Whether from our communication point of view we need to think 
about offering patients the numbers and you know if they know that for 
their pattern of disease there’s an 80% chance of a recurrence despite 




This brings in an interesting element of what acceptable risk is.  Presenting risk data is 
certainly a quite a different rationale to the patients’ way of thinking in this sample, who all 
wanted the opportunity to pursue liver resection.  
6.2.2.3 Treating with curative intent means an active wait 
 
A key feature of being considered for CRLM, is waiting. Waiting is a notable feature in cancer 
delivery and has often received much negative press in the media related to targeted waiting 
times. Yet, a major part of waiting in this CRLM pathway is not a passive wait (unlike the 
comparison of liver transplant in Chapter 3) but an active wait and can involve a combination 
of treatments consisting of primary surgery/synchronous surgery, chemotherapy, and portal 
vein embolisation (PVE) to increase the capacity of liver resection as discussed in Chapter 3.  
In addition, radiotherapy may also be indicated in the treatment of rectal cancer which will 
then extend the workup to potential liver surgery should there be synchronous presentation 
of rectal cancer with liver metastases. In this sample, only one participant had short course 
radiation prior to primary surgery and in this case the liver metastases was detected during 
follow-up. The majority in this sample underwent neoadjuvant chemotherapy treatment 
prior to surgery (n=9). Chemotherapy was also utilised in two patient cases as adjuvant 
chemotherapy following primary surgery or synchronous resection and in one patient as 
palliative treatment when liver resection was not feasible. Only four did not have any 
chemotherapy as part of their overall treatment.  
 
All nine patients undergoing neoadjuvant chemotherapy prior to liver resection spoke of the 
difficulty undergoing treatment. At the time of being treated a maximum of six cycles of CA-
POX (capecitabine and oxaliplatin regime) was indicated.  This commenced between 4-8 
weeks following primary bowel surgery and is important to note that at this time patients 
were beginning to feel stronger from the bowel surgery. Starting cyotoxic treatment after 
going through major surgery and beginning to recover is often a reason why some decline 
adjuvant chemotherapy but in this case as seen in the previous section, patients do not feel 
they have a choice.  The reality is that in wanting to get control of the cancer (ultimately seen 
as liver resection), patients are willing to ‘sign up’ to what the complete treatment may entail. 
This hits home, that in order to have the liver resection the majority of patients will have 
undergone two major surgeries and a chemotherapy regime (synchronous or metachronous 




Side effects during chemotherapy were a reminder of that long haul. Six out of nine patients 
who had chemotherapy prior to a liver resection, recounted difficult side effects that either 
led to a dose reduction or omitting a cycle of chemotherapy.  Words or phrases used by 
participants to describe this period included, “horrific” (Chris) “couldn’t handle it anymore” 
(Andrew), or “very tough” (Lynn). These are a reminder that quality of life was severely 
affected for these participants and suggest something of the bleakness of this period. It also 
acts as a powerful reminder of the lasting impact of this time, for some over a year later. 
Listening back and reading the transcripts brought this back as the participants recalled vivid 
memories about chemotherapy.  
 
Common side effects included diarrhoea and peripheral neuropathy from oxaliplatin. Two 
people experienced ongoing problems with neuropathy over a year later. Alex encountered 
chest pain while on capecitabine and required admission and then conversion to 5FU by way 
of a Hickman line. Lynn had difficulty with low platelets caused by oxaliplatin which twice 
delayed her chemotherapy. Looking back about this period she said, 
“It was a time where I lost control of my body. I was doing what 
someone else told me to do.” (Lynn). 
This feeling of being particularly low in mood and having to fight against the negativity of 
symptoms was common the further individuals got through their treatment regime. In 
particular, mid-way through the regime was when these feelings of negativity were 
heightened.  One participant spoke of this when she said,  
“I got to mid-way and I was crying all the time, which wasn’t like me at 
all.  I couldn’t bear the thought of having more.  I couldn’t stop crying.” 
(Jennifer).  
Yet despite these side effects all participants carried on unless clinically told to stop. At the 
time of treatment eight cycles of chemotherapy (CAPOX) was indicated as adjuvant post-op 
chemotherapy. It is only with the results of the SCOT (Short Course Oncology Therapy) trial 
(Iveson et al 2018) that for the majority of patients,  four cycles of CAPOX (three months) are 
deemed to have comparable disease free survival outcomes while having the benefit of a  
significant reduction in peripheral neuropathy. What did surprise me somewhat was the 
significant level of side effects experienced by 66% of this group. We cannot assume as health 




The meaning that individuals attached to continuing on chemotherapy helped to see why 
individuals carried on.  
“The chemotherapy punched the cancer. It was worth it.” (Richard) 
and 
“The chemo was doing what we wanted.” (Robert)  
Richard’s description of the chemotherapy giving cancer a punch is reflective of the fighting 
language that is often used around cancer, some of which is often not helpfully received by 
patients (Hauser & Schwarz 2019). The second spoke of the desire of both himself and the 
medical team in seeing visually on imaging that the chemo was working. This meant that this 
time served a purposeful wait. Engaging in chemotherapy was an active wait. It meant that 
the time spent and the side effects experienced did not serve as a redundant wait.   
 
The indication for lack of chemotherapy prior to resection could be viewed as negative as 
Helen revealed when she did not have it prior to resection number two. Having had liver 
metastases diagnosed during follow-up, Helen had adjuvant chemotherapy following 
primary bowel surgery and then at just a year was diagnosed with her first liver metastases. 
When it came to the planning the second liver resection, she was told she did not need 
chemo. In her mind, she had equated the chemotherapy to making the surgery more feasible 
and she spoke about how it played in on her mind, in addition to other concerns which are 
outlined in the horizon section.  
“I couldn’t understand why no chemo before the second liver resection. I 
knew there weren’t as many tumours to shrink but isn’t this the thing to 
keep tumours at bay?” (Helen) 
This shows the interplay between knowledge from a patient’s perspective and the medical 
team. Having had a comparison liver resection before, this patient was relying on 
foreknowledge to aid her understanding, much like the explanation of tradition that 
Gadamer speaks of (Gadamer 2013).  Indeed, going deeper, it also hints at issues of strength 
of evidence for treatment in that as outlined in Chapter 3, there is a lack of hard evidence for 
sequencing of events in this area. This might to some degree be expected in a recently 
expanding area of medical experience but the challenges remain as to how such issues are 
communicated and heard by the patient behind the treatment. There may be a tension 
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between what the clinician knows as to the rationale for treatment or lack of it and what the 
patient understands. This brings in the idea of the ‘professional’ patient, who may be 
researching their own treatment but may be lacking in the context of decision making (Briggs 
2016).  
 
What I found most intriguing and resonated with my experience and challenge of 
communication in this area was how chemotherapy was viewed when a liver resection was 
no longer feasible.  Julia expressed this, showing how she struggled with conceptualising the 
reason for neo-adjuvant chemotherapy. On reflection, for this participant, having the 
chemotherapy prior to liver resection seemed to indicate a delay and on hindsight, she may 
have been able to achieve liver resection had she forgone chemotherapy.  If there is difficulty 
rationalising this process, it may be difficult for an individual to rectify why they could not 
proceed to liver resection without chemotherapy.  
 
Three of the participants also required portal vein emobolisation (PVE) as discussed in 
Chapter 3, required with the intention of rendering the liver operable by leaving sufficient 
liver remnant. None of the three patients had been prepared that this may be required and 
having had PVE meant that liver surgery was performed 2-4 months after the patient had 
expected. What was apparent was that after further imaging (often PET or MRI) when the 
patient thought that the next step was chemotherapy, PVE was indicated. At such a time, 
when expectancy was high and the patient thought they had got over one hurdle, they found 
that this was an unexpected hurdle as the following quotations show. 
 “There was a delay in getting it sorted out as to whether they could cut 
the three tumours out due to their location. They would have needed to 
cut out 84% of liver and you can’t survive with 16, so they said, don’t 
worry, we’ll go to Plan B and do a liver embolisation.” (Chris) 
Chris went on to say, 
“I had been gearing my mind up to get the operation in January and 
then there was that complication so the embolisation only went ahead in 
January or February time. Fortunately it was successful.” (Chris) 
Further insight on learning of PVE is also seen in the words of the following patients,  
“I was told they would have to do PVE. They did explain why. I thought I 
would get the liver operation in January but the PVE was done in 
January. This meant the liver operation was rescheduled for May but I 
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had to have a few more weeks of delay because I had a UTI (urinary 
tract infection.” (Andrew) 
and 
“My oncologist who told me that the liver surgery was going ahead but 
before we could go on, we needed to be sure there was enough liver left. 
I was a bit worried, I had never heard of this PVE before. One spot in the 
liver was 15cm and was very near to the part they were to leave.” 
(Jennifer) 
While all three embolisations were successful, clearly on reflection, at the time requiring a 
PVE caused some alarm and anxiety, mainly because it pushed the date of the liver resection 
further away than anticipated and added a further layer of uncertainty. Not having any 
anticipation that it might be required nor the added months for the liver to increase in size, 
made it harder to visualise the certainty of the pathway in their minds. In addition, the 
mention of the urinary tract infection, is a reminder of the fragility of health, in that other 
health conditions, be it resolvable, can jeopardise the liver resection. This reveals that good 
health in addition with successful neoadjuvant chemotherapy plus or minus other 
procedures have to line up with getting to a liver resection.  Anticipation is a way of keeping 
options alive. This anticipation of working down routes in a pathway, is shown by Chris when 
he offers, 
 
“I asked lots of questions about the treatment and liver embolization, but I 
didn’t ask what if it doesn’t work.” (Chris).  
 
Feasibility of a synchronous liver resection was also noted by the focus group to make a more 
problematic pathway for patients. 
“It can be quite nerve racking I think, patients waiting for a synchronous 
resection because you have to co-ordinate liver surgical colleagues in the 
same theatre at the same time and that can be quite difficult. That can 
cause a further wait and of course the patient is thinking my cancer is 
still growing (Oncologist no.2) 
This was certainly the view of Lynn who struggled with decisions off centre stage between 
her colorectal and hepatobiliary surgeon. On reflection she realised that it took time to co-
ordinate theatre time but patients could benefit from some idea of timeframe for decisions 





6.3 The companion of uncertainty: a unified horizon 
 
Merging the data from the focus group and participant interviews revealed a second major 
theme in the CRLM pathway as that which I have entitled, ‘the companion of uncertainty’. 
There was the sense that this was constant, a travelling companion that had to be learned to 
be lived with and accommodated as part of life. The combining of the perspectives of both 
participants and health professionals made me arrive at the conclusion that this theme could 
be seen as an overwhelming unified horizon from both participant groups. This was a first-
hand experience for the participants and an observation of experience for the health 
professionals in which they recognised the ongoing struggle which permeated this pathway 
for individuals being considered for CRLM. Experiencing and observing meant that 
uncertainty almost took on a personified role. It became a sojourner, having no fixed resting 
place in the pathway but moving and transferring itself to a different form of itself when a 
different situation or obstacle was encountered during the process of being considered for 
CRLM. Uncertainty presented itself at the onset of diagnosis, not only of CRLM but notably 
of the primary tumour itself as was evidenced in section 6.2.1.2 Confronting a doubly 
shocking diagnosis. At this stage it had become less fluid and something more tangible 
moving on from what was described in section 6.2.1.1 Transitioning the diagnosis:  from the 
well to the not so well. From the diagnosis, uncertainty became a recurring feature as 
expectedly individuals hoped for possibilities of treatment (section 6.2.2.1 Looking forward 
to possibilities in medicine) being mindful that without surgery by way of liver resection, there 
was no choice that would either provide cure or provide the best chance of extending life 
(section 6.2.2.2 Acknowledging: ‘There is no choice’). Options and sequences of treatment 
were explored involving imaging, and for many chemotherapy or for a small number PVE. 
Such treatment and phenomena experienced were presented in section 6.2.2.3 whereby it 
was seen that waiting was an active process undergoing treatment as part of consideration 
for liver resection. During this time uncertainty bubbled as a constant undercurrent with 
some situations, notably repeat imaging and complications of chemotherapy, giving more 
cause for hope or doubt that the pathway to liver resection was still secure.  
 
Perhaps the reason for this constant companion of uncertainty is not just the obvious nature 
of the biological unpredictability of the presence of cancer but also the context of the 
pathway itself. The context of the pathway is not something always fully recognised by 
patients themselves, perhaps until they are further through the pathway or have had 
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opportunity to reflect upon it. After all, patients are the one going through the experience 
while the health professionals benefit from having a wider angled lens of knowledge of the 
difficulties of the pathway from encountering different situations from previous patients and 
seeing the whole and not just the part. The context of uncertainty is seen in the light of a 
pathway in transition.  
 
Discussion in the focus group highlighted something of the evolving nature of this CRLM 
pathway, a reality which echoes that of the developments in the management of this area as 
referred to in Chapter 2.  
“There are not many situations where, you know, aggressive 
management of metastatic disease can lead to long term disease 
control, it’s not unique but it’s an unusual situation in oncology.” 
(Oncologist 1) 
 and 
“In the last few years the pathway itself has changed quite dramatically 
as well in the number of patients that are having liver surgery.” 
(Colorectal CNS) 
The progress made in this area was also noted as a personal motivating factor for having a 
specific interest in this aspect of bowel cancer management with two health professionals 
expressing this. The transition of the pathway is part of the appeal which drives learning, new 
ways of working and better outcomes for patients. 
“The area is interesting from the point of view of the number of different 
strategies you can use to try and achieve complete resection of the liver 
metastases, that is interesting.” (HPB surgeon) 
and 
“This is exciting from the point of view of more aggressive surgery which 
we hope translates into more patients remaining disease free long term 
but certainly more challenging as well in terms of patients having more 
and more radical procedures which for some of them have less chance of 
getting to that point of being cancer free.” (Oncologist no.1) 
The later quotation highlights some of the challenges of more aggressive surgery and 
treatment, uncovering that while medical advancements bring much positivity and hope, 
they also throw up additional challenges, as outlined in Chapter 3 and cross referenced as 
comparable to that of many of the uncertainties faced when waiting for liver transplant. 
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While the pathway has evolved over recent years, there was also recognition that the 
pathway was one of personal transition and evolution for patients being considered for 
CRLM. Certainly, the language used by health professionals to refer to the pathway or 
pathway events, such as ‘route’, ‘grind’, ‘long haul’ and ‘traps encountered’ suggested that 
the health professionals were very aware of the personal time commitment to this pathway 
and that events could change the course intended. This is further accentuated in that the 
patient group being considered for CRLM resection could not be identified as a homogenous 
group but were a “diverse patient group” (Oncologist no.1) and that this in itself presented 
certain challenges. 
Understanding the diversity of the patient group, meant that uncertainty for patients was 
also encountered in the challenge of management. The difficulty of defining liver resectability 
prior to an operation was evident in the literature and discussed in Chapter 3. With this in 
mind, the issue of patient selection becomes crucial but determining resectability and 
successful patient outcome, is not always straightforward and requires a multidisciplinary 
approach to management.  
“The big challenge from my point of view is trying to define for a new 
patient, is this someone that has a realistic chance of being cured or 
remaining disease free with liver surgery or is this someone where 
biologically the disease is behaving in a manner where you think…that 
intervening with aggressive surgery for one site of the disease is not 
going to be of benefit” (Oncologist 1)  
and 
“What guides my decision making is which is going to be the site that 
will mean that we can attempt treatment with curative intent, if we 
delay it…if the site doesn’t make a difference, then your decision is down 
to whether it is technically possible or sensible to do a simultaneous 
resection” (HPB surgeon) 
The health professional possesses a clinical vantage from which to assess resectability. It 
might be difficult to present some of the clinical realities of the individual’s disease to the 
individual for fear of destroying hope when undergoing treatment. Certainly, the emotional 
experience in caring for patients, particularly at senior or consultant level is an understudied 
area, as Orri et al’s (2015) qualitative study with surgeons suggests. This may be closely 
related to the concept of infallibility as expounded by Gwande (2007), which he suggests has 
been compounded by traditional medical training.  
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In addition, due to the nature of surgical work-up, this process is often timely and has to be 
conducted in with the constraints of other workload commitments. Getting patients through 
whichever management deemed suitable for them in a timely fashion was also seen to 
present a management challenge. 
“It is a multi-stage process and each of those stages does incur time and 
that really, when you add it all up, it can be several months from 
diagnosis of a colorectal cancer metastases to resection” (HPB surgeon) 
and 
“You do have to think about a number of different ways of achieving it, 
(resectability) be it with chemotherapy, be it with portal vein 
embolisation, be it staged” (HPB surgeon) 
The pathway can be onerous in terms of time because of the complexity of decision making 
involved at different stages. Even once someone is deemed resectable after imaging and 
often following treatment, there are surgical considerations which can add time to the 
process of going ahead with a liver resection. This factor of time adds an additional worry to 
the patient as seen in section 6.3, the knowledge that metastatic cancer can be removed but 
that albeit necessary considerations add in delay. Lynn spoke of the perceived delay when 
being considered for synchronous surgery. In the end, she had primary resection and liver 
resection however she remembers feeling, 
“Suddenly here I am with bits in my liver and the potential to have it 
everywhere and I don’t have a plan for any surgical dates.” (Lynn)  
However, perhaps because there is no ‘one size fits all’ treatment, that responding to 
different tumour presentations and disease patterns, can add in further elements of 
uncertainty to the management picture.  
 “Patients are so individual and because management can be 
complicated, things can change” (Oncologist no.1) 
The context of the liver resection pathway is one of transition which responds to people 
individually therefore emphasising the need for personalised medicine. This feeds into the 
uncertainty of management and in turn can create uncertainty for patients. It is hard to 
escape this uncertainty. The picture is that it is something to be lived with, a companion that 
is staying for the whole journey but a companion that could too easily get ‘out of hand’ and 
take over in an unhelpful way. It would appear helpful that measures to contain this 
companion of uncertainty would be employed.  Certainly, due to the inexact science of 
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management for this group, the nature of change is something which can be an expected 
feature of the pathway. Perhaps the only thing that is certain is uncertainty in this pathway. 
Clinicians in this pathway were not only aware of the clinical management challenges but 
what is evident from the data is that as a by-product, their role also became about managing 
patient uncertainty.  
 
6.3.1 Health professionals: guardians of the CRLM pathway  
 
William Osler, when writing at the turn of the last century reputably stated that  
“Medicine is a science of uncertainty and an art of probability.” (Osler as 
cited by Taylor, 2011) 
While this could be true of many a medical situation, it is certainly apt of the pathway of 
CRLM.  Determining the probability of CRLM is an ever evolving art, grappling with the 
constancy of uncertainty.  Health professionals do not hold this uncertainty amongst 
themselves but have to communicate it to patients working between the interface of what is 
probable and what is realistic.  In this the way uncertainty becomes a common feature to 
each and something of a unified horizon to view things from in a way to gain more knowledge 
about features or treatment of the pathway and an ultimate bid to gain more certain ground 
of what was going to happen. They were seen as guardians of the route to CRLM once that 
was something that was considered feasible. In this way connecting with health professionals 
was a way of connecting with hope.   
 
Hope in this context had a certain phenotype.  It looked like the plan.  Undoubtedly the most 
important aspect of connecting with health professionals throughout the pathway was the 
maintenance of a plan.  In this way hope towards liver resection was maintained. 
Identification of a plan early on following diagnosis of a liver metastases, was key in keeping 
the option for liver surgery open and also in determining trust and subsequent safety in the 
hands of the health professionals. A plan was a powerful tool, keeping a balance of emotions 
in check that either nothing could be done or that there was not some lurking awareness that 
uncertainty was ever present and a liver resection might not provide ultimate eradication of 
disease.  
“Ms X, (colorectal surgeon) was positive that she had removed as far as 
she knew everything and that there were secondaries on the liver but 




“They (liver team) said well I think we can operate on this and that was 
left at that stage.” (Chris) 
All health professionals were seen as important in imparting the plan although notably 
colorectal and liver surgeons saw their roles with differing levels of intervention and function.   
 “I think our role is probably more defined than yours because we tend to 
obviously be at the initial diagnosis and we tend to deal with almost our 
side of the problem…or we will be assisting them further in getting other 
specialists involved” (Colorectal surgeon) 
and 
“If I can't do an operation then it goes back to oncology” (HPB surgeon) 
Helen reported not having a plan when her second liver metastases was found after her first 
liver resection.  She remembers when she saw the oncologist she thought she would learn if 
further resection was at least a possibility. In the end it was, but she felt abandoned, 
recounting, 
“Instead of saying we will see what the liver surgeons say, she said, now 
is the time to go and do what you want to do. I thought, hang on, that’s 
not a plan. That’s not a good perspective.” (Helen) 
It was this communication difficulty, later expanded on in 6.3.2.1 that Helen admitted to 
struggling with for some time with a negative impact on her mental wellbeing.  
The colorectal surgeon tended to see the majority of those who had a synchronous diagnosis 
of liver and bowel primary and from there it was important to outline a plan, primarily 
through the mechanism of the multidisciplinary meeting (MDM). The hepatobiliary 
involvement centred on the feasibility of liver surgery but the role here did not encompass 
delivering a plan if liver resection was not feasible. The MDM was seen as crucial in bridging 
the gaps between three specialities of which two were in different teaching hospital 
locations. 
Discussion at the health professional focus group noted that alternative health professional 
perspectives could be revealed, if the study was conducted in a different region of Scotland. 
This was considered to be due to the variation in approach to the management of CRLM on 
a national level. 
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“You should go across, you should go to the West of Scotland and repeat 
the exercise, because it's very much a regional, and there is so much 
regional variation in Scotland, it would be really interesting.” (HPB 
surgeon). 
and 
“I think we are fortunate here we are very joined up, and certainly my 
impression from sitting in on a Tuesday, is that the liver MDM is much 
more targeted towards cancer.  We are very fortunate we do have the 
liver surgeons coming here as well” (Oncologist 2). 
 
The presence of the liver surgeons coming to the colorectal MDM to view scans was seen to 
reduce time between decision making, and was central in providing a plan at any stage of 
presentation or post chemo review for downstaging or neoadjuvant treatments. The 
consensus was that this area was fortunate to have the MDM in operating as it did and that 
that in turn eased management uncertainty for health professionals and in turn overall 
uncertainty for patients.  
While overall health professionals were seen as guardians of the pathway, communicating 
specific insider knowledge within the context of the patient’s specific case, oncology had a 
central gatekeeper role, co-ordinating decision making with input required from surgery as 
and when needed.  
6.3.1.1 Oncology: a place of safe keeping 
 
What emerged from the data was that for many patients being considered for CRLM, 
oncology represented a place of safe keeping while being considered for liver resection. This 
may not be surprising given that 75% (n=12) of this sample encountered oncology as part of 
their overall treatment with 62.5% (n=10) having known their oncologist when undergoing 
neo-adjuvant or adjuvant chemotherapy. For this reason, many of patients had built up a 
relationship during a review period with their oncologist with one referring to their 
oncologist as “the follow-up and maintenance man” (Chris). Given that the hepatobiliary 
surgeon and colorectal surgeon alluded to having a different depth of role with the patient 
in section 6.3.1. Then again it is not surprising that the feeling was one of ease with their 
oncologist as exemplified in the following,  
157 
 
“I think X (oncology consultant) is one of these people that can sit and 
talk to you and explain things in basically layman’s terms as I would call 
them and make it more understandable.” (Andrew) 
There was almost a sense of homeliness and being comfortable in oncology because of the 
relational aspect that had been built up over time. It provided a safe place where hopes and 
fears could be understood in a commonality of understanding. There was also a knowledge 
that the oncologists worked closely with the liver surgeons so they were able to impart a plan 
for likelihood of surgery.   
“Dr X (oncologist) was quite clear on the course of action, consult with 
the liver team first as it was felt the surgery was the solution.” (Helen). 
Being in a period of review allowed patients to understand how both liver and colorectal 
MDMs worked so that when the liver surgeon was not present at the MDM this had an impact 
on timely decision making.  
“The oncologists and liver surgeons often have a meeting to discuss 
diagnosis and decision making. It would be beneficial to have them both 
together at the same time so that there is no back and forward 
situation. It doesn’t have to be face to face but a conference call to avoid 
veering between the two and waits between the outcome of different 
meetings.” (Helen) 
Interestingly what we assumed might present a challenge in patients not seeing a liver 
surgeon until after imaging following treatment was not. The fact that patients did not seem 
to mind not seeing the liver surgeon early on near the diagnosis of liver metastases or at 
interim imaging suggested that patients felt held or safe in oncology, in the knowledge that 
their case was under discussion at relevant timepoints with the hepatobiliary team.  
While the feeling was one of safety of management from patients, it was clear that trying to 
maintain this safety was a huge communication challenge. The issue of tempering 
information by realistic eventualities was highlighted by the oncologists present at the focus 
group.  
“The big difficulty in communicating to patients is, you know in one 
sense you are trying to communicate that yes we are trying to get you to 
a position where you are cancer free with a chance of remaining cancer 





“Although it sounds very easy, bowel cancer, liver mets, we’ll remove 
that, all sounds very straightforward but actually the reality is an awful 
lot can happen during that time and communicating that uncertainty 
and the reasons for waits and the scans as x indicated is quite 
challenging” (Oncologist no.2) 
It was noted that often issues were communicated when problems arose, rather than 
labelling out everything that could go wrong along the pathway.  
“It’s not so easy to temper (communication) with the 100 things that 
could go wrong during that process and it’s often you just tackle those 
problems when they arise rather, than warning patients” (Oncologist 
no.1) 
and 
“If things go well in terms that they get through everything unscathed 
then that’s very satisfying, but its preparing patients for the eventuality 
that this doesn’t happen” (Oncologist no.1) 
Marrying up pathway expectations of health professionals with a patient’s expectations, can 
be seen to be something of a skill and an art. Several factors can interplay to make this 
difficult. The first may be differing expectations of timeframes. Since 2011, The Scottish 
Government have made clear a 62 day wait from referral of suspected cancer to treatment 
of a cancer primary (ISD Scotland 2019). For someone with CRLM cancer who has been told 
that surgery is the only treatment of optimum choice with the best outcome, it instantly starts 
the idea of the clock ticking. This can be challenging to try and reduce anxiety around this 
time when the professionals treating the cancer have other insight into outcomes which are 
not only based around time.   
“Whereas I might understand that things take time, the general public 
perception is that if you have got a cancer, that unless you have it out 
within two weeks, it's a bad prognosis”. (HPB surgeon) 
and 
“I try to explain the rationale…what I try and tell people, what I try to 
explain to people is, it is treatment done at an appropriate time, not 
treatment done now” (HPB surgeon) 
This plays into the fact that it can often be knowledge about disease features that can affect 
expectations. The health professional may have a more nuanced understanding of the 
biological features and overall picture of a patient’s liver metastases, which may affect how 
straightforward their pathway may be and could be used to prepare patients as to what to 
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expect. Understanding the cancer secondary at cellular level is important but as yet there are 
not the tools to adequately predict which patients will recur after a resection as highlighted 
by the following. 
“Yes, technically this may be resectable, but biologically is this a disease 
where surgery is actually going to make a big difference? (Oncologist 
no.1) 
Such cases may represent patients where disease recurs in a short period after surgery and 
are more likely to be part of the continuum that are towards the palliative end of the 
spectrum. Yet, the on the other side of this is the unexpected expectation that the pathway 
can yield and that is when treatment advances bring about a surprising result and open up 
surgery as an option. This has occurred with the use of downstaging chemotherapy with 
Cetuximab (monoclonal antibody) for those that are KRAS wildtype.  
“Until then we may be talking about disease control but at no point have 
we discussed you might get to a point where we will be talking about 
further surgery but there is always an obligation that things have gone 
so well that actually you have you opened up a door that wasn’t likely to 
be opened.” (Oncologist no.1) 
This possibility whilst infrequent, again highlights the pushing of treatment boundaries. The 
oncology team are central to managing these scenarios since they maintain the review of 
such patients and thus a place of safety of care is also recognised for these patients also.  
Finally, difficult time-points in disease assessment were seen to play into the expectations of 
the pathway. The end of neoadjuvant chemo, following scans and completing chemo after 
liver surgery as the following quotations relate to; 
“The end of pre-liver surgery chemotherapy scan, because is it or isn’t it 
going to happen and some patients even get the length of going to 
theatre and you suddenly discover that there is a lot more disease than 
you expect. I’ve had a couple of patients in that situation and it’s been 
just awful for them” (Oncologist no.2). 
“We’ve imaged them as best we can but still sometimes we get an 
unpleasant surprise and that can be devastating for patients” 
(oncologist no.2) 
“Getting them through that last part of the pathway is difficult and the 
evidence for incorporating that bit of the pathway is not really there, so 
you know I think that’s tough.” (Oncologist no.1) 
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Notably, the oncology team are mindful of how friable the pathway is because of the nature 
of disease and how demanding the pathway is. Yet, perhaps because of this, there is 
knowledge for patients that there is a security in oncology taking on a role of key 
communicator between the liver surgeon. Interestingly, no patients from this group had 
spoken about wishing to see the liver surgeon earlier in their workup to a liver resection and 
were content that the liver surgeons were “waiting in the wings” (Laura) to review scans and 
provide opinions until they were ready after a period of treatment to meet. This itself 
suggests, that oncology was well suited as a place for care to be managed. Patients also went 
back to oncology for further follow-up after their post-operative liver review and felt satisfied 
for that to be the right place for continuous review. Patients who did not, went back to 
surgical follow-up under the colorectal surgeons for review following liver resection. While 
this may be adequate, questions might arise if this is the best place for long term review and 
detection of recurrence in the demands of busy surgical system. It might be that if patients 
could not be followed up in oncology, a nurse-led model of follow-up might drive a more 
protocol driven and timely model of follow-up (Al Chalabi et al 2011).  
 
6.3.1.2 Nurse specialists: a welcome companion  
 
Several colorectal guidelines endorse contact with a nurse specialist for the trajectory of an 
individual’s cancer illness (SIGN 2011, NICE 2020).  This was also the case in earlier guidelines 
which were applicable when patients in Phase 1 were having treatment. It is reassuring to 
know that all patients in both Phases had contact with a nurse specialist and in some cases 
and four in Phase 1 had also had contact with a hepatobiliary colorectal nurse specialist. The 
overwhelming message was that the nurse specialist was hugely valued across the treatment 
pathway, being seen as someone who travelled alongside the highs and lows from diagnosis 
to current care. They were seen as one who travelled with them on their journey, a travelling 
companion but with a different experience of the journey.  Their role and input was 
welcomed, bringing professional insider experience with the added benefit of knowing the 
pathway. From the focus group, the Colorectal CNS present saw one of their main roles as 
managing patient expectation across that pathway.  
“It’s so important that patients still are maintaining hope along the way 
but it’s how you temper that with realism” (Colorectal CNS) 
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Here the CNS views their role in having responsibility to balance out what is possible in the 
pathway with realism in order that a realistic hope may be maintained. It was acknowledged 
that getting the same message across about treatment aims and possibilities was at times 
difficult but not only was the MDM important in this but the CNS was also important in 
blending the views of the whole team to maintain realism. 
“a colorectal surgeon may be biased towards one viewpoint…a nurse 
specialist might be tempered with a bit more bringing them back and 
the oncologists and liver surgeons may have another different spin on 
exactly the same clinical situation” (Oncologist no.1) 
and 
“MDM is a starting point but I think it comes from communication about 
this is what we’re doing and actually seeing patients together…we often 
have a nurse specialist in and we are agreed on this is the message we 
are transmitting. It is very much managing expectations”. (Oncologist 
no.2) 
Discussion amongst other health professionals recognised the role of the CNS had to play in 
helping to manage patients with metastatic disease. There was also an appreciation that the 
CNS role had evolved differently in Hepatobiliary than Colorectal and that more resources 
could be placed in nurse specialists, especially in the hepatobiliary unit.  
“We would value the role of clinical nurse specialists across all our 
patches. The workload is too great for one.” (HPB surgeon) 
 “We are not geared up for cancer as such, so we see patients in out 
patient clinics, which is a general out patient clinic… I think the facility 
that we manage out patients from is not the best and you realise that 
the more you look at the facilities that are available across at the other 
hospital.” (HPB surgeon) 
“Patients are, do not get the same level of support, care, that is available 
for patients with the bigger cancers… be that colorectal primary, breast 
cancer, lung cancer.” (HPB surgeon) 
From this, it could be seen that the contact level with colorectal and hepatobiliary nurse 
specialists was inconsistent across the hospital settings partly due to differences in attributed 
funding which meant that the role of the hepatobiliary CNS had evolved differently than that 
of the colorectal CNS and could therefore not proportion the same amount of time of contact 
to those with colorectal liver metastases in the midst of a workload primarily with primary 
hepatobiliary cancers. This may explain some of the feelings of gaps in care that prompted 
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the study whereby patients and relatives were contacting the colorectal CNS team by phone 
with queries related to progress and decision making outcomes for those being reviewed by 
the hepatobiliary team. In addition, it also alludes to the fact that as treatments emerge and 
become more frequent as an established treatment, then the associated level of supportive 
infrastructure is not always present where focus tends to naturally be resourced on existing 
service needs. The level of accessibility to the hepatobiliary CNS was on an ad hoc basis, 
available if there was time to see patients rather than a given that contact could be made. 
 “I did have a helpful chat with the liver co-ordinating nurse at the Royal. 
She came into Intensive Care to see me as I was kept there for a few 
days before moving straight to the ward.” (Andrew) 
and 
“I hadn’t seen X (liver CNS) during the first and second resections but she 
did see me before I was discharged after the third resection. I always 
knew and do know that if I have any queries I can field them to X 
(Colorectal CNS). All the nurses on the team would tell you if they did not 
know the answer and would get back to the appropriate person for you.” 
(Helen) 
Perhaps the fact that all patients had met a colorectal CNS at the onset and had built some 
relationship over time there was that understanding that they could be accessed throughout 
the duration of the treatment and follow-up as the above quotation suggests. The idea of 
accessibility and presence may become an important feature for patients in helping to 
manage uncertainty and allay fears. Time too becomes central in knowing that the CNS has 
that ability to deal with concerns adequately, otherwise the value of access may not be 
worthwhile or realised by patients or family members.  
 “X (Colorectal CNS) had told us that if we had any more questions to 
pop back and see her or phone her.” (Chris) 
 “They (Colorectal CNS team) make you feel that you’re the only person 
that they’re talking about, that there is nobody else in their mind when 
they’re talking about you and what you’ve had done.” (Andrew) 
“You don’t feel as if you’re on a conveyor belt, you don’t get that feeling 
at all.” (Wife of Andrew) 
 
What emerged from the focus group was a consensus on how beneficial it would be to have 
a CNS take forward a metastatic caseload and work with patients who were being considered 
for surgical resection of CRLM.   
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“Having one person who was the colorectal metastatic nurse specialist 
or liver mets nurse specialist makes it slightly easier for us.”  (Oncologist 
no.1) 
“A point of contact throughout the whole pathway.” (Oncologist no.1) 
 “We’ve spoken about it for a while that we would like a metastatic 
nurse for these patients, someone to take that service forward and not 
just for the patients with liver disease but for others as well with 
secondary disease” (Colorectal CNS) 
“Because of the unpredictability it emphasises the need to have a 
keyworker, a key person to be a constant in a system that by its 
definition is likely to knock them” (Oncologist no.1) 
Unexpectedly, the positive nature of the CNS role was highlighted from both patients and 
colleagues but the lack of consistency within and across site working was something that 
perhaps did not make best use of the skill set of the CNS in order to more effectively provide 
a supportive network for this group of patients and their families.  
6.3.2 Reliable information: a remedy for uncertainty   
 
Good communication in any healthcare and cancer care setting has been well documented. 
With what has been revealed about the nature of the pathway so far, it would stand to reason 
that communication is the ingredient that helps to oil the wheels in a rapidly changing 
pathway. Perhaps what we are guilty of as health professionals is that in our ability to see 
things with a wider angle, we can see the overall pathway in clear distinct sections. We can 
split each part up with certain characteristics or processes that are peculiar to that specific 
phase. When individuals are being considered for CRLM, distinct phases and understanding 
of each are only more readily identified in hindsight and inviting participants to interview has 
given them the opportunity to reflect on not just the whole of their individual journey but 
also the parts that have made up the whole. Yet the glue to making that pathway flow from 
one phase or part to the other is communication which informs parts of the overall plan in a 
timely and relevant way. Such communication cements the pathway together and gives a 
feeling of solidness or security. 
Identifying helpful communication early on was one of the features that patients highlighted 
as important in the overall process. This gave character to how they felt the process would 
go on and a resultant confidence. 
164 
 
“I think the tone the consultant sets at the first meeting is very, very, 
important, that’s critical that they have at that stage some kind of plan, 
even if it’s only a we’re not sure about this but this is our intention and 
this is the route map that we want to go on” (Chris)  
Here, communication tone is linked with a plan, suggesting that qualities of hope are kept 
alive.  
There is a significant input of time on planning how to achieve resectability and the MDM 
was seen as a central forum for decision making.  It was noted as a “complex 
interaction”(Colorectal surgeon) between members of the network and one that “doesn’t 
work well if people don’t communicate with each other” (Oncologist no.1) or “didn’t feel 
confident to ask an opinion” (Oncologist no.2). The CNS team imparted some of the 
information from MDMs in order to convey and act on information in a timely manner. While 
it is easy to gloss over this as very much a factual process, the majority of conversations took 
place on the phone and does not necessarily mean that imparting such complex interactions 
are easy. It requires an advanced set of communication skills which require the CNS to be 
imparting such information over the phone.  
The lack of specific information on the CRLM process was hard to find. Nine patients had 
accessed the internet at some stage in their pathway and the majority of individual’s family 
had done so.  It was hard to get relevant UK information and information that was also not 
bleak in outlook.  
“The bulk of reading on the internet was American material.” (Helen).  
This was a sentiment that was also echoed by health professionals.  
 “There's lots of information, but sometimes it is buried in a lot of 
nonsense that is worrying or not relevant for patients.” (HPB surgeon) 
and 
“I’m not aware of any or much good information in this specific area but 
in terms of literature specifically on this pathway, I’m not aware that the 
team use anything or there is anything easily accessible.” (Oncologist 
no.1) 
Information seemed to be given verbally rather than written or signposted to internet sites. 
The CNS team were seen as useful to access for specific information and those that did felt 
encouragement to get in touch, also highlighting that they pointed out also useful services 
that they or family members might want to get in touch with.  
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“And she also mentioned the Maggie’s centre and Macmillan service” 
(wife of Andrew) 
and 
 “The nurse in the Royal was brilliant as well for information” (Chris) 
While patients revealed that they did not have information on CRLM pathway, only one 
thought that practical aspects of physical recovery were lacking.  
“I would have liked more guidance on recovery from liver surgery, 
especially to do with resuming physical activity” (Chris) 
It must be remembered that by and large as discussed in Chapter 3, this group of patients 
are deemed fit for surgical resection and information on resuming lifestyle activities may be 
particularly important. This participant was an active gym member and wanted to remain 
focused in attaining a good post-operative level of fitness.  
Finally, eleven patients had expressed that they would be happy to talk with other patients 
and seven had willingly offered during the interview.  The possibility of a patient buddy 
system arose from the discussion and while recognised it may be worthwhile for some, it was 
likely to be a very individual service. This is concept is taken up later in Chapter 7. There were 
also some concerns on how patients would be matched to existing patients having gone 
through a similar experience.  
“I suspect there are some patients who will benefit from it (other 
patients who have had similar experience), I suspect there are some 
patients who will not benefit it from it, how you choose, it also depends, 
so again it is a yes and no, because I don't think there is a one size fits 
all” (HPB surgeon) 
and 
“It’s difficult because every patient is quite different and their 
experiences are very different and their own cancer is very different but 
there may be some benefit” (Colorectal CNS) 
 
6.3.2.1 Struggles of communication give way to fear 
It can be seen how much disease management, uncertainty and communication are 
entangled and dependent on each other. What becomes important is helping patients to 
manage their expectations along that pathway. Without this artful management, uncertainty 
begins to rise and makes the communication process less stable.  
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“It’s pretty difficult, you know, and sometimes it’s managing their 
expectation but it’s really difficult because you know it’s a long haul and 
patients need to see a reason for that long haul… in some ways to be 
able to put up with the grind of going through that pathway” 
(Oncologist no.2) 
and 
“It is splitting it up into the stages for the patient as well, realistic stages 
as well which may be starting off with their primary, removing their 
primary and then leading them onto the next stage. It’s about keeping 
the patient up to date with what is happening as well” (Colorectal CNS) 
 
Health professionals recognised that there were several points where communicating that 
uncertainty were heightened for patients, first of all occurring at a diagnosis of a liver 
metastases and also throughout the pathway when imaging can upstage disease and change 
the whole scenario of resectability.  
 “I suspect that it's the time between being told that they have got 
metastatic disease or recurrent disease to knowing that we can 
undertake resection or not undertake resection, it's that period of 
doubt.” (HPB surgeon) 
and 
“You can go from a very seemingly straightforward position to actually 
this is more complex, this is more advanced with an extra scan and the 
whole situation can transform for potential cure or radical treatment to 
very obviously palliative, I mean that’s a very difficult transition” 
(Oncologist no.1) 
and 
“It is difficult for patients because they think they are on the cure route 
but there are so many traps along the way”.  (Oncologist no.2) 
The interesting use of the word traps by the oncologist in the later quotation suggests the 
idea of trouble waiting to pounce unexpectedly by several means. Ordinarily, the word traps 
may suggest that something can be done to avoid them by relying on some degree of skill 
very much like Snyder’s (2000) hope theory whereby hope was seen as the power to 
overcome obstacles by the capabilities of that individual. The reality is that there is no 
individual skill as to whether patients would have resectable disease. All of this relies on the 
biologics of the tumour.      
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 “There are some in between patients where the decisions are quite 
difficult and if you’ve got multiple lesions in all segments then you are 
drifting towards the palliative end of that spectrum, but you can’t be 
definitive about that and these are the ones that you have to leave some 
uncertainty” (Oncologist no.1) 
 
In the above quotation, the oncologist highlights how personal knowledge of the disease 
process and the pathway might suggest that liver resection is an unlikely possibility but that 
hope needs to be kept alive until the hope of liver resection is ruled out. In addition, an 
individual’s communication preference were also noted to play a factor in communicating 
uncertainty. For some people, it is difficult to look at the alternative route until it is no longer 
an option.  
 “If there is a chance of a cure…why bother engaging the brain on the 
alternatives until you categorically hear it can’t be done and I think a lot 
of patients do just that, it’s what they want to hear” (Oncologist no.1) 
Conversely another surgeon felt that for some patients, the nature of disease meant that 
they knew that surgery might not happen.  
“Their expectation is that they are already uncertain, they know it is 
difficult, they know it is awkward and that it might not happen.” (HPB 
surgeon) 
It may be that unspoken levels of knowing pass between health professional and patient but 
in such situations there is the error that patients have not correctly understood or their 
understanding has been blocked by ineffective, misplaced communication as the following 
quotation suggests from Helen who had three liver resections suggests.  
“There was no plan. This spun me into a negative scenario. If they 
waited to see the outcome from the liver surgeons, I would have been 
ok, but they put into my head this negative seed of doubt and it never 
left.” (Helen) 
She then proceeded to describe how because of a different oncologist’s communication 
style, the seed of doubt that she would not get to liver resection started to grow from this 
point. She encountered many dark days and pulled away from contact with her brother 
because she found his style of communication negative at the best of times and it was not 
what she could manage. She then was diagnosed a few weeks after this encounter with 
depression through an intervention symptom trial accessible at the oncology clinic (Walker 
et al 2009). Through here she had counselling and was started on an anti-depressant.  
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“The second liver resection was a different scenario to the first, it wasn’t 
fully explained, I didn’t see the same doctor I had seen before and there 
were multiple lesions on the liver. Then came the third scenario of the 
third recurrence. It was quite clear what they were going to do, cut it 
out, and chemo phase. The focus was different.” (Helen) 
Perhaps on the second occasion of liver recurrence, not having the trust relationship with the 
same oncologist unsettled this participant, combined with the different emphasis on 
communication style which somehow reduced the role of hope until the option was reviewed 
by the liver surgeons.  
Another participant spoke of the emotional impact of learning that her case had not been 
discussed at the MDM as intended.  
“My case had not been discussed at the meeting it was scheduled for, so 
that was another week, so there was a whole series of odd delays. It was 
very difficult. At this stage, a week’s delay seems a significant time.” 
(Julia, no op)  
This shows that in a pathway where patients are often informed about when discussion will 
occur on an MDM, the anticipation of discussion has a significant impact on individuals, 
especially if that discussion does not result. It can also make it harder for those (often the 
nurse specialist) to contain information for those patients and provide necessary reassurance 
when sought after information is lacking. 
 
6.3.2.2 Language has a memory  
 
Closely connected with the appreciation that struggles of communication gave way to fear is 
the understanding that language held memories for patients which became hard to escape.  
Language use by health professionals can create powerful memories for patients which can 
hinder how individuals access hope during that pathway.  This is often notably what is or isn’t 
said.   
 
Looking upon one example more closely, it can be seen how language spoken early on in the 
pathway, robbed hope and coloured how the effectiveness of treatment might be seen. This 
participant recounts remembering how on the morning of her elective bowel surgery, 
chatting with her surgeon before going to theatre. At the time she knew of her liver 
metastases diagnosis but was focusing on getting through her bowel surgery.  
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“I do remember on the morning of my surgery, which was about 
September by this time, and I still was feeling very well, he said to me 
something like, ‘well you're a borderline case’, but what does this 
mean?” (Julia, no op). 
These words about being a ‘borderline case’ confused and jarred with her, especially while 
trying to focus on what was ahead of her and feeling already vulnerable just minutes away 
from the anaesthetic room.  
“He didn't really explain but he did go onto say, you know if we do this 
surgery and then once we see how things are, the other surgery will 
depend because we won't operate if it's going to be futile, and that's the 
two words that I have carried on my head to this day, borderline and 
futile. It knocked me for six and I didn’t tell anyone about it, not even my 
family. I thought I can’t mention the word futile.” (Julia, no op) 
Here it is evident how much language sets the tone of what might come ahead. Not only was 
this participant unable to query the phrase verbally due to her compromised situation but 
the words suggest that she was also too stunned by the words of borderline and futile so 
much so that she kept it hidden from anyone. The opportunity for interview allowed some 
of this language angst to be voiced and the hidden to become transparent.  Helpful language 
or conversely unhelpful language can have long lasting effect and colour other events along 
the pathway. Language can determine how others have the confidence to communicate to 
their family/friends about treatment. The interview itself may have allowed Julia to share the 
devastating impact of this language that she had carried with her, therefore assisting her to 
work through some of these issues. Nguyen et al (2108) were able to demonstrate that fear 
played a part in poor memory recall at a clinic for newly diagnose cancer patients that was 
independent of patient age. While it has been well documented that patient recall of medical 
information can be poor, what Helen recounted was a certainty over certain words and how 
they had impacted her. In accounts were language has been problematic it has not been the 
message but the use of certain adjectives or nouns that have been remembered. Dizon (2012) 
writes,   
“While our colleagues may understand what we mean when we refer to 
treatment …the same may not be said of how our patients or the 






6.3.2.3 Uncertainty: a forever friend  
 
The findings have shown that uncertainty is something that is a feature of the whole pathway 
and is also apparent part of the whole by being apparent at specific stages of the pathway. 
Gaining knowledge of a specific part of pathway experience during an interview was in the 
context and flow of the whole pathway experience. Helen who had three liver resections  also 
shows that a previous knowledge of the pathway does not make managing uncertainty any 
easier and can give a different feel to the overall pathway. This is why it has also been 
important to include patients who were not able to proceed to liver surgery and not achieve 
the outcome they had hoped as the focus became issues in the pathway irrespective of the 
outcome in hindsight. Not only is anxiety favourably managed by a plan as seen in section 
6.3, it is also apparent that personal attributes and past experiences in life could cause 
individuals to react differently in similar situations as seen in section 6.4. 
 
For those who had a liver resection, one notable time where uncertainty became apparent 
and ‘reared its head’ was in follow-up imaging. Both Lauren and Richard recounted how the 
process of having scans in follow-up caused significant disruption to their family life also, not 
being able to focus on normal life. Lauren recalled, 
“I had just about learnt to put it out of my head when another scan 
came up. I am beside myself at the time, waiting for the results. Were it 
not for my partner, keeping my focus, I would not be able to function.” 
(Lauren)  
At one point, Alex had talked about how he thought there was liver recurrence when a CT 
showed something suspicious. It was a further four weeks before he had a MRI and PET scan 
and had been informed after a MDM that the liver was clear. While his wife found this time 
very difficult to manage, Alex said that he managed to keep fairly calm, stating.  
“I always knew there were no guarantees. Nobody actually had said to 
me, that’s it, your liver is cured.” (Alex) 
Perhaps the only thing that is certain in this pathway is uncertainty. It is clear that the 
changeable nature of the CRLM pathway can present additional challenges in managing 
patient anxiety and that health professionals in the team cannot eliminate this uncertainty. 
It will always be present during treatment, in follow-up and into survivorship. However, 
finding ways to manage expectation and reduce unnecessary uncertainty and anxiety 
become increasingly desirable for this patient group.  
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6.4 A journey of personal revelation: an individual horizon 
“Science may provide the most useful way to organize empirical, 
reproducible data, but its power to do so is predicated on its inability to 
grasp the most central aspects of human life: hope, fear, love, hate, 
beauty, envy, honour, weakness, striving, suffering, virtue.” (Kalanithi 
2016, p. 170)  
The final super-ordinate theme relates to the personal learning which participants discovered 
through their experience, those which are more existential, touching on the value and 
purpose of life. Paul Kalanithi (2016), a trainee neurosurgeon wrote about the impact of stage 
IV lung cancer and the lessons it afforded. These were lessons that only he could declare. The 
same goes for individual learning through a cancer experience. As health professionals, we 
cannot declare any positives of an otherwise negative experience for patients. This 
remainder section will briefly touch upon some of the individual horizons shared by patients. 
Returning to this aptly describes how Gadamer explained that we apply our pre-
understanding to interpret the present and in so do we complete the circle of understanding, 
for a time (Clark 2008).  
The word journey in cancer, can have negative connotations for patients, (Semino et al 2017) 
mainly because a journey normally has an element of choice and is an enjoyable experience. 
Yet, Semino et al’s (2017) mixed methods study showed that patients used the word online 
more than health professionals did and that it did not always have a negative connotation 
because there often were insights gained that they recognised would not have occurred had 
they not been on this route. It seemed relevant to use it in this theme because it was evident 
that patients had viewed it as such and often used words such as track, route, path.  The 
interviews provided participants the opportunity to reflect upon a period of life where their 
health and indeed life itself was at risk. Four of these participants, who could not proceed to 
liver resection were known at the time of interview to be in a palliative situation but yet it 
was not clear who might develop recurrence from the participants who had been able to 
proceed to liver resection.  The previous section highlighting the certainty of uncertainty in 
this situation is a reality, bearing in mind that the interviews only provided a snapshot in time 
of the then current situation. They could not point to any of the longevity of the results over 
time. Allowing the participants to cast their mind back to their diagnosis all the way through 
to their present situation in the context of having secondary spread to the liver has also 
yielded the participant’s individual horizon from which to look at the overall process. In some 
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ways this showed the sense of meaning that they attached to this episode in their lives and 
also what afforded examples of personal learning throughout the process. This was in many 
ways an unintended pathway but one in which we may often not be party to as health 
professionals. This unintended route was a by product of the cancer diagnosis and would not 
have occurred had it not been for this diagnosis.   
6.4.1 Unintended pathways 
 
Two pathways that were particularly evident came as a result of being able to both reflect 
upon their experience and look towards the future. These have been entitled as ‘learning 
looks forward and ‘gratitude gives back’.  
 
6.4.1.1 Learning looks forward 
 
In addition to the support that the health professionals had afforded in previous sections, 
learning was identified as learning from others and learning lessons about self. On a number 
of occasions, people alluded to learning from other patients that they met through their 
experience. This may be a brief encounter or may take place as a more regular contact, such 
as being scheduled for chemotherapy on the same day.  
 
Robert had spoken about how he had been in a hepatobiliary ward after his liver resection 
with patients who were awaiting liver transplant and had been alcoholics, seemingly having 
no control over their drinking habits. It had made him realise that although ‘it was not a 
cheery place to recover’, it did afford him the time to think that he could take a part in his 
recovery and future decisions. Julia also spoke about how she had been on a ward with some 
patients who had throat cancer and had found the symptoms of their cancer ‘quite 
distressing at times’. Although Julia could not have liver resection, she had considered that 
her situation was not like theirs as she was able to enjoy, in her eyes, a much richer quality 
of life. Craig remembered meeting an older lady regularly in the chemotherapy unit, whose 
attitude to chemotherapy and life had inspired him and although he did not know anything 
of her cancer or circumstances, the encounter had been made him more determined to 




There were additional lessons about self which were to do with adjustment of the process of 
illness. Helen had recounted how getting through a period of extreme depression was one of 
the toughest periods of her life.  
“Just before the second liver resection and particularly after it, I went 
into a depression. …I couldn’t see a solution other than death. Everyone 
else was planning holidays and years ahead and I could only see to the 
next blood test.”. (Helen)  
Having got through that period and then underwent a third resection, she had explained that 
she had learnt a lot about how she coped with this darker time in her life.  At the time of 
writing, Helen remains disease free but had realised that she could not always rely on 
planning her way out of situations in health that were beyond her control unlike other 
situations in life and work where she always had an element of control. Lynn also had realised 
how much she had moved on in her thinking from struggling with a previous alcohol 
dependency issue. She remembers a difficult wait when a decision was being made between 
the surgical and hepatobiliary surgeons as to the feasibility of a synchronous resection. The 
wait seemed to go on keeping Lynn in limbo as to any plan. She recalled, 
 “I could have done with a drink.” (Lynn)  
What Lynn would have done to cope with this situation had changed but at the same time, 
the situation taxed Lynn so much that she was in danger of returning to destructive health 
habits. Due to the seriousness of her drinking, this in itself would have jeopardised her ability 
for resection.  
In a similar vein, others had realised that having been through all the treatment and had a 
successful liver operation, that they were in better health.  
“Emotionally and mentally I think I am quite happy where I am at the 
moment, I am fit and my energy levels are back to normal.  I feel at my 
healthiest for years.” (Amy) 
For others it was the sense of time that had been accentuated through the process and how 
they wanted to guard it for the future. For both Chris and Robert this meant cutting down on 
their time commitments to work to spend time with family. Robert had spoken about how it 
had made them reassess their time commitments to work. Robert had recollected,  
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“I could have been in South Africa and America in the same week. I 
realised I was hardly seeing my wife and family. It wasn’t how I wanted 
to go on.” (Robert) 
The reaffirming of significant relationships was an important feature for several participants. 
Closely linked to this was a sense of appreciation for these people in their lives who had 
accompanied them. Participants saw that their significant others had no choice in 
accompanying them in this route either and wanted to frame the future differently. Knowing 
that there was a future to be had allowed participants to appreciate their journey. This was 
irrespective of achieving liver resection or not but was part in part of the instructing nature 
of cancer as Annis writes,  
“And then cancer did the unexpected. She taught me how to find 
gratitude. Cancer is a good teacher. I can't say I like her, but I do 
appreciate her. I'm grateful for the valuable lessons she's taught and 
yes, I might have learned those lessons without her, but with her, I think 
I learned them a little better than most.” (Annis 2018) 
 
6.4.1.2 Gratitude gives back 
 
The feature of gratitude was evident in the participant stories. Gratitude has the ability to 
look all the way back to the individual’s original position, benefitting from perspective.  This 
stemmed from the knowledge that liver resection was possible as explored in Section 6.1.2.1 
in the context of treatment advances that made it possible. For Richard, this began before 
confirmation of diagnosis. After his liver resection, he wrote to the bowel screening centre, 
and giving a paraphrase of his letter he wrote,  
“You saved my life, you are absolutely brilliant and without it I wouldn’t 
be able to write this letter now.” (Richard) 
Richard also picked up on the sense of bewilderment when people whom he knew did not 
participate in bowel screening as for him it had saved his life. This made him determined to 
do some volunteer work to help promote screening.  
  
Many of the participants had expressed a willingness to be contacted again to help with any 
further work or speak to others who were in a similar situation.  This concept became one of 
the strands of the support model and is enlarged upon in Chapter 7. This was something 
entirely unprompted by myself as researcher at the time of the interview. It may have been 
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that through the interview, the reflection process, enabled feelings of gratitude, that were 
already present, came to the fore.  
 
Additional feelings of gratitude related to personal circumstance were also evident. Three 
patients noted that they did not have dependants to consider in this process, having come in 
contact with people much younger who also had metastatic cancer. Others mentioned they 
did not have pressures of work to consider getting back to being now retired and three 
mentioned they were grateful they did not have monetary concerns. Robert remembers one 
of the chemotherapy nurses mentioning to another patient that a digital thermometer would 
be useful, 
“It made me think, that’s about twenty pounds. I mean if you were short 
of money or you were at work, I mean you couldn’t work through this, 
the pressure on you would be heavy.” (Robert)  
The ability to share in the humanity of another and enter the shoes of someone in a similar 
situation was apparent. 
6.4.2 Arriving  
 
At first glance, it may seem difficult to talk about ‘arriving’ when the evident uncertainty in 
the pathway to liver resection presents a fluidity that means one might ‘arrive’ to have a 
resection only to later have a recurrence or one might think they will have a resection only 
to find that they cannot. A helpful definition of ‘arrive’ in the context of this study is, 
“To reach a place, at the end of a journey or a stage in a journey.” 
(Oxford University Press, 2018, online, paragraph 2.)  
 
This definition helpfully encapsulates that it is not just the overall end of the journey that is 
important but the stages along the way.  At the time of interview all participants were in no 
doubt as to what point in the journey they had arrived but were mindful of the uncertainty 
ahead. Having understood this, two further sub themes, ‘What matters most’ and ‘Keeping 







6.4.2.1 What matters most  
There was recognition that having had the diagnosis of secondary colorectal cancer and been 
on the pathway to liver resection, the preciousness of life was accentuated. This was evident 
in the appreciation of the small things of life as the following quotations suggest, 
“I’m trying to life a normal life. I’ve found it difficult to meet some 
friends. I know that’s a small thing, but it’s the small things in life that 
make it worthwhile.” (Robert) 
and 
 “I’m living each day as it comes. I’ve lots more living to do.” (Julia, no 
op)  
These quotations support the popular adage, ‘one day at a day at a time’. For the participants 
there appeared to be some genuinely life affirming moments where the importance of 
family, friends, a quiet moment, a sunset were realised as if in slow motion but what is not 
clear for many patients is, if disease is no longer containable, what does that mean in terms 
of time? Paul Kalinithi struggled with this very aspect when he wrote,  
“The truth that you live one day at a time didn’t help: What was I 
supposed to do with that day?” (Kalinithi 2016, p.161) 
Several patients alluded to the fact that while grateful for the treatment, cancer was in itself 
a huge inconvenience to the normality of life. Many participants appeared apologetic for 
mentioning social situations, family gatherings or holidays that they had missed because of 
the cancer treatment. The reality was that these things augmented and helped them 
continue, with Lynn saying,  
“During treatment, I felt like I had given my body over to someone else. I 
didn’t have control over where it needed to go over the course of a 
year. Keeping up social interactions and travel after the resection was a 
way of getting that control back.” (Lynn) 
This highlights how important it is to work with individuals and their sense of priorities and 
yet may present some challenges in how we can accommodate flexibility in a busy healthcare 
environment. It also points to the fact that when liver resection is not feasible, perhaps we 
do have an obligation to help manage an expectation of time as Paul Kalinithi also alludes to. 
What patients might choose to do in that time might change depending on their knowledge 
of it.   
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6.4.2.2 Keeping hope alive 
 
Hope was the common concept which rippled through the patient stories at diagnosis, at 
treatment, at point of decision making regarding resection and beyond. For all patients, 
regardless of liver resection, it became a way to define the future.  
For many, vocal confirmation from the Hepatobiliary team about the status of the liver, 
allowed them to be confident to have a future,  
 “He (liver surgeon) sort of just said, it’s all gone, away you go, go and 
get on with your life.” (Amy) 
This was also reinforced by the oncology team when they confirmed that follow-up would 
remain with them and there was no further need to see a liver surgeon.  At the same time, 
patients were aware that there may be other things the liver surgeons could do should a liver 
recurrence return. This relates back to Section 6.1.2.1 on believing in possibilities in medicine. 
Possibilities keep hope alive.  
For others, it meant that their future could only be evident if other health needs were 
addressed. For Steven this meant taking measures to reduce the risk of stroke as his 
chemotherapy had been stopped due to likely cerebral vascular attack. For Alex this meant 
starting treatment for prostate cancer.  
Others had mentioned feeling hugely saddened to learn of well known people who had died. 
Both Jennifer and Julia had mentioned the death of author Iain Banks leaving them more 
devastated than they expected. They had invested in his story with their own story running 
parallel.  
Hope was evident in those who had not proceeded to liver resection while at the same time 
they were aware of the reality they faced. Tom had made clear,  
“There are no miracle cures. I’ve tried everything. I’ve done everything 
but I’m on a trial now. Trials are there to help someone in the future and 
I might do that.” (Tom, no op.) 
Both Paul and Julia found that receiving an explanation as to why treatment could not go 
ahead from the liver surgeon was important in moving them onto the next stage to allow 
them to consider other options. Having done that, Julia had been able to say that she was 
“looking towards the horizon of summer” to enjoy some things she had planned. This is an 
important aspect to consider and offer when so much time has been invested by the patient 
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in being considered for liver surgery. If the pathway comes to an abrupt halt, it may require 
some time to process the rationale for no surgery with the help of health professionals 
involved. Perhaps this ability to look back in order to look forward provides a realistic hope 
and is a more complex process akin to that of Oettingen’s (2015) mental contrasting outlined 
in Chapter 4.   As for Gadamer, people learn their limitations and restrictions by the presence 
of disease. There is no doubt, that the process of being considered for liver resection is 
particularly challenging, but as Gadamer would attest, it is only the real person who can enter 
and let us know the difference between health and disease (Šolcová 2008). Our position is to 
listen.  
6.5 Hope in a complex pathway 
The themes uncovered through Phase 1 data, can be condensed to central concepts of 
expectation, uncertainty and understanding. All of the particpants saw the goal of CRLM as 
something to be held up and attained. In essence, what they shared were stories of hope. 
Hope was the mechanism used throughout the pathway and expectation, uncertainty and 
understanding were components of that hope that flucuated and in turn affected hope.  This 
can be see diagramatically in Figure 6.1. overleaf. There was an ebb and flow of hope that 
was responsive to situations encountered throughout the pathway. Connversly, these 
situations often altered an individual’s view of hope. This links back to the philosophical 
underpinnings of hope as discussed in Chapter 4, whereby hope has had both positive and 
negative connotations. Understanding these components and how they can ultimately affect 
an individual’s hope, has a bearing on how health professionals can work with patients to set 
expectations, manage uncertainty and check understanding throughout the CRLM pathway. 




Figure 6.1: Components of hope operating through a complex pathway 
 
6.6 Chapter summary  
This chapter has presented that findings of the participant interviews merged with the health 
professional focus group in Phase 1. Uncertainty was evident throughout the pathway. Using 
Gadamer’s fusion of horizons allowed to find meaning in the layers of data. Three horizons 
were formed which allowed to see that the process of understanding liver metastases was 
rooted in an individual’s diagnosis, the oncology team were best placed to co-ordinate 
treatment related to liver resection and that overall these experiences were stories of hope. 
While uncertainty was a given throughout the pathway, maintaining hope provided an 
antidote to uncertainty during the pathway and beyond for individuals who proceeded to 
liver resection and did not. The findings then provided the basis for developing a model of 







Merging patient experience with revision of service delivery  
“The improvement of understanding is for two ends: first, our own 
increase of knowledge; secondly, to enable us to deliver that knowledge 
to others.” (Locke 1689 paragraph 405).   
 
7.1 Chapter overview  
Having presented the findings in Chapter 6, this chapter will explain the response taken to 
revise the current support pathway for those being considered for CRLM liver resection. It 
was the intention to marry the patient and health professionals experience of the CRLM 
pathway with a response that was both fitting to the data, appropriate to the patient 
population and matched existing nursing resources. What resulted was a support pathway 
of three parts, executed predominantly by the colorectal cancer nurse specialist team. This 
comprised of a telephone support model, development of patient literature for the CRLM 
pathway and formation of a patient buddy support service. This chapter will incorporate a 
reflexive approach that seeks to respond to the research findings as I firstly revisit the original 
intentions of the research study and then outline each strand of the overall support pathway.  
There is a growing body of literature on the relevance of all three of these strands in cancer 
literature, (telephone support, patient information and peer support), yet while reference is 
given to some relevant literature, this chapter is not intended to spend time reviewing the 
current literature. The reason for this is clear. The approach adopted for the support pathway 
was in clear response to the analysis of the data in Phase 1. To remain true to the experiences 
of the patients interviewed and the perspectives of the health professionals in the focus 
group, the support pathway required to model these experiences rather than take its 
inference from existing literature. In addition, the approach used, should be conducive to the 
methodology of hermeneutic phenomenology in seeking to improve the experiences of 
patients being considered for CRLM. In this way, the study methodology supported the 
method of developing the intervention of support and similarly, the method applied, 
supported the methodology. What follows is not revision of the CRLM pathway itself but 
revision of the way nursing support was delivered to patients at the time. As Locke’s (1689) 
quotation at the opening of this chapter suggests, the study was conducted as a nursing study 
in order to deliver new found knowledge to future patients who might benefit from it.  
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7.2 Revisiting intentions  
From the start, this study encompassed the nature of the ‘so what?’ of the research question. 
Selwyn (2014) in an editorial, shares one of the key lessons learned during his doctoral studies 
and that was always to be mindful of the ‘So What?’ question. Selwyn recounts that this has 
significance both when publishing but also early in the research process of academia to 
reinforce to the researcher that the connections in their head as to why the research was 
conducted, require to be easily conveyed as relevant to their intended audience.  This study 
was never intended purely to encompass an exploration of the patient’s experience of the 
CRLM pathway and the views of health professionals without aiming to improve future 
patient experience. It was intended to build on what had already gone before by taking 
account of the merging horizons of patient and professionals experiences which in turn 
would allow for greater focus on this group of patients in order to help address needs during 
consideration of CRLM resection. At the same time, the outcome of the study was not pre-
emptive of the data gathered in Phase 1 but was responsive to the findings, focusing on 
individual patient experience and the collective patient experience as set out in Chapter 6 
and analysed with the use of IPA methodology. Importantly, as the data were analysed from 
Phase 1, it was also apparent that acknowledgment should be given to the context of an 
emerging treatment field and how revision of the service needed to be responsive and 
applicable to potential changes that might occur as treatment options emerged. Additionally, 
it was vital that any options were considered against what resources were in place to deliver 
the change and more importantly, in order to sustain any future change. The quotation above 
from John Locke, known as the father of liberalism (Hersey 2019), was relevant to the context 
of reading but aptly describes how gaining understanding or knowledge is of little value if it 
does not make its impact somewhere. It also highlights that change does not need to be 
hugely radical in order to make itself apparent and felt. Indeed, it may not always be obvious 
to others within the service but it ought to be experienced by those using it. It is this emphasis 
on putting the results into practice or translating them that has driven this study.  Too often 
nurses rely on experiential knowledge, trial and error, and peer opinions for decision-making 
instead of research (Stokke et al 2014 as cited by Younas & Porr, 2019).  Application to 
healthcare improvement ought to be evidence of using nursing research as the following 
quotation suggests.  
182 
 
“Knowledge translation (KT) emphasizes a shift in researchers’ practice; 
that is, rather than merely publishing in journals, presenting at 
conferences, and shelving research reports in university repositories, 
researchers should strive for the research uptake and its actual 
application for the improvement of healthcare and patient outcomes.” 
(Younas & Porr 2019, p.924) 
At this point it is worth reconsidering the original aims of the study. The aims were: 
●To inves gate how pa ents experience the pathway to liver resec on 
●To examine how health care professionals view the pathway to liver resec on for 
patients 
●To use the experiences of both pa ents and health care professionals to plan and 
implement a service improvement to the pathway with the addition of supportive 
nursing intervention.  
●To explore whether addi onal nursing interven ons during this pathway improves 
the experiences of patients being considered for surgical resection of liver 
metastases following service change. 
This chapter deals with the third aim, implementing service improvement. It acts as a 
reflective pause between chapter 6 and chapter 8 to consider the results, seek to implement 
a response and then re-evaluate the service. The results discussed in Chapter 6 highlighted 
an existing service where many of the actual patient experiences were hidden from health 
professionals involved, yet at the same time the health professionals had the knowledge that 
the pathway to CRLM resection was complex and due to the nature of the disease itself had 
the potential to cause huge uncertainty. Chapter 6 has presented the findings merging both 
the patient interviews and health professional focus group. This was achieved under three 
main themes which incorporated a fusion of horizons including my interpretation of the data 
as someone who was unapologetically both researcher and insider. The three overarching 
main themes: 
- a path of expectation: an enduring horizon 
- the companion of uncertainty: a unified horizon 
- a journey of personal understanding: an individual horizon 
 
The themes comprised both super-ordinate and sub-ordinate themes as set out in Chapter 6 
and also overleaf in Table 7.1 (although with differing number referencing in this chapter 
table). As with all phenomenological research, there are a number of ways to present or 
describe themes. I had arrived the above themes as I felt it had captured what was presented 
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in the raw data and reflected both the Gadamerian philosophy of fusing different viewpoints 
to arrive at a viewpoint which was aptly conveyed the input of health professionals involved 
in the pathway but also with the context of the insider/outsider position of myself as 
researcher.  
Master theme Super-ordinate themes Sub-ordinate themes 
1. A path of expectation: an 
enduring horizon   
 
1.1 Travelling with the backdrop of 







1.2 Hoping for chances: desiring 
life, desiring time 
 
1.1.1 Transitioning the 
diagnosis; from the well 
to the not so well 
1.1.2 Confronting a 
doubly shocking 
diagnosis  
1.1.3 Questioning in the 
context of ‘me’ 
 
1.2.1   Looking forward 
to possibilities in 
medicine 
1.2.2. Acknowledging: 
There is no choice 
1.2.3 Treating with 
curative intent means 
an active wait 
 
2. The companion of 
uncertainty: a unified 
horizon 
 
2.1 Health professionals: guardians 




2.2 Reliable information: a remedy 
for uncertainty 
2.1.1 Oncology; a place 
of safe keeping 
2.1.2 Nurse specialists: 
a welcome companion  
 
2.2.1 Struggles of 
communication give 
way to fear 
2.2.2 Language has a 
memory  
2.2.3 Uncertainty: a 
forever friend  
3. A journey of personal 











3.1.2 Gratitude gives 
back 
 
3.2.1 What matters 
most 
3.2.2 Keeping hope alive 
Table 7.1: Themes revealed from Phase 1 
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Conveying the essence of the findings in order to implement a service change, however, can 
become more challenging in the context of the clinical setting. This to me, is where that ‘so 
what?’ question of research really comes to the fore. How can findings become embedded 
or useful in clinical practice if they are not well communicated? For me, the themes required 
to be re-communicated in order to capture easily the essence of what was already good 
about the service and what could be improved. This meant using workable phrases to 
understand the findings within the context of positive experiences and against more 
challenging experiences. These phrases were therefore simply divided into positive 
experiences and more challenging experiences for the purposes of practical communication 
and can be viewed in Table 7.2. The phrases have been shown to map to the themes listed 
in Table 7.1. 
Colorectal Liver metastases pathway: a pathway of hope 
3 main components of hope permeated the pathway 
- Expectation 
- Uncertainty 
- Understanding   
Positive experiences More challenging experiences 
Sense of cohesion between teams regarding 
plan of care (2.1, 2.1.1, 2.1.2) 
 
Uncertainty from changeable nature of 
pathway 
(1, 1.2, 2, 2.2, 2.2.1, 2.2.2, 2.2.3) 
Sense of security in being anchored in oncology 
(2.1.1)  
Managing a realistic hope  
(1, 1.1, 1.1.1, 1.2, 1.2.1, 1.2.2, 1.2.3, 2, 
3.2.2) 
Sense of gratitude to team 
(3.1, 3.1.2) 
Lengthy co-ordination of decision-
making/management (2.2.1) 
Unexpected personal gain e.g. re-evaluation of 
what matters in life (1.1.3, 3, 3.1, 3.2, 3.2.1) 
Inconsistency of CNS contact (role valued) 
(2.1.2)  
 Specific information lacking (pathway, pre 
& post liver resection 
(2.2, 2.2.1) 
 Feeling of being alone (1.1.2, 3.1.1) 
 
Table 7.2: Summary mapping of positive and challenging experiences with related themes 
in Table 7.1 
The three main components of hope: expectation, uncertainty and understanding were 
overarching themes, evidenced throughout the pathway. Table 7.2 is a means of translating 
the intellectual  and philosophical findings from Phase 1 into the reality of clinical practice 
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and individual experience. It was also  important to communicate these themes within the 
context of a rapidly involving treatment picture and dual site working. 
 It has to be made clear that presenting the data as experiences was not an attempt to reduce 
the data further nor an attempt to mould the data but the data required to be presented to 
convey the findings easily and plan an appropriate service response. Practical communication 
of the themes was deemed as essential in driving forward a service change and give 
momentum to planning change.  In time pressurised, clinical environments, clear 
communication is a necessary precursor to successful change (Miller & King 2015,). One of 
the key components of this is using a common language that is easily understood by patients 
and health professionals alike (Miller & King 2015) so that a compelling case for change is 
made.  
A cautious approach must be taken when viewing the table to understand that how the 
phrases correspond to the theme findings does not mean that phrases are disproportionately 
accounted for. This is purely an attempt as showing connection. As concluded in Chapter 7, 
hope has been the key element that links the experiences at every stage of the pathway of 
CRLM. A model of support was needed that reflected the overall feature of hope identified 
in the patient experiences and health professional focus group. This hope was seen in three 
main aspects throughout the experiences shared; firstly, a hope that was reflective of the 
story of treatment advances in CRLM. Secondly, an individual sense of hope despite personal 
difficulty encountered and lastly being helped to maintain a realistic sense of hope by health 
professionals. These three elements can be visualised in Figure 7.1 to help explain that the 
context of hope, the individual sense of hoping and the role that health professionals played 
in maintaining hope came together to show how integral hope was in this pathway. This hope 
was evident whether or not they were able to proceed to liver resection or not and very much 
reflects Kubler Ross’s (1970) foundational work that a persistent hope is generally evident 
when prognosis is not favourable, stemming from her study of end of life in those terminally 
ill. Perhaps this reveals the complexity of hope as outlined in Chapter 5 in that it can be both 
an internal feeling set deep within our very being but also can be adaptable to different 
situations which are independent of outcome.  
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Figure 7.1: Aspects of hope identified in findings Phase 1 
It was felt that as hope was such a feature of the CRLM pathway, whether viewed positively 
or with a more challenging connotation, the development of a new service model needed to 
utilise hope, celebrating both the success that was possible in this area but also being careful 
to provide a realistic sense of hope related to surgical possibility in response to the clinical 
presentation of each individual. What follows is a 3 pronged model of support that enhanced 
existing structures in place within the existing CRLM pathway. It is crucial to point out that 
the 3 central approaches were not changing the service but were enhancing already existing 
structures. There were of course, larger more structural changes that could be tackled in 
order to improve the overall pathway, such as ensuring ongoing liver surgeon presence in 
the colorectal MDM or seeking to improve timing of imaging but while this study flagged up 
the importance of such structural changes and is further given reference to in Chapter 9. It 
was not possible within the remit of the study to undertake larger issues which required more 
time commitment and negotiation, although the study may itself evidence the need for 
further structural changes. The response to the findings from Phase 1 was a nuanced change, 
picking up on the themes exposed from patient experience.  
7.2.1 Deciding on revision of service delivery 
The first step on deciding how to deliver a service in response to the findings was that there 
was no reason to suspect that the findings did not echo a similar perspective from other 













the study sample and findings was essential, otherwise change might not occur. For a 
qualitative study the sample size of 16 patients was a more than reasonable number to hold 
to this position. The findings resonated with the concerns found in the health professional 
focus group and in this way the findings had a mutual validity. Likewise, having that insider 
position within the team, the findings also reaffirmed the concerns shared amongst the 
specialist nursing team, some confirming the very concerns that were the catalyst for the 
study in the first place. My position as insider/outsider researcher has been set out from the 
inception of the study and I believed could not be detached from this part of the study either. 
My awareness of personal reflexivity was rooted in my knowledge of the pathway and patient 
group and my reference to the nurse specialist position. Although I was removed from the 
day to day work of the colorectal cancer team, I was still part of that team and therefore it 
was right that after data analysation, my colleagues were involved to find a response to help 
manage the overarching uncertainty encountered during the CRLM pathway.  
Realising that the pathway itself was in a developmental stage as the number of referrals was 
gaining momentum, it was important to ascertain if some of the other larger U.K. centres had 
addressed concerns by being proactive about this CRLM patient group in particular. A 
professional UK network, of which I was a member, was emailed through a forum after the 
findings were gathered and a further literature review undertaken including assessment of 
conference papers but there were no incentives specifically to tailor support to patients in 
this pathway. In addition, a colleague and I visited a large national centre in North West of 
England which had recently made changes to structural aspects of their pathway. Again, 
while it was not the structural aspects that were our specific interest, this did allow for 
meeting with the CNS team who were involved with CRLM patients. Meeting with the CNS 
team proved valuable and in particular we took away some core messages about 
communicating the next steps of the pathway for individuals, in a pathway that is constantly 
evolving and creates uncertainty within that process.  While their HPB (hepatobiliary) unit 
manages a number of referrals over a widespread area similar to our HPB unit, at this 
particular centre, the hepatobiliary CNS team took more of a direct role with CRLM patients. 
This highlighted how each area and colorectal liver metastases team had evolved differently.  
Each national network is constrained by geography and additional factors so that who may 
be the best person to provide support service in one area may be different in another. In our 
area at the time of designing the service intervention, the hepatobiliary CNS was a singular 
post and was funded to primarily focus on primary hepatobiliary cancer. There was not the 
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remit for this postholder to engage more fully with the CRLM patients due to funding 
constraints and workload requirements. In addition, a further interventional literature 
review was undertaken at this stage to ensure that no support interventions with a CRLM 
patient population had been published during this time.  
The results of data analysis were discussed primarily with the colorectal nursing team and 
fed back to the study steering group, giving way to the three pronged model of support 
outlined in the implementation of change diagram, Figure 7.2., as seen overleaf.  
An important element for the nursing team was the underlying ethos that the new model 
would have drawn from the data in the study. So much of the support work offered from the 
specialist nursing team has been understanding the relevance of an individual’s life cycle to 
cancer.  All team members draw heavily upon understanding the context of cancer according 
life cycle, key relationships, social contexts and personal beliefs. Understanding this is critical 
in caring more holistically for individuals as all too often the cancer adds to the burden of 
existing life situations but is not only the main consideration. How cancer impacts on life has 
to be understood in what is life for that individual. In understanding this ethos of care and in 
considering the model of support to future CRLM patients, I was drawn to Rolland’s 
publication in 2005 in a supplement to the Cancer journal, entitled ‘Cancer Survivorship: 
Resilience Across the Lifespan’.  I refer to the name of the supplement as I think it is pertinent 
that the words, survivorship, resilience and lifespan reflect the spirit of the progress made in 
CRLM treatment. The paper was discussed with the team in addition to the findings. 
In Rolland’s paper, the Family System Illness model was used to help manage the stresses 
and uncertainties of cancer. The value of this model was identified as: 
 “it informs clinical practice to identify predictable strains and to 
facilitate optimal coping and adaptation.” (Roland 2005, p.2585) 
I will come back to draw out some important elements of this model in Chapter 9 in relation 
to the application of hope but the Family System Illness model allows for understanding the 
illness not just in the context of the family life cycle but also against the patterns of illness 
across the illness trajectory. These patterns included variations in terms of onset, course, 
outcome, incapacitation and the level of uncertainty (Rolland 2005). Individuals root their 
experience in their diagnosis (onset), relate to continuing treatment (course), understand the 
reality of secondary disease (outcome), experience side effects of treatment (incapacitation) 









                                                                                   
                                                                                
                                                                                    
 








       
                                                                                   
This descriptive pattern of illness fitted well the trajectory of illness revealed in the findings 
in Phase 1 where the overriding feature of the CRLM had been in maintaining hope amidst 
uncertainty. In this way there were two continuums running, the trajectory of family life and 
the trajectory of illness.   Two key sentences which stood out for me in the outcome and level 












                                             
 
 
                                                
       
                                    
 





Nursing team + 
steering group 
 Systematic telephone support by CNS team at key time 
points indicated by patients 
 Development of series of patient information 




“The extent to which a chronic illness leads to death or shortens an 
individual’s life span has a profound psychosocial impact” (Outcome 
pattern) (Rolland 2005, p.2586)  
and 
“Generally, families that are able to put long term uncertainty into 
perspective ae prepared best to avoid the risks of exhaustion and 
dysfunction”(Level of uncertainty pattern) (Rolland 2005, p.2586 )  
The quotation from the outcome pattern of illness has a particular pertinence to those being 
considered for CRLM. As discussed in Chapter 2, there are few other comparisons in cancer 
where surgery is used to remove a secondary liver disease with the intention of significantly 
improving survival or completely resect diseased tissue. Holding this in mind while 
considering the fluctuating pattern of uncertainty throughout the liver metastases resection 
pathway, underscores what a turbulent time this process can be and how it has the potential 
to create an elongated period of uncertainty which may formerly not have been seen in this 
area when there was no surgical treatment option. The second quotation, hints at the work 
undertaken in order to develop the Family Systems Illness Model which drew on clinical 
experience with over 800 families at the University of Yale and Chicago. This suggested that 
in long term chronic conditions, uncertainty was always going to be integral to living with the 
condition but in order to create resilience, the longer term uncertainty had to be set aside in 
order to adapt and avoid a risk that may be harmful to the individual. This article summed up 
all that had been important in our development as a nursing team and was an important 
parallel to setting the context of the findings of Phase 1. The model that we choose to help 
support patients with potentially colorectal liver metastases, needed to be flexible enough 
to help identify and manage expectations. 
7.2.2 Team inclusion and ownership   
As indicated in the previous section, the existing nursing team was very much a part of 
formulating a response to the data analysis. They were the key team members who would 
be co-ordinating the support model. It was vital that they felt the model was not only an 
appropriate response to the data but also would be feasible with current team resources. 
The nursing team needed to have confidence in the new model and have ownership of 
knowing how it might work or what might cause it to fail. It was also important that the 
nursing team could voice concerns upfront. This part of the interim period had a duration of 
four months. Perhaps being conscious that the study required to run to time due to resource 
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allocation, it could have been tempting to have been descriptive about what the model might 
have been. Yet, inclusion and ownership and discussion were essential components across 
two sites delivering care. Failure to have done this may only have led to further time delays 
later in the study or failure of the nursing team to be able to commit to using the model.  Due 
to resource allocation the colorectal nursing team took ownership of the model and were 
responsible for using it with new patients being considered for liver metastases resection. In 
addition, the hepatobiliary nurse specialist was also closely involved with discussing change. 
This helped to build on existing links with the specialist resection centre but also understand 
how further collaborative working could be furthered.  
7.2.3 Rejection of alternative considerations 
During the decision making process outlined in Section 7.2.1, time was taken to consider 
other tools which may be useful for gaining an insight into this time of active waiting for 
patients. During this time, the Holistic Needs Assessment Tool as developed by Macmillan 
(Snowden et al 2015) was also considered. The nursing team had experience in using this tool 
within follow-up practice finding it valuable in highlighting needs and ongoing treatment 
issues. At one stage the Holistic Needs Assessment was considered as to whether it could be 
given to patients at specific time points in the pathway in conjunction to the timings on the 
telephone model of support (Figure 7.2). It was briefly thought that this could be used instead 
of the SWIFT tool discussed in Section 7.3 but it would have given a different feel to the 
method and perhaps have felt too much like a tick box exercise on the phone rather than 
utilising the SWIFT tool within a conversation with a skilled component. This consideration 
was rejected by asking the question as to what purpose it served in eliciting the experiences 
of patients on the pathway. While the tool was valuable in a follow-up setting or after 
treatment periods, a model was desired that didn’t just focus on late or longer term effects 
of colorectal cancer treatment but that could also encompass these issues. It is clear that a 
number of patients do have late effects from colorectal cancer treatment (Denlinger et al 
2009) particularly in pelvic surgery and radiation for rectal cancer (Knowles et al 2013, Sanoff 
et al 2015). A furthermore fitting reason for rejection, was that its use did not adequately 
reflect the use of the hermeneutic phenomenology in the same way that the SWIFT tool did 
and this will be picked up in Section 7.3.  
In the same way quality of life tools were also rejected such as the EORTC C-30 (general) and 
C-38 (colorectal cancer specific) (https://www.eortc.org/) and the FACT-C 
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(https://www.facit.org/facitorg/questionnaires) tool as this would have introduced a mixed 
methods approach which was considered to have detracted from the qualitative 
methodology. Once again the focus was on uncovering the experiences of those on the CRLM 
across a timespan of potential treatment and both reflections on the value of collecting 
quality of life data and discussion with the hepatobiliary surgeon on the steering group, 
confirmed that this would take the study in a different direction.  
7.3 Provision of CNS telephone support  
Taking into consideration the results from the data analysis, one of the key interventions to 
addressing the key concerns of how to manage realistic expectations was the provision of a 
telephone model of support run by the colorectal CNS nursing team.  A large proportion of 
the nurse specialist workload is carried out by this approach. There has been a significant 
increase of interventions led by cancer nurses to meet the growing needs of those affected 
by cancer (Charalambous et al 2018). A key document highlighting the value of the nurse 
specialist role, based in rheumatology practice, outlined that the significant contribution of 
managing patient care was achieved by telephone, (Leary & Oliver 2010)/ Warren et al 2012 
. Previous work by Leary et al (2008) had identified that 50% of the clinical caseload was 
managed by telephone workload, predominantly in providing advice and by so doing could 
reduce GP consultation and often hospital admission. Much earlier work by Hughes et al 
(2002) had shown that having a telephone caseload could enhance NHS value and cost-
effectiveness. Certainly, within our practice, an audit of our time allocation, echoed the 
findings of Leary et al (2008) showing our workload as equivalent to 50% of clinical time 
allocated to the telephone.  
There were several benefits in using the telephone as the main support model. Firstly, when 
considering how to bridge care that traversed three potential departments (surgery, 
oncology and hepatobiliary surgery) and two major teaching hospitals, telephone support is 
able to transcend physical barriers and make support more readily accessible. This method 
is suited to being responsive when communicating within a pathway that was fast paced and 
could easily change direction.  Secondly, communicating by phone was already a method 
which was used within the practice, especially for passing on results of post-operative 
pathology via a well established telephone clinic. It was the practice of the nursing team to 
seek an enabling approach to gain acceptance of this method so that those not wanting this 
method of communication could come back for a face to face clinic consultation. This method 
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was generally considered acceptable and more efficient, reducing hospital visits and 
speeding up knowledge of plans for treatment. With 66 million people in the UK and 
approximately 94% of all adults owning a mobile phone (Henshaw 2018), there has been a 
cultural shift of the necessity of efficient communication generally for everyday life and 
relationships in that it has become a communication norm for all generations. The out of 
hours healthcare of NHS 24 has embodied the telephone to triage more urgent cases to be 
seen at local out of hours centres across the UK.  Thirdly, the colorectal nursing team were 
familiar with this method of communication having developed and adapted communication 
to take into consideration the lack of face to face contact and inability to read non-verbal 
communication.  It could be argued that as a result there is a particular type of skill to this 
clinical telephone communication. While it takes the basis of a conversation, it seeks to 
address concerns in a holistic manner, listening to tone and giving opportunity to expand on 
other areas where they patient might want to direct the conversation. It is also requires 
advanced communication skills to deliver this type of communication and is something of a 
skill that has to be acquired in conjunction with knowing the overall colorectal pathway. For 
this reason, two of the more senior team members took responsibility for the telephone 
support and also meeting the patients at diagnosis to act as the main point of contact 
throughout the pathway. While the systematic support by the CNS team at timely intervals 
was the main feature in this enhanced pathway compared to the pathway in Phase 1, offering 
support without a framework was not thought to be enough. A tool was required that would 
provide a holistic framework for conversation and assessment and that would also honour 
the concept of the Family System Illness model discussed in section 7.2. The tool chosen was 
known as the SWIFT tool and is explained more fully in the following section. The acronym 
encapsulates the following areas of life which may be used for assessment by a clinician, in 
this case the nurse specialist and are as follows; 
- (S) Stress/coping 
- (W) Work/home 
- (I) Ilness/condition 
- (F) Friends and family  






7.3.1 Incorporating the SWIFT tool 
The team was first exposed to the SWIFT tool by attending a course entitled ‘Developing 
Practice’, designed to support experienced clinical staff to address psychological needs of 
their patient caseload. This was designed by the Psychology Directorate, within NHS 
Education for Scotland in 2013 and in association with NHS Lothian.  The complete SWIFT 
tool can be viewed in Appendix X. The tool was designed on the back of an Emotion Matters 
series (now an e-learning module) which came as a result of a document entitled Emotional 
Support Matters (2010). In a way, the report formed the policy bedrock upon which Emotion 
Matters was built and in turn which produced the SWIFT too. This was published in response 
to people with long-term conditions needing a more holistic approach to their care. At the 
time the Psychology Directorate had been involved in work with practitioners who felt they 
did not have the skills required to address emotional issues when working with people living 
with long-term conditions in conjunction with the Long Term Conditions Alliance Scotland, 
(LTCAS). The aim of the Emotion Matters series was firstly to increase understanding and 
awareness of the psycho-social aspects of living with a long-term condition and secondly to 
provide skills that would enable a more holistic, collaborative and person-centred care.  
In many ways, the timing of the Emotion Matters series looking at the emotional needs of 
individuals for long term conditions was fortunate for the timing of the study. This was at a 
time when the overall treatment of CRLM was emerging for many as a long-term chronic 
condition. The Emotion Support Matters developed from work with groups of individuals 
with long term conditions had clarified that, 
“People with long term conditions want holistic support that includes 
emotional and psychological support as part of an integrated service 
and not just as an add on.” (LTCAS, 2010, para.5)   
This echoes many of the sentiments of the Family Systems lllness Model and those that we 
sought to identify in practice. What the Family Systems lllness Model lacked was the practical 
‘how to’ application for conversational assessment. The suitability of the SWIFT tool was that 
it was broken up into different areas with prompts to cover each area. By naturally covering 
each of these areas, knowledge was gathered that could then be used to help address any 
concerns, signpost further or take other action.  In addition, it was also considered useful to 
use the widely available, Hospital and Anxiety Depression Score (HADS) tool, (HADS 2016) 
should the conversation suggest this. This is was unlikely to be undertaken on the initial call 
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but followed up with a further telephone call at the clinical judgement of the nurse specialist. 
The consideration to include this tool, if needed, came from the study findings and the 
experience of the one participant in particular who had three liver resections and others who 
had spoken about anxiety and low mood during chemotherapy (Section 6.1.2.3, 6.2.2.1).   It 
is important to note that there were three main calls in which the SWIFT tool was used (four, 
if an individual had neo-adjuvant or down-staging chemotherapy) but there were also 
additional calls depending on the needs of the individual or family members. Using the SWIFT 
tool gave form and structure to the conversations at key time points. 
Development of telephone timeline 
The agreed timepoints as seen in Figure 7.3 (overleaf) show four main areas that that came 
from the findings. These were both a blended interpretation of the data from my position as 
a researcher and an insider and also discussion of the findings with the immediate colorectal 
nursing team. The time points were deemed particular points of high anxiety either due to 
reflecting on what the participants had revealed in the interviews in Phase 1. The time points 
chosen to carry out the SWIFT tool were diagnosis, key management decision, midway point 
of chemotherapy and post-resection or equivalent timeframe if no resection. Patients who 
were not able to proceed to liver resection still had a telephone call after a decision of liver 
inoperability was made as this allowed the nursing team to assess the impact of this decision 
and continue to support this group of patients. This was carried out approximately 2-3 weeks 
after a decision of no liver resection was made. This had particular relevance for this group 
of patients in allowing them to reflect on that decision and pre-ceding treatment which 
despite participating in, had not resulted in liver resection. Learning how this experience 
affected others might also be of value and help to shape support for others in the future 
within the context of hoping for potential liver resection. 
7.4 Development of local patient information 
As a nursing team we were aware that the current patient literature on CRLM was not 
adequate. As often is the case in medical developments, the accumulation of literature, 
particularly literature that is practical in nature is lacking (Tran et al 2019). As such there 
exists a gap between what is accurate and what is possible and getting access to specific 
information is difficult and has the tendency to leave individuals feeling overwhelmed or 
disheartened by what they read. Certainly, at the time of commencing this study patients 
often reported that there was little by way of patient information that suggested anything of 
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the hope of liver resection. Much of it was related to the prognosis of liver metastases and 
survival figures and which did not seem relevant if surgery was a possibility. Of the 
information that did relate to CRLM, patients often relayed to the nursing team, that much 
of it was too technical and cumbersome with a lack of understanding of decision making or 
practicalities about the overall process. This was highlighted to me by the following situation, 
when after publishing an article in a UK nursing journal (Sherwood, 2015),  a relative of a 
patient who was being cared for in New Zealand contacted me by email to ask further 
questions as her father was due to undergo a liver resection for secondary bowel cancer and 
she was having difficulty finding relevant information online. At the time she also expressed 
appreciation as the article had allowed her to hope by knowing that her father was eligible 
for liver resection and in detailing some of the context of that decision-making process. At 
the time of writing she was working in America and could not be with her father for a few 
weeks. While this did not influence any of the response to the findings, it did confirm the 
importance of having easily accessible information about the process of colorectal liver 
resection that was relevant to our local practice and setting.  
The decision to produce a series of leaflets came from listening to the stories of the 
participants in Phase 1 and in knowing that the potential for heightened anxiety from the 
internet in the absence of any relevant site specific was likely to occur, either in patients or 
family members. Three information leaflets were designed with the colorectal nursing team 
and joint input from the hepatobiliary nurse specialist, gleaning information that was lacking 
in the CRLM liver pathway from Phase 1 participants. The leaflets were not only to pick up on 
what information participants had found lacking but also were aimed at explaining the overall 
process and be reflective of each area moving from a diagnosis to treatment and 
aftercare/follow-up pattern. This also aligned with the model of telephone support and 
reinforced the pattern of more formalised support and assessment with the SWIFT tool. The 
leaflet series was produced in the interim time period of four months between Phase 1 and 
Phase 2 and approved by the local communication team.   
7.4.1 Integrating key information from interviews  
The leaflet series incorporated the following titles, as seen in Figure 7.4, below. 
- When bowel cancer spreads to the liver; understanding surgical management 
- When bowel cancer spreads to the liver; your surgery 




Figure 7.4: Patient information series 
 
They can be viewed in the relevant Appendix XI – XIII. All leaflets contained contact details of 
the hepatobiliary and colorectal nurse specialist teams to reinforce accessibility and allow 
easy contact. Close working was maintained between the local hospital communication team 
to ensure that the leaflets were in accordance with reading acceptability and local 
communication guidelines. Each information leaflet in the series flowed from diagnosis to 
surgery to recovery and was designed to be specific to the local site but also to be applicable 
to a range of patients being considered for CRLM. All leaflets began by setting out the 
purpose of the information contained within and focused on incorporating what had been 
lacking or important to stress from the previous participant sample. Table 7.3, overleaf,  
details the key messages that had come from the findings of Phase 1 which were essential to 
highlight to potential patients being considered for colorectal resection.  
7.4.2 Leaflet review process 
After the leaflets were compiled by the colorectal nursing team and hepatobiliary nurse 
specialist, the leaflets went back for review to the steering team and immediate surgical and 
oncology consultant team. Positive feedback was received and the series was welcomed. 
There was also a suggestion that a similar series was developed for the consideration of a 
lung resection for secondary lung metastases from a colorectal primary. The leaflets were 
reviewed by eight patients who had conducted the interviews and feedback was sent by post. 
The leaflets were also reviewed by a further five patients attached as patient representatives 




Leaflet title Key aspects of inclusion from Phase 1 findings 
When bowel cancer spreads 
to the liver; understanding 
surgical management 
 
1) Process of surgical management 
2) Multidisciplinary approach 
3) Planning individual treatment essential 
4) Planning effective treatment requires time 
5) Explanation of liver metastases – not liver cancer 
6) Explanation of secondary  
7) Who is involved in decision making 
8) Possible treatment options 
9) Follow-up  
10) Ongoing support/ access to previous patient 
When bowel cancer spreads 
to the liver; your surgery 
 
1) Current surgical management 
2) Preparation pre-surgery 
3) Potential Portal Vein Embolisation (PVE)  
4) Potential cancellation of surgery (liver transplant 
unit)  
5) Immediate aspects of care 
6) Mood 
7) Going home 
8) Follow-up 
9) Ongoing support/ access to previous patient 
When bowel cancer spreads 
to the liver; your recovery 
from liver surgery 
 
 
1) Early recovery post-operativeperiod 
2) Longer term recovery 
3) Fatigue as result of resection 
4) Alcohol intake 
5) Sleep 





10) Ongoing support/ access to previous patient 
   Table 7.3:  Key information aspects of inclusion in liver series  
 The local network welcomed the leaflet series and once formalised, requested to have them 
accessible online. Two oncology consultants also took the leaflet series to outlying clinical 
areas so that they could be adapted and considered for use in those areas. The use of the 
series was also reinforced and supported by the telephone method and helped to introduce 
the idea of peer support in addition to professional support available.  
7.5 Establishment of patient buddy service  
To build on the provision of the CNS telephone support and the development of local patient 
information, a considered action in response to interpretation of the data was to establish a 
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patient buddy service. This was something which the nursing team had often contemplated 
before but had not set up formally. Previously, the nursing team, had on one off occasions, 
linked patients at any stage of primary or secondary cancer at the request of patients who 
had indicated interest in this. What had prevented any formal establishment until this point 
had included concerns about how effective interactions might be, perhaps more from a 
paternalistic point of view that interactions might only cause harm or confusion. In addition, 
there were concerns that patients who had volunteered as a patient buddy might perhaps 
become more heavily embedded in the cancer process when they might feel that they 
wanted to ‘move on’ and put their cancer experience behind them. A final concern was the 
sustainability of such a service in that managing training, new volunteer buddies and 
matching might involve on an already busy nursing service.  
At this point it is worth reflecting on some aspects of buddying in general before outlining 
how the service was established, in order to understand what the service was and more 
importantly what it was not to be. It was also important to consider what attributes were 
important to the nursing team and how they wanted the service to be experienced by future 
patients.  
A definition of buddying by Campbell (2015) describes buddying as  
 “an arrangement in which persons are paired, as for mutual safety or 
assistance”. (Campbell 2015, p.992) 
This definition hints at a commonly understood aspect of buddying in that it is support for 
peers. There is not normally a sense of a hierarchical relationship structure. Already though 
this definition raises potential concern about how might peer pairing or matching take place. 
As much of the success of the buddying and original intention might only be achieved 
depending on personal qualities of the buddy and on that relationship develops.  Simpson et 
al (2017) recount that, 
“In most cases the ‘buddies’ are individuals who have been through 
similar experiences as the person they are ‘buddying’ and as such they 
are able to pass on their learning and knowledge based on first-hand 
experience” (Simpson et al 2017 p.3). 
It was that peer aspect of support that from the research data in Phase 1 was thought to be 
missing from the process and being able to offer this as an additional resource to tap into 
was seen as something particularly important when health professionals did not themselves 
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have that ‘first-hand experience’ of what it was like to experience the pathway towards 
CRLM. Incorporating a buddy service was also thought to lend itself to the Gadamerian 
philosophy influencing the study, in that there was an awareness of the limitations of our 
understanding as health professionals to understand the CRLM pathway as much as we knew 
the possible pitfalls of the pathway, we did not share knowledge from a first-hand experience 
and that this first-hand knowledge could offer something unique in addition to the other 
forms of support offered.   
The concept of ‘buddying’ is evident in a number of settings but as a review led by Simpson 
et al (2017) for CLAHRC NWC (Collaboration for Leadership in Applied Health Research and 
Care North West Coast) points out there is a lack of literature relating to the theoretical 
underpinnings of the term ‘buddying’. The review while undertaken as a response to support 
the use of community resources in the North Coast of England, has gleaned some relevant 
understanding of the buddying term. There are of course some generally understood 
elements of enabling and supporting that a buddy would offer when teamed up with another. 
This is seen in the different types of contexts it is applied to. From their review, Simpson et 
al (2017) report that it is commonly been promoted in the workplace when it is used as a 
practical intervention that is used to support an individual starting a new job. This may be a 
new recruit, student or apprentice. Within health care, buddying can often be part of 
induction for junior doctors and student nurses (Honney et al 2012). It has also been 
identified as a social and psychological support intervention for physical and mental illnesses 
(such as cancer, type 2 diabetes and depression) and within the public health setting, 
buddying has been used to promote and encourage healthy lifestyles, such as smoking 
cessation and increasing physical activity. (Simpson et al 2017). Additionally it has also 
reported use to help to counteract school bullying (Dockett & Perry 2005), help foster 
educational support (Campbell 2015) and support military personnel return to civilian life 
(Greden et al 2010).  
While the introduction of a patient buddy service in this research study, was not based on 
what was already in the literature, it is worth noting that there is limited evidence as to the 
effectiveness of buddying programmes. Startlingly, Simpson et al (2017) suggest that this is 
because the majority of studies have been qualitative and descriptive in nature rather than 
randomised controlled trials (RCTs), suggesting that use of qualitative research does not have 
value in the experiential nature of buddying! This would seem to contradict the very nature 
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of applying suitable methodology to the research question. That is not to say that RCTs have 
no place in addressing the question of whether buddying programmes work in cancer, but 
the richness of qualitative work should not be omitted. Campbell et al’s paper (2004) 
reported on the efficacy of peer support programmes some fifteen years ago previously and 
although it included a few RCTs, there remains little published in the literature including 
RCTs. Perhaps this is about to change, as a resurgence of interest seems to have occurred 
around the use of multi-dimensional support in cancer including peer support. Simpson et al 
(2017) drawing on the work of Nigah et al (2012) in the use of buddying in professional private 
sector suggesting that this may be more due to economical reasons rather than any real 
evidence. Buddying has often been used as a method of encouraging behavioural change, i.e. 
smoking cessation, weight loss and one can see that it the social sector, cutting down on such 
programmes might be a way to reduce cost. However, the reality is that buddy services need 
to be monitored by professionals for participant safety and it would be alarming to think that 
increasing peer support would be a way to cut costs and thereby risk reducing health 
professional input and that given from the charity sector. However, from abstracts and 
conference papers, it would seem that several RCTS are being considered within the cancer 
setting to look at this issue. RCTs, I suspect, may not adequately get to the heart of the 
complex matter of uptake.  
Nonetheless, discussion with the nursing team on presentation of the findings, had agreed 
that in order to help address some of the issue pertaining to being considered for CRLM 
resection, namely uncertainty, isolation and protection of self as distinct from the input that 
family or friends could give, that establishing a patient buddy service might be an apt 
intervention to adopt in this smaller patient group of patients with liver only metastases who 
may be eligible for resection. In addition, the results had shown that 9 out of 16 people had 
offered voluntarily, without prompting, to speak to others should that be something which 
may be helpful. This was willingness came from an understanding that they may be able to 
share or understand aspects of what another patient may encounter.  It also came from an 
attitude of thankfulness and a desire to give something back in the realisation that they had 
been able to proceed to  liver resection or had been given the opportunity to have been 
considered for potential resection as the following two quotations emphasise;  
“If I can help in anyway. I’m quite happy to be involved and speak to 
others, to do something so that people see I’ve been through it. That’s 
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important and I wouldn’t be here now had I not the opportunity to go 
through this”. (Chris)      
      and  
“If there are others out there who have been through a similar thing and 
might find it useful to speak to me. They need to know that there is still a 
day to be lived”.  (Julia, no resection)  
From Phase 1, the drive for building peer support was to meet the needs of isolation and 
managing uncertainty from the uniqueness that peer support could offer, something which 
was missing from the previous phase of study. Indeed, the following quotation, highlights the 
attributes that the nursing team wanted in the patient buddy service.  
“In general, peer support has been defined by the fact that people who 
have like experiences can better relate and can consequently offer more 
authentic empathy and validation. It is also not uncommon for people 
with similar lived experiences to offer each other practical advice and 
suggestions for strategies that professionals may not offer or even know 
about. Maintaining its non-professional vantage point is crucial in 
helping people rebuild their sense of community when they’ve had a 
disconnecting kind of experience” (Mead and MacNeil 2004, p 4).  
It was true that from the data in Phase 1, patients had undergone a disconnecting experience 
that had taken them further than a diagnosis of primary cancer alone had taken them, in 
placing them closer to the potential non-curative aspect of their illness and that had 
disconnected them from life as they knew it, and for some changed their sense of 
connectedness to family, friends, work and social situations. It seemed wise to attempt to 
introduce peer support as a way of building in additional community. There was recognition 
from review of the data of the role that families and individuals played in managing patient 
wellbeing but peer support was recognised to be a reciprocal process as the above quotation 
illustrates. It would have been perhaps naïve to think that patient volunteers were ‘finished 
with’ or ‘over’ their experience of liver resection and that there might also be a therapeutic 
effect of future interactions with other patients.  
7.5.1 Setting up the buddy service 
The reciprocal nature and level of personal involvement at a significant time point in a 
patient’s life meant that patient selection for the buddy service was crucial.   In reality, there 
is little recorded in the literature about the transparency of this process.  A more inclusive 
approach might be to advertise within hospital clinic settings and invite all were who eligible 
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to come forward for buddy training, yet being honest the paternalistic side of the health 
professional, prevents this from happening as we all can recall patients who might come 
forward yet may not acquire or be able to develop the skills required to be a patient buddy. 
For example, a willingness alone to help others was not simply enough and some may find it 
difficult not to use the interactions with the current patient to project their experiences too 
strongly which would unlikely prove beneficial. Additionally, patient character arguably 
requires to be understanding and balanced, putting the focus on the current patient, despite 
their own previous experience.  
Having had a sample of patients for Phase 1, the colorectal nursing team selected patients 
who had been involved in patient interviews. One of these selected was one of the pilot 
interviewees. The benefit of inviting these patients, was that they had been familiar with the 
intention of the study and its aim to influence future practice as outlined in the study 
information sheet but they had also, at the time of their interview, volunteered  through the 
interviews to speak to other patients. There may have been an element in which the 
interviews had some therapeutic effect as they reflected on their own personal journey with 
diagnosis and treatment. This concept is later picked up in the discussion in Chapter 9. The 
buddy group characteristics can be viewed in Table 7.4 overleaf.  
Potential patient buddies were contacted by telephone by the nurse specialist who was 
known to them and invited to consider the invitation to become a patient buddy. They were 
given initial information about time commitment and training and time to reflect on the 
invitation. All five agreed to come to a one off in-house training but it was stressed that this 
did not commit them to becoming a buddy. The training took place on one of the main 
teaching hospital sites in a cancer charity facility. The cancer charity was skilled at running 
the training, regularly facilitating a number of group sessions for cancer patients and their 
families throughout the week.  The training was adapted in conjunction with input from the 
colorectal nursing team in order to make it more specific to the colorectal liver resection 
pathway. The training took place in an evening in October 2013 and was intentionally 
structured to flow from reflection on the buddies’ own experience to that of what 
characteristics might be needed. The centre lead facilitated the training and in addition to 
the five potential buddies, one colorectal nurse specialist was present and I was present in 
an observer capacity. No methodology was applied to the observation as this section of the 
intervention could not have been predicted at the outset of the research study. The evening 
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was roughly split into two parts with a break in the middle. Box 7.1 below, outlines the 
content of the evening. 













Further 2 liver 
resections 






Female 65 Colon Synchronous Synchronous 
resection 
Chemo 







Male 55 Colon Synchronous Primary surgery 
Chemo  
Liver resection 
Table 7.4: ‘Buddy’ characteristics 
 
Buddy training event – content 
Part 1 
- Ground rules 
- Establishing safety and confidentiality 
- Personal reflection on own journey to liver resection (in pairs). Exercise to 
condense their own cancer story, involving highs and lows of experience. 




- Presentation and discussion on positive attributes required to buddy 
- Practicalities to consider in setting up a buddy meeting 
- Navigating more challenging situations that may be encountered 
 
 Box 7.1:  Content of buddy training evening event 
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It was agreed that the CNS would act as a liaison point and would establish how the patient 
wished to be contacted, i.e. if they wanted to ring the buddy or vice a versa. Meeting was 
often seen as preferable and was encouraged to take place within Maggies for the first 
introduction so that a safe and familiar place of meeting was established. 
At the end of the evening the participants voiced that they had enjoyed the evening, in 
particular, finding it helpful to have met others who had gone through a similar experience 
of being considered for colorectal liver resection. All of the five participants agreed to be 
patient buddies and did not wish further time to think about it. It was stressed that being 
available as a patient buddy meant that it could not be guaranteed how frequent their 
involvement might be required and that they could still opt out from the buddy service at 
any time. The findings relating to the buddy service are discussed in the following chapter as 
part of Phase 2 overall findings.  
Summary 7.6 
This chapter has detailed the interventional approach as a response to the findings in Phase 
1, which previously presented in Chapter 6. The chapter has been purposefully reflexive in 
nature, revealing how the approach was arrived at by interpretation of the data as both an 
insider and outsider and importantly with the inclusion of the colorectal nursing team who 
were key in implementing the approach. It also lends itself to Gadamerian philosophy of a 
fusion of horizons as detailed in study methodology in Chapter 5. The model chosen was a 
three-strand approach involving a telephone support model using the SWIFT tool 
assessment, provision of a series of patient information leaflets and the development of a 
patient buddy resource.  The next chapter presents the findings of a second phase of patient 
interviews and health professional focus group which was completed with a consecutive 









Looking again; examining new horizons - findings from Phase 2 
“To think historically always involves mediating between those ideas and 
one’s own thinking. To try to escape from one’s own concepts in 
interpretation is not only impossible but manifestly absurd. To interpret 
means precisely to bring one’s own preconceptions into play so that the 
text’s meaning can be made to speak for us” Gadamer p.398 (Gadamer, 
2004). 
8.1 Chapter overview  
One of the dilemmas afforded to qualitative research is how to deliver the findings so that 
the form selected shines light into the understanding of the reader in the same way that the 
researcher has viewed the interpretation of the data. This demonstrates a consanguinity with 
the very concern of hermeneutics, being the art of understanding and the intention to make 
language understood (Zimmerman 2015).   In this instance presenting data from two phases 
of qualitative interviews is indeed challenging, both from the volume of qualitative data 
afforded from two phases, and in the task of displaying the findings from a study utilising 
phenomenology and incorporating a service revision.   From the outset, the purpose of the 
phenomenological inquiry was to have a practical intention in driving forward a service 
change as outlined in Chapter 7. Di Cesare, as translated by Keane (2013) exemplifies the 
practicality of hermeneutics when he writes,  
“To understand means to apply; understanding is always put into 
practice and thus becomes a form of action in itself, in the world, and 
with others” (Cesare 2013 p.109).  
To this end, this study has been unapologetically practical in nature. It has sought to utilise 
the theoretical to expose the practical value of examining the underlying patient experience 
of being considered for liver metastases. In his 1972 essay, ‘Hermeneutics as Practical 
Philosophy’, Gadamer emphasises the central tenet as he sees it of hermeneutics, that 
understanding ought to be applied (Dobrosavljev 2002).  Here hermeneutics takes on what 
Gadamer sees as an ethical dimension whereby it goes beyond the task of understanding but 
extends to change. Appreciating this allows the reader to see the continued suitability of 
phenomenological hermeneutics as a methodology to this study. This chapter is primarily 
concerned with presenting the findings of determining service revision but will also refer to 
and validate previous themes as identified in Chapter 6 and seen in Table 8.1 within this 
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chapter. Further iInterpretation will utilise concepts applicable from Gadamer’s practical 
hermeneutics, mainly being, authenticity, fore-structure, temporality and history. As in 
Chapter 6, pseudonyms (first name only) have been adopted within this chapter to protect 
the anonymity of participants.   
 
8.2 Revisiting methodology 
In reflecting on how most fittingly to present the data, the realisation cannot be escaped that 
I have been part of this research alongside the experiences of the individuals and in so doing 
have had my own personal research journey. This I recognise arrives at a time when I can 
more fully appreciate those words of others encouraging me to undertake this study for the 
journey that I would go on as allude to in Chapter 5. A central underpinning of Gadamer’s 
work in Truth and Method (1960) is the idea that our understanding in never only subject-
oriented in behaviour and is always historically limited. As Duška writes,  
“The notion of prejudice loses its negative connotation and represents 
not only the link with our tradition, but also the original source of all our 
judgments.” (Duska 2017, p.219). 
Undeniably, my position as a researcher has been difficult to disassociate with this work, on 
two counts; firstly my position as interpreter on a professional level means that I will always 
bring something of my own foreknowledge to the interpretation of the interviews and focus 
groups and secondly my position as researcher with an insider/outsider dual role will add a 
further level to interpretation.  Rather than ignoring this level of involvement, Gadamer sees 
one’s own position as relevant in the interpretation, as the opening quotation of this Chapter 
vigorously claims.  
As language is the determination of hermeneutics, a concept explored extensively through 
Gadamer’s Truth and Method (Gadamer 2103),  the sense of meaning has been weaved from 
the process of the interviews themselves, the committing of the words to written transcript 
and through reading and re-reading of these texts. The use of Interpretative Phenomenology 
Analysis (IPA) as chosen analysis methodology discussed in Chapter 5 has been particularly 
useful in focusing on the breadth and depth of the data contained within the transcripts, 
giving due recognition to the complexity of the participants’ accounts. This has also reflected 
the concept of the importance of interpreting the part and the whole as exemplified in the 
hermeneutic circle.  
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This occurs on two levels. The use of IPA as a methodological framework allows dual aspects 
of interpretation by participant and by researcher. Through the process of data analysis, it 
can be seen that the patient is both participant and interpreter and the researcher is viewed 
as both observer and interpreter. Analysis is an attempt to understand what it is like to stand 
in the shoes of the participant. As Pietkiewicz and Smith (2014) outline, analysis is both 
descriptive because it is concerned with how things appear, and interpretative because it 
recognises that there is no such thing as an uninterpreted phenomenon. While the 
participant might share what they know of their experience, Gadamer holds that we (or in 
this case the researcher) will interpret this experience with any foreknowledge or 
background to that situation or indeed any prejudices they may hold (Gadamer 2013). This 
is an important reality to be aware of during interpretation, particularly with the pre-
knowledge that I had of both colorectal cancer and the liver metastases resection pathway. 
For myself, looking at interpretative meaning through horizons was hugely significant as it 
occurred on multiple levels within the study, where all viewpoints from both phases could 
be pulled together to arrive at a more complete sense of meaning.  
In addition to this, interpretation has also been further developed through the process of 
writing and re-writing. With the large sample size involved this has often been an arduous 
process in deciding what text to draw attention to and which to eliminate from presentation. 
Indeed, Gadamer himself when asked if he found pleasure in writing replied,  
“No, it is violence. It is torture. Dialogue is fine. Even an interview! But 
writing for me is always an enormous self torture.” (Gadamer as cited by 
Lawn, 2006, p.27).  
Although this appears amusing and even encouraging to every qualitative researcher during 
the process of writing, Gadamer loved the practical nature of dialogue and devoted much of 
his earlier life teaching where the process of conversation was rich and very apparent. Yet he 
also knew that writing allowed his process of thinking to be shared. It is only through the 
cognitive process of writing and committing understanding further to text that the 
interpretation deepens. Morse (1994) has summarised the cognitive process inherent in 
qualitative research believing that all qualitative analysis regardless of specific approach 
involves four phases of cognition. The first is the comprehending of the phenomenon specific 
to the study. The second relates to synthesising the phenomenon according to relations and 
links with other aspects. Thirdly, theorising is used about how and why relations appear and 
finally recontextualising is the final cognitive process. Here the researcher puts the 
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knowledge gained about the phenomena with relevant linkages into the context of evolving 
knowledge. On reflection, in this study, cognitive stage one and two have been more evident 
through the process of analysis utilising IPA and using the MAX-QDA package to structure 
relations into the themes and additional themes arrived at (see Table 8.1, overleaf). The 
cognitive processes of theorising and recontextualising for me have evidenced through the 
process of writing. Using all of these intellectual processes means that raw data can be 
considered, examined and reformulated to become a research product (Thorne 2000).  
8.3   Determining service change 
The main drivers from the findings in Phase 1 were to provide a service that could be 
responsive to the overarching themes identified in which expectation, uncertainty and 
personal understanding were prominent throughout the pathway. From Phase 1, the nurse 
specialist was seen as a welcome companion (Section 2.1.2) in the pathway who had a central 
role in facilitating aspects of service delivery to help manage expectation and to help 
individuals and their families live with this uncertainty. The findings from both phases have 
totalled thirty-two patient experiences, with twenty-four patients having had liver resection 
and eight patients not able to proceed to liver resection. 
When considered in its entirety, this has equated to a substantial number of participants for 
a qualitative study and has not surprisingly, yielded an extensive quantity of data. As already 
stated, the major focus of the study, as outlined in Chapter 5 and revisited in Chapter 7, has 
been to establish change through a service intervention. Sections 8.3 to 8.7 will focus on the 
service change by examining the three intervention areas, (1) a structured nurse specialist 
telephone service (2) implementation of leaflet series for CRC liver metastases and (3) 
development of the buddy service, whilst the remainder of the chapter confirms the results 
from Phase 1 through the application of concepts in Gadamer’s practical hermeneutics. As 
was the case in Chapter 6 and the earlier section of this chapter, participants responses are 
blended with health professional responses on appropriate sections rather than looked at in 
isolation. This continues to complement the methodology of hermeneutic phenomenology 






Master theme Super-ordinate theme Sub-ordinate themes 
1. A path of expectation: an 
enduring horizon   
 
1.1 Travelling with the backdrop of 






1.2 Hoping for chances: desiring 
life, desiring time 
 
1.1.1 Transitioning the 
diagnosis: from the well to 
the not so well 
1.1.2 Confronting a doubly 
shocking diagnosis  
1.1.3 Questioning in the 
context of ‘me’ 
 
1.2.1   Looking forward to 
possibilities in medicine 
1.2.2. Acknowledging: There 
is no choice 
1.2.3 Treating with curative 
intent means an active wait 
 
2. The companion of 
uncertainty: a unified 
horizon 
 
2.1 Health professionals: guardians 




2.2 Reliable information: a remedy 
for uncertainty 
2.1.1 Oncology: a place of 
safe keeping 
2.1.2 Nurse specialists: a 
welcome companion  
 
2.2.1 Struggles of 
communication give way to 
fear 
2.2.2 Language has a 
memory  
2.2.3 Uncertainty: a forever 
friend 
3. A journey of personal 









3.1.1 Understanding looks 
forward 
3.1.2 Gratitude gives back 
 
3.2.1 What matters most 
3.2.2 Keeping hope alive 
Table 8.1 Reference to themes Phase 1  
8.4 Systematic telephone model 
To reiterate, the telephone service aimed to have a minimum of three key in depth contacts 
with patients (see Chapter 7, Figure 7.4) or four contacts if patients had chemotherapy prior 
surgery. The reality as evidenced from a patient database maintained as part of routine 
nursing service, was that these calls were carried out ensuring that patients were having an 
in-depth assessment  of how decisions and treatment was affecting them but in addition on 
average a further eight contacts were also maintained by phone and a further six in person 
at clinics. This was accomplished by the use of the SWIFT tool (Appendix X). When liver 
metastases were suspected, and a nurse specialist had initiated contact with that patient, 
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the process to a decision made about liver resectability was often lengthy, in part due to 
optimising the liver for surgery. It was also explained that with their consent, the nurse 
specialist would maintain contact at key decision points and have undertaken more in-depth 
phone calls at these times to try to reduce the impact of this wait in their lives. While there 
was no key ‘script’ for this introduction of the telephone support, the key concepts of 
telephone contact, managing the wait, assessing the individual and ensuring access to nurse 
specialist were highlighted in a memo of support. This was left to each nurse specialist to 
provide this information, delivering it in their own style and blending it with the, often 
sensitive, situation of diagnosis. It was important that the information was not given in a 
prescriptive way but adapted to each context. The mention of the SWIFT tool was not 
explained for this reason. Once again, these concepts were revisited again during the first 
phone call. Due to the nature of the impact of either a synchronous or metachronous 
presentation of liver metastases, it was expected that patients would not retain all aspects 
of telephone support, as is often demonstrated in the literature in clinical consultations 
(Kessels 2003, Nguyen 2019 et al).  
8.4.1 Valuing the telephone contact as a natural  
From the participants interviewed it was clear that the majority valued the systematic nature 
of phone contact, with 14 participants mentioning the idea of key contact at regular intervals. 
There seemed to be no doubt that patients had grasped the idea that a nurse specialist from 
the specific cancer team would be in regular contact and would feedback specific information 
discussed at the MDM at appropriate time points. 
“It was explained right at the beginning that (x) would ring and I was full 
of praise for that as I had not had experience of hospitals before. My 
recollection was the days when the Professor was god-like and 
everybody sat back and waited, whereas if you are getting a balanced 
input you should get a better outcome” (Charles)  
This quotation suggests that some of the historical context of how information was 
exchanged had changed so that the power balance of decision making had transformed for 
the better. The input from different experts at the MDM was welcomed as care became more 
complex and ensured that decisions were given with the input of a range of experts. This 
participant’s wife also drew on their previous family experience of obtaining information in 
a cancer diagnosis.  
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“Well, my parents had cancer and the difference was night and day. The 
care was all so fragmented, if a condition worsened, there was no one 
available and all the time you felt you’d fallen between the cracks. If you 
did speak to someone, they would say, that’s not our area. It was on the 
relations to try to pull the thing together. It was like walking in glue.” 
(Charles’ wife)  
This is similarly captured in Cook et al’s (2019) paper when multidisciplinary members of a 
gynaecology oncology team described their nurse specialist role as “glue for our team” (p7). 
The experience of others also conveyed how good it was to have someone there to bridge 
the gap between different areas of care.  
“I can’t say how good it was to have the phone calls. I had known up 
front she would phone at different times, but she was also there for a 
number of things. You could phone and ask about literally anything or 
check an appointment. It was like having a PA for cancer”. (Lisa) 
and 
“I had a feeling I was being very much guided through the process. I 
knew where I was standing, that I was beginning quite a long journey” 
(Ann, no op.) 
and 
“Contact with x (CNS) was great. It definitely helped me get through this 
time. I knew she was going to keep in touch at various points. Even my 
husband, if he could see something stressing me out, he would say, ‘I 
phoned x today’, so he felt comfortable giving x a ring”. (Lindsey, no op.) 
The wide range of role was also appreciated and the sense that the nurse specialist was also 
there for other family members. This could lead participants to say that they felt well 
supported and understood the role that the CNS had so much so that it became part of the 
natural. These particular patients had nothing to compare it to from a previous pathway, 
apart from their connotations about different eras or family experience of cancer. This shows 
how much previous experience and what Gadamer calls forestructure is present when 
individuals come to an experience for themselves.  
The involvement of the CNS also encouraged individuals that something was happening 




“She was keeping in touch with what was happening and she had 
regular contact on the phone to let you know what the next move would 
be. It gave me confidence that they were actually doing something 
about it which was excellent” (Daniel, no op.)  
The data itself is also affirming of the role of the CNS in general and of the importance of the 
relationship that is built over time. This is especially the case as for many being considered 
for liver resection can take place over a number of months. 
“It is essential to have someone in that role, to oversee and look out for 
you. I don’t think that communication would work well if that role didn’t 
exist” (Ruth)  
and 
“It’s been really good, someone to contact when you don’t want to 
contact doctors (Lindsey) 
and 
“She built a relationship with me and got to know me and knew how 
much information she could give me over the phone and knows that’s 
the kind of person I am that I want to have that information. It’s an 
essential relationship” (Ruth)  
As the wife of one participant points out, having someone outside of the family but with their 
own knowledge of the condition is helpful due to the amount of shielding that individuals 
take on to protect others in the family.  
“People are being brave for each other and they need someone to talk 
over the reality with, to have someone to look at and say I’m really 
scared” (Wife of Charles)  
8.4.2 Two axes of contact; access and presence  
The development of the concept of ‘presence’ in contemporary nursing can be attributed to 
the work of Patricia Benner (Benner, 1984). She coined the verb “presencing” as one of the 
eight competencies of the helping role of the nurse. The findings have shown different levels 
of presence that the CNS has. This was mainly done in two ways, by ensuring that access was 
encouraged by telephone contact and by an actual physical presence at consultations or clinic 
dates.  
In addition to the structured telephone support there was also the knowledge that people 
could contact the CNS.  
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“My CNS made sure that I knew that I could contact her at any time. I 
mean, I think, its’ brilliant.” (Karen)  
This provided reassurance and would suggest that this individual certainly felt it worthwhile 
to contact. In other situations, the CNS was contacted to fill in missing gaps.  
“When the path didn’t move, I rang x [CNS]). The expectation of 
management has been so good but I was left in no doubt that I could 
also call” (Ann, no op) 
Similarly, there was evidence that patients knew that when at the liver unit, the CNS could 
be contacted even though she was not able to be present at liver MDMs and consultations.  
“There’s continuity with the one person who has a knowledge of your 
background rather than you having to go start at base one each time, so 
you can get in contact when at the liver unit.” (Wife of Charles) 
On one occasion, a participant was alarmed when she missed a call and was left wondering 
if it was the CNS team.  
“There were supportive phone calls all the way through but someone 
phoned me on Friday and I didn’t get them and I worried about it all 
weekend.” (Susan)  
This may or may not have been the team as normally the team would leave a message but it 
characterises the importance of the calls to individuals. Rather than creating a dependency 
culture, the calls normally alleviated anxiety by keeping individuals informed. Only one 
participant preferred not to make contact on the phone as he wanted limited information 
but did express that he had allowed his wife to make contact and take calls.  
“My wife has spoken to x [CNS] and been kept to date. I don’t like to talk 
about how I’m getting on. I’m one of these people if people keep 
phoning me, I’ll not heed it, like double glazing salesman.” (Kenneth, no 
op) 
This particular participant’s informational style was respected although it was clear that his 
wife did benefit from the contact. Had there been no family who were keen for contact, this 
participant’s information preference would have been respected but the key contacts to pass 
on information updates would have been maintained. Had someone declined being kept in 
touch using telephone contact, then appointments would be arranged at consultant clinics 
to pass on information. This participant was alone in feeling like this. A similar sentiment was 
also uncovered by this participant when considering patient information. Without probing 
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further, which was not possible to do so in this interview, it was difficult to tell whether this 
participant was utilising denial as an effective or ineffective method of dealing with the 
reality of what was happening. Certainly, much information is passed on in the current 
healthcare system via the medium of phone, helping to speed up information giving, prepare 
patients in advance regarding care and increase efficiency of appointments or treatments. It 
is difficult in this climate not to incorporate the use of the telephone and indeed there is 
much scope to incorporate additional technology in patient communication and assessment.  
The additional aspect of contact was through being with individuals and their families at clinic 
consultations as the following quotations demonstrate. 
“It’s good to have somebody who knows what’s going on because 
sometimes you see different people all the time. She was on the phone 
but also would come and see us at the clinic” (Judith)  
and 
“She [CNS] has kept in touch all the way through until now. She rang to 
make sure I knew what was going on, and discussed what had been 
discussed at the regular meeting they had. She would say the next step 
is, or your case was discussed but we need further information or we are 
waiting to hear from the liver side or whatever the need was. In fact I 
saw her yesterday when I was here yesterday.” (Diane)  
and 
 “Sometimes she would be in the consultation, I don’t know how it was 
sometimes not, perhaps due to what was being said or if she was free, 
but it was great that she would be there and that you could come out 
and there was another sort of checking and verifying your understanding 
of what had been said to you, because there’s an incredible amount of 
information to take in and a lot of white noise.” (Wife of Archie)   
This verifying aspect of the CNS role after the consultation was helpful in processing 
information given during the consultations. The sense that patients were better prepared for 
clinics was also captured by both oncologists present at the focus group with one voicing the 
following. 
“My suspicion is that patients are probably better informed of the 
uncertainties whey they come to clinic, they know there are various 
options being discussed rather than coming to discuss a definite plan. I 




While the colorectal surgeon did welcome the support model, they did not see the full 
extent of the revised support since their input was often prior to much of the support 
offered.  
“Normally we see the patient in clinic and then are referring on so we 
don’t necessarily see them for a while so we probably don’t see that 
much of a difference in our clinic setting” (CRC surgeon)  
Much of the support work was hidden from the colorectal surgical colleagues, mainly being 
understood in the context of the oncology and liver setting. Indeed, much of the contact is 
by way of phone so is often hidden from what is seen by other clinical team colleagues.  
8.4.3 A holistic sense of care  
It was the intention of the SWIFT tool to guide conversation and ensure holistic assessment 
around by including the following areas in discussion, stress and coping, work/home life, 
illness, family/friends and things I like to do (see Chapter 7 section 3.1 and Appendix X). The 
aim of the tool was not to feel like it was a tick box exercise so that with skilled 
communication techniques adopted by the CNS, the use of the tool would feel more like a 
conversation. Having already established in section 8.4.1 that the telephone support was 
successful in relaying information at critical time points in the pathway, it was important to 
assess if patients felt a sense of holistic care about what was important to them in terms of 
their life cycle stage and additional commitments and priorities. Analysis of data relating to 
this area found this to be the case. One participant reflected,  
“Looking back, it was good the way she did it. She found out you had 
understood the information and it taken it on board. She was concerned 
about everyone in the house, the kids and my husband. She would often 
say ‘how does x [husband] feel about things, especially if I had difficult 
news” (Lindsey)  
 This conveyed how this patient was able to reflect, in hindsight on how they were 
encouraged to process the information given at the time and how the emphasis on care was 
for all concerned in the family. This demonstrated the use of the SWIFT tool, specifically 
relating to the section on family/friends and reflected the ethos of the Family Systems Illness 
model as discussed in Chapter 7 section 2.1. The participant in hindsight saw how honesty 
and the need to keep communication open was facilitated by the CNS among relevant family 
members who were also impacted in her diagnosis.  Judith recalled how her CNS had spent 
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time talking to their brother and sister to put their mind at rest. A further participant also 
expressed this,  
“She didn’t just look out for me but looked at everything, the whole 
family and how we were coping”. (Ann, no op.) 
This participant had previously experienced sudden infant death syndrome as an older 
mother and now had a young child. The sense of their experienced loss as a couple was great 
and this understandably fed into their concerns about Ann proceeding to liver resection.  
Attention was also extended to issues of work also as one participant recounted.  
“She was interested in all aspects of how cancer affected us, and how I 
was getting on returning to work with managing family life” (Ruth)   
Here this participant was able to comment on how well supported she felt amid returning to 
work while balancing young family life.  This holistic sense of care went beyond the illness 
alone as shown in section 8 as the CNS nursing belief echoed Wright et al’s (1996) sentiment 
that illness is a family affair.  
Being able to pinpoint potential issues of stress and help to identify coping strategies was 
also realised. 
“x (CNS) has been absolutely tremendous. She phones me and my 
partner back and forth to see how we’re doing. She understands and she 
gets to the bottom of what’s bothering me. She’s really fabulous. 
Although she wasn’t working with the other hospital, she was keeping us 
informed.” (Mark) 
While the conveying of information concerned with liver resection was maintained, this 
participant also valued the fact that the CNS was able to extract out the emotional concerns 
when perhaps the participant did not fully realise what these were. This may come from the 
foreknowledge of the liver resection pathway on the CNS part and also the combination of 
the CNS’s ability to use advanced communication skills to assess each patient individually. As 
such, this quotation also shows that they were aware the CNS was bridging the gap between 
the liver unit and the referring hospital. This in itself was reassuring since this was part of the 
original intention of the study. Patients appeared to feel that they were treated personally 
throughout a complex process.  
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“My CNS kept in touch and said that anytime she was at the end of the 
phone. It made me think somebody is caring, you’re not just a number 
going through a conveyor belt.” (Michael) 
Overall there was the sense that the telephone support enabled individuals to talk about the 
cancer.  
“Cancer is such a big scary word which has been the bogie man let out of 
the cupboard you know. The fact is that if you have problems you want 
to speak to someone about it who is involved in your treatment. It takes 
a lot of the stress away. It’s been good to have the telephone support to 
do this.” (Archie) 
The combination of the CNS knowing the reality of the disease and building a relationship 
with the patients allowed individuals to speak more openly when perhaps they could not 
always do so to others closer to them. Other participants had reiterated this understanding 
also, knowing that the support they had provided had been central to helping them through 
this period, with one saying,  
“Oh I doubt I would be here if it wasn’t for them (CNS team). To be 
honest, I can’t get over them, they were fantastic. They looked at all 
aspects of how the cancer affected me.” (Hamish)  
It appears that the SWIFT tool enabled the CNSs to ensure a holistic approach to patient 
assessment surrounding illness, friends and family, work, stress and coping and patient 
priorities. Discussion at the focus group found the tool to be particularly useful by the CNS 
who used the tool and carried out the majority of the telephone assessments.  
“The tool is also straight forward without being prescriptive. It helps to 
explore information with the patient whilst building a good picture of 
their home and health situation.” (Colorectal CNS no.1) 
and 
“There was always the fear that we had missed something before and 
were maybe taking different approaches. This way the tool standardises 
and formalises what we need to know and ask. It does help the 
telephone support with patients as it starts to establish the relationship 
we have with patients. I hope this in turn means that they can feel more 
comfortable and open in further contacts we have with them”. 
(Colorectal CNS no.2) 
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In addition, there was also the recognition that using a standardised tool was beneficial for 
new members coming into the team in order to give a structure and prompts for more 
complex patient assessment.  Both CNSs voiced this with one adding,  
“It has been very helpful having a specific tool that we can all use so that 
we are all covering the same relevant issues with patients. This is 
especially pertinent when we have new staff coming into the team” 
(Colorectal CNS no.2)  
8.4.4 Attributes valued by patients 
While not the intent of the study, it was apparent that the supportive contact provided 
through the structured telephone model and through presence at clinics, highlighted certain 
attributes of the nurse specialists involved which were valuable to patients and their families. 
Looking at these in more detail enabled me to see that these enhanced and gave further 
value to the telephone intervention.  
Listening was recognised as a significant process that was active in nature. This was bound 
up with the concept of access in section 4.2 of this chapter and as highlighted in the following 
quotation.  
“For a kick-off, she listens to you, she does listen and she’s got that 
calming way of talking to you. You phone her anytime. I phoned her at 
the back of six one night and she phoned back” (Judith)  
This quotation highlights several insights, Firstly, through listening the CNS helped to bring 
calm to a period of uncertainty experienced through consideration for liver resection. This 
listening involves entering into the world of another and trying to understand a frame of 
reference different from their own, which forms the basis of hermeneutic listening (Kimball 
& Garrison 1996).  The CNS listens to that individual understanding that they go through their 
unique experience but they also listen with a sense of fore-knowledge having known the 
pathway as experienced by others. One participant noted that the CNS had an attentiveness 
which was low key and not intrusive which complemented how the CNS listened. Secondly, 
the tone of voice being mentioned to as ‘calming’ also added to gaining a sense of control 
over a situation that is out with each individual’s overall control. In fact, the tone of voice 
was also mentioned by others,  
 “She had a positive voice and gave positive messages despite 




“She is a very clear speaker and is not a fast speaker so you can take it 
all in, which is ideal when they are trying to explain it to you” (Timothy, 
no op.)  
These extracts highlight the importance of tone and clarity in speaking that help to take some 
of the franticness away from the individual health experience. This leads into the concept of 
containment. While uncertainty keeps possibility open, it cannot provide confinement to a 
situation. Lack of containment can lead to a sense of overwhelming. It is the foreknowledge 
that a CNS has developed from her experience with the pathway, that helps to contain the 
events for the individual. Finally, the first quotation also highlighted the accessibility beyond 
normal working hours in that the CNS was often ringing later than expected. Two other 
participants had also commented on this level of dedication, noting that they were often 
surprised that the CNS returned a call out of working hours.  
While attentiveness towards the needs of the participants is a valued attribute of the CNS 
role, it can come at a price for the CNS. The nature of workload may mean that it is not so 
easily contained for the CNS within the boundaries of normal working hours. This additionally 
is a consideration on how the CNS ensures the emotional nature of involvement and 
workload is kept in balance in order to prevent against workplace burnout.  
Familiarity was also identified an important feature which was only possible through 
ongoing relationship with the CNS. This ability to put at ease was an important part of 
getting to know the CNS but it also was important for trust as the relationship continued.  
One participant noted,  
“It’s as if you knew her all your life” (Lisa) 
Several participants had known their CNS since their primary bowel surgery and this sense 
of knowing made them feel secure that the CNS would help them address future issues as 
they had experience of them having done so before.  
 
Finally, the language used to describe the CNSs revealed them to have an enabling role which 
was valued.  This enabling worked both ways, in seeking to help patients directly with 
concerns but also in enabling individuals to live well during the process of waiting. Two nouns 
were used by one participant and his wife revealing the enabling nature of the CNS.  
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“You know, she was like a little butterfly settling on his shoulder, really” 
(Wife of Charles) 
and 
“She was like the glue to the whole thing” (Charles)   
Both of these words powerfully describe the value of the CNS role. The use of the word 
‘butterfly’ was used to describe the CNS being present at times when needed and the noun 
‘glue’ suggests an element that helps a process cohere together.  Other participants spoke of 
being ‘carried along’ (Diane) or of having a ‘comforting presence’ (Janice) all the way through. 
These attributes mentioned seemed to contribute to the telephone model and contact being 
of additional benefit to the patients who were being considered for liver resection.  
Overall, there was a good level of evidence that the use of the telephone model worked with 
individuals who were hopefully looking forward to liver resection. This could be cross 
referenced with sub-ordinate theme 1.2.1 - looking forward to the possibilities in medicine. 
There was also evidence that they could deliver reliable information to provide more 
certainty which could be cross referenced with super-ordinate theme 2.2 – reliable 
information: a remedy for uncertainty and with helping to deal with treatment, related sub-
ordinate theme, 1.2.3 – treating with curative intent means an active wait. The CNS acted as 
a companion throughout this period and a holistic or integrative approach also allowed 
individuals to understand their health situation in line with personal situations. This was in 
line with theme 3 – a journey of personal understanding; an individual horizon in which sub 
themes of understanding looks forward (3.1.1) what matters most (3.2.1) and keeping hope 
alive (3.2.2) were most pertinent.  
8.5 The leaflet series 
The development and patient review of the liver metastases leaflet series is detailed in 
Chapter 7 section 4. It was well received. All patients who proceeded to liver resection were 
given the three leaflets throughout the duration of being considered for liver surgery. The 
second and third one, about surgery and recovery respectively, were only given to patients 
for whom a certain decision had been made about liver surgery. For this reason, the four who 
did not proceed to liver resection only received the first leaflet, explaining the process of 
being considered for CRLM resection.  Only two participants did not recall seeing any of them. 
These were both individuals who did not proceed to liver resection. The reasons for this was 
cited due to personal information style although he did understand that his wife had taken 
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the first leaflet and read it (Kenneth, no op.). The second could not remember getting the 
first leaflet as he always knew his position in getting to liver resection was not secure, saying, 
“I’m not aware of it. I may have got it but maybe I didn’t because it was 
uncertain I was getting the liver operation.” (Timothy, no op.) 
There were only two participants who were ambivalent about the purpose that the leaflets 
played for them for different reasons. The first had felt that she knew most of the information 
from the oncology and surgical consultations. The leaflets were designed to complement the 
consultations and in particular the first one was designed as a bridging gap before the initial 
liver consultation. There was one thing that she did learn from the leaflets that she could not 
recall learning elsewhere, commenting,  
“I do remember reading in the leaflet that the surgery could be cancelled 
if there was an emergency and I thought that would be awful, but most 
things were explained to me either in consultation or over the phone so I 
didn’t pay a lot of attention to the leaflets.” (Karen)  
This was a key item that was gleaned from the interviews with participants in Phase 1 of the 
study whereby better preparation that cancellation for liver surgery was necessary for liver 
transplants.  The other participant who did not find benefit in the first leaflet was directly 
related to his preferred method of delivering information. He was not able to proceed to liver 
resection. He was aware of the uncertainty over getting to liver resection and hence he 
adopted a more cautious approach in taking on too much information in case it unnecessarily 
had an unhelpful effect. 
“Yes, but I had been quite reticent about the liver that I didn’t take too 
much from the leaflet. I was taking it a stage at a time” (Kenneth, no 
op.) 
8.5.1 Written information and the reinforcing of expectations 
Feedback from the nursing representation during the focus group commented on how useful 
it was to have the leaflet series and how patients had commented on their value.  
“a high number of patients commented on the written information and 
they do find them really helpful” (Colorectal CNS no.2) 
The first leaflet aimed to set out what was entailed in the consideration and workup to 
possible liver surgery. The information in this liver leaflet, in particular, was welcomed and 
clearly remembered as the following comments suggest.  
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“The first liver op leaflet was really helpful because it sets out the 
process of what is involved” (Lisa) 
 “I thought the leaflets were excellent. They were very good, they 
covered everything and made me realise what the whole process was 
about.” (Ruth)  
“Yes, I remember the leaflets. They were useful, especially the first one 
which told you about the workup.” (Wife of Charles)   
“I got the leaflets and they were helpful, my CNS gave or posted to me at 
different times, one about what would happen, the surgery and the 
recovery” (Michael)  
The quotations emphasise how the first leaflet conveyed the totality of the process involved 
in arriving at a decision for liver resection and gave the sense that this was not a quick 
decision. The words used, ‘process’ and ‘workup’ suggest that often a number of elements 
have to come together and knowing this was helpful in reinforcing expectations already set 
out verbally through consultations or via telephone contact. This written information helps 
to layer up this concept of process and also acts to provide continuity across the service as 
evidenced by the following participant. 
“Everything happened exactly as it said in the first leaflet. I came away 
from the liver consultation and thought, everything was discussed like 
the leaflet said.” (Michael) 
This aspect of preparation was encouraging. Where there is potentially so much information 
to take on board across the pathway then relying on verbal information alone from a 
consultation may not be sufficient.  This also touches on the ability of written information to 
marry up information from different health professionals encountered. That could be done 
for those participants and also their families who may not have been present at 
consultations. The above quotation from Charles’ wife  highlights how family were able to 
benefit from the information which was shared as does the following, 
“I found the leaflets very clear. They helped my daughter understand 
what was going on too.” (Archie)  
This has a benefit in bringing in additional family members or relevant others to an 
understanding of the process and can therefore pick up on aspects that are easier to overlook 
by the patient due to the process of anxiety. This is similar to the calming effect of having a 
friend or family member in the clinic consultation as evidenced by Esther in Phase 1, who 
although she did not proceed to liver resection, the presence of her friend in the consultation 
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helped to allay fears and lead her to a more hopeful state of mind. Even if the overall end 
process was not one of liver resection for this early participant in Phase 1, the important 
aspect was keeping hope evident. The overall outcome of course, is only known as time 
passes. Additionally, having the leaflets made the process more concrete or real as one 
participant disclosed, 
“The fact that they were there made me realise people go through this 
so that was encouraging.” (Lindsey)  
This was particularly in the face of seeking information online and either retrieving 
information that was not applicable or was focused on survival statistics which then became 
alarming. It may be that information that was locally relevant also made for a more reliable 
sense of trust.  A number of previous participants in Phase 1 had voiced that it was hard to 
find reliable information that related specifically to their pathway. As is evident through this 
thesis, there is not one typical pathway to liver resection but providing local information 
about the pathway process between the two hospitals involved, surgery and recovery is likely 
to provide reassurance and a sense of confidence in local care teams.  
8.5.2 Providing continuity with the CNS role 
The information series had a complementary role to the CNS as described through 8.3 and 
as evidenced in Chapter 6, section 6 in Phase 1. The provision of the information series 
allowed the nurse specialist to work with material, adding information at appropriate 
timepoints in line with how events unfolded at timepoints in decision making.  
“x [CNS] gave me these leaflets for when bowel cancer spreads to the 
liver, surgery and recovery. There were three of them and I got them at 
different times.” (Mark) 
and 
“as well as keeping in touch, she sent me information, I got leaflets 
about liver surgery and bowel cancer, there’s three leaflets. She would 
have sent me more information if I’d wanted.” (Diane) 
 
To do this ensured that the CNS was able to know at which points patients were in the 
pathways which is often time consuming. Working closely with the CNS in the liver unit also 
allowed for co-ordination of this but this may not always easy to do in the midst of other 
clinical commitments and as additional pathways for more complex treatment develop. As 
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seen in Chapter 6, oncology was seen as the place of safe keeping for patients who were 
receiving treatment (2.1.1) so having a presence at oncology clinics became an important 
aspect as evidenced in section 8.4. The MDM could still be used as a method of facilitating 
contact with patients but the additional contact could not be maintained through oncology 
clinics. It is for these patients particularly that access to CNS may be lacking.   
Two patients commented on how the leaflets had addressed specific queries which had been 
beneficial to them. 
 “I asked a question, I can’t remember what is was and x (CNS) answered 
it on the phone but she also sent me leaflets which again answered the 
very question I had asked but I thought, isn’t that amazing you know, 
that she had taken note and posted the information out to me.” (Susan)  
and 
“I thought they were a lot of help, especially when it came to the mood 
swings, I didn’t think I was doing that until I read it.” (Charles) 
Susan seemed to pass surprise that the CNS would almost go out if her way by posting the 
leaflets suggests that the she did not realise that this was part of the normal course of events 
but that they were sent because of something relevant to them. The second participant 
reveals how information about potential low mood post-surgery helped to give a sense of 
authenticity to what he was himself experiencing. In turn this helped to broach discussion 
with his wife who had noticed but had found it difficult to bring up in conversation. The 
provision of information in the leaflet series enabled a large amount of information to be 
given and the reality is that some aspects might prove more relevant to others. The important 
aspect here was that the development of the series added further choice as to how 
information was received, by a method that complemented the CNS role. Feedback from the 
focus group, supported this advantage,  
“I think the written information is incredible. I think ultimately it’s part of 
the key to CNS continuity and support.” (Oncologist no.2) 
8.5.3 Additional considerations 
Only two people commented on additional information that would have been valued at the 
time of recovery post liver resection. The first commented on requiring further information 
on wound care and the second on requiring nutritional information to improve healing.  
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“I thought the leaflets were excellent. They were very good, they covered 
everything. The only thing would have been good was advice to keep 
wound dry because I struggled with the wound after discharge”. (Ruth)   
and 
“I could have benefitted from more nutritional information post liver 
surgery when you consider how important food is for healing” (Karen) 
Certainly, it was difficult to keep the information concise without becoming overwhelming 
to read. Key contact numbers for further information were provided by both CNS teams and 
encouraged to use.  
Perhaps the most major consideration from feedback on the leaflets was based around the 
differing needs of people for information and prompts questions over how much we engage 
with individuals on their preferred method of information. One participant who valued the 
information would have preferred to have all three leaflets together.  
 “To say here is all the information, if you want it that’s where you find 
it… some people do want to overload with information and it also allows 
choice but you don’t have to read it.” (Lisa)  
The element of information choice is vital in allowing people to have control (Tran et al 2019) 
especially in circumstances that are beyond their control, yet this quotation is perceptive on 
behalf of the individual in that they know while they themselves have a high drive for 
information, others may feel overwhelmed by too much information rather than comforted 
or in control. In reality, choice may mean something very different to different people. It is 
also interesting, as it is given in hindsight when this participant had the liver resection. At the 
time the first leaflet was given, there was no knowledge that they would proceed to surgery. 
The decision was made at the time to only give the first leaflet out when patients were 
definitely considered for liver surgery. The other leaflets were only given if the decision was 
made to proceed to liver resection. Deciding not to give all the leaflets at one time was taken 
as a decision to protect patient emotions and raise an unrealistic sense of hope, with 
information that was not relevant at that time. It is here that the sense of pre-knowledge or 
forestructure comes into play as this particular patient was thinking of what may have been 
relevant for her without realising the complexity and diversity of patients on the pathway for 
liver resection. This participant was different from the other participants who did not 
mention wishing they had the leaflets at the same time. This may be explained by differing 
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information needs or may reflect the need of patients to take have a ‘one step at a time’ 
approach, realising that not all information may be relevant for them.  
On the whole, the leaflets were welcomed by health professionals and patients alike. Their 
use helped to aid the CNS role in managing uncertainty and containing expectation and 
specifically in providing more trustworthy local information, than what might be harder to 
find online. This can be clearly cross referenced with super-ordinate theme 2.2 – reliable 
information: a remedy for uncertainty.  
8.6 The buddy service  
The implementation of the buddy service was set out in Chapter 7 in response to the findings 
in Phase 1 where over half of participants voiced they would have found it useful to speak to 
someone having gone through the same experience and seven participants offered to speak 
to someone in the future if it would be of any help. The main aim of the service was to 
connect people with similar experiences being considered for liver resection with those who 
had already had the resection. All the five buddies who had undergone training were disease 
free after resection and continued in follow-up.  All 16 participants were offered a buddy 
early in the process of consideration and the leaflet series also reinforced the idea of the 
buddy service.  
Perhaps one of the most surprising findings from the buddy intervention was that no one 
actually took up the offer of meeting with a buddy at any point in the process. This appears 
surprising given that half of the participants in Phase 1 had voiced a desire to do so believing 
it would have helped, particularly to alleviate the feeling of isolation experienced in that they 
felt they were the only ones going through the workup for CRLM resection. It is clear that 
there is much to learn from this and that the process of reflection or what we commonly 
refer to as hindsight, varies hugely from going through the process of consideration for liver 
resection in real time. The reasons for this and future applications for consideration are 
explored further in Chapter 9. For now, reviewing some of the reasons why the buddy service 
was not taken up, may be helpful in understanding the lack of engagement.  
Two participants could not recall being offered a buddy. It is both fascinating and important 
as health professionals to realise how memory and a priority of recall operates for different 
patients who will all receive the same information. At the time of receiving information, 
participants may have a common understanding in its receipt but on recall may have different 
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opinions of what information was shared. Both of these participants did not proceed to liver 
resection (Kenneth and Greg) and therefore did not receive all the liver leaflet series, which 
helped to reinforce the buddy service.  Both had recounted not engaging with the first leaflet 
as there was too much uncertainty over their particular route to surgery, preferring to be 
guided by medical staff. Both of their responses mirrored the two types of responses that 
were reflected in the group as a whole, those very definitely opposed to meeting a buddy 
and those who said they may consider it again. The first stated that even if he had 
remembered being offered it, would not have helped. 
“No, on a personal basis, no. It’s just the way I do things. Just the way 
I’ve been brought up, still upper lip and all that. It wouldn’t help me.” 
(Kenneth, no op.) 
The second participant, on hearing it was a possibility, did not rule out the possibility that it 
might be useful in the future, while at the same time remaining non-committal about the 
need to do so.  
“I wasn’t sure it was offered. I just kind of get on with it but I might 
consider that one, I could again.” (Timothy, no op.)  
Curiously, he also added at the end of his interview, that if he could be of any help to anyone 
in the future from his experience, then to get back in touch. There seemed to be a genuine 
willingness to help others and give back something, as evidenced in the Phase 1 participants 
but a reluctance to interact with others as the receiver of information.   
8.6.1 Fear of negativity 
There were a further ten people who were clear they would not have found contact useful, 
with fear of carrying forward negativity, being rated amongst the reasons.  
 “I think some people aren’t as positive as I like to be in this situation and 
I didn’t need that”. (Lisa) 
“It was one of those things I was aware of and I thought do I need to 
know about someone else’s experience and I thought, I don’t think so.” 
(Archie) 
“I didn’t want to take on other people’s concerns.” (Hamish) 
 “I could have spoken to another patient, but then again, I thought if 
knew what was ahead, I’m better not knowing.” (Judith)  
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There was a personal awareness among these participants of the uncertainty in the pathway 
for them as individuals and taking on the journey that someone else had with their own set 
of particular concerns may have led to more negative thinking. If anything from Phase 1 and 
Phase 2 the need to maintain hope was paramount in working through the process of 
consideration and managing the wait for liver surgery that patients could not afford to imbibe 
possible negativity. This could be understandably overwhelming and restrictive in how 
individuals encountered each step in the way. The quotation from Judith, highlights this step 
by step approach of not reading too far into the future, certainly an approach that has been 
utilised in the support offered by the CNS team and during the telephone intervention. 
Interestingly, three of these participants were among others to offer to help to speak to other 
patients if needed in the future. Perhaps those who offer to buddy think they will be good 
because of their experience but at the time of their own experience they were not convinced 
that anyone will be able to speak appropriately to their situation.   
8.6.2 Personal experiences of negativity 
One patient was clear that he did not want to be put in contact with a buddy due to a previous 
encounter with a patient during his primary surgery. He had complex pelvic surgery involving 
removal of bowel primary and formation of urostomy and ileostomy. At the time he 
remembers being keen to speak to someone else before the surgery since his surgery and 
the impact on his life was to be so radical. He remembers organising this through his nurse 
specialist but the conversation did not benefit him. He recounts,  
“I phoned up him and he was all doom and gloom and he said ‘maybe 
we can meet up for a cup of tea.’ I said ‘maybe I’ll ring you back,’ but 
after that I had no intention of meeting. I was all doom and gloom. It 
was the down side of it all. I was wanting someone to be a wee bit more 
perky about it all. He depressed me. I thought I’ll have to delete his 
number.” (Mark)  
This rather amusingly told situation, unpacks a lot of important detail about patient one to 
one support. The participant rang the previous patient at a time that was convenient, giving 
them control of a situation that could involve some anxiety. His focus and desire was on 
hearing a positive story that while this was life changing surgery, the previous patient was 
regaining normality and mastering life. The reality the participant heard was very different 
so much so that he had to skilfully extract himself from the conversation, having shut down 
the possibility of further meeting in his head, while being polite at the same time. The 
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conversation was so negative that he felt he could not maintain contact. This experience 
meant that the participant did not want to meet a buddy again, fearing carrying yet more 
negativity into a situation that required a brighter or more ‘perky’ outlook.  
“After that, I wasn’t wanting to speak to anyone who didn’t know what 
they were talking about from a  health professional so I just kept in 
touch with x [CNS]” (Mark)  
For this reason, maintaining support with his CNS (who incidentally was the same CNS he had 
contact with for his primary surgery) was important to him and being guided by the medical 
team. The professional support who were able to draw from a range of observed experiences 
was deemed more supportive and affirming.  
8.6.3 Too many variations in experiences 
For others, the idea that an experience from another patient could fit into their own 
experience was seen as unlikely, as there were too many variations in the process leading to 
liver resection.  
“It’s very much an individual consideration, for me it wasn’t high on the 
list. One of the things that has become clearer is how individual people 
are, treatment has to be customised to you because you could react in a 
completely different way from the person who has just had it before. 
Whilst it is helpful to be aware of somebody else’s experience, its not 
necessarily relevant because there are so many permutations out there 
that could come together” (Ruth)  
and 
“No, not for me, I can understand why other people would want to but I 
can only talk about my experience and that involves breast cancer too. 
For me talking to someone else would not have been helpful.” (Diane)  
Ruth benefited from the targeted therapy Cetuximab (only suitable with k-Ras wild-type 
mutation) and was aware that her pathway to resection was likely to be different from many 
others. The advert of targeted therapies and tailoring individual plans does mean that 
pathways are often different for patients with the same cancer type and as outlined in 
Chapter 2, there are many presentations of both synchronous and metachronous liver 
metastases, complicating pathways further. Diane felt that her previous breast cancer could 
not be extrapolated out from her colorectal experience and that both were unique to her, 
that the one could not be considered without the other. Perhaps in this situation, she may 
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have felt that she was putting the additional burden of computing another cancer onto 
someone else and that this may not have been helpful.  
8.6.3 Family and friends’ support  
The last finding that prevented individuals from making contact with a buddy was the security 
that individuals felt within their own family and friendship circle. Whilst it is recognised that 
not everyone has such social networks or equally wants to have support from existing 
networks, the source of family and peer support has already been evidenced earlier in this 
chapter and in Chapter 6.  Two individuals cited family directly with providing adequate 
support.  
“I didn’t consider meeting someone else. To be honest, I have good 
family and friend support. That was enough for me. I have a good 
relationship with my family.” (Ruth) 
and 
 “The truth was when I went to the hospital, I just wanted to get back 
home. I could imagine, if I didn’t get to my allotment and wasn’t able to 
walk my dog, I could imagine meeting with others so I could speak to 
someone” (Susan) 
The last participant reveals how much the things of home bring comfort and normality, a 
stark constant with time spent at the hospital. For those who have undergone primary 
surgery and then develop a metachronous liver metastases during follow-up, there can seem 
no break to hospital consultations and imaging, interrupting the normality of life. 
Interestingly, this participant thought that meeting others, “sounded like something for 
comfort and diversion”, while distinctively, she mentioned activities that she did alone 
provided her with the comfort and diversion that she needed. Comfort and diversion in 
themselves form a necessary part in maintaining the normality of life for individuals and 
hence in maintaining hope. What might be comforting and divertive for one individual may 
not be the case for another. This is especially important when considering introducing the 
concept of the patient buddy.  
8.6.4 The notion of ‘on reflection’ and ‘hindsight’   
The remainder of participants on reflection considered that it may have been something that 
could have been helpful although it appeared that they could not consider it at the time or 
certainly not before the surgery.  
233 
 
“Maybe I should have met someone but I think I had too much to think 
about. I just wanted to have my treatment” (Michael) 
The words from this participant, who later went on to the buddy group evening four months 
post liver surgery, reveal how all-consuming the process of having surgery was. It was too 
overwhelming to think about meeting others. The fact that when a further opportunity was 
offered to meet as part of a group, she accepted, showed how the interest to do so was there 
but the timing had to be right either to meet individually or in a group. A further participant 
also echoed this sentiment of time being an important factor.  
“I could not take it on as there wasn’t time to process meeting someone 
but in hindsight, I think I would have benefitted from meeting with 
someone afterwards. There are a lot of things that you’re not sure 
about because you’ve never experienced it so you don’t know what is 
normal. It would be good to see now how people are getting on.” 
(Karen) 
My dual role as both researcher and professional insider, meant that I felt I needed to 
mention this to the nurse specialist team so that further opportunities to explore potential 
support should still be offered. The participant consented to me doing so but in the end 
decided not to take it further. What matters here is access to options and choice not 
particular uptake. It also highlights the contemplative nature of hindsight. Voicing ‘it might 
have been helpful’ or ‘I could have’ is very different to actively seeking out that support when 
offered. The following quotations show this from two participants who voiced a 
contemplative nebulousness about what they could have done but didn’t.  
“It may have been helpful, but I didn’t at the time. I just want at the time 
to know that I hadn’t fallen out of things” (Janice) 
and 
“I did meet people in chemo unit, we were going through maybe not 
same thing but similar so I was happy with that level. Maybe it would 
have been useful to speak to someone who was in a very similar 
situation…” (Ann, no op.) 
Kenneth who was not able to proceed with an operation, found adequate levels of support 
from other cancer patients during treatment times, a similar concept to networks in section 
8.13.3.  He also revealed that,  
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 “I think it would have helped to have spoken to someone who had gone 
through a similar experience but I think I was partly in denial and if I 
spoke to someone, well that’s quite a big step.” (Kenneth, no op.) 
Taking formal steps to voice what is happening can be frightening and is a part of a dual 
narrative that is often evident in individuals whose illness is palliative, a concept that is 
discussed in Chapter 9.  
8.6.5 Buddy group evening, Maggie’s Centre 
While it was recognised that a buddy meeting in a group setting was not part of the original 
intervention, it does represent an interesting diversification of the intended one to one 
buddy system. All of the twelve participants in Phase 2 who had undergone liver resection 
were invited to take attend the evening by their nurse specialist. Of these potential twelve, 
five had shown interest but on the evening two were able to attend, one with their spouse. 
Four of the original trained buddies were able to attend the evening. Two of the participants 
and one spouse picked up on the impact of the evening during the patient interviews. The 
overall sense of the evening was one of encouragement. However, it highlighted a dualistic 
aspect of the concept of a buddy, indicated in the previous section, exposing both 
encouraging and jarring emotions.  
The security of the environment and the company of the others in attendance allowed for 
participants to feel safe as evidenced by the following words. 
“It was encouraging to meet other people who had the liver surgery 
many years ago. It felt a safe place to ask questions.” (Michael)  
and  
 “The evening was very useful. I think the fact that we all had this 
commonality of the same cancer it was good to have this discussion and 
share our experiences. I don’t think I could have handled it before. I was 
full of questions before.” (Archie)  
All buddy representatives had met each other before during the buddy training so knew of 
each other’s particular cancer story. At the time, all of them remained in follow-up from liver 
resection.  This in itself was seen as encouraging by the participants equating this with no 
current disease recurrence.  Archie’s wife also stated, 
“It was good to see everyone looking so well” (Wife of Archie) 
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Looking healthy was seen as a hopeful sign of recovery and moving on from the process of 
liver surgery. Although, this is interesting in itself, because it is known that even with the 
presence of metastatic disease, individuals can look very well and culturally we can tend to 
place much emphasis on equating appearance with health.  This is something which is 
evidenced from patients whom I meet with outside of this study, frequently commenting 
about the frustrations of receiving well-meaning comments from family and friends about 
how well they look when in reality their life may be very limited.  
An important aspect of this meeting together was the function of safety, with one 
participant commenting,  
 “There were about six of us and I was the youngest and I thought, they 
all seem older but we’ve all had the same kind of cancer. It was 
interesting because I could talk and say what I felt and how I went to 
pieces” (Michael)  
Despite being somewhat younger than the other group members, it could be seen that 
cancer acts as levelling the playing field. What unified them was, the same cancer and that 
everyone had shared an experience relating to this cancer type. Another aspect of this 
unifying was that it provided safety in being able to reflect back through the worst of 
emotions and share them. This is something which both earlier in this chapter and in Chapter 
6 was apparent that could be difficult to do with family. In some ways, there was no one to 
hurt and protect in this situation, unlike the complex protective mechanisms that can often 
make it difficult for family to open with.  
The one nurse specialist who attended this buddy evening had also commented in the focus 
group, where she saw encouraging interactions from those in attendance.  
“For myself, as a nurse specialist, going to the buddy support meeting at 
Maggie’s helped me see how isolated patients feel at times. It was a real 
eye opener to sit with them. The whole study is working to give the 
correct information, in the right amount at the right time, helping to 
make a big difference to how individuals then carry on with everything 
else that happens.” (Colorectal CNS)  
It helped to hear about isolation at first hand. This was particularly the case, when the team 
have often been sceptical of buddy interactions which was driven from an over paternalistic 
sense of how to protect patients if they had negative encounters with another patient.   
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Yet despite this, the concept of jarring emotions which are often unexpected do arise, which 
denotes something of the dualistic nature of the benefit of such groups with one participant 
being struck that he had learnt that one of the patient buddies had liver surgery three times. 
This was something which he returned to during the interview which showed how difficult it 
was to clear this aspect from his thinking.   
“I thought it was a very good thing. The only thing I found scary was the 
guy sitting next to me on my right, had surgery three times. You know 
when somebody says something and this explosion goes off in your head 
and you think boy, what did I hear, three times!” (Archie)  
To hear this did cause jarring emotions and raised the possibility again of recurrence. At no 
time, did he mention that there was any positive message attached to each time the disease 
was removed, which a different individual may have picked up on. To face recurrence and 
three liver resections was almost something he could not get past perhaps because this was 
the first time he had learned it was possible and he had implied that going through the liver 
resection once had been an ordeal the first time. He later voiced that hearing it made him 
think he couldn’t go through the liver resection again.  Interestingly, his wife did not hear 
‘three times’ and did not pick up on any of the negativity that can sometimes happen from 
group interaction. It may be that while being aware of it at the time, that she did not recall it 
as she took hope from the possibility of further resections or that she genuinely did not hear 
during the group. Perhaps seeing those who had gone before in the same operation and were 
still alive was positively colouring how she took on information that night. This clearly 
demonstrates how being in the same room and hearing different things can occur. One 
participated through the knowledge and reference point of being a patient and the other 
through the support of a family member. Any potential recurrence or possible liver resections 
would ask for different things from each involved.  
Meeting with others can be valuable to maintain hope but equally it can destroy hope, 
something which when considering liver resection, participants have felt is critical to 
maintain.  Overall, the use of the buddy and buddy support evening as in intervention in this 
study has raised more questions as to how and when we use this external peer model of 
support. This is further explored in Chapter 9. The existence of the buddy service, whether 
accessed or not, allowed for an element of choice of interaction. This was especially 
important in treatment where there was no overall choice of management (sub-ordinate 
theme 1.2.2 – acknowledging: there is no choice). For those who did encounter the 
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individuals acting as buddies at the patient evening, there was evidence that the context of 
knowing a similar situation allowed for exploration of the diagnosis. This was relevant to 
super-ordinate theme 1.1 – travelling with the backdrop of diagnosis. Equally this was 
relevant to the major theme number 3 – a journey of personal understanding: an individual 
horizon. Interestingly and again, as in Phase 1, a number of participants offered to meet with 
others going the same situation if that would be helpful. This reflected the sense of gratitude 
for having undergone liver resection or being well to want to give back which was identified 
in sub-ordinate theme 3.1.2 – gratitude gives back.  
8.7 Additional gaps in service; closing the loop 
Part of the commitment to determining change, is also identifying further gaps as the service 
evolves and pulling out aspects where further change could improve. This is especially 
important in pathways which are prone to change due to being responsive as new ideas and 
research emerge about how best to treat the disease. This is also reflective of the study 
methodology chosen and the role that Gadamer’s fusion of horizons has played in the study. 
Closing the hermeneutic circle of learning is ongoing in that the evaluation can yield further 
aspects that were not part of the original aim of the study but yet are crucial to the patient 
experience. The following aspects were identified that had particular bearing for patients 
across the spectrum of being considered for liver resection; early intervention from the nurse 
specialist team, expansion of the role of the CNS at the liver site, correspondence of 
consultations and the structure of the MDM.  
8.7.1 Early intervention from the nurse specialist team 
One aspect that arose highlighted a process that could be improved early on in the process 
of diagnosis. This was trying to bridge the communication silence between investigation and 
seeing the initial consultant surgeon, especially after colonoscopy and during staging 
investigations. Although as health professionals, we may not strictly see this related to the 
liver resection process, on reflection for four participants it was all wrapped up in the overall 
diagnosis. This was the case for these four participants who were also diagnosed with 
synchronous liver metastases as these quotations demonstrate from two participants.  
“It was three or four weeks before I saw him [consultant] so it was 
actually extremely quick and I know it was extremely quick but the 
problem was that I did not know anything, nobody had told me anything 




“It’s like a lifetime, one day is a lifetime at that point when you are 
waiting, so I know in retrospect it was dealt with very quickly but it 
didn’t, it feet like it.” (Judith) 
and 
“for example if the nurse comes into play earlier, who could literally say, 
or somebody, somebody just say, you’re not going to hear anything else 
until after the scan.” (Lisa) 
As expounded in chapter 6, waiting was a prominent feature of being considered for liver 
resection. Seeing the difference that a nurse specialist could make throughout this process 
meant that individuals could see that early contact by a nurse specialist in the initial period 
of waiting for confirmation of diagnosis could also be beneficial. Early contact can prove 
challenging without confirmation of histology at risk of wrongly confirming a diagnosis but 
perhaps there is an earlier role to be deployed here which may help to set out expectations 
of the initial wait to management plan, particularly when endoscopic investigation suggests 
a cancer. Additionally, earlier contact would also mean adequate resourcing to set aside time 
to make earlier introductions across all referring sites.  
8.7.2 Expansion of CNS role at liver site  
For some, the development of the liver CNS would have been welcomed, especially those 
who had a more complex pathway to liver resection or those who had difficulty post-
operatively like the following participant, who experienced post-operative pain.  
 “I would have liked the equivalent of the colorectal nurse at the RIE. I 
would have found that really helpful. Probably she is overworked  but it 
wasn’t easy to get her” (Lisa) 
The reason the colorectal CNS team primarily carried out the intervention described in 
Chapter 7 was due to the different evolution of the role of the liver CNS and the realisation 
that they would not be able to do this due to time allocation with other aspects of the role. 
In some ways, the colorectal CNS team bridged the gap. Since the study was undertaken 
further resource allocation has been made for an additional role within the liver team. This 
may mean that additional support may be developed for patients on the liver resection 
pathway. This is particularly applicable when some patients feel like the liver team are 
waiting in the wings and there is no name or contact of those involved as Lisa also indicated.  
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“I would have preferred to have some contact with the liver people or at 
least to be saying this is the person we are dealing with because it was 
all a bit like the ‘the liver people.’” (Lisa) 
This echoed some of the experiences from Phase 1 whereby for some, not meeting or having 
contact with the liver team until after treatment was too long away. Developing the liver CNS 
role for early contact may help to alleviate this concern for some people.   
8.7.3 Correspondence following consultations  
The documentation of information for patients following consultations which would help to 
reinforce proposed treatment plans and rationale. This could be a copy of a letter sent to the 
GP but it would outline key information gone over in the consultation.  
“This might be time and effort, I suppose, but if after a consultation 
things were written down, you know you would get the same letter from 
your oncologist or surgeon that your GP gets, that would be helpful. I 
would like to have a copy of that. Sometimes when you are in a clinic, 
you are trying to listen and then trying to think what to ask, it would be 
reasonable to get a copy because we are all entitled to see our notes” 
(Karen)  
From the words of the above participant, this seems to stem from two reasons; firstly to 
consolidate the information discussed as it can be difficult to remember the volume of 
information discussed and secondly from a patient sense of entitlement, since the 
information relates directly to them.  As early as 2000, the British Government had set out 
as part of the The NHS Plan (DoH 2000) that patients should receive a copy of any health 
professional correspondence to another health professional. While in Scotland, the revised 
Charter of Patients’ Rights and Responsibilities (Scot. Govt. 2019) states that  
“I have the right to see my personal information that is held by NHS 
Scotland. I can do this by making a ‘subject access request’ (verbally or in 
writing) to my local health board or GP practice, and I should receive a 
response within a month. It does not usually cost anything to make a 
subject access request (Scottish Government 2019, p.17)”. 
However, it does not specify or suggest that patients should automatically receive a copy of 
their consultation. Indeed, there is a move that all out-patient letters and discharge 
summaries that are currently written to GPS and copied to patients should be revised and 
written directly to patients with a copy to the GP, as stated by Raynor et al (2018). This would 
put the patient back at the centre of their care and rather as an aside and it forms the basis 
of recent guidelines developed by the Academy of Medical Royal Colleges (2018) in writing 
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letters to patients. Furthermore, a number of pilot studies, also run within the same locality 
as this study have gone further in audio recording consultations with colorectal, breast and 
prostate as a way of increasing patient decision making, reducing uncertainty and regret in 
decision making (Hacking et al 2013, Shepherd et al 2018). Certainly, incorporating letters to 
patients would seem a good starting ground as a means of building on both the telephone 
model and the leaflet series and as a way of re-balancing the relationship between patients 
and health professionals as was the original intention stated in the early 2000s (Eaton 2002).  
8.7.4 Structural issues within the MDM   
For some, experiencing difficulties with timely communication from the MDM was a result 
of structural issues. Many patients are now well familiar with the role of MDMs from charity 
and hospital websites so that they expect to know when they are held. The co-ordinating role 
of the oncology team, meant that information was fed back from the liver MDM.  
“It all came through the oncologist, saying the liver people have been 
able to look at your case or it wasn’t discussed this week. I didn’t find 
that very satisfactory. Are they looking at it or not? I just wanted to 
know the facts”. (Lisa) 
  and  
“It was all a bit vague, it was almost like a bit second hand, a bit triple 
hand” (Lisa)  
When this information did not come through or was not discussed for whatever reason, it 
was here where frustration sets in and the potential for trust can break down. The idea of 
triple hand information conveys this. Discussion from the focus group showed that the health 
professionals were all too aware of this possibility and that looking at options such as 
changing the discussion order of patients to allow the liver team to attend the colorectal 
MDM or teleconferencing were discussed. Such structural aspects can make huge difference 
to patient experience.  
8.8 Returning to hermeneutics; a further inspection 
The use of hermeneutic phenomenology as a methodology in this study has also allowed 
further layers of interpretation to come to the surface during analysis of the findings from 
Phase 2. It can be seen from preceding sections, that concepts of expectation, uncertainty 
and understanding were also evident in Phase 2. Correctly, the focus required to that of 
determining service change but the findings also validate those from Phase 1. To present 
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Phase 2 results under the same headings as Phase 1 would be difficult within the restrictions 
of this thesis but by utilising Gadamerian hermeneutics, it can be seen that similar themes 
emerge. This is a novel way not only to engage with Gadamerian philosophy to show 
understanding and applicability of Gadamerian methodology,  but also to demonstrate that 
Phase 2 results confirm the results of Phase 1. 
The themes of expectation, uncertainty and understanding are applicable to key concepts as 
outlined in Gadamer’s Truth and Method (2013): being, authenticity, pre-conception 
(forestructure), historicity and temporality. Gadamer’s philosophical hermeneutics has been 
well suited to the practical element of the study design as suggested in section 8 and having 
undertaken the analysis these key concepts are seen to be reflected in the findings, showing 
particular pertinence to this study. Among other notable concepts discussed in Truth and 
Method (Gadamer, 2013), these concepts, Gadamer suggested are critical when reading, 
understanding and interpreting text. Regan (2012) emphasises this by writing,  
“What makes these concepts significant is the central interpretative 
relationship of the researcher within the qualitative research process.” 
(Regan 2012 p. 287)  
Through the active process of analysis, a greater awareness of these concepts has been made 
known. To conclude this chapter, each of these concepts will be briefly considered in turn, 
thus returning to and emphasising the experiential findings of the nature of the CRLM in 
Phase 1 with Phase 2, which may not have related to the revised support pathway itself. It is 
here the ontological focus of philosophical hermeneutics can be valued.  Gadamer (2013) 
held that it is only through language that we can know experience. As Regan writes, the 
Kantian meaning of phenomenon was “that which shows itself in itself” as discoursed by 
Heidegger (Regan, 2012, p.287). In this study, language was known through the discourse of 
interviews and focus groups. The dialogue between interviewer and interviewee was the way 
in which new phenomena were made known. The spoken and later written word, captured 
in the transcripts and now this thesis have helped to make elements of the CRLM pathway 
known. Understanding takes a method suitable to it and engaging with philosophical 
hermeneutics has been the means to this. Gadamer recognised that the old ways of 
positivism based in natural science were not conducive at getting to the soul of human 
experience.  One of problems of natural science was that it eliminated the observer. In this 
study recognition of my position of researcher with insider knowledge of the colorectal 
pathway was also central to the concept of interpretation and a fused horizon.  This study 
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did not shy away from this but echoed the sentiment of Gadamer that in order to understand 
we always bring something to the interpretation (Gadamer 2013). 
8.8.1 Being 
The concept of ‘Being’ (Dasein) is expounded by Heidegger in his magnus opus, in 1962, Being 
and Time (Heidegger, 2010). Gadamer takes up tenets of this concept in hermeneutic 
phenomenology. Being makes language possible. By being in the world, we are aware of the 
world around us and immersed in it, sharing that world with others (Alweiss 2002). Without 
question, the subject area of this thesis is pertinent to human existence. It is also manifests 
a sharing of experience, of which Gadamer’s sense of ‘Being’ incorporates. Participants have 
shared this pathway with others who have travelled it before but while there may be shared 
aspects, their experience remains unique to them.  A path of expectation: an enduring 
horizon was keenly felt among participants in Phase 2, as in Phase 1 with participants clearly 
understanding that while there were no guarantees that a liver resection would mean no 
future recurrence, it was the only possible way of cure or extending life in what would be 
palliative situation.  
“Psychologically, here’s me thinking, Oh God, I don’t want to die or you 
know, I feel like running away with what’s happening to me” (Susan) 
and 
“It was a very sobering time. I’m not sure that it was an option for you to say, I don’t think 
I’ll have the chemotherapy, I will go straight to the surgery” (Wife of Charles) 
In this way, participants understanding of their predicament was wrapped up with their 
diagnosis and also the understanding that in order to pursue possible cure, there was no 
choice but to proceed to liver resection. It could also extend to their families as shown by 
Charles’s wife.  The preciousness of being was understood so that the pursuit of continuing 
‘to be’ was a path they needed to travel. 
8.8.2 Authenticity 
This concept is developed from Heidegger’s thinking.  Heidegger believed that authenticity is 
being true to oneself but this was at the exclusion of the community surrounding that 
individual (Regan 2012). In contrast, Gadamer acknowledges the interplay of others to the 
individual. There is always a context to how a situation affects us and consequently others 
around us. (Gadamer 2013). Being an authentic being means not only operating in relation 
to considering self but considering how others influence our thinking past or present (Regan 
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2012). For Gadamer, we must also be open in order to genuinely understand and be 
authentic.  Throughout the process of interviewing and on reading the transcripts I had no 
reason to believe that participants were not being open. Rather, there was a sense of candor 
and frankness, often revealing deeply personal aspects of how the diagnosis of liver 
metastasis affected them and others. For me, looking on, the participants were revealing 
their authenticity of experience. The rawness of emotion captured in words and often 
emotional reflection, revealed this. The often emotional or heartfelt responses resonated 
with similar findings in Phase 1 showing that while improvements were beneficial, they would 
never diminish the uncertainty of their diagnosis and potential treatment.  
“The fact that I didn’t have any symptoms, I was completely shocked 
that it had spread to another part of my body. I was really, really 
shocked. I was with my sister at the time and she could see I was 
devastated.” (Ruth) 
This itself is realistic and provides authenticity in the findings, relating back to the sub-
ordinate theme of ‘Confronting a doubly shocking diagnosis’.  While it is difficult to select 
examples of this authenticity above other examples, there are some that stand out, that 
again resonate with Phase 1. Such an example of this real emotion is considering the personal 
pain that one had experienced with experiencing cancer in the family before,  
“It brought everything back to him” (Wife of Hamish)  
Hamish’s first wife had died as a result of breast cancer and he had cared for her throughout 
treatment and in her final days at home.  In some these words are also tied up with the 
concept of ‘historicity’ in Section 8.15, but the fact that his world had been so connected with 
another who had experienced cancer, shows the interplay of lives. As such this information 
could not be withheld during interview.  
Another interesting example is from Daniel who was not able to undergo liver resection 
despite treatment workup. He recalls how as the result of a consultation, his girlfriend had 
picked up more of the reality that his liver may not be operable.  
 “My girlfriend said, ‘maybe you’re borderline. I thought I don’t want to 
borderline.” (Daniel) 
This word ‘borderline’ which was so bruising to Julia in Phase 1 who could also not undergo 
liver resection, made Daniel also ‘kneejerk’. It was an immediate heartfelt reaction that made 
him want to continue to pursue liver resection until deemed otherwise.  
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Treatment related examples of authenticity that resonated with Phase 1 were an 
acknowledgement of low mood or irritability with others during treatment, with five 
participants expressing this as especially bad through chemotherapy. In addition, there was 
an acknowledgement by eight participants that they felt the liver surgery to be more of an 
ordeal than bowel surgery with Archie saying, 
“I felt like I’d been hit by a truck,” (Archie) 
The use of such words bring him right back to the experience of liver surgery, even though 
he was recounting it over a year later. The ability to bring back a memory demonstrates the 
vividness and reality of the experience. 
Finally, experiencing such a distinct health experience has implications for recovery. This 
finding was also evident in Phase 1 in the theme, ‘A journey of personal understanding: an 
individual horizon’, under the sub-ordinate theme of ‘keeping hope alive.’ Quotations from 
Hamish and Karen below highlight this.  
 “We’re going to have a ‘to do’ list and we’re gonna do this and that. We 
won’t look back.” (Hamish)  
and 
“I’m looking after myself now. I’m taking time out for myself.” (Karen)  
Being able to undergo liver resection allowed participants to look to the future, not being 
blind to the possibility that the further recurrence might happen but because of a renewed 
appreciation of time that had been given.  
8.8.3 Pre-conception 
Pre-conception or forestructure as Gadamer often referred this to, is most keenly to be 
implied to the interpreter of the text or diaglogue. This relates to anything  pre-existing within 
the mind of the interpreter that may inaccurately flavour the text itself. Citing Heidegger, he 
writes that this should be the ‘first, last and constant task’ of the hermeneutic method 
(Gadamer 2013 p.279). There should be a continual working out in the mind of the 
interpreter whether they are interpreting the text with the structure that they have imposed 
upon it or whether they interpret using what they know to resonate with the text. We must 
refrain from trying to project meaning as soon as an initial meaning appears in the text but 
rather work backward and forward between any wrongly pre-conceived ideas in order to let 
the text speak for itself. As Gadamer conveys,  
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“This constant process of new projection constitutes the movement of 
understanding and interpretation.” (Gadamer, 2013 p.280) 
For myself as researcher with previous insider knowledge of the CRLM pathway, examining 
my thoughts as I approached the text for any wrongly placed interpretation took ongoing 
discipline. However, as seen in Chapter 5, the position of the interpreter was not to 
discounted but rather valued. In this way what has been experienced before gives the 
interpreter a working hypothesis from which to further develop understanding (Regan 2012). 
In addition to my own pre-conceptions, there was also an awareness that pre-conceptions 
about colorectal liver metastases were being challenged.  
“We’re pushing the envelope more and more, we’re potentially giving 
more options to those with borderline disease. It makes it difficult to say 
to patients, categorically, this is not going to happen.” (Liver surgeon) 
This pushing of the boundaries, as referred to at the outset in Chapter 2, challenges what is 
possible but at the same time means that it is not possible for everyone. What was clarified 
for me with my own pre-conceptions of the pathway, both from the participants and the 
focus group sessions was the real challenge of management that exists for those with unclear 
liver resectability. As one of the oncologists pointed out; for such patients it is not one 
discussion regarding getting to liver resection, it is many; between different departments, a 
period of treatment, imaging and rediscussion. Certainly, looking at other methods to 
improve a faster turnaround of review from the liver team would be warranted in the 
absence of a liver specialist being able to attend the MDM. This may prevent the experience 
of the following patient,  
“The liver people weren’t there this week and then my case wasn’t discussed. I didn’t find 
that satisfactory. I didn’t care knowing one way or other if my case was going to be looked 
at but I wanted to know the facts.” (Lisa) 
 
8.8.4 Historicity  
By our very nature we are historical beings. We are thrown into a world that has a historical 
context and this makes us a product of our history at any point in time. Gadamer saw that 
our sense of history becomes more clearly understood and often more appreciated the 
longer we are in time or as Dasein matures in time (Gadamer 2013). The nature of the family 
life cycle becomes relevant to this concept as there will be priorities and a different sense of 
historical context related to where we are in that life cycle (Rolland 2005). The fact that we 
246 
 
enter a world, without our choosing and into circumstances unavoidably not of our own 
making is especially relevant to how cancer can be viewed, displacing not only a sense of 
one’s being but of one’s world.  
There are two areas that stand out in relation to historicity which are common to Phase 1 
and Phase 2. The first relates to those understanding their current health situation in the 
context of genetic background. This is situated within the sub theme ‘Questioning in the 
context of me’, situated within ‘A path of expectation: an enduring horizon’. Several 
participants had this on their thoughts as they approached the pathway.  
“I only found out after my operation from my Mum, that my Dad had 
bowel cancer and my Grandpa died of that, died young too.” (Greg)  
and 
“Mum’s three brothers died of cancer. And I wondered if I’m taking that 
path.” (Carol)  
Greg’s quotation is interesting as it hints at the possibility that his mother may have not told 
him about his family history until he was through the primary surgery. This may have been 
evidence of how that link to the past is so deep-seated that it can sometimes be hard to see 
ones own future in the context of it. Carol’s words expand on this when she considers if she 
is facing the future of her uncles. This is difficult to set aside in her thinking before treatment 
has even begun because it may be that despite treatment her path is already established. It 
was as if Carol could see a number of paths laid out before her but she did not know which 
was hers. Only with the passing of time would this become clear.  
The other area where a sense of history is apparent is by encountering a lack of or limited 
historical background. Once again there were no one who had knew anyone who had 
underwent this type of surgery before, although Mark did meet someone at chemotherapy 
who was also on the same pathway. The knowledge that is path did not have much of a 
history itself may also have been unnerving. Lisa recounted this when speaking with one of 
the surgical team,  
“He said you know this is really hard to get your head around, if this had 
been 10-12 years ago we wouldn’t be treating you” (Lisa)  
Lisa remembered struggling with this idea in her thoughts at the time. The liver resection was 
only possible by advances in medicine. Her sense of gratitude, known only through a position 
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of hindsight, stemmed from this knowledge. It also echoed sentiments applicable to ‘being’ 
in that were her existence not to have been within a certain period of time, then there may 
not have been the option to proceed to liver resection.  
8.8.5 Temporality  
Finally, the concept of temporality has an important bearing on interpretation. For Gadamer, 
the transient nature of speech means that when a message is revealed it also resonates 
within temporal understanding (Gadamer 2013). That is only when it fades into the past, can 
true meaning be acknowledged. That is not to say that present dialogue cannot have meaning 
but it may also deepen with time, both for the one imparting the words and the interpreter.  
Working with transcripts in this study has helped to capture the essence of the spoken word 
at a precise time of participants’ thinking. Having the opportunity to present the findings 
orally and through committing the findings to paper in this thesis have been a study of 
interpretation over time.  Gadamer suggests that unlike contemporary  ideas  of  memory  
recall that were being debated at the time,  the  passage  of  time  deepens understanding   
and   the idea of ‘temporal  distance,’  can provide a sense of objectivity when  feelings  
associated   with   an   experience becomes more distant (Gadamer 2013).  The remainder 
quotations from those who could not undergo liver surgery emphasise this.  
“I realise now when the liver surgeons couldn’t operate, there wasn’t 
much I could do.  I couldn’t fix it myself.” (Greg, no op.) 
“I never appreciated quite how much they were going to take away, 
three quarters and so I realise it was quite a serious operation.” (Daniel, 
no op.) 
“It’s taken for granted that scans can do a lot more than they can. It’s 
not until something happens like this until you realise they can’t.” 
(Kenneth, no op.)  
This ability of hindsight was a feature present in Phase 1 in both the main themes of ‘The 
companion of uncertainty: a unified horizon and ‘A journey of personal revelation: an 
individual horizon.   One of the areas where I could clearly see the value of temporality in 
interpretation was in grappling with apparently conflicting statements. For example, for 
Greg, (who could not undergo liver resection), he declared near the start of the interview 
that, 
“I know that I can’t have the liver resection.” (Greg, no. op.) 
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Sometime later in the interview, he also declares,  
“I don’t mind if they want to go back and take a chunk at a time, take it 
all in a oner or take a chunk and wait until the liver grows back.” (Greg, 
no op.) 
During the interview, these words jarred with me as a researcher, finding it difficult to 
reconcile that this participant knew a liver resection was not possible. A similar situation 
occurred in Phase 1 and it is through the lens of temporality that this was actually an 
expression of hope in the context of something that was not possible. This is further 
discussed in Chapter 9.  
For patients going the CRLM pathway, each stage in that pathway can feel like it can last a 
lifetime but with time it moves onto another phase.  The pictorial image at the beginning of 
this thesis depicting the snail climbing Mount Fiji and in conjunction with Isso’s poem, 
appears to show each stage in the climb going on forever until a new horizon is met. The 
nature of each stage of the CRLM pathway is set within the context of a health situation that 
makes one realise of the very temporality of life.  
8.9 Chapter summary 
For Gadamer, the truth is always coming into being as we adapt our view according to 
information through the fusion of horizons (Gadamer 1964). However, this study has been 
more than an effort to understand. This chapter has presented the response to that renewed 
understanding detailed in Chapter 6 and is reflective of the practical element to the study, 
committed to utilising the data and driving forward a service revision to support patients 
being considered for colorectal liver metastases resection. The findings have shown that the 
implementation of a telephone assessment model and leaflet series have been well received 
but that uptake with an individual patient buddy had not been accepted. The use of 
hermeneutic phenomenology in this study has worked on two levels. It has viewed language 
as a set of words with a message but it has also exposed a reality for those on the CRLM 
pathway.  Using Gadamer’s fusion of horizons has allowed for the merging of not only the 
service revision in Chapter 7 but also the interpretation of the data gathered and presented 
in this chapter. This work has further implications for practice, especially how we work with 
patients’ sense of hope to contain expectations and manage uncertainty. These thoughts will 





Paths with expectancy, stories of hope: reflections on learning from a 
fusion of horizons 
"Man cannot live without hope; that is the only proposition which I 
would gladly continue to defend without qualification." (Gadamer 2002, 
as cited by Grodin (2004)  
9.1 Chapter overview 
To date this thesis has sought to uncover the experiences of patients who are considered for 
colorectal liver resection and in response, present the findings of a model of support for this 
patient population. The study was conducted in two phases with an interim period of service 
development placed in between. There was limited relevant literature to endorse the chosen 
model (as discussed in Chapter 3) therefore the model of support was solely driven from the 
data in Phase 1 (Chapter 6). Fundamentally, this thesis has allowed individuals to tell their 
stories of an experience unique to them, but through analysis it was also evident that those 
stories held components of similar shared experiences with others. While the stories centred 
around the pathway and treatment towards possible liver resection, the experiences did 
more than capture experiences about that pathway and service. What was powerful, was 
that individually and collectively, these were stories of hope, embedded within an onco-
surgical context of evolving practice. To conclude this thesis, this chapter will look back at the 
journey, the methodology, the power of the patient story and the contribution of this study 
to existing research in this setting. It will discuss the related concepts of the medicalisation 
of mortality and realistic medicine, and the need for a new conceptualisation of metastatic 
disease before raising some considerations as to how we might, as health professionals, give 
shape to hope in this pathway.  The chapter will close by considering the study limitations 
and recommendations.  
9.2 Reflecting on the journey  
This study arose from the sense of unease around the lack of support for patients being 
considered for colorectal liver metastases resection, as identified by the colorectal nurse 
specialist team. It was clear from the outset that managing both the practical and emotional 
burden of this pathway was difficult for patients and families alike and that this often 
appeared to be intensified with the involvement of two different hospital sites. This study 
has attempted not only to investigate how that pathway was experienced but also to address 
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some of the lack of support for this patient population. This has meant that it has been a 
study of two distinct parts. Phase 1 gathered and analysed the responses of 16 patients and 
a health professional focus group. In response, an interim period allowed for the 
development of a support model, primarily led by the colorectal cancer nursing team. This 
period involved the development of a telephone assessment service, a series of patient 
literature and a patient buddy service. Phase 2 encompassed an evaluation of this newly 
implemented support model by conducting, in the same method as with the first Phase, 
further interviews with 16 patients and a health professional focus group in order to 
determine the value of that overall intervention.  
This thesis has presented the journey, beginning by setting in context the treatment of 
colorectal liver metastases in Chapter 2, before considering the relevant patient experience 
literature pertaining to this study in Chapter 3 and examining further the role of hope as a 
response to managing uncertainty in Chapter 4. Chapter 5 detailed the chosen methodology 
of hermeneutic phenomenology as central to the study with the use of Interpretive 
Phenomenological Analysis (IPA). The findings of Phase 1 were set out in Chapter 6 and to 
follow chronologically, Chapter 7 discussed the interim phase where the new supportive 
model was presented. It then returned to discuss the findings of Phase 2. Overall the study 
yielded findings from each phase. In Phase 1 the experiences were captured under three 
master themes which were attached to three horizons of understanding,  
- a path of expectation: an enduring horizon 
- the companion of uncertainty: a unified horizon 
- a journey of personal understanding: an individual horizon 
The development of the revision of support by way of telephone model, development of 
leaflet series and patient buddy group all sought to confront and equip in dealing with the 
difficulties of expectation management and uncertainty and to augment personal 
understanding. With the exception of the patient buddy service, the support model was 
welcomed and while additional support could never eliminate uncertainty, it was shown to 
alleviate the burden of uncertainty. 
When viewed in a paragraph, the journey of this study seems easily reducible, but the reality 
has been an immersive journey for me as researcher, as I have sought to do justice to the 
experiences of those patients with the aim of developing a service. I am aware that I had the 
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privilege of being trusted with their stories and learning through listening about their own 
personal journeys.  
Without the willingness of these patients to share their story of this time in their lives, there 
would have been a significant delay in improving this area of support and the result would 
have been informed by only health professionals, giving a very unilateral viewpoint. In 
addition, the work has been applicable to other areas of practice and has had implications 
for the separation of the colorectal nursing service into primary and secondary teams 
(Section 9.12). It has been a strength of the study that it has been informed by patients and 
health professionals and the underpinning structure of Gadamer’s ‘fusion of horizons’ 
(Gadamer 2013) has given a beneficial focus in drawing together differing patient 
experiences, with health professional experiences and my interpretation as both insider 
health professional and outsider in a researcher capacity. There has been a demonstration 
of fusion on multiple levels.   The journey has been significant as it is the second study to 
examine the experiences of patients being considered for CRLM and the first to use a pure 
patient sample and then use these experiences to implement a service change.  Considering 
this, the patients’ stories have given this study its potency in allowing both the singular and 
collective patient voice to be heard.  
9.3 The appropriateness of methodology 
Chapter Five detailed the rationale for how the study was conducted and the use of 
hermeneutic phenomenology. After completion of the study the appropriateness of the 
methodology was realised from a different vantage point.  Traditionally, healthcare has 
focused on presentation of signs, symptoms and treatment. While this has been correct, it 
has tended to focus on the how of healthcare but has left little to the ‘who’ in healthcare and 
how being on the receipt of care affects individuals. Chapter Three contended that with the 
advent of greater technical possibilities in medicine operating across different disciplines, 
there is a greater likelihood of supporting pathways to such care becoming more complex.  
This is evident within the CRLM, due to the presentation of disease, changeability of that 
disease and involvement of different disciplines, as outlined in Chapter Two. As health 
professionals, complex pathways hold an unknown entity for us and if we are to be truly 
patient-centred, we must ask ourselves what is it like to experience such a complex pathway? 
How do individuals experience such emerging treatment when the context of treatment is 
placed within the reality of secondary disease? Is there anything that we can do, to make 
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such pathways easier? As Buckley et al (2016) write, any progression in illness by its nature, 
causes individuals to respond differently because of the absence of health.  
“As their illness develops, they are compelled to move to a different 
path, walk along a different life-map and re-navigate as they respond 
and adapt to a changing health status.” (Buckley et al 2016) 
As health professionals we look on to this path yet we are more than onlookers. Inherently, 
in this study, the involvement of the nurse specialists action of implementing a support 
model has shown that they are committed to help individuals re-navigate life and make living 
a priority in the midst of an uncertain health situation. They do this from a different vantage 
point, having the realisation of a number of possible outcomes for outcomes for patients. 
When we attain a new horizon we gain the breadth of vision that a person who is trying to 
understand must have (Gadamer, 2013). This is the benefit of our vantage as health 
professionals; breadth of vision. This position is difficult to obtain when going through the 
pathway as a patient. This process may involve setting aside preconceptions for both health 
professional and patient so that each moves beyond their own individual understanding to a 
more universal understanding together.  This part and a whole framework is critical to the 
nurse specialists as they work alongside individuals, understanding each part of the CRLM 
pathway and also the whole in the context of the colorectal cancer diagnosis.   
The appropriateness of using Gadamerian philosophy has helped to realise that ‘part’ and 
the ‘whole concept of understanding.  This has occurred on three levels. The first level is the 
acknowledgement of the segments of experience that individuals themselves see but that all 
of the experience can only be fully appreciated from a distance when the chaos of the 
situation fades away. The second is the weaving of the experiences of individuals and the 
understanding of the health professionals, the individuals representing only part of the 
understanding required in order to comprehend the CRLM, with the health professionals 
adding a wider lens of experience which stems from knowledge of the disease and knowledge 
of routes or deters that the pathway may yield along the way. The final level is that part and 
a whole experience which comes from my position as a researcher as I have sought to analyse 
the data as parts, merging those parts into the whole as findings. This is an analysis that 
recognises the interplay between past and present, whole and part. This understanding 




 “In understanding we start from the connection of the given, living 
whole, in order to make the past comprehensible in terms of it.” (Dilthey 
as cited by Monk, 2004, p.44)  
This was exemplified in that the interviews did not just contain clinical experiences about the 
pathway itself but the humanity of how their lives were affected at the time of diagnosis and 
during treatment and being considered for CRLM resection. The current is always flavoured 
by the past and the participant looks back in order to find meaning in their present.  
The use of IPA as an analysis method also sought to draw out that experience. Pietkiewicz 
and Smith (2014) believed that studies incorporating the use of IPA should meet certain 
characteristics. They suggested that the aim and research questions should be to understand 
the individual, in-depth experience of a participant. Sampling should contain purposeful 
sampling and enlist a homogenous sample but smaller sample sizes are often adequate so as 
not to compromise depth. Methodology should involve participants being able to tell their 
stories in an unhindered way without placing additional structure on them. The analysis 
should identify descriptive and interpretative themes engaging the reader to see more of the 
lived experience of the subject group and the importance of the researcher’s position should 
be noted through reflexivity in the study approach and analysis. With the exception of a 
smaller sample size, this study has met this criteria having a sample of patients from two 
phases who despite their entry into the CRLM pathway, they all had liver only metastases 
and were all being considered for liver resection. The total larger sample size was combined 
from both phases and was required due to the practical nature of assessing a change in 
service together with including a number of patients who did not proceed to liver resection. 
The semi-structured style of interviewing was used more as an aide memoire and facilitated 
their experience without little prompting. In addition, the place of the researcher with 
insider-outsider knowledge has been interwoven throughout the research.  
Furthermore, due to the timescale of the pathway to play out, particularly in Phase 2, this 
was a study that was suited to a longer timeframe and hence suited the part-time nature of 
the researcher. The data collection could not have been carried out in a shorter timeframe. 
While the study had the practical emphasis of service improvement it was withheld that it 
was not action research (as outlined in Chapter 5) due to the focus on hermeneutic 




9.4 The significance of ‘the story’  
While I sought to understand patient experience in this patient population being considered 
for CRLM resection, I did not expect be surprised by the strength of the voice of the patient 
as storyteller. Collectively what bubbled up to the surface of analysis was that these accounts 
were stories of hope. The etymology of the word ‘story’ has its roots in the Middle English 
word ‘storie’ and Anglo-French ‘estorie’. This is thought to be a combination with Old French, 
‘estoir’ and Latin, ‘historia’. Although the word has become widely used to mean anything 
from a personal account, to fictitious tale or anecdote, the historical context of the word 
helpfully conveys the sense that a personal story is rooted and holds some sense of history 
pertinent to the storyteller.  The author Donald Miller writes,  
“A story is based on what people think is important, so when we live a 
story, we are telling people around us what we think is important.” 
(Miller 2009 p.125) 
 
While sadly, reports such as the Francis Inquiry (Mid Staffordshire NHS Foundation Trust 
Public Inquiry, 2013) have revealed upsetting examples of poor-quality care, they have 
stressed the importance of giving a voice to the concerns and experiences of patients and 
their families. The revision of The Nursing and Midwifery Council’s code of conduct (2015) 
accentuated the importance of working in association with patients. It makes it a 
requirement to “listen to people and respond to their preferences and concerns” (p.6) while 
being able to “work in partnership with people to make sure you deliver care effectively” 
(p.6). Searching out and listening to the story therefore sits within the culture and the 
requirements that we practice in. Buckely et al (2016) state that it becomes a responsibility 
to listen reflectively to patient stories and to consider their position within the patient–nurse 
relationship. From my position, it became a responsibility to not only listen but to act in 
response to those stories in order to improve future patient experiences. 
Although this work has centred around the pathway and process to liver resection, the 
interviews have allowed patients to tell their stories from the advantage of a historical 
viewpoint. Primarily for all of those interviewed in both Phases, their end goal was to achieve 
CRLM resection, yet having that longer-term historical vantage to tell the story, has allowed 




This concept of story lends itself well to Gadamer’s hermeneutic phenomenology on two 
accounts. Firstly, the belief of historical perspective is important in Gadamerian 
phenomenology because the past forms part of the key to understanding the present. This 
can be clearly seen in Chapter 6, section 6.2 under the theme of ‘A path of expectation; an 
enduring horizon’ and more specifically the super-ordinate theme (6.2.1) of ‘Traveling with 
the background of diagnosis’.  None of what the participants shared could be understood 
without going back to the time of diagnosis and in fact there was a constant revisiting of the 
original diagnosis (whether diagnosed as synchronous or metachronous liver metastases in 
follow-up). Secondly, the concept that our traditions (also defined as our preconceptions) 
which are rooted in the past often collide with our present understanding to form a new 
understanding on a situation is particularly relevant.  This means we cannot remove 
ourselves objectively from the past. The past is embedded in our horizon. The reality is we 
may not be conscious of preconceptions or aware how they can influence our present 
understanding. This is clearly punctuated through all of the themes uncovered through the 
findings. The first sits within the theme ‘A path of expectation; an enduring horizon’, under 
the sub-ordinate theme ‘Questioning in the context of me’. It has been apparent that an 
association or link with cancer either in the family or support network can influence patient 
understanding either positively or negatively when considering their own individual situation 
and this can often present a challenge to redirect to a different viewpoint. Difficulty in 
removing oneself objectively can also be seen in the sub-ordinate theme, ‘looking forward to 
possibilities in medicine’, when the possibility of what a patient might want to happen is not 
possible due to lack of understanding of what is technically possible or due to presence of 
disease which limits possibilities.  
The second sits within the theme, ‘The companion of uncertainty; a unified horizon’, with the 
sub-ordinate theme, ‘language has a memory’. A struggle to let go of some unhelpful ways 
in which aspects of care were communicated or were perceived to have been communicated 
was very evident here.  
The final sits within the theme, ‘A journey of personal understanding; an individual horizon 
under the sub-ordinate theme of ‘understanding looks forward’, where it was acutely 
apparent that only on reflection was there a fuller understanding of what the whole pathway 
to liver resection entailed. This was very different to those health professionals interviewed 
through both focus groups who were able to hold that wider angled view of the overall 
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pathways, knowing both about the possible pitfalls in the pathway and also the disease 
process.  
An additional benefit of capturing the story with a longer viewpoint was the unexpected 
benefit that it had to participants. The ease that participants came forward to participation, 
once approached, suggests not only the sense of gratitude that they wanted to take part but 
also the sense of importance to talk about something which mattered to them and in which 
they were a central protagonist. They knew their own script because it was their own 
experience. All eight participants in both Phases who did not proceed to liver resection were 
willing to come forward showing that it was not just the end point of liver resection which 
was relevant to them. Indeed, Callum (Phase 1) identified that had he not gone through the 
process his life would be in a very different place. Despite his immediate anger about not 
being able to go through the liver resection and having a period of trying to make sense of it 
all, he had been able to work out priorities in his life and voiced having a stronger repaired 
sense of relationships which were important to him. As health professionals learning from 
this is critically important. Firstly, while we do often get to develop relationships through 
time, we often see snapshots of people’s lives. We do not see the whole story. Were we to 
see Callum at the time or in the weeks after it was conveyed that liver resection was not 
possible, we would have seen despair.  At the time of interview, Callum had hope, yet the 
decision had been made several months before that he could not proceed to liver resection.   
He had revealed that had this diagnosis not happened, his life would not have been in the 
strength of place he now saw it. This example depicts the task of supporting individuals 
through this challenging pathway where the ebb and flow of hope is evident. The ancient 
pre-Socratic philosopher, Heraclitis (c.535 – c.475BC) is reputably to have said a similar 
sentiment,   
“Everything flows and nothing abides; everything gives way and nothing 
stays fixed.” (Heraclitis of Ephesus, as cited by Butler-Bowden 2013, 
para.9) 
Engaging with the CRLM pathway from a different horizon has allowed me to gain a greater 
sense of appreciation of the changeable nature of that pathway for individuals and 
consequently the fluidity of hope contained within it. 
Furthermore, the use of the story in periods of ill-health or the derived term, illness narrative, 
is a way of an individual making sense of their experiences (Sulik 2010). As a medical 
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sociologist, Arthur Frank has been instrumental in developing the concept of illness narrative, 
set out through his influential book in 1995, ‘The Wounded Storyteller: Body, Ilness and 
Ethics (2013). He was able to use his own cancer diagnosis and recovery to reflect upon the 
illness story which commonly follows a restitution, chaos, or quest pattern, weaving its way 
through the story. The restitution period signifies the belief or hope that this period is 
temporary and will be overcome. This can move into the chaos period where the illness is 
seen to get worse. This I can see is where uncertainty takes hold and hope fades into the 
distance. That may also happen because of an elongated treatment process which may not 
have the desired effect. Finally, the quest section of the story is where the experience of the 
illness can be used positively, and the individual might seek to transform oneself through 
overcoming adversity and re-learning what is important in life. I can the applicability of this 
pattern to the patient experiences in this study. Although I see the restitution period 
occurring after the shock of the diagnosis and that transitioning from the well to the not so 
well. Clearly the quest period echoes the third master theme of personal understanding but 
I would argue that it is not only gained by overcoming adversity but it may be gained through 
the process of adversity as those who did not proceed to liver resection showed.  
This brings together the personal value of sharing an illness story and the suitable 
environment that the interviews provided in order to do so. Interestingly, Frank (2013) 
considers that the chaos narrative is generally told retrospectively as chaos itself is 
prohibitive to an individual in being able to tell a story.  This is clearly evident through 
listening to the patterns of chaos in the collective stories. Reflection allows the distance to 
look with different eyes and indeed provides the time for another horizon to form for that 
individual through which they have reassessed their understanding of the situation. It also 
affords the benefit of control which Frank (2013) states is seen to be the opposite of chaos. 
Generally, control occurs when chaos ceases. Gaining that long-term view can only be 
achieved through time and having that opportunity to discuss their story with someone who 
they know is also familiar with their journey provides a therapeutic encounter (Morecroft et 
al 2010).  
9.5 Contribution of this study to current knowledge 
The contribution of this study is in relation to the overall intention of the study. The aim of 
the study was to use patient and health professionals’ experiences of the colorectal liver 
metastases pathway to plan a support model for future patients and then to re-evaluate the 
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revised pathway by reassessing patient and health professionals’ experiences. These aims 
were important due to the perceived gap, as identified by the specialist nursing team, in the 
support received for those being considered for colorectal liver metastases resection. The 
study questions therefore have direct relevance to future patients experiencing this pathway 
and to health professionals, helping them navigate the pathway. The study does three things 
in relation to furthering knowledge in the area of the patient experience of liver metastases 
and the management of uncertainty in patients by, 
(1) adding to the body of phenomenological knowledge regarding patients being 
considered for colorectal liver resection 
(2) demonstrating value of knowledge by incorporation of the model into clinical 
practice 
(3) contributing to the implications of hope theory in surgically resectable metastastic 
disease 
Firstly, it expanded on the findings of the three studies identified in Chapter 3 all of which 
presented a phenomenological account of patient experience of surgery for liver metastases. 
The only directly related study was that of McCahill & Hamel-Bissell (2009), with the Vidnes 
et al (2013) study incorporating the use of liver surgery, albeit liver transplant for liver 
metastases and an aspect of Whale’s (2016) doctoral study featuring a phenomenological 
account within a quantitatively based quality of life study. These studies had valuable, but 
only partial, insights with limitations as detailed in Chapter 3, Section 3.2.1. They have not 
been able to provide the full picture of the pathway from diagnosis to a period after liver 
resection or the decision not to proceed to resection. This study adds to what might be 
known about the colorectal liver metastases pathway by viewing it along three horizons: 
patient expectation, uncertainty and personal understanding. Each horizon contains 
additional viewpoints that lie within it, allowing further insight into the pathway itself, as 
detailed in Chapter 5. These horizons serve an enriching purpose when considering other 
pathways of a complex nature to allow assessment of what measures could be considered to 
meet the support needs of the patient population associated with it.  
Secondly, the model used in the study has been incorporated into clinical practice, providing 
a workable solution to gaps in support originally identified at the start of the study, whilst 
also determining its value after implementation.  The learning gained from the lack of uptake 
from individuals to the buddy service is valuable in designing patient participation and shows 
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much potential in the possibiity of individuals meeting with similar individuals after they have 
been through a health event rather than before. The use of the SWIFT tool as detailed in 
Chapter 7, has also a purpose in other aspects of the specialist nursing team’s clinical practice 
and has been shared for use within the department. To date there are no other published 
studies that have documented the use of the SWIFT tool. Furthermore, this study has 
affirmed the work of the nurse specialist in complex disease management. Furthermore,  this 
study is original, in that at the time of writing, it is the only study recounting the use of 
phenomenology to drive forward a service change and then return to phenomenology to 
assess that change in the area of colorectal liver metastases resection. The study is not 
merely about a hermeneutic evaluation of experiences in order to enhance cancer care, in 
the area of colorectal liver metastases, but it is the only study demonstrating change as a 
result of phenomenological inquiry in this field.  In this way it has reflected the part and the 
whole viewpoint that is integral to hermeneutics (Regan 2012). 
Finally, this study contributes to the implications for the theory and application of hope 
within the potentially curative possibility of metastatic disease. It can be seen that aspects of 
Snyder’s hope theory (2000) and Herth’s work on hope (2000) are particularly  germane. 
While Snyder’s hope theory (2000) relating to goal attainment is more challenging to apply 
to the nature of cancer in general, as argued in Chapter 4, it can be seen that aspects of goal 
attainment, i.e. the goal of getting to the next stage in liver resection is still evident. However, 
this falls short when the obstacle of cancer cannot be overcome as hoped. This may be the 
case when further imaging upstages the disease from that previously understood and 
renders the patient inoperable for liver resection. However, it is evident from both Chapter 
6 & 8 that hope is not lost but rather readjusted in those who did not proceed to liver 
resection. Herth’s (2000) focus on hope takes into account the changing needs in the context 
of illness and of the significant role that it can play in terminal illness, shifting towards 
differing types of hope as curative aspirations translate into palliation and the reality of life 
limitation. Both Herth and Snyder view hope as a way to maintain personal motivation yet, 
perhaps the contribution of Snyder and Herth do not go far enough in relation to how hope 
is utilised by patients in the context of metastatic disease that still has the potential to be 
curative. Perhaps there needs to be a new way of conceptualising such metastatic disease 
that blends the contribution of both Snyder and Herth to date to generate a new 
understanding of hope in metastatic disease.  This is further picked up in Section 9.8.  
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9.6 Resection of colorectal liver metastases; where does it sit within the 
‘medicalisation of mortality?’ 
 
The current situation with CRLM is the result of cumulative advances in medicine, notably 
technology in surgery and pharmacology in oncology. It has a comparable survival outcome 
with post-operative adjuvant chemotherapy and there is no doubt, where it not for these 
advances, we would not have seen the success in extension of life that we now see. At the 
same time a tension is evident, for the success stories are not all we see as this study has 
shown by use of a phenomenological exploration into the experiences of some of those being 
considered for CRLM.   A perhaps more cynical look at the situation might conclude that CRLM 
for some might only be delaying the inevitable and that is death itself. It is worth pausing to 
consider if for some, CRLM might only be the medicalisation of mortality. Medicalisation can 
be viewed as “defining a problem in medical terms, usually as an illness or disorder, or using 
a medical intervention to treat it.” Conrad (2005 p.3).  
There may be a close connection to overdiagnosis but van Dijk et al (2016) are quick to point 
out that medicalisation is not by definition negative having seen some tremendous benefits 
in certain situations. Childbirth itself has seen huge outcomes in terms of live births by 
medicalisation, but negatively an increase in Caeserean section rates.  
Medicalisation of mortality means that we have entrusted death to medicine but this does 
not mean that either one can be fixed (Gwande 2014). We now must learn to cope with the 
limits of our knowledge.  
“We have no greater unfixables than ageing and death itself” (Gwande, 
Reith Lecture, Edinburgh, 2014b)  
Gwande (2014b) reflects that learning about mortality was not part of medical training. It 
was about how to fix people so much so that it did not equip medical staff to deal with death 
well, perhaps not only for their patients but also for themselves. Clark (2002) on speaking 
about medicalisation writes,  
“The term has become synonymous with the sense of a profession 
reaching too far: into the body, the mind, and even the soul itself. Its use 
is now almost always pejorative, negative and antagonistic.” (Clark 2002 
p.905). 
Clark (2002) gives homage to Ivan Illich who developed his original assessment of 
medicalisation and in particular the medicalisation of the dying in which he claimed that 
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modern medicine had “brought the epoch of natural death to an end” (Illich 1976 in Clark 
2002, p.905). There was a growing concern about how to improve end of life care on both 
sides of the Atlantic during the 1950s but by the time Illich was writing mid1970s, concern 
had grown about futile treatments with poor outcomes. Illich’s critique of the medicalisation 
of dying encapsulated four main facets. Firstly, there was a loss of capacity to accept death 
and suffering as meaningful aspects of life. Secondly, there was a sense of being in a state of 
war against death at all stages of the life cycle. Thirdly, a crippling of personal and family care 
was evident with a devaluing of traditional rituals surrounding the dying. Instead this was 
replaced was an institutionalised form of caring for the dying which was often equated as 
less personal. Finally, there was a societal rejection of terminology associated with the dying 
or bereaved which often was associated with a negativity of as Illich referred to within his 
culture, a form of deviance. Following on from the 1950s, came a rise in the palliative care 
movement, notably acclaimed to Cicely Saunders, become a worthy inspiration and model 
to follow. Despite the growing movements in palliative care, Illich saw that the wider medical 
system continued to view death as something to be resisted, postponed or avoided (Clark 
2002). Indeed, attacks were also made on the medicalisation of palliative care.  In many ways 
medicine has always had the problem of balancing technical intervention with a personal 
humanistic approach to their dying patients. Today, this tension has deepened as options for 
extending life have grown. Although Clark was writing in the early 2000s, the sentiment of 
his interpretation on Illich is valid for today and particularly relevant for CRLM. Clark (2002) 
writes  
“just that palliative care has encouraged medicine to be gentler in its 
acceptance of death, parallel developments in the medical system have 
redoubled efforts in the opposite direction” (Clark 2002, p.905).  
Yet the picture that we see of CRLM having an equivalent outcome of post-operative 
adjuvant outcome can in no way be equated with palliation. Somehow both the message of 
Illich and the message of hope need to balanced.  
9.7 CRLM and its place in realistic medicine 
At this point, the value of placing the CRLM pathway within the context of ‘realistic medicine’ 
is seen as referenced to in Chapter 1. The idea behind Realistic Medicine is that any models 
of care have “an empowered patient in a shared decision-making partnership with the 
clinician” where impact of treatment or no treatment is weighed up (Scottish Government 
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2016 p.9). The first report was written while some of the data collection in Phase 2 was being 
carried out but echoes with the sense that life goes on despite the cancer diagnosis (or any 
diagnosis) therefore engagement with individuals to find out their preferences is key.  
“Real people have real lives, real stories, real problems and real priorities 
and, therefore, no person is a ‘typical’ member of the public.  So, when 
engaging with the public, one tends to encounter a diversity of views, 
sometimes with subtle yet important differences. Capturing such views 
can be more of an art than a science.” (The Scottish Government 2019, 
p.15)  
Where there is potential to remove residual disease in resectable liver metastases, the intent 
of treatment is not palliative, yet as is evidenced by this study, there is a propensity for 
scenarios to quickly become palliative. The value of this study is that it has included eight 
patients in total who due to a number of reasons, were not able to proceed to liver resection 
as this displays the reality of the pathway. The further reality is that in Phase 1, five patients 
were no longer alive a year after interviewing and likewise 4 patients in Phase 2. All were 
cases of recurrence, either in the liver or elsewhere that made surgery not possible. This 
demonstrates the unpredictability of the nature of disease and how a realistic approach to 
what is possible requires to be discussed with the patient in their everyday world. To me, this 
fits in with the thinking behind the Family Illness model as explained in Chapter 7.  
The interesting thing is that not one person when weighing up the risks of liver resection or 
potential recurrence, declined potential treatment. Very much in the same way that Snyder 
(2000) uses hope theory, the goal of liver resection was something to be attained. It was held 
up and patients were guilty of planning their way to it in the same way that life goals could 
be worked up and conquered. Perhaps this was because all of the individuals had little or no 
clinical symptoms so there was nothing to resonate that they were unwell. Yet, health cannot 
be conquered in the same way that life goals can. Gadamer spent much discussion on this, in 
his Enigma of Health, 1996, (Šolcová, 2008) whereby disease was only known by what was 
absent and that absence was health. Participants in this study had a thirst for life and a desire 
for survival. Perhaps this was because the CRLM pathway gave them hope by the mere fact 
that they were on it until they came off it. This is very different to other health situations or 
scenarios where people have lost hope and have no desire for survival, suicide here being 
the scenario that comes to mind. Due to the fact that the situation can change quickly the 
intent of resultant treatment can change to palliative intent.  At this stage a further discussion 
regarding realistic treatment will need to occur. One of the benefits of social media is that it 
263 
 
has helped to challenge living with life limiting illness in a more positive way. Examples of this 
include Hannah Francis, Doddy Weir and Kate Gross, the journalist who herself was 
diagnosed with metastatic bowel cancer and later died when her twins were four years old. 
Preparation for the end of life, whilst still living a full life, became key for Hannah and Kate. 
This study has unintentionally given affirmation to the role of the nurse specialist and has 
given insight into some of the complex and often invisible communication work that nurse 
specialists carry out, balancing hope and preparing for uncertainty.  
9.8 Surgically resectable metastases: a new conceptual understanding 
Having determined that the overall intention of CRLM does not sit comfortably with palliative 
care, there are some challenges in how we continue to perceive colorectal liver metastases 
both as health professionals and in how we communicate to patients.   Clark (2002) writes 
that palliative care opened up a space somewhere between the hope of cure and acceptance 
of death. Having access to the CRLM represents that active hope of being disease free and as 
the interviews have shown all 32 patients wanted to take that hope. We need a new way of 
conceptualising metastatic disease and utilising how we use hope where previously this had 
not been the case in metastatic disease. 
Throughout the interviews, hope was rarely labelled as such by using the word ‘hope’ or any 
derivatives of the word ‘hope’. However, by digging below the surface of the spoken words 
used, the sentiment of hope is evident in its expression across different elements of the 
pathway, all the way through from diagnosis, treatment planning and after a decision was 
made about liver operability. It is a pathway centered on hope.  There is an ebb and flow of 
hope identified across the pathway and hope is sought at different stages of the pathway for 
individual reassurance and to foster the ability to move on to what is perceived as the next 
stage either in treatment or conceptualising survivorship.  What is required is a skilled and 
nuanced form of communication in order to assist with this. What shape this takes is created 
through understanding the potential difficulties of the CRLM pathway and through listening 
to the priorities of individuals as they go through treatment.   
9.9 Giving shape to hope  
Through discussion in Chapter 5 it was apparent that ‘hope’ is a commonly assumed concept 
yet a multi-faceted and often elusive concept at the same time. It is used within a continuum 
of situations from the mundane to the poignant. Hope without effort is often viewed as a 
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weakness and believed not to be enough on its own, as exemplified often in times of war and 
political strife and evidenced in Chapter 4. This idea sits more comfortably in situations where 
we can exert some control over situations, much like Snyder’s (2000) goal attainment theory 
but this falls short in cancer where favourable outcomes have more to do with cell biology 
rather than mustering up strength to overcome cancer. Similar to the concept of health as 
discoursed by Gadamer (2013) it is also known by its presence of absence. It can also differ 
widely in personal experience and does not remain static. It is because of such factors that it 
is a highly versatile belief and often an asset in personal circumstances. As health 
professionals we often talk about pathways as having very distinct pivotal points and a range 
of resultant flow chart systems that stem from major decisions. For patients, they do not 
know the path that they step out on but they do know that it has a beginning and as 
understood in this study, they only see the clearer path once they have walked further upon 
it. At the point of journey entry, hope for liver resection is at one of the peak points because 
the future cannot be known as the following suggests,  
“It is only because we do not know what the future holds for us that we 
can have hope.” (Hastie & Dawes 2001, p.328) 
There are four key considerations from the research that are essential in utilising hope in this 
area. They do not attempt to provide answers but operate as discussion points from which 
to view current individual practices in this area.   
9.9.1 Emerging pathways require an evolution of communication  
Only on reflection and glancing back can we see where we have come from and in same way 
only by looking back at medical progress in this area can we see how far advances have been 
made in treatment of CRLM. What has been clear from this study in fusing the horizons of 
both patients and health professionals is that as pathways emerge and develop in response 
to treatment advances, there is a need for communication about those pathways also to 
evolve. 
Many patients have indicated that they have only understood the pathway from being 
through it, i.e. that  longer vista is required. Equally health professionals are well placed to 
know the possible twists and turns of the pathway as those with a viewpoint of those with 
longer vision. Communication skillset is something which has adapted in response to this 
pathway. Some of the initial set of patients were diagnosed in 2010 at a time when the 
frequency of CRLM was not what it was now. It may be that at the time health professionals 
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adopted a more cautious communication style pointing out and reinforcing what might go 
wrong because it was more unchartered territory.  In adopting this more cautious approach, 
it may be hope was taken away or harder to utilise as a resource. The example of Paul as 
discussed in Chapter 6 may suggest this. However, as time continues and confidence in the 
pathway grows, health professionals may reflect a more nuanced and hopeful 
communication style. The possibility of not getting to the goal of surgery is always there but 
perhaps may not be laboured at every turn, just as no doubt was the case in any surgery of 
progress for example, the early heart transplant surgeries may have followed a similar over 
cautious communication style, although there is no evidence for this. That is not to suggest 
that risks are not properly addressed and discussed. There is also the challenge for health 
professionals learning how to communicate in response to certain situations that present 
themselves as the likelihood of liver resection begins to slip away. This was something 
recognised clearly from the health professional focus group in Phase 1.  
If anything, the stories depicted are of keeping realistic hope alive throughout the process. 
After all, the interviews have shown that the participants were in no doubt that once spread 
has occurred into the liver, it is not good news. This clearly starts the terminal time clock 
ticking. The data supports that individuals do not need constant reminding that this could be 
the case but that they want to keep hope evident. This links in with the importance of a 
therapeutic relationship with health professionals as outlined in section 9.8.4.  
9.9.2 Hope has a language 
There are two aspects of language that need to be considered, the first is the language used 
by the health professionals and the second relates to that used by patients. Several accounts 
by the participants in this study have shown that certain language used can have a lasting 
negative and detrimental emotional effect to patients. The most memorable of this was 
Ellen’s description of the word ‘borderline’ and ‘futile’ in Phase 1 being used while she was 
waiting on the ward for her surgical theatre space to come. In this case the technical use of 
borderline dispelled hope. We must be cautious that technical language that contains specific 
medical knowledge may have a different and negative meaning for patients than it does for 
us as health professionals. Where we do use technical language, we need to allow time to 
explain it. Ellen’s situation had allowed little time for explanation. In the second phase, there 
were more positive examples of the use of language. This may have also represented some 
change in health professionals becoming more confident with the pathway. In addition, 
266 
 
having the presence of nurse specialists routinely involved at points throughout the pathway, 
means that patients have an opportunity to discuss any use of language that has uncertain 
meaning. This is something which is often evident from working in this area where patients 
check and clarify words or phrases that have been used during consultation either after the 
consultation or by ringing following to check. 
The other language situation is a pattern often seen expressed by patients and that is the 
apparent expression of denial after a treatment option has been closed. This does not just 
occur in this group of patients but it is one that occurred for those who were not able to 
proceed to liver resection in both phases. There were two strong cases where this occurred. 
The first was Sam in Phase 1 who, after interviewing him in his home, alongside his wife, I 
was left wondering had I been unethical in recruiting him to the study. During the interview 
I became concerned that it had not been communicated to him clearly enough as he still 
seemed to be talking about getting to the liver surgery or whether it had been clearly 
communicated but he had been denying it. Such thought around genuine denial vs a 
misleading denial had been something that earlier in my career I had often contemplated 
when people pass on information about a patient and their understanding of how grave their 
health situation was. My experience and to that end, these data would suggest that very few 
people have a true denial. Often what looks like a denial is oddly enough people expressing 
a sense of hope. I was relieved to see that this is something which Frank (2014) had also 
struggled with. In his paper, ‘Finding ways to hope, seeing beauty’, he uses a personal 
example of his father seemingly not to grasp the situation that his mother was dying and he 
talked about a future event as a goal that his wife would not make. Frank had thought that 
both himself, and the hospice had communicated clearly that his wife was dying, only for 
Frank to realise that what his father was doing was using the agent of hope while knowing 
the reality of what would happen. He recounts that his father’s reluctance to name the 
situation was not denial but ‘it was an affirmation of life as it remained’ (Frank 2014, p.143). 
 In some ways, this use of hope was a transition between the hopeful state we have when 
we do not have enough information and acceptance of a new situation. Careful analysis and 
reflection on Sam’s interview, made me realise that he did know that liver resection was not 
possible but that he was really saying, ‘if only it were possible’. This was also experienced in 
Timothy’s interview in Phase 2 when he drew on hope to express that if the chemotherapy 
(palliative) worked he might still get to liver resection the but by this time, I was comfortable 
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with the signs that he knew that he would not make it to liver surgery. The challenge for us 
as health professionals is not to label denial too readily but to consider that the verbalisation 
of what cannot be, is often bridging the gap between what is no longer possible and 
considering what that will mean for their immediate future. Careful assessment of everything 
else patients are expressing in order to consider the whole of the story and not just the part 
is necessary. We need to avoid potential conflict over patient management if we arrive at 
different perspectives at different times, just as Frank also had to resist conflict with his 
father. 
9.9.3 Hope is more than that embedded in treatment 
Having a treatment plan when liver metastases were diagnosed was identified as critical to 
participants. It gave participants hope as discussed in Chapter 6 and several participants 
noted that this is how they were helped to get control back in a situation that seemed beyond 
their control. In this way a plan fuels hope and it could be said that hope equalled a plan. 
However, as seen by those participants who did not proceed to liver surgery, hope is more 
than treatment alone. This is critical for us as health professionals, as we need to be reminded 
that hope is not only evident in survivorship. There are different ways to hope. When the 
possibility of liver resection is removed, life suddenly becomes very limited. Several patients 
spoke about the devastation which that news brought. Transitioning into this phase of 
understanding that life may be shorter than thought is important. Some patients spoke of 
the clarity that this time brought to them and that an admiration for the aesthetics and 
beauty in life is sharpened, very much as Kate Gross described in her autobiographical 
account of living with metastatic disease (Gross 2015). There is a median survival of 5-20 
months (Valderrama-Treviño et al 2017) for patients with liver only metastases who are have 
systemic anti-cancer therapy, with figures towards the end of this median being more 
common. This means that a rapid decline is unlikely but helping to prepare patients for the 
end of life also becomes part of good practice from within the same cancer team. As 
mentioned before, the impetus for including patients who did not receive liver resection, was 
to include the reality of the caseload. This means that those patients who do not proceed to 
liver resection require  care that is responsive to their needs alongside those that patients 
who do proceed to liver resection.  
Our desire in the nursing team is that the message of living with cancer is emphasised yet at 
the same time our experience of working alongside patients highlights some of the desires 
268 
 
that patients have in preparing for what they know will happen. To hold this in balance is 
what appears to be me as the ‘now but not yet’ approach that life is limited. This takes into 
account an acceptance of the situation in the now. This may involve a number of personal 
planning approaches for the inevitability, but life is for living until this point.  
One of key aids to this is the priorities approach as helpfully set out by Atul Gwande (2014). 
Priorities, I believe, are closely related to accessing hope. After interviewing over 200 people 
with terminal or chronic illness and including frontline staff involved in their care, Atul 
Gwande (2014) concluded that he learnt important lessons about people’s sense of priorities.  
Gwande (2014) notes that people have priorities that they want to serve and that the best 
way to find out priorities is to ask them. 
 “The most reliable way to learn what people’s priorities are (and 
there are highly technical studies on this), is to ask. And we don’t ask.” 
(Gwande 2014, live broadcast, Reith Lecture series, Edinburgh) 
He goes on to say that asking has a special power. If we do not ask, we take away the 
opportunity for people to voice priorities and we take away the opportunity to give shape to 
their lives, to pass on wisdom, to allow for meaning. It opens people up and gives them the 
opportunity to face their anxieties by putting them into their own words. This is not done by 
listing medical facts. This is obviously done on the understanding that the facts and figures 
about their condition have been discussed but it is not the whole picture to care for them 
and leave them at this stage.  
Gwande (2014) refers to four guiding questions that seek to elicit a sense of an individual’s 
priorities.  
(1) What is your understanding of where you are with your illness at this time? 
(2) What are your fears and worries for the future? 
(3) What are your goals if time is short? 
(4) What outcomes would be unacceptable to you? 
Again, it takes skill and sensitivity to ask these questions. This is not just some tick box 
exercise. It takes time to listen and time to ask but if addressed especially when treatment 
options come to an end, can give permission for individuals to prepare for the end of life. 
Perhaps it is no surprise that Gwande’s book ‘Being Mortal’ (2014) and the Realistic Medicine 
international movement were occurring at the same time (Scottish Government 2016).  Both 
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have been a reminder of the need to temper expectations in the midst of treatment advances 
where not everything is possible.  
9.9.4 Relationship: a mechanism for facilitating hope 
To conclude this section, this study has demonstrated the centrality of the health 
professional relationship in facilitating hope. Although, indeed valued across health care 
professional teams in surgery and hepatobiliary care, the patient- professional relationship 
within the oncology setting was intensely instrumental in having a guiding role through the 
CRLM, and in the facilitation of hope.  The nurse specialist, working across all three teams, 
was identified by patients as having a role that was indispensable to them by way of access, 
knowledge and a holistic sense of support, understanding their particular context of life.  The 
combined support intervention was seen to enhance the nurse-patient relationship that 
went far beyond the face to face encounters at clinic consultations or treatment areas. As 
has been argued, it is the consistency of this relationship over time, that served to maintain 
an individual’s sense of hope which, in itself,  remained evident, regardless of the eventual 
outcome of feasibility of CRLM. An unexpected finding from the study was the therapeutic 
value that participants found through the process of the relationship based interview.  This 
could further be explored by way of patient invitation to meet with the nurse specialist at a 
specified interval (for example, 6-12 months) post liver resection as a time to pause, reflect 
back on treatment but maintain the focus on the future. In addition, there may be value in 
nurse specialists facilitating follow-up for patients post liver resection, in  much the same way 
as has been modelled for primary follow-up patients (Knowles et al 2007). This would meet 
the requirements for detection of metastatic disease, the management of treatment side 
effects and ongoing emotional adjustment to the impact of treatment.  
9.10 Limitations of the study 
One of the limitations of the study was the length of time taken to gather the data for Phase 
2. In Phase 1, invitation to the study was based on those who had already undergone or been 
considered for liver surgery. In Phase 2, invitations could only be made prospectively and 
because of the complexity and involvement of multimodal treatment, this could mean an 
elongated pathway for patients, especially for those diagnosed with a synchronous 
metastases but not able to have synchronous surgery or for those having down staging 
treatment for a rectal cancer prior to consideration of liver metastases. While, patients were 
recruited in a reasonable and predictable timeframe of 6 months for Phase 2 having had liver 
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resection, it took a further 9 months to complete recruitment for those patients who were 
eventually considered ineligible. They could not be approached until it had been clear that 
the decision had been discussed by the medical team that they could not proceed with liver 
resection. To have done so any earlier, would have not only been unethical but would have 
been detrimental to an individual’s understanding of working through the process when their 
one sole aim was to proceed to liver surgery.  In one sense, the difficulty of not having a larger 
number to recruit from in those individuals not proceeding to liver resection could be 
interpreted as better clinical decision making.  As much as the clinical team want to keep 
options open for individuals with disease that appears to be resectable, there is also the need 
for adequate patient selection with clear intentions of treatment so as not to unduly give 
false hope about a situation. Equally the smaller pool of such individuals may also represent 
the nature of disease in these patients at this time as at the time of writing, there were a 
number of patients in quick succession who were deemed not able to proceed with liver 
resection. Either way, this displays some of the realistic struggles in negotiating the logistics 
that present during research, many of which are unpredictable and making decisions in 
response to such challenges when the study is often bound by time and finances.  
A further limitation may be seen in using a different approach for participants and health 
professionals. Considering the methodological emphasis was on phenomenology throughout 
the study, in combination of delivering a service change, one might ask why were the health 
professionals in Phase 1 and Phase 2 not interviewed in a similar way to the participants 
rather than collectively in a focus group? This has been referred to in Chapter 5 but the 
reasons being were that the health professionals did not have the same horizon of first-hand 
experience of the CRLM pathway as of the participants. For this reason it was justifiable to 
take a different approach to gain the insight from the health professionals viewpoint. There 
was no requirement to hear solely the individual voice of the health professional in the same 
way as the patients’ voice.  The element of service improvement also meant that a different 
approach was permissible for the health professionals as they were the ones delivering the 
service while the patients were on the receiving end of the service. 
A known challenge with the acquisition of qualitative data is the time-consuming element of 
dealing with a large amount of data and subsequently what might be elicited. Issues of 
reliability were overcome by reading the transcripts with audio recordings and with field 
notes present. The use of MaxQDA also helped to organise the data and make the stages of 
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analysis potentially retraceable for another researcher to view. In addition, a selection of 
interviews from both Phases were read and checked by two independent researchers to 
affirm themes and check for other missing sub-themes or themes.  
Finally, an unexpected consequence of the support model was having no uptake for the 
buddy interaction. This reveals some of the gritty reality of conducting research in general 
and came as a surprise set against  the expectations from Phase 1. Research can often show 
us that we can expect something to happen but we cannot guarantee an outcome. This 
unintended direction is hard to explain but if seen through the eyes of Frank (1995) suggests 
that one almost has to be distant enough from such a situation before you want to go back 
and connect with others in a similar situation. He writes about how someone who has 
experienced deep suffering becomes, 
‘the compassionate being who vows to return to earth to share her 
enlightenment with others.” (Frank 1995 p.119) 
This would correspond with those in Phase 1 who expressed a huge sense of gratefulness for 
the treatment they had but wanted to give something back to the service and willingly 
offered to meet others as an action driven by gratitude. This actuality, as Frank (2013) has 
expressed, falls into the chaos period of illness as discussed in section 9.4 and it is likely that 
being present in the turmoil of uncertainty prevents engagement with others in a similar 
situation. There is also the concern that one cannot force an unnatural connections.  I expect 
that the reality of successful peer individual or group support is that a connective chemistry 
needs to exist and not just the commonality of disease. Commonality is not enough. 
Certainly, in the buddy evening, I observed a good connection. This could explain how the 
two participants in Phase 2 attended had a good experience and how the one participant 
who had contact with a previous surgical peer did not. This lack of chemistry was enough to 
put him off meeting anyone again in a similar situation. One might expect that the 
uncertainty experienced in the chaos phase accentuates patient vulnerability. Choosing not 
to meet peers is therefore one way of reducing vulnerability and maintaining control in a 
health situation where overall there is limited control.  
9.11 Recommendations for future research 
Where treatments and subsequent pathways are in evolution, there will always be scope for 
research. The CRLM pathway is clearly one pathway where transition and unpredictability 
are evident. In many ways this means that ideas for research into or related to this pathway 
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have been activated by this study rather than brought to a close by the work contained within 
this thesis. In addition, the model of support developed in the interim period, with systematic 
telephone review, information series and patient buddy may have value in other areas, such 
as the colorectal lung metastases pathway. Recommendations for future research proposals, 
can be seen to be as follows: 
• To explore hope directly in this pathway by using Herth’s Hope Index (Herth 1992) in use 
of mixed methods research, combining qualitative research to specifically explore what gives 
hope in pathways of uncertainty. 
• To conduct interviews with family members to look at the wider and often hidden aspects 
of family experience. This is particularly relevant when considering the context of the family 
in the Family Illness Model approach to care.  
• To conduct a similar study in a different geographical area.  
• To conduct a qualitative study exploring the emotional labour (as defined by Hochschild in 
1983 (2012) and further developed by Smith, (2010, 2012)) of nurse specialists, plus or minus 
additional members of the multidisciplinary team involved in the complex management of 
patients being considered for CRLM.  
• To conduct a qualitative study exploring the language of uncertainty and its effect on hope 
as a framework for understanding the experience of cancer in complex surgery for metastatic 
cancer. 
 
9.12 Policy/ practical recommendations  
A further number of policy related recommendations can be drawn from this study, despite 
current complexities in operational infrastructures. 
• Given the need for liver imaging to be reviewed by liver surgeons, there is a need for novel 
ways to connect liver teams from specialist centres based in different geographical areas.  
• In line with the above point, and the evidential benefit of CRLM, there may be a value in 
instituting Quality Performance Indicators (QPIs) for different settings and centres. This may 
help to facilitate appropriate referral to the hepatobiliary team in particular. 
• Given the anxiety burden, by such patients waiting for CRLM, it may be worth considering 
time guidelines to liver resection/metastatic surgery with potential curative intent, reflective 
of treatment guidelines for colorectal primary surgery. 
• Given the complexity of such pathways, there is a growing need to attend specifically to 
the needs of patients having surgical resection for colorectal metastases. This however, will 
mean additional input of nursing resources to support this work and may require the 
separation of the primary and secondary colorectal case load within the future.  
• Given the rapidly evolving practice of surgical resectability of metastatic disease, (liver and 
other sites), there is a need to maintain educational awareness among health professionals 
caring for patients on complex pathways for surgical resection. This may also include 
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education on the way metastatic liver disease is framed, the use of supportive language in 
communicating complexity with patients and an understanding of the emotional burden 
carried by individuals being considered for surgical resection of metastases. Nurse specialists 
would be well placed for educational invovlement in this area. 
 
9.13 Chapter summary 
This study has explored the experiences of patients being considered for resection of liver 
metastases from a colorectal primary. Bringing this thesis to a close, presents an opportunity 
to look back at the overall journey with three clear destination points along the way; the 
guiding motivation for the study,  how the chosen methodology has given shape to the 
research and how patient experience has been used to drive forward a service improvement 
for future patients on the CRLM pathway. Gadamerian philosophy has been of value in giving 
understanding to the different levels of horizon throughout the study as evidenced by 
patients, health professionals and myself as researcher. The findings have revealed three 
overarching horizons from which to view the CRLM pathway; patient expectation, 
uncertainty and personal understanding.  The resultant findings have revealed that 
collectively, the stories presented are less about the pathway itself, but essentially are stories 
of hope in the context of potentially resectable metastatic disease. This has implications on 
how as health professionals we give shape to hope throughout that pathway. The study has 
also been an affirming piece of work for the role of the specialist nurse who has a key role in 
working alongside patients and utilising their inside knowledge of the pathway in order to 
manage pathway uncertainty and patients’ expectations. To conclude, with reference to the 
context of potentially resectable colorectal liver metastases, hope can be facilitated within a 
relationship with health professionals in that pathway, hope has a plan, a language and yet 
hope is more than treatment alone. Hope never rests. As Ruth reflected,  
“I was taken one step at a time. Looking back, I never lost hope, I’ve still 
got hope.  I can’t not hope because it’s the nature of human beings to 
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